var title_f23_19_23856="Oblique fractures of the lateral and posterior malleoli";
var content_f23_19_23856=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F64402&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F64402&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Oblique fractures of the lateral and posterior malleoli",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 405px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGVAhwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5YpR1pKUdaALlt1Fdh4PGbscVyFpyRXZeDh/plaR3MZnqdqP3C8dqtWa5ce9V7b/VLg9qt2a4bOaswOiZf9BP0rzu+AN9L/vV6PJxY59q83uub2X/AHjUvcaHxDoMVajTBqvECMVeiXJUetMDuPD0Wyxj9xWu4wKqaSm20jH+yKtyCmxEJGetQSDI461YPWoSPzpAQY61Gx/Kpm74qIr6/lQAwxhhk9M1Ki7j6KKYTjnrinx/e+tAD0Xa/HQ1e/gqihPmAds5q9H91hQB4l8b0xcWpx6141djrXt/xwjwLVsfxGvErvqayZvS2KVFFFI2CiiigAooooAKKKKACiiigAooooAKu2V1HbxHcm5ic1SpxGFU+tNOwpJPRmsuqw8ZgOPwqQx2l+h8kBZB2xg1h1LbSNFOjL1BqlN9TN00tYhcQtBKUfqKirY1uMGNJB1zg1j0pKzLhLmVwoooqSgooooAKKKKAFBwQa9q8DyCTToueq14pXrnw4l36dF7VUdzKrsd+pIj5qvIgbkdM1YJ+QkHnpUUhyuF6mtTnKbrhjk03JL89KfKME5HNRYIGRigC1GVIAIGatW2M5xzWdE5HbmrkEmMc0COtsCGixXO+NIeIpPqK3NLfPXpVPxfHusN39000C3POJRzUcgwD9KsSr1qKUfKPWkUc5rCgoa4q5UCRh713WrL8pzXEXoxO3pUSNIFFxUZqWSoj1rM3QlFFFAwooooAKKKKAClHWkpR1oAuWvUV2ng0Zus1xdt1Fdt4M/19XAxmeo2/EPHpV+x+4PWqMJPkDH0rQ08fKPrWhznRSDFh/wGvNrj/j7lx/eNelyj/QG/3a81kAN1If8AaNS9xonhXoTWhaJumjX1IqlAPl5rT0ld99EO2aaA7+xXbCo9qlcc0luMRgU5jmmIhI5qKQYqY9ahk60gIcZzjvTG4zmpTmoyAetAETfM3sKWJv3ufSlAO7bjimxoQ/GaAJ4uXx2NXYwRkVTBwAenNXITktmgDyb44p/odu3o9eFXw5Jr6C+NkedGRsdHFeA3o7VnI3pmZRSnrSVJuFFFFABRRRQAUUUUAFFFFABRRRQAVaNtK9tFJGjMpznA96q10enX0NjpkJlBJbOABVRSe5nUk4pWMH7PN/zyk/75NX9M0yWSQSTIUjXnnvW5b6/ZySLGVZd3GSKfr100FlvhAyeM+laKEd7mMqs37trXMPXpgSkS9uTWRTndncsxyx6mm1lJ3dzohHlVgooopFBRRRQAUUUUAFemfDGXNrt/utivM6774YS4klT0amtzOr8J64uAtRTHg7Rg08AiPcMk1G/Ynj0rU5SrKwY+h70xcDOR0omOGJHIz3pIm+U0wJkKkAipcYXI4qBDuFTK3GD0oEdHpDYVCTmrfiGLzdNl47ZrN0uTAA7DFbt2vm2bDrlaaA8mlHJz1qu/QZq7dKFuJAf4SRVWQZ/CkyjE1cDYa4bUlxMa7zVBlDXD6suJamRpT3MpulRGpX71EetZHQhKKKKBhRRRQAUUUUAFFFFAF227V2/grm4riLXtXc+CQPP/ABq4mNQ9OgOYQCOlaenjnHas62wFOemK07LiTHarOc6KX/jybH92vNmH+kyf7xr0sjNgf92vN3H+kyem40nuCJoxjFbfh2MtfqfSseMZUV0nhaMmdmpoZ2EXyoKR+BUij5Rmo35FIRGeoqFl559amIOajl4zQBCRjNMI9KkkBwKYVJ6dMUCIgCWPNCDDAEnHWnhcZPGabEvT1JzQMkUHKjqCatwEhjkVUYNnC9hmrUJy2PSgDgfjNFv8OMR2YGvne8HWvpj4sxb/AAvc8dBmvmm9HWokbUjJbqaSnP8AeptSdAUUUUAFFFFABRRRQAUUUUAFFFFABV27H+gWv0NUq0LwY061prqRLdGfXSpJ9u0fax+bbg/UVzVa+gy4MsR6HkVUHrYmsrq/YyTweetJVnUI/Ku5FA4JyKrVLVjRO6uFFFFIYUUUUAFFFFABXY/DaTbqUi+uK46um8APs1rGeopoip8LPb0f5RngelMZgxHHSiPlAT0GOaa5G0HHQ1qchXlXLEetMXj5ehqRyW3Doc04bWUA8e+KYhoXnOO/apEBB60wKyn+WKehJkUN1NAGxprA9eMcV00Xz2vtjFcrp568c5rqbA7rYChCPMtZjEWq3CH+9ms5h7dRW/4vhEerscfeGaw36jjqMUMsyNTX92a4bWR+9rv9SX92c1wmtrh6llw3MJ6iPWppKhNZHShKKKKBhRRRQAUUUUAFFFKKALlp2ruvBAzPXC22ciu+8Cj99x61cDGoemW+MEVqWYxIo61nWuMetatmMuPpVnOdABmyI9q83mUi7lH+0a9LQZtDj0rzm6QrezH/AGjSe4IliBwK6/wvERFux1NcpAOgru9Ch8q1T6U0M1jkAAVEfWpj0qIjNIQ0jINROM1IelMccDmgRAeTTe2B1qYjvUfqe1AyBjgkd6bET5hz0Ap2MkZpVXb0HpQBKvCA554qSM4dsetR5BwD0BogOZDzjnFAGP8AEWHz/C94B12E18vXw619Z+KIfP0G7T1iYfpXyjfrtZh6GokaU9zCk+8aZUs4w9RVJ1IKKKKACiiigAooooAKKKKACiiigArQvHU2FuoIyKz6mWAlA25QSMgE8mmiZJaNkNT2cvk3CP2zg/SoxG3kmT+HOKRELthevWkN2aLurOkkiPGwPGDiqFFFNu7uEVyqwUUUUhhRRRQAUUUUAFb/AIJbbrsXuKwK2PCb7Ndtj70Ez+FnvUJxAGpmOG5706L5rZfcUHHltjrjNbI4yBshse+TTAdynGcZ61JITgDoSKZGu1VUcj1oESxnPDd+BT1Q+YD2oC9PrSspVlC80wL1nwfY11GkHMNctbkjGeCO1dJohzG1Amcz46hxLHJ+Ga5N+QPpXfeOIN9gzjqpBrg1GQfUUMpFDUVzH+FcJrq/MfrXf3ozETXDa8OtS9i4bnMyDBqButWJagasjqQ2iiigYUUUUAFFFFABSjrSUo60AXLbjFegeBB+8rz+36ivRPAQ7mriY1D0q0XKnmtixHzDBFZFp04ra01d7HjtVnOb8A/0cg+ledX2TqUw7BjXpMYxDjvivO9SXbqk3+9Se4IlsULzoo7mvQ7CPbEorivD8W+8Ax0rvbdCEApjHMMVGamYYqPGRSEMYc1ERUzCo2z1NAEQHXNMYEKc1Lzj60xwce2aQFZR83T2py88jPWnEYI7EikQEEjuBQAEElAM885pIwQ//AhSkbVUnrmmQkhxnnk0AW71BLp0q9QVIr5N12Lyry5jxgrIw/WvriJc2pU9a+XPiFbG18SahGRj94SPxpSLhucNP96oqnuBzUFQdSCiiigYUUUUAFFFFABRRRQAUUUUAFWIAJmSN1OOgYdqr04MyghWIB9KBNXLccZNhcIvzMjg8VFZAi6UEEE5FRJI8edjFc9cUhdi+4sd3rTuKz1FkRkYhgRzTKczu/3mJ+pptIaCiiigYUUUUAFFFFABWl4cONatT/t1m1f0M41a1/3xQKWzPoCElbRMdxTkGHy3Q0yNS1jHg46VKrggDjPatTiKzEF+c4zikj7c9KdJxLyOfSo04Kg+uTimBaUswUgU9VIYEnkdKdHgkD0HNSsGGMYYCgQ+AfxZGTXQ6Dna4PWudiXEYI4xXQ6C2fM56YpiZJ4kh87TZ1/2TXmKDGceleu3sYktnU9wRXlUsXl3Eqd1JFDKRn3Sny2HvXDeIlxu4rv7lflcGuF8RqcPUsuO5yMlV2q1LVZ+tZHShlFFFBQUUUUAFFFFABSr1pKUdRQBethyK9G8Ar8v4151bdq9L8CLiIfWriYVD0KyzkccVv6UvPvWDagjB6Cuj0oZUcZ96swNlB+7/CuC11duqS+9d+vCgVw/iRf+JsQPSpYI1PCsOWL4rs4xgCuZ8LJ/ooPvXU9qbKRGRk00in4NNYdaQmMK5yajZetWAOtRuvU96AK7DpTGBx1qdlxx3pjDJoEQbQCM80zHzMQalK4YHFJt7Y+tAEUn8OTgUwHGSOe1PmUs5AqJuWVQMDNAGjaNuUj1r58+NVl9n8TNJjiVAa9+s2Pmda8p+Pen5S1ugOBlSaTKjueA3I+aoKtXa8/jVWoOtBRRRQMKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACrujcapa/wDXQVSq5o//ACFLb/fFAnsfQUbYsIx7ClgKsASMY6Uij/Q4gf7ooHIAxzzWqOIHK7z7Hmmqu1WwM96WVSJBz7mpYEy2T17e1AD4+VHGCRVjbhsDnIpUQdOOnFSpGN7H06ZpiI4xwB2rc0AYd+vPWsmJeTkE88YrY0YESkcdKYM2gMqwrzTXYPs+szDsxzXpcfDnNcb41tNt5HKBgMuDQETkZhlWzXE+IgNzg967qdTtGBxXDeKeJXxUs0jucZKpwaqSCteSP90SPSsqQc1mzoiyGilNJSLCiiigAooooAKUdaSlHWgC/ajp6V6h4FX/AEZTXl9rzXq3gdMWMfuKuJhUO9sxmMetdJpAwinNczbHoK6jSxiNSatGJqkdK4rxIB/aufUV3BH7rpXC+JedVPrgVLEdR4ZTFpF09a6BuayPDke20TPYVrnoabLQ1ugpMdSad1wMUuMdu9IBjA8kUzHtU2CGpNuT7UA0QNyTUZHUgcAVOV4qNlyrYoJKzjJP0poXsTz3qRs9P1pQp25I5NAiu6/NnpVR22sucn1rQZd0noBiqcqlgcEYOaQBbkr8w6DtXPfFuy+3+ELh1GWiw9dASVUcD3p2oW63+jXVuwzvQr+lAz4/vE5NZx61v61ata3k8LjDRuV/WsKUYY1B1xd0MooooKCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAq/oQ3avaD/poKoVp+G13a3aA9N4oFLZnvch2xQj0WliXMinr6Ut2pEcWDzgcVLZ8ElvwrU4hJEXjd96nQ5XGRknvTmyQcDo3BNSx/eT26imBOiAKTjOfSplHIyMGmomQcdyKnUKR3oAiiADc9K1NGyJzz26VREa78Ej2rU0hQJH/AK0xM0XJVxisjxnbmTTllHVD/OtiX73HpUd/B9q0uaIj5ipoBHmFxGRGMmuA8Vj96/1r0i8QrCQeCp5rzvxKm6bHvSZcTnWj/c/hWDMME11UkfyEe1cxdLiVh71m0bwZVNJTnptSahRRRQAUUUUAFKOtJSjrQBftB0Neu+EBssIsdSK8jsuWFexeGVIsoR7VcdjCodhYoXdeDXV2i7SgHpXNaSmfmJ6V0tic4welWYGsRiDJrhNSXz9cA9SK7x8G3Y1xcUfma3I56LwKnqNbnX6Quy2HrWhj8Kp6dygWrzLhiKbKWwmAM4607bx705UzinbO9IojbmmEEDjrU7LknAppAJPHNAEBHBzTMDBxU8i+xwKjIPOBzQS0VsFj6f0puDyeTT2z2GQKQYAxyM0EkLjgH9apSDAYBulXnGEPuaqSKNzY9OaQinMx25PHQ1ds5eqscnOKoXJG0kDgDFEE+2UAHOetAzwr4v6T/Z/imd1XEc48xfr3rzW4XBNfRHxq0r7bo0F9EMvbnDfQ18/Xa8mpZvSehQopTwaSkbBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVt+DozJ4hswBn56xK6r4cReZ4jhY9EBNBM/hZ7RfMFZAecAVJCpO3I46VVnfe5HvnNXYFwODk4zmtUcY5oz8wPTINTIM7eBk05QWQZ9OakhODnb3oAnjTBI569amZcwgE9fSnRjB6dT3qxheV29MUxFWOICQ+3AzWppagM2eaoRgeYMcAg5rW01RzySeDTBlpxkcGnwnnae4xSsAV/Gmfdbd70COF8UWnkT3CgYB+YfjXl2vLmcDvmvbPHVvvsFnUdOCfavG9ajPnhqGaIxFTKnIrldQTbcyD3ruPJG5selcfrK7byQVm9jSD1MmSo6keo6g3QUUUUDCiiigApR1pKVetAGnpq7pUHuK9n0GMiCJV9BXjuiIXvYVHUsK9usAttEij7+K0jsc9Q6W0You0DgDk1v6ZnZ83WuZtGJXk8966bSxlM560zI2Tzbtj0rnoYAl07HqT+tdIgzEfpWM4AuGGMnNLqBr6WMv7VoH5pDnNU9KBDDjtV/Hz9KGXHYUD06VJgdMUBcDHapAuOaRaREwGeM0zb17VORmmEHGKQrERGOn51EwHrzVhhjn9KYB1PX60xMpMvB5qMjgAHpVmTtxxUODn2pkNFeYAA47VUcbmYjjPer8g4JqnIOuM9KQihcDcGGOhArOeQLL0ArRuwRGcdc9TWPMT5mCPegEWdQhj1HTp7ObBWZNv0NfMniCwew1K4tZAQ8Tla+kI5irnB6fMM15b8X9I/fxarAvyyjbJgdDSZcHZnkcgw1Mqe4HNQVJ0oKKKKBhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXc/C+IC/nnb+FcCuGr0T4eJ5dhK+OXbFNGdT4T0FDvKgnGT1rWt+Vz7CsezG+QqenbNbVsMqAOK0RzMuIvTBzzyakRACGByCadEmVXAwOvNOC8EHOB0oEW4+dpJ/OpyOmeARTIR7dqsqpKgn06GmIq+XgoF5GOPetPTQMk8+lUoozvUccVq2MYGfrTETYwTxUUq8fWrBXk/WonxmgCre2632nTW75+ZSBXi2u2hWR0YYZDg17R5u2bIPGcEVwvj+wEFw1wi/LLz+NBUX0PP7SLzN/FcR4jTbfsK9E0+PEzjBwRXC+LYtmpPUPY1hucxIKiqzKKrnrWZ0ISiiigYUUUUAFPj+9TKkiHNAHTeDYPN1OIkcKc16pFJunBHPYV594Jh2uZPau+0uMs/J+brWiOabuzq9OQsi/wCFdPpoAAFc9p4BUAZzXS6YOB7UzM24l/de2Kxp1/0okHBrdjUCPB9KybhA11S6jaNXS0Oxj7VdUfnUNgNsHH61YHJ6UmaRWg/Bx1pccUqjilA96RQ3uaCD2p1ITzQBDKD9Paou1TvyMimbeMkUyWitIOSccCq5OWJq1JzknNVsZJ4oJZFKMjA61UlGKuuCOfaqMoJHNBDM+6wFJBPHGKxZzlyQeK27pcI2ax5QNpPrxQCM24l2SAk454rL1hU1GyuLK4GQ4wD6HHFW7w7W+Y8NWfNPhzjPJxSGeEarbPa3UsEgw6MVNZtehfEnTwJ0v4xgSfK+PWvP2GDUnTB3Q2iiigsKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK9L8FLs06IcetebKMmvTfDH7uyhHTgCmjKrsdvp4BI3YzW3boN/fHasOxHKEZ4/WujtV+Qegq0c7LifKFHUYqYgZHHPemogOQB0qdVyM+3emhEkKnK8dKubAcA9KhVAVyKuICQOMd6okgVdpzj8K1LFcE8VTWMZ571p2a/uyaBrUjZSGPNV5fuk9cVafqaqznAagDMkPPPrVXXrNdT0mSDrIoyn1q3PjP61SNwY5cgd6APNrGBlm2v1BORXB+OotmpZx1zXs2o2ka60k0WPLl6gdjXm3xV04211DMo+RsjNJrQ0g9TzWUVVcYNX5l4qlIKyZ0ojooopFBRRRQAVZtELOBVcda1tHh3b37CmiZOyOy8NR+XbA9CTiu10zKupHpXJ6Gqi1jx611mnnDrVnNI63TcqgOPrXTadkAYNc5pi5ADGumsxhQB9KZLNyA5z7is6YETfStC16A1WuE/wBIwPWl1G9jUsOYcH0qyFHFQWS4b8KugAGkzaKuNVOKcEx1FSqfalqbmiiQlKaUz3qwaaRRcOVEBQU0xgggGp9uaaVouS4ldoBt5NQmBFBJJNW2XvUTqcAe9MlopSxxg4w1Z0yJjG7Jz6Vrzr3LDFZlwoRMgHOaZnJGNqHGTkZFYs69uTx29a17s5dl429ayL37zjGMLnj1oIRkXUG5TkFmHNYtxuLyIw75GK3bg7pAQ21uuT3rHvIzFL5jDh+eP50DMHxDarfafPbEA703IcfxCvHLiMxyMrDDKcEV7nPHg5TGQc4rzHx9pgstYd0H7qf514/OpZrTetjk6KU9aSkbhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAD4/vCvT9CQCCL6A15lCPmH1r1DQhmKLuGUU0Y1Ts9IGGGeRXSQLgAAGue0qLDgHtXU28eFBPGBnmrRgWoVxgZyDVhIzjkZ9qLeIlR/dNaEcXyAnrmmiSNI9y4HQGrSxnA68VLDBn7oJqylq+eRxTBJlPbgCtG1TEA96YtoxxnHJq95GEABpNlxizPcZJx2qjcdcGtlrcjOCKoS2bliQR+dO4nFmPIMnBHPas6VBubHTNUL/xFc6ZrF1aapp7NDG/yT2p3nYeVLIeehxlc8g8Vbs7+z1KJpNOuYpwv3lU4ZD6Mp5U+xArSVKcEpSWj2Mo1IybUXdrczLpdl5z0rC8d2CX2jkNg7e+OlbmsIwuYz61T1KFpbCeIkZK5FQaLc8AvoHgkeNxgqcVmSiux8S2m5mf+JetclOtZSVjpg7lSilPWkqTUKKKKAHKOa63w/br9jYt1auUhGXArvdIt9tsq8AbeapGdR6GrowG0Be1dVpsZDZb8q5TTyULbUJYAkDpmvUvhbonh3xFJEvibxG2nXbNhdLUeQX9hO3D59I8MMdaq9jJRctgsLuKOaKD55LqTmO3hjaWZ/8AdRQWP4Cuq0icXVnBOiOiSqHAfAOD616XrWgaP4X8DazHoscGixvbsst5FZyXUgB4LsqHzJCATznI69q8khuIkA8vxZkDoP8AhB9T/wDjlLmHKnY6+zUEdeaS8XbMDjrXLvql5C1r9g1g6lK91BE1v/wiOoWmY3lVZG86SQom1CzZIx8tddf/AHh7Ci9xSjZFq0A2gjvVsCs/THyuCa1QKTNYaoQCnUoFLipNBtIRT8UmKAG4ppGakxSEUARlRmmsmecVLijbQKxTkg3A8c1mX0DovTPoBW/tpHiVhzTuRKnc4Odfvl14IrOuYG3Pjkbe9d5eaZHLkhRz1rGu9NABwvIGKowcHE4CeBjHzgkcismT5m2HJXPA9K7i604gc43Aelc/NYFZGJUZ6jFBJzU1tsCsOpFc943006joLyhcz2x3Ajuveu8vLIPHgAj3qi0QCtBIq7WUqc96RSdj5zkGG5plbXirTzpur3EBGFDZX6Vi1J1J3VwooooGFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBPD1Fen+F3EtjA3oADXmMPUV3/AMPrlXL2khAJ5WmjGotD1HS1wwHcdT610VpzyRnsRWfpNkF2ORuAAPX8xXT2trGOVTIYAg1aOdktlbF0XAODzWta2iIuXG4jtTLUbFb0HpVmLL8knBHSmOKJgyBMqBShyQcdRSpHx0NSLH6DtSNUmRRsxbBqck49qckWB9acU4ouUkVZiQjEdqpsSWPXGKvzJlT71WMeCxpoiSPM/H11b/2yhJSP7PBiaRmwOTlQSemBk/8AA65mOxuNXdZdNsJXcDCXrMbdVH+zIPmI/wB0EV6b/wAIlpi6pPqEtubq7kkMgkuTv2H/AGAeFwOAQM4HWr8kYwc9cV60czlTw6w9OKt1vr+G35njyyyM8Q8ROTv0tp+O/wCRwP2G/s7KJdRvzfXIfO/ygmB6cdcep6066OY1Yk46GtnU4mecYHfkCsu7UrwR+GK8s9M8r8U24ivJ0OcZyPoa89vE2sw9K9X8Yw5ZZgMZGCPpXl+qLidsVEjamzIbrSU5xzTazOgKKKKALenpvuY19TXf6b8pxjOTiuI0Jd19H7c13Omr84yOauJjU3Ni3jLuGwBXQ6dCssZhmiV424KsMhh7is60j/eonSuqsbFyVJBCDuBVIxZ0WgXWr6fZva6XqMqWUkZjawvAbi2ZSMFQhIZBgnhGUc9DW7oyTpaQLesrXCqBIyHIY+o6Vl6TbkICc47HNbtupHpRawczejNaADiqV5Ov2h1Yjirlufl57CsbVIj9sB7MKkuWxp2mNoZe3YVpRzMB8w4qnYRCKFQOuOa0EwRyKTLgmCzqe+KkEg9aTy0PVRSGFT2paGuo7zF9aDKKYYB2NMMB7GgV2SGdc0nnrmoWgftiozby4xRoK8iw1yB0FRm6znFQNbzbSBgZphtJz0Kjj1p2RLlIla9wuTTV1BCeWx9aoXNndhScbgPQ1yWtXU6MY1LIQeexp2Rm5yR6NDcK/GcimXMauDkVxnhvUpJFCu5JHWuwim3rz1pWLU+ZWZjXltgnjisO+s1OCwArrbpNy+9Zd5CDkYzn2pmUlY466tyE+Q4IrHuYmLtkZK+1ddd2pAOB8xrJjtxLOUPBoJPE/ipYbJEnxg15tXsfxvCwNbwg/Me1eON1qWdNLYSiikbpSNBaKZmjNAD6KZmjNAD6KZmjNAD6KZmn0AFFFFABRRRQAUUUUAFFFFAE0Rrb0i6ezuop4jhkOfrWFEea0rU8igiR9LeBtattZtEYALJj5ga7e1g2Hbj5cce1fNvgLUZbHUozG5AJwR2NfRmgagt5Zo/Vhwa0TOVqzNOGA/hV2JAo4FRo4PSpAcDJOFHei5rFJFhACPepQorJl1WKMYh+Y+tUTq87NkY2kcUcrH7SKOm2rSHGOlc1DcXdxMMO2D6VtRpMNvzH3pONhxqc2yJ2Td1qN4wB0px8wfxfpUbSOPvKD9KBsieMYNZ11A2CcYFWLrUoodwYNuHbFYt5rvHyJuB7VSRlJplWe23yluRisXVYeCT6da0U1BHkYMxCsOrVXvZIXhYFwD2OaoyPN/GEY+wEnqrZzXkeo/NKxr1XxvdRJYzxI25ww6dq8puAWYnuamRtTMuYYNRVPcDmoKyOhBRRRQM1/D6k3JI7Cu/0GPfMufXiuE8OY898+leg+G1xJvPQVcTCpudHYW7tc5KnArs9OXKg4fJwMVy8CHzAqNjdyc11+jEyIpGAoPI96pGJvWcZTAIOB0rXgGB06/pVG14bkEn1rSiUE9D+NDHEuQLwap3sW+7h474q9DxwBTHTdcofTmpNWrosouBVhV4pqLwKlAqWapWAClApaKRQUYoooAQijFLRQA3FJTiKTFADOprlvG9irQJcoo3A7Wx3rq8VS1y3Fxpc6H+7kU0RNXieX6ZO1rfx84VmANehWr5bKsCPrXnF3GUlz0INaun+IJY5kDqB71RzJ2O9OWBqpLFgngkdTU9jeJcRhuMmrTKrDIpGtro5q5hOWPXPTjpVK1sSJjI64C811EkCHrisfxRdQ6ZpFxOWCBUPJpmbjbU+Y/jJqH27xbcohzFBhB9e9ecv96uj8ST/AGvUrmfkh3Jya56UfNUs6KeiI6R+lLSP0pFjKKKKACiiigAooooAKkqOpKACiiigAooooAKKKKACiiigB6HmtC0bBGaoIOatwjGKCWdJo9wY7mNgccivoPwNeeZaAkjJAr5v09vnX0r27wVK7WcWwn7o6VSOaZ6qLpIVyxyeyioHmnum44THTtVDT7djzK2TW/ZWxbGBxVkq70KMWml2HJ+grTttFhXBcEj0rShiWJeOT61LUuTN40l1I47eKPhFA+lShQO1FLUGqSQhAqNo1NSmmmgZmXdksgPyg1zmp6UQCYhj2rsW71VuVVlIYCtEzCcEzy3UIWUMrDa3WucuwyEgsxHQeleoavpYmUlFGexxXnWvxPZyssoG89MelWYHCeIITsbP8Z5rg50IJzXpOqIZo2JHOetcJqEWyeQY71DNIs5+4WqhrSuk4OKzmGDUM6IjaKKKRRteHT/pZHqtejeGv3hKjqa8y0V9l4hB616P4VkG4lThga0iYVNzu/lTYQPmxjpXR6K7CPkkd6x7aFZEVwa3LVAqKBwx4xTMToLJ9wGQT71qRtnGDz6GsiyDLGMY+taluSxAxQxxNOD7tMilEl0VXkLUNzMIIMD/AFj8CnaPEeWPU1Jqnqka6DgU+gUVBuFFFFABRRRQAUUUUAFJS0UAN70SqHjZT0IxSjrS0AeV65b+TdSqR0YisSVSOnau58Y2hW4MwHDjNcXN/EDVnG1Z2NXw5rBjcQSt9Ca7SK83IMGvI7gmNgyHBHeuj0TX18oJcNhh60DTsdc95Iz4yBzXknxo1qWSSHTo5DsA3yAHr6V22r+Ibazt3m3gnHAHc14f4kvJdRv5rmX7znP0FDEtWcZfryTWLMOa6C+XrWFcDk1B0QK9I/SlpH6UGgyiiigAooooAKKKKACpKjqSgAooooAKKKKACiiigAoopaAJEWrMPXmoI8/hVm3BZgKCWbOkQGedUFe6eAYtljHFtA2/nXlfhayyynbkjrXsnhC1KH5eC2MVaOabud3ptvvAHUVvRBY1CqKo2gEUQUdcc1aRqGXBWRZSpBUKt3pGl5IFTY25ixRkVV3n1pQ56miwcyLJNMY8Um6mlqLDuNaqkxGKsv6ZqpODgmqRnJleUjBBHBrlPE2kRajEQflkH3Wrpnycj86pXUbDO0VojnkeNarplxZM6yoSnZh0rgddt9srOO5r6B1mJGQ715xXkXjmxRI2kiUDnnFJocWebXQ4NZUv3q1rvvWTL1rNnTAjoooqSy1ZNsmRvQ16H4SnHnHPX0rzeE4Ndb4fuikiMD6A1cTKoj3HRxvjQknk8CuhSEiYEcADFc14NuPPjQld39K7BCC7YqznZbtV+Ydq1LdggLt2rNhOB1FSTys22GPqetJgnYsw7727yen8hXRWkAhjwKraVaC3hGfvnkmtEVEn0OmnC2rCiiipNAooooAKKKKACiiigAooooASloooAzNatFu7V0P3hyK821G38pmHevVLg4YVynijS9yNPCvB6j0qkYVFrdHndwm7PrWbODG/BOe1bk8O1yDWB4he4t7G4ltUV50UsqMDhsckceopmRl6nJJIMOcgVzV+uTWvc3knkrLdW7xxMAwmj/eRkHvuAyB/vAVn3e1490TK6sMgqcg1dSlOk+WasyadSFRXg7o5a/Xg1z9yv3q6e+TrXOXa4yKyOmBn0j9KXvSP0pGoyiiigAooooAKKKKACpKjqSgAooooAKKKKACiiigApR1pKUDJoAmj9K09Mi3zooGTms6JSSAM13/gfw5NcSrPPGypj5QR1pozm7I6vwpZ+XAhI5PtXrHhe3AhEgxgcCuS0nTTG6oqnd2HpXoOkWv2W1C4OAPzNWjm3NGKQrweoqwsvIOeDVEORngU6OTGfftTsUpWNETbh14FODjHPWqCtnBHQVOrknOcr3pWLUi0DS5IAqKLAHXINTDFItEinIpSab0HrS5zSGJjNRPHuqdVyeKVgFFFwtcotEADms6/kUJhauXtxyQtYl8zMOK0SMJtbIw9XuFZSGxivLPF86OjKCPpXoetRsY3659q8x8SWMjK+wsW680yUecakQHYCsdzk1t6nbSRsQ8bD8KxZFIPQ1kzqgMoooqSx8Zw1a+mzmJwe1Yy9a0LQjIpoiSPTfDHiS5tCggAx716PpGtSS4Mg5PJrx3w4NxXNenaGoKritEc8jure7LoNv3q6DQbTe/nPye1ctpqZIxXf6ZGIrZB7UPRBTjdmggwMU6minVkdYUUUUAFFFFABRRRQAUUUUAFFFFABSHgUtI39KAIJnwORmoZNpQh8FSMEGnyc9aqXjlISe+KZnJnC+JdO+zT+ZHzCx49vauS1Bd272rtvEUzCNIyeW5Irjrxcs3FM5zndGPkC4sWOPszZj/65Nkr+A+Zf+A1z2umymuSlpALeWRRKl1G2BMD3AHyt+PI9OQa2tatpvPjlgKgMrQTZ7xnn8wRgf7xrCvYI7eNlkV2sGbeyx/ft3/56R/1Xvz7g+48yVfDRw0tHa13qvL8OvQ8aOXOjiZYmOqvey09fx6dTDv0255yfWuavhgnNdLeMRNJC0kUxQAiWI5RwRkMPQ47dvyNc/fjrXhzi4ScZbo92nJSSktmY56mmv0p7feNMfpUnQMooooAKKKKACiiigAqSo6koAKKKKACiiigAooooAK0NL02a9lCxoSPWpNGsVuZl8z7vpXpmjwLHEqwxKkY4zjr9KaRnOdtEQeGPD1naBZbhPMYc4xnNer+HY4hGGaDbjpnsK53RbXP31Axjt/Oupt8Kqls+Wv8PqapI53qdHbi1hAcKMtUv2vzRhOFB/OsIyuzZJA9PYVJHL5fzenRc/rVEmsHO4jOalikycNjI6GsxZvuszYB5571chxncMfnQIvq5Urz+VWopRjAx9KoRIWKnBNW1gYLwDz1oZcbl1cYHY1LGSTx1qOFOFDdQO9TPPFEvJAPpUmy8yXHHNCEMcAfjVQXHnNtj6etWgwiUZ60WKTuT8AVl6lc7FYCoNS1MwqSCMisaxurrVbkp5YFuv3pPX2FNRtqyJ1L6IsWkUsrGVidnaluI/l5rXKKkYUcADpWZeHriqTuZONjnNTiBzxk1xur2W8MdpwO9dxfHG719xXMX7hiQQV5pko4G/05W425HutYN5pUfJ8sD8K7u/Q7shhkeoxWHc2yyE7zGT7k0rFJnD3mloOygVnPYKG+6tdXf2kKk42f99Vmm2jP8cf/AH1UtGikcTV2zPIqlVuz+8BUI2lsd14YHAPevTNCOAorznw6oWOP1r0TRSNy1ojmkd5oybpFA9a7y2GI0HoK4Pw5lruNfWu/QY20pbF0kTrTqatOrM6AooooAKKKKACiiigAooooAKKKKACiiigBjKDk+lYt8xMoRjwa3aw9UAW6UnpTRnU2ON18F7uQjoOAK524HLDFddq8GbiRxypOa5y/QDOBTOc5bUl3RkDtWBOuUIrpr1MqawrpcE9s0DRyV9AkW5Y0VBkkhRjk1zGoDrXY6omN1clf8g0jSJhSfepj9Kkl++ajfpSNxlFFFABRRRQAUUUUAFSVHUlABRRRQAUUUUAFFWdPs5b66SGFSSx/KukvvBl5bWfnhSy9yO1BLkloyTwdbiVEcAEDg5r07TYFXaVUbu7nsPYV5r4ISS31BreYEBhuH1r1ayiDoFY5TuB3qkYT3NezdSyrCn+8x6VosQHBByB27VnwqAqLGDt744q0SWYFQAuPWqILEcjc4AZ/SrUKNjDct3JPSobSA/fH16VeVQCxPXPPvQINhMgXhlx0J6VZV8qQAAw9fSqh8xCHABX0709CxYZYBfSmI1bedAoLN1q4+sQ2iKGyc+nNc5I2SOeOoFQygzyRyHICDBFMabWx3C3cUkYeNhkjOKzLp2ebJ6d642+1GS1uA0UhUjtXS6Hf/b4FaRcN0IoWg3Jvc6DTVCxbj0qxKPM4qOEYjAqdQABUm0VZFJ9LhkOZQXHoTVqOGOGMJEgVR0AFSiopG4oDlSK9wcKcVk3b46VeuXznmsm5cBTn+VUjGbuZt7I2CCQQfWuf1MkRkMoz64raupQAQUP1FY9625Tg7TTJRzF62M8ceoNYU75DfLgd/WugvtpdlBAPU1hXkYKktk+4FBSOfu5E5DDPtis9wpOQg/Kr97HtzjeR9Kz3Az95vwNSUjh6vacu6VRVGtTRU3Tj2rNbnRLY77RIwAgruNILCReK4zSRtK122lMDtyOa0OVnoPhGPNxu7Cu8XqK43wgmFVuxrsR97HalI1pbFhKdTRTqzNwooooAKKKKACiiigAooooAKKKKACiiigArM1mPcFIrTqC8j8yLHpTRMldHKXUW4HPOa5bUI9pau3vIDHG3H0rlb23dy3y4+tM5WrM4y7+8Qe1YN/gvn0ro9VtnjlOBj1rnb44LYoGjndVHBGK47UQASK7W+G5Ca43Vh8xpMuJz033zUT9Klm+9UT9KR0IZRRRQAUUUUAFFFFABUlR1JQAUUUUAFTW1u9xIFQfjTYImmcKgzXW6RYNDEMphjznHSgmUrGn4Ks4LS/jWQZJPWvcbPTIbrTzHtBVl6EV5NpFiUKyOuPQd69e8IXAktQpOfrVI5pPqeYahohsdbWTy9oR8H6V2FvZOqLsBx6j0rp/Eejx3CmTYDnvUWlQAwiOUjcnB96YmzOhRdgCgnuRVlY15Z8F+yntV6eFYyPLAx3xVZ3DZAXaaYhyOSOv4ZqcNNgFlBBPTNZHmFZNp3ADr71KJ+2ScnjJoA11fCgYG7HPpVM3UXO1sv6Z6VVNxsjcqrZPv0rLM43EspJBxx1phY3YpjIxGM9zVqcrDalmwO5z2qjpX7zDA7lA5JrnvF+vBpfsNo25zwxWhBa421ZtU1R5DnZnai+1d5pYW0Cp3H6VzvhLTTb2wnkXoOPet/wAuTdkg/hQhM6KC9UsFHPritBH3DIrAsVwRnGT71uxn5R2oZrBtkjPgVUuJttLPIQPSsy5uMNjJzQkE5BcTZPUisy4l5IIOPem3V5gkfr2rMubzP3WBPT2qjHcbdyqyYY/iDXO3j9dj7ueMmrV7dEA+YiMPVTg1g3lwGyMsvs1AyG4BcsTtO32rn78DJG7aR6GtG4dgv7sEg8nmsa6YyE5Jz6EdKRaMu7J6K+az2aTcflQ+9XbgfNkgKPXtVV9u7v8AhSY0cVW14dH74msWt/w6o2Fj61Edzeex3WmrkrkV2OkIZJUVfXFchpXavQfCdt5twjEcCtEczPSvD0QjWJF5wOTXRqPmrH0cAEAVsoRuqZG1LYnWnU1elOrM2CiiigAooooAKKKKACiiigAooooAKKKKACg0UUAVbuJXTFYV7p77mxgrXSSDIrPnXIYHkU0Z1IpnB6zp6tETg4715trcX2dmHvwa9p1CJNvTk1574u0zeXdV4/kaZz7Hmdy+UYGuR1cD5jXV6ghVyuMEGuV1jBzikaRObn+/UL9Klm++aifpSOgZRRRQAUUUUAFFFFABUlR1IKAClUZYD1rU0/TBMVMxIJ6KK1R4baS1WWAZcNyB6UWI50dV4Q8LQTWBkjw05APNbsWhyQtl1yMcD196o/D29ktroW0g4PGTXrZsIbiESpg5H61SMJN3OJisCoBYAsP0rovDshtZgSflPBP+FLNZ7cgj5adDE0YI7+1Mk7eJo7mDbwwIrAvrd7KcSR/dHUeoqfSbnyIlVuB29q1Z/LuIsP0I60wMJpUuIgyE4P6VnvhZlCkD3NW7u2ksnZ4/un8jVaMrPMoHDeh/pQIz7weXcMpx68daoLct5nlhiMnBwOlP1W5/4mM3YHH4Cq+jgz6kFB3A8mgZu2cCyRqWBOOCTVqLT0ZhlRjNaNvbLFGM9D61WvJHIaG3RsMMFwOlMkq6k0ccLWlm2wtxI4/kKr6H4IhlmW5kfK9frWho+iM8iyXA+Udm5JrrLcrGoSNdqr6UDRBHprRYwo2qMKB0ps1vOxIUYB71om5AOBUgmBHagrlRUsbUoQZOtXZJFVevFVLi+jjyMjNZl5qAj43e5otcLqOiLOo3scK5c9elYF1qO5SUO4Z7Vka1qRnclGB5woB6Vz76i0Z2u+CDjJ61RL1N+4v0JYbwRnoeCKzLm+Qgh2yPft+NUp52dAy7ZCffBrInnDlg6suDxuNIC7eXAOQG+Uc9az3uS3LDcB3HWqEt2uSDKQAMYxUCTlEYqRg+nQfhQMkmkDM3lucehqhO3zZYZp7zgg7x8p9f6Gq0jYUsBuj7nPI+ooGVLoMg4ClTz9apMEznBTPYVqKodcEho6ieFWOQ2B2BFIaPPK6TQRiFPeubrptF/wBVH9KiJvU2O00g5I9q9V8GqqlMjkivLNHGQD616j4Qb7o7itEczPStMXBPGK0wvOap6dgxKw71oAcVnJnRTWg9OlOpF6UtSaBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVWnjB5HBqzUcgzQJq5jX1qJY2YcNXManZebEyTDnpXbyqDz/ABVlanCjKeOf51RhOPU+fPF+mtZ3ch2kKea841Y8NX0J4ysEuo3Vhjjv2rwTxJaPaXDxPzg8EdDSYoM5OX71RP0qecYaoH6UjoQyiiigYUUUUAFFFFABWjpUPnTMAoYgVnV2XgeyE13OSOgFVBXZnVlyxbLGmWMrSxsFJzntXe6DbLEvlsgYnqD0p+k2KSXilFAXac5FdCbJYo1ljBIXg1c1ZnLCXMrmXquiHT2iurVMDd29DXWeG7mZrdEcHkd6v6Ukepac0TgeYowM+lLaWRtpNrA5XjFQUWpIywy6gmoGQDBC8jitBQGTnrVe6jBwFOF6/wD1qYFHdnlj8w7dqlgv3hOJRu7D61BJtIbzMjb2FUy5D7j1I6/3aYG/9oWRWD4kTr9KI7W2eF5EwpIOD6VgQzHzlRDg9yO9XNSuf9DZFBVsdVoFY848YvfaTqxmGZbRuBznFXfCuqqmZtp3N29BTtX0y71KJst831pdL0PyrdNzYccMB2NBVz0HRb37Uu2Vhg9B6VtBFj6YrzS3a4sbrZKx2jlT6ivQ9MulvbIOD86j5hTJLQuMNjj2phu+SB0rPvZCjeo9KoPeA5wfmPYUxG89wEOd2R3qhc6r5QdUPPse1Y1xqDGHaGAHc1i3uoKq4JJYjBOKAL+o6v5ija7bujH1+lZc2pyPDjecg9z0rOmn3TMRnaOBVHzRtOSCc0XKsLfauImYxZVH6hj3qmbj7SWYt+8xwPWqN4quJYz8uPmU+tVo7hGiUF8OODxilcZae9eN9isQB1qrJqDsSWfzEHfuPrSNKsjlZjuIHJXqPesq7Unft+b9DQCL73QkfCL+FMZwEO0sD/tVkqzJgnPpkdqt/alwvmfM/v3pXHYnJ24Hb270mSDuBK9vrUSuJSU5HsRzTlZwv94DjFADkc5CEBGPJHYinEAnlip9DSLH5q/Jw3XntUm0gDK0wPNq6TRjiGP6VzddFo3MSVETeex3fh854Jr0nw05jkQ15rofCqa9H8PjLJWiOZnqehzCSEAcYrbxxXKaW/lkEdDXT20nmRj1qJrqb0pXViVelLRRUGoUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFIwpaKAKkw61k6g5DDIH41vsoYYIrL1Gz+XeOQKaZnOLa0OJ163E6FhjOK8M+I1kIAj9yTX0JqEO5hge2K8M+KbK9ysa9s8U2YR0Z5FdD5qrP0q5eD5z7VTfpUnUhlFFFAwooooAKKKKACvTvh5Colusjd8q4NeY16z8PBsS7cHnCfyNa0dzmxT907zSIB9s3FtzBTwK6fTbYSlhMAY2421zugNvu5DjnbnHrXXWiMrA5HA6dKqr8RhS+ErLbS6fdAqcKeUI71tQTRXkahxtlqeJEniCzAMp7+lQy2HlHcnO3owrM0Jlj2ttxximSR/KD2z6VDFdvE2JwWUdx2FXIJoLlf3cik56dDTAyZoAH9WNYWqo1u+UJYsenrXaSWwGXOD9Ky3tg8ollRAi8jd1oAxdJtJS7OYwFxyxqfULdHcASEj0XpU11exRg7lLDPA6CqcGoJM2Cu09QMUCHCEpGcx7FxwTVKVds/7vkDkn1q7e3QaMKrbm756iqMNwNxRsD0OOtAFi6slvrP5eJ4/mX39qoeHNcWz1BY5ThJDsYZ6VrW8u1twA4rnPF2kwiZby2/d+ZywU459aBnf3wikUjdXL6nD5bFklwBzWfJqUp0y3lErFtuGOe44rDvdXkZCsjkjtVXFYt3F2yk5YkZ9eKy5b5mfGFPesZrudy2WIGcDuKUzN8qlWHv1pFWNczyNHnAx6VTMrxxqzKMZOaj3siP8AMOg71FdSCSNVUsPlycmkIguLhRtcAE5K/hWHLJtn5OcnkVfuEyke3BA6jNVrmAo4YsoyMigpETSSAEoQO2ahLGTlSdw4OKeAmMO5I60+Nkj4iXce9AAqoxHm/K+OvY1XeKRZCxUg/wANTeU0jjg5/lVxpCECIpY4weOtAXKcO5iMHPq3pV1bdmO4HGO/rSxpgr5i4/2QKsAOWIx8o7Y6CgCEA5JVTVhUKjlge9TKiEFdwHpVWRZFYjLcVQjzCuh0I/ulrnq3dDPyD61nE6J7HoGiL+7UnpXpHhpSSh7V53oI/crxmvSvC/UYrRHMzuLL7oFbNm5QqQeKx7LoK14OgxSZdM2ByM0VHCcoKkrI6QooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACkYBgQelLRQByviJBZxSSE/7tfN3jUSPeyvIMZOa+ofElus1v83UdK8D+JOkGOyluUH3Tg1RzSVpHiN+uJWrPetfUIznPesmXg1JvHYjooooKCiiigAooooAK9g+HcAa3u5GGVATg9DxXj9e1fDZS2nXZx8uU5/CtqO5yYv4Ud54btwbiSXHRce1dPGCGwR8orH8MD5pSw+6vINdIIgGJByO9Op8RlS+EYtwoyBuC4xWhBMFj681nyW+074vvHoD/OmO7qdqDPPJ96zNDQuI4pEJ2jJ9PWsp9Pw2+BwH7571L9qJbaOT2A7+9NVnG7gjIzTAwdd1a+tZUtbdyknXdnIp1pdXflkzzM5IxzU97a/aGhlYfOzY4qO52wjaAMgd6AM+6kZ8s0jEnp7VXhPzEAg55bB5plyfNVirrgnBANZjXJiciFckfyoA3ri5i2Z24U9h1qsZgCuSAO1ZDPI7oY8k8cZ4qyCEc+YwJ9c0AaizHbuYng9PWq+pXK3FhLHnLAbhWdLehDjOQfeqa3IMhBOB0xmmBAl4GsZIB1V8j8axrmQeXySM5HXpTmlEd9NF0VuR+FUr2Xk9sUirFYzbSVDcmpUcxlctknrzmqTyBQwwM9qbBOd+GYAfSkFjajDkZ55qKQ4fLDouMU2KZSpwx4H4VFPcj5sFuhphYhuXdDlcAEVVdZJ+A2WX1qdmaZRyRirtnZO/O0YPc0AZCWrSEbsVo2tntAAUux7Ctm30uJSGkIAHaroNvAvBAxRYV7mSunyOFyAD6CrsWm+WM7Rn3qO412yts5mQfQ5rLufGNqn3PnNOwJNm2LJQckio57TcCE49q5S58ZFvuLj6Vl3Him6cnYcfjRdIrkZ2zadJkMWAx71MsabQJXQsO+RXmM+tXsx+aZh9DVNrudjlppCf96lzIr2TK1behngD3rErW0VsHHvUR3NZ7HpegN+7QV6R4bIVlzXmfh9htQmvQ9Af96nNanKz0Oy6Cti3IwKwLRzha27ZsgGkyoGpbntViqsB5FWqzZ0rYKKKKQwooooAKKKKACiiigAooooAKKKKACiiigAooooAKDwKKQjIoAq6hD59swHUV5N8QrT/AIkt6hXnGR9K9gztIB71w3xA08GynZRlHXH0poxqx6nyZqUXLCueuRhzXca/ZmC4dWHGTXFXwxM31pFQZWooooNAooooAKKKKACva/hR5kWn3O8ZhdlBz24rxSvon4W2XmaBPKuCdyjH/ARW9Dc5MW7RR6D4egQrMdvPFbXk7Fz1GeDVHw7Dtt3z1UjgVqXP7tM8EelFT4mZ0l7iM6UnzGw2G7Ed6r3MpKFVBDHqe1TuwfkfKP51BIFVCT1bjNZljIkSNeSdzck0/wA5C2wbumMVDDGZnU5OO56VdWBIl3PgeppgRyiOO3V2+XBPNcnqV2S7DsehHUVs3tz58zY4hQYUeprldQVfP3EEleeaAEhLsGXyiR6ioJIFCnaMknkmoWuhHMudwBOSM9adcXyMAyjAPHNA7Csse8HnnvmqU04MxVRgDjpxSy3R8pixXLdBjoKyLq5ZJjg4GMkn1oCxJNcr5p3HPJ6VH569Mj1rEjmcStuXPfJoluDkkjAzikOw7W7kQXlvMDwRzWbJqCSufnwfWotamE0AwclTXOl+euKTZajc6KUeZysoP401I2ByHHHXmube4YfdYimJeSochzmi4+Rnb27fJjPUYxTlQc84z61yMerzqO2abLqtw4xvxRdC9mztUmt7fl2Wop/EkEPCEYHpXCSTySffcn8aizRzFKmjqrzxZMQVgXHuaxbrVry5z5k749AaziaTNLmZSikSM7MclifrTC1NJpM0ih1JnmkNJQMXNFJRQAV69+z54W0fV7nX9c8XwtL4b0W0Ms6qzKXkb7igqQc4DHAPXA715DXpXhn4m3fh/wCHLeF/D9vcaZfT3v2u51W3vGSSVcYEYCgFRwv8R6HjmmhM9t07wJpWn/G620J7fztAvFa5tk81sNEYXZcMDuIDKRnPOPeuhttI0e40DxBexWCadLpd61vDJFLIVmAbG0h2bJ+mOtcF4d+Lkk9x4Tv9S0xrzU9Ejlhe6e7w10roUG7KEgjIOSTk59abeeJNQ1vUJZry8u5YGmeWKGadpFiDHouemBxwB0rRXMXY7uwfKrzW7atgVyGlXGY155rorOQnHOabM1ozo7blhVyqenj5Nxq4KyZ1R2CiiikMKKKKACiiigAooooAKKKKACiiigAoooNABRRRQAUUUUARyrlT61keIIftGnyoQCSvQ1suCQao3kbPbyKPwpomSuj5f+IWnG3kZsY5NeS6mMTt9a+ifi7Z4tmlC4I7189awMTH60MzpmdRRRSNgooooAKKKKACvpf4POR4dk9DIOf+Aivmivpj4To0fhYEfxSf+yiujD7s48Z8KPUNGhBjkdOu7pUt0QVKsOfequjSkWznBzurQ4cZcA/WpqfEwpL3EY4tu5BUA1HJAXyc/KOMCr1zGUP7tsrn7pqAT7ImaXaNvpUlWK6BbSAyy4AHasi41UXTHb8qDjFR3d1LfysGJEYPCiqk1uEjOBg9xQBOiAxlgeOwrntUJUt/eY81cN3JbyKjH5OopJikxLhQc0Ac/JFucsSeBVaVSwwoxjnHoK25bdCSQOT1qhPbn5hGOo6ikBkXLYZTkngAise+kJuC38JPArYuomyDg8A8Vi3kTyEFQcE9SKBkDkiUlThTVS6kBjYg068lEY2bgSKzppSQB2xQNIo3kxBIrJkbk1dvWySQeKzmOTUmsUIzZplLSZpFDgcUZpuaTNADia9Q+EHhbRvEHg74i32r2f2i60nSjc2T+a6eVJtkO7CkBvujhsjivLa7z4aePbfwfpPijTb3SZdRttesxZymK7Fu8S4cEqTG4Jw/cdu9AzmvDGnW2raslndtqYEgIRdOsReTM3GAIzImR15z+FevaT8HLPSfGngUeIJr650TxBK6/ZrmxazuUdQMxyx+ZlAc/eVj06HIrk/BHxC0jwVqmoT6HoGoG01CwlsLlLnVEacB8YeKVIF2EY7q2eOmKu3PxdEVr4Hg0XRGtk8K3Mk8Jurzz2uA7Z2viNMHGckeucDpQBbl+FVn4h+IHi+x8KXGoJpWhTXBukNgZJYtsrqkECLKzTkhSAWKE7ecU8/Ay7Hinwfpz6lc21j4kSYxzXmnGG5tnijLsksBfg8DHz85z9c+D4rWdn4m8S31n4dlOleJ1kGr6dc6h5nmF2Zi0UixqYyN7YyGxn6YoeFPH2i+EvFPh/VtC8LyqulyzyyfadQEk90ZIygDSCJVVVzkAJ3OeuaAI9S8E+H7PxFDo1n4m1DW7vMsU8ej6I80kUyyBVQLJJHvBG47lJwQBg5zXb+HfhUvhb4o/D3+1B/aWka68jrbalYeRKuxBuSaBywBBde5zXFeCviUfDeueK7x9Ma4tfEMM0EyQ3XkTQCRicxy7WwRk/w88elbI+MFtBefD57Hw7JFbeEfPEccl/va5EgUct5QCkbckgEHPQUAcF8QreG08feJbe1ijht4dTuY44o1CqiiVgFAHAAHGBXP1peJtU/tvxHquq+T5H2+7luvK3btm9y23OBnGcZwKzaACnxHDjFFFAHa6FMwRK7zRJSStFFbI53ud5o7nYtdXYsSVoopknWWxwigelXB0oorF7nStgooopDCiiigAooooAKKKKACiiigAooooAKbJ9w0UUAJExZATT6KKACiiigBG6VE44eiigDzD4tWUc3hu4Y8OhyCBXynr4xOfrRRTZjDcyaKKKRsFFFFABRRRQAV9OfCNt/hOIH/AJ6Nz+Aoorow+7OPGfCj1HSYVNqSeuakuQEUgUUVM/iZdNe4jIlkZsk1mzStLdmEnC5xRRUgVokEcwAGd1QX52ozAc80UUAc7OPMlXcT0rUhxFECFFFFAhJZ03FTCpz3zULhfLOxFX6UUUxmTeQjY3PP0rnNQgUHqSOuKKKTBGFc20ZySMljWBfgQsyrzxRRUspbmJcyE8VTYnNFFSbIb2pKKKBhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAH/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    While the fracture of the lateral malleolus (white arrow) is clearly seen on both views, the posterior malleolar fracture (blue arrowhead) is only seen on the lateral view. This combination of injuries&nbsp;is unstable, as suggested by the widened medial joint line (blue arrow); orthopedic referral is needed.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Scott M Koehler, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_19_23856=[""].join("\n");
var outline_f23_19_23856=null;
var title_f23_19_23857="Flail chest";
var content_f23_19_23857=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F79746&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F79746&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Flail chest",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 211px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Flail chest occurs when multiple rib fractures result in a loss of stability of the chest wall. The loss of continuity with the remainder of the rib cage causes the flail segment to move paradoxically. B) Pressure within the chest is negative during inspiration, causing the flail segment to retract. C) With expiration, intrathoracic pressure becomes positive and the flail segment bulges.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_19_23857=[""].join("\n");
var outline_f23_19_23857=null;
var title_f23_19_23858="Placement of injectable soft tissue fillers";
var content_f23_19_23858=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F54021&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F54021&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 550px\">",
"   <div class=\"ttl\">",
"    Placement of injectable soft tissue fillers",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 530px; height: 385px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Soft tissue filler placement in the superficial dermis (A), mid-dermis (B), and subdermal (subcutaneous) layer (C).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_19_23858=[""].join("\n");
var outline_f23_19_23858=null;
var title_f23_19_23859="Pyogenic granuloma - chest";
var content_f23_19_23859=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F67395&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F67395&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pyogenic granuloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFFAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDm4ZgjKOBn0rS+UxkqwJ78VnrZu7bgp4NWGikwFKhffNeJGUYqzPcabd0TF0dQOAaptBuOc/gKseTtQgYzjrUEbMjkkVE2txxTLVpaB15WnSWwjJznFWbW7QduT1p00yOcc81XNFwDW5QRAzYAB9Kl+zFQWYcVZghVz1wBRO6xDacmpUFbmY79CDyiSBjj606WIBSDwKRZGY9Me1PdHkxnI9qSTeoNkFtbBm6cVba3VQCRjtU1pbOMHIAqy9u0gHPFVGDtYlszdi8jtShfQc471LJCyHgcZqSCMOeRz6UrtD3KbQF+3FPS1GBkZJ6Vprbfhmo/IKvwM1ol1aDfQoSWmP4cGoltirdCAeK2Co/iHPvTgisMEcU7XJ2MeSBmXG2oktGY8ggit2QIqneKZEyAkHkUmlcfQyms8HkdaDZlUJUHHpWuwUnOR9acqKydcii2oXMFrZieAcdahe3cnha6Mwp7ZoMCFuBxT5Quc6LJ8DI605bAk4C9PWug8hWPynp6VE0flt/9ajl7hcwZdPIPINNW2VTjGD6VvSoGjAA5qhNEQ3SoaUdhpmdJb9SBgGofsmc5Jx2rYWP5eRxVaTC5AGaNAZkXFqB91c9jQkBCeg9KuuCTxjj9ackPGTxQn2FYzJEP8INBBx0rQkiyuB1zxVd04wRjtTUgcSixAYZ5/rSnkjnn0oMJLHrUpj2Y96QKxGnGM08HBI9e1QtIFPNL5qkcZoTsHKK5x1GPf1qFG+bHBzSl9/H86cqcjFMLDw2DxxS+Zg5OcdKTgdf1qLndg9KbESggE46Ux3+bGcd6THvUT9ck5oTAnRs9KfnI4qqh/Cpgw4/Wi4Dyce1KZTg4PFRnng8gU1yO1NgSCXjmnrIAevWqijLVKiHOfSkBM0vbv60CYgdahIHUHNN6DnmlYaLkUuO/404yD16dapbsHg08HA+tMbZ2sEYUdSCOKSS2L8jOOuasyRbSMCp4hgYz+BqeW+gXszL+yg/eOfekeySTpjPc9K0JIsjJziiNRj5Tn6jpUcivaxVzM/s1Y2yrEc9adJZkx53ZIraeP92SW496rlQRjHNaOmloSm2U7O1ZME96dc2nmNk84NXoUK5B4PYmmT53EKecc+9NJKNge5REShdo5PrVuGAYBOfrSQqob+lX44w+O2O1EddAaKyKVP3T+NWYt2MY5+lTrEpHA/GpkCgH168Vsl3IuU3iDkjoKrT23lHKg1pH5z0pyxblOSCaXLzOyHcyo5sZ3VOJ0K85z7VO9gXfkCmPpb8EEkemKpRktxb7Fcx7jkL+NNyVG3HNWUR4CQ+T9atQQxzckc+tNJPRbk7bmLcoxzkGoI43x0wa6R7NOvWmy2kY5CjiplS1uWpI51y4x1x6VYt2J4PQ1pG2RjnA/CpEskB3Dr6VKhqDfYotFgcnNRp9/B4A7Vsm2BXnHtUH9mktkMOtaSpdUSpdyKGIAEjFNmh3n/CrBs5Ix1qSEYbDfrTcOjFzGclsFwSDUc9sCO1bLWwdgynj2oktQq7m/CpdN2sPmRz4t8AhiMe3Sqz2uWxj8q1pSM46ZqB4z1waxcC7mTNbonIzxWfNIQSFFbs6ZXGcCqwtkIyefpUtLZDTMZnxgsPmphfjkcGtK5gjB4GR6iqNwUUFcH8ajZjuVDINzYHNU7pzjI5qZwC3U02VM4B49BVKb2FYyyZHY4BIp8cUpHOeK0vs4VQTwDTwgxjPPahtDsVYEz1FSSnaOBnFThAp4wTTZIsrgZouhNFF3y361IpyCcf/AFqe8HPTpTkUdxRdCsV2cLkHOPWoSw7HNWbtAwwvFVUtz1oHYkT25qVlJ5XimCHaMDPFSLg8HNFwsMDY4OAfekz6irBjBXDcimxwn5tp6dqYrWI178U9fSgo3Hb2pduM5oAeRxyKhZQKcSfXikPJFVe4hoAzTj1yPTFJxu9KM88UmM9JUb5COevpVmGJS2Dyc9DUduyu5xgHPWrLR+VnrjrWkLbgyG4RWYKvbsKiEJU56VMVL8qDn2pkpkVSGzk+1TJrewhJ4yUzkkDrUEYbGQPxqwsUrqBUzgW8RLAcfjS5XJ3HdIp5UkAAfWkmVETGRzTYnE0p6Aeo6VPLaF3U9s+tK+mhSWuoy1tCTuPU9PSrYTYeT7VctYlSLBAOPakZF3buMdxVqnyrQXMQSShIW4wcUkaZtwyEeZ1P+FPvo1aE45PbtUUDeXEC3QDBxVXd9SbLoWrSaOZSQNrDhh6VZEC54xzWXcFgRPCo3fxKD94VENQeTBgPQ4IPUVopJPUlo2JEZRgHioxIQcMCalt2ZolMmKdJhmI6/QVckt7guxXIErHK5B9amjhjTgUkZRGwV5qQoJPu5H41KsgZRuS28+W3GelNAlUjOcHvU89sQ2c81PC+I9pGP60JJvUdrIit0DsN2KmkhGcLjNRSMYF3Z4qt/aK5+Yn6ijmjHRis3qSyRlOCfpmiK4WM4bHXrSZ87BB+Wq09uWBzkUKXVBbuXzeR9GIqPKScrjNYFxE0J4Yn6mn2Zm39z75qPatuzHyaG2VaP7px3qGacsuGORVaZ50Hv7mqU0srCtZTsiUidVQkdTz1qO7kVI/vZNV45fn2k8iiWOVweBtPQ1g2kitXsZ8zOx5Y496jFwdpHBPTOau/ZJZV24I7dKINKKSDK4+tTJJr3Rq63K0cRkU53c+nrVS8sdxJOc4rqYIFiycACqOpkMSq88Y6UmmogrXOR8hlkJIGKVVDvyOa1ZIfkIIAPXFRQ2o5bHPSsdeppp0I/syOoBBzTXs0HrWkkOwc9KdIFVclePWnoxamK9uV5AqrJN5YHOWPBq9PciRtiLlfWoBa5+Y4+mKOZDsZU805J2gD60kV1twsvy571p/ZQzdMn+VNubFdpBXtTvcLFcKJOVORUiQgDnFVYke3yUOQpwc1eikV8N0qZabBYRogPrUDJuzt7Vdd1A4AzVcnJyMUboCBcjAYfjU0Y6Y+9TWYDsKli5APGaE2FiNsKxRu/Kn1qGU4PvU88Zb7v3hyPrUKjcu4Hj+tVcQ1Vz1oYbe1SBaGTI70XCxX/i6U7aAc1J5eCCKcsZ2ngUJiZ6OkJRlPQ9asMSyfMCSKV5VmkyqkL2461Oo+XOOK1S6R2FfuV4nfadqE49RVO6aTeCw+YngVrLcxRwk4GRWYshvLoyjHlpwKJKytcEWYHkY8LwKSZTO218j6U55mSE5U+1JatvcEqcU3L7ArdSt5KRMNgNXV27FOOakuYkYAqAKrRyCOT7pOKSXK7dB/FuXN4WMg8GowFA3g9PWql9eM2Ts4HWord5bsZAwoHTFOU1eyDl0uaRdZQdnQcdKzxA7S7XzsFaEKTCL7uFqOYsATt5FVKN0mxJ2IJbchPkkxj+GqkUbGbzYQDKvVfWo7+eVd2c7j3x0o08SlhKAwOcEYpRld2sDWhvwyNJEjgcGpmLBuhqKBhFIoONsuSP8AeHWrXMq5KgfSt+XoTcjKgHcxHNSG4SNQBn6YqOOEgkyHcuetSPaxkhjk/jTastBkEkplPr+FR8oDkjNaURiVPugVDKqyZC9/aocPML9DNuJsqA/OKgEMUy9CD61oGzA5k5NKLMYynFZcsm7l3RQht3g4Rtw9KfNMyodwwBViP5XI7gdKrXiGVsYOf0qrcsdCepThVbuUiQ7fp0rSiso1U46jgelU2KInllSCO9T2Usqnk74xUwauNppDZlZX+bp7805YY2U/KAavSSxOnK4akSeFVxkfiK0UWtyb3MdrBBITj8Knihy2No4q05QscMPakDCM7mIHrTl2EinMrRSdM1BLMCflwT65pdQvFZwFfPsKrmaMR5UAsaz6ldBl3K+OWAx0qksowwY5Pc05LWa7mLEkJV+HTY0I3MD61i5Sm9CuVJWZlBHYnC4X+8RT/J65xn2rcKW6ptzkj8qpmOIMMsF+tVZx8wMxRtyWJqu7ecWUNkH9K1p7UOh2H8c1nCAJIQFI9vWs3Np2aKtcqrapH25qLbubjnntV+6jZk+6eaznglVsjIHpUOy2HqTC1KPkZx7Uyc498dqnRnaMrnOOKa1uD1IH0p2tsK/cyOHLIq5B71DLGcYXPXvWs6xxhgOCB0rNUlmJIJpXtqBGsbAYY8dyKlWMBeOam8ksuQOKhXcCR0xQ5hYSSLHQfnTQChyR07VdQbup5+lRypljjNCfUZCxyPfrUMI/fOo78irIjI/3aEUCdeMNg5q1qSxPLJ54HtTSvzgY61bIGKgYfNxwf50BYiK80oA284AFSlflGaY6fjx1pBY9PjwsYCpz61FcyFSAzYz2pHnEEQeNd3OOPWmxFJTufBOcHd610t30It1ILmMPGEhyXfj6VC8ZTbFCuNvU1dVozcMwYAD5RiiVEAwjc+tROHYcXYbjMQVj+NNkkEEeI+D6GpB+5XJbJPenFheQ7AmMd6pNPbcb0K0U8kv3s46cVaAG0AD6mq0cW19m/p61btEYScncKmDb0YSS3RXuyscW3AOTRaSGIBVTjpTtTVmlQ7cLnHSpreBnmA4CD0ok2pWQdNR8sty2BHwKhRJzIMtg+prUNs24lTwOgNPiRQp80DJ9q15JN3bJulsYlwjs3zRggdSB1q5YNEMbl+T1q7MUSP5I92aw7hpo5t8a/u+60P3HcW5p36o0TGLO6M+YMe3/ANahpSGXy8kH+VQRXBKxkLndxmpLcsm6Nk5Tj8O1VJ3BIuDLwjBOaWORkIDLnNNgLkggcCobq6bzAkS7j60+aw9zRkMeAqgA1GJYosfMDms4QyMA7n8BU6opwqj5j1o5/IViw2JX5b5OvFQtIfM2Q8qOtNeCUPsQ5H1qzDBth5GGPpT3AozYhlDP1NO86M5Ow57ZFRahDuuY13H3q9HDuAEaLj1o3YGVLF5jEhTkGq+2VT8gOPWuiii2vh1HpxUWoCGBOAGY9AKz9l1uPmtoZUbyKQJNu0dzSySxHP3SB1ANFxDLPH0KD0rIuNIuZctE5IHqaUm4rRXFoyeTUI4t4VCzdAcZxWcVv7t2ZCyx+/cVZtlNu6i4Qtith54sIkRALdjWbvUW9rFWUWc+NLncgruz35rQFhNFGCY8/hXQ2NuseWY5z3NK8q7mXt04qlSUVdg5MzLWNQhAIU+9RyQFpGAY4q9cWysu4cH1FVhbPH80bFvY1TWlrAu9zMms2D/fP4VXuYMIMMQfQ1rzRNnnK59ar/ZCzDccj09KycLaIpO5lRKyYKkkDtU8Uqvc8gA49OtXLqxCfMh5HXiizjQHc6YaoUJX5WGm5AUSVwCuPaqd5bZBA49qvyYa4Kxg9euKlngCx8noOuKfKpaAnYwkthsJOMioPm3bQMg1oygsCidabDb7CGes5LVDTMvyWjcSMAR6Gq4tgAWIwD2rfudjKFqu9uNgHrTlG+iEn3M6OMhQCcD0qGRF8zt16Vqy24WLIxisp4zvJ9alx6DuPkj/AHZxx9KrRAux4PHekWRlZhzilgYrMDTS5geiuPkT0PNUm3faDjqoxWtdp5URkJBA7Vmhcruxgk5qnFxeok00TD5lGTz3zUZwD70qISpLVDcZB68elT6FE25W6HgcUduBUESk4birKbgcnp6UCO1tYy7DeXAJzirktnsKl3IBOcZrRjjgDGVOQOSKqX0/mOGxgZGBiulU4xWpnzN7DLe13Flj4B7mlNr5aspOW7YqWO7WRCCvHqKie4KSnyVZz2OKLRsO7KswMagP19DVi2nHk7Vwp96a0TTSqbnd17CnSqiMPK6L6ila2qK3Vh3lo0e+ZCAO9Pt5oY8YGfWq9zJeXEiKxXyh0VRT44SpLDBbuDVKST91Cs+rHa1fCW02W0WADycY5pLBmIVWVgeuRUF4rb0TJK55AFXkAjXKuA2PxpXk58zCyUbIvxyKF+TJbFVZHBcFjk9wKgklZHwMhjV+wiGwsQGJ5zWild8pFuoPPuiAhjwe+apzxFwQTlj1AqXzG85iBnaadbyHczMOc96HaW4/hMCeV7SVEIPk7xnIrpMiJoZwco37t+c8HofwNZutbJFgQhCZHz+AqXYTGCOE2kFaILlbW4m77Ghf/ubcyJj5jj61HDGr7QB7k+tY97qbrFBA4JZHAb3ArTjv4Vg3ZIyM/SqcrthYvSqvyqg59Kktrfy2yy5rMTUYGIZZct9KkOptGgfDPnsKFNdR2ZqMqtKPk280y+uIYBk8Y7Vn3mpSsilQELfpVaIw3DFp5M47U5T6IS8ya1JuZjM+No6CtaKRYgCeBWbbyxb9qAY9KtSKrEAPgelODbQmN1G63IfKBJ6Y9PeqdnB5kuJCCwPU04yLNd+XEyjaMHPer0UQVTlgG9qNGwV0hGgERIYAnrRGVGd4pJYpG5Zjj2pCjDkj5MdR1p9dAuQahaRPCWwAxHBrm006WOQtu+bORmt6QSSS4V8gdD6025jkbYCpOawqRUnsXFsqwyXMYAJDLVhIY5F37tr9xmnj90QjIduOSacsSu4ZM7aqKvvqJ+QqSBFwWBNRGRN/zDH0qR3jjOTwOme9OSIS5YjjsT1q99EStNwmaF4wCAaqBFySnQ9RTZ4zuP7zAqBgYx9+ocrsaHPcRqSr4B9Khm2+WXUk02dUZMsCacsaLECTx1welZ6tlCW7IemadflQgUt19ahRhI5WEYP1qrPazSSHcxxUOVo7DtdjkjWIbmIJPNS+X5ke4cfSkjt8p8zcioZt+4hWwD69qSXLuNlYQSGZiuCO2TUMiusmHGB13Cr0CEsOeB+FXI1jxukAPsaFG+wm7GU+0xHJDN71jyxP8zAYyeK2b21WWQuCVUHvVSRJA20EEdBWc0XFmdHYuVLAnJ7Us9m0cQdjjB6mtlIpdoBZRUclurgbyXwe9EKaRLk2YcrveRrv+VB0HTdTLdSZNuRWrc2xWPOKy0gZLkEnGeeKcpO9mNJdCwwKDkE/hWfPgn5gfwrf2qyDvxUDWKvkqOfem0+gk9TIiZd2P8irMR+Y/MGz6UktnskyPpUkKbcLyT2OOaldhnokDAQuuSD7CoIwPPwzM2B0NaKsBbNIeJB0GOKoCBJJfNuG2gnPy11WaSW5N7k9yo+yqkCdTzzUMDzRA4GMdOKV5UgQrEjFh/FmpIvObEgZApHIJp3begkrIsbi9sZJmwp7kVXjhVifn+Q9jSTOjRqk6ttz0U01vLbAVZF780N8zsFizFGsbqJWG31ovWt4fmib5T1I55qrdArKC5CpjgE9ahEBdAVIPcg8Yoc2tEg5SFA0tzlywBPHGM1fgjjWRthDOB1pzCNEQYYyY4IGRTcrGAFRnc9RipiuXUp6kDySxyMzKMDpzV6xumDEIuMjBp6xQRxPcTKFwM+We1Y6ym9k3/PBa/7OQ8g+vYfqab9yzuLfQ0TfW8M0iyyHzD1RV3H8hUTXhuTstLW5Yf3mTav61Zg8qzg/cQbUPU4/rVgukdmJwSoAzwapLS1yG+pmC1Mt0sl4QNowAoyFq2ohtbhXBDRjsTVW1F9duzw5SP1kI5+gqdbSDzF8zfJJ3LHNEXpsNozr/wAu71+2ZVALK3APftWn9glZcBTj09qybmIR3n2q1VQRINpPoOK1pbq7uMFhtA4JU8Uly3fNuVrZWHJZ+WwKqNyjpRdXhh2ReWMtyST0HrT4LdzIJHWUDHXPFNiiilvpHYnI+QA8jAqtloS/MhRVvT+7j4/vHrVpdNdYdmNqn+Lrmrc0K4BjURhf7p60s0uy3XexI7AHJq+X+YV7mMthLbse47tUkJEiFSpK5+9nmrBl804kDhgeF5/WrRmgtbZp7gRxwqMs5OABUxik7RKbursqwWClvMCsuKddfZrDbcXlxHDDkKWkbaOfrWN4l8Z2WjeHY9URmD3X/HrBMu15Ocbsf3eOprw3xLrviXxdO/2m6lntYsMtquEEQycYHf681rGhd26mMqqWx9M2s8NxbiW1lSWI/ddTkGmzbycFhivmCLU9e8PpPNp1/LbsIlbarkqSSN2ByM9Pyrs/A3xjuZyln4qji29FvYl27f8AfUfzFVOlOCuyYVoydj2Yr5bbgMqRyB296dvUcnOaktrhJbeNkZJo5FDK6HKkHuDVE3lvFcy28hkjEWP3jLlQDyMntWN0jYsnbgK+QCe9LPst4WZiAAPzpRAZcOrBlAyGByMetZ00sdxP8zZiT7qgZLH/AAp3tuAy3hknlM8i8H7oPYU+6aU5VW+X2q0/nzL+5i8qMd24J/CoxDKACGTd3wKnl6AUihBHm9O57VJIlu6rsIzTbtZBxcqcf3l5pdPgicZB3AevNTs7DequVJ9kZI6j0qvMyyxHAwO1bdyluI+GQEetZ/nweZsC5+gqJKz3Baozrd0tmIOSp9qla/V2IjGQOppL6VCxCx1UjVoU3rGSufSo1jpcrRl+1CzTYJ7ZI9abdIGlKqBgHr60lpIXy6gZ9qvWttLcMXKgIOrHv9K0hFzjZCk+V3ZlzL5Ue4cnsKqB5h88wOM9PatO4eMXHYgHBFJIEfBbGKznFLZjTKG8zndjAHapLW2VnLHr61aeNfJJXiqhd0GzJ/xqUlF9xvVEsyBWIHA9apyZLqRgjvVxGAUmQZx3NZ0t2hn2x/dpy/mEtdAupQuRistjl+R16CtKaMBNz9/SoVtt6ZUYOODWTu2VsJApCbmBx1z6VY85QuM89venRL+5YEcjHFVTGfNbPBrWWlmiFqLHGJXHGVzSXEARuTVlwI4SyY6dKpxyGV8dh1qWkgR3DzO8ZgQ4IOG+WmSzskfluB2wKS8muI5ipkAjGSQo4P41Yt4Ip4zIlxskAzt2ZNdN7yst0O3UpXaqZFjRyUxlmPr6VatY0eJ9uGIGfbFOuI4YYFdgzyOcspOP0quIYmQMhESMcEL1NGzDdEyuzzHyY05GFJGatSI8VoJJ2yzcBdnSqcRjhf8AdRl8cB92cU+aS8kAMi5iyAN3HFCnZBykaxysfM8rcB/E3IqZwsiYdBnHVT1pZ7dRbgW8paY8lRkgU+x3QKGltg4Hcg801vZg9UUIybgiI5jHYg1aFq0RjRJGd93JI6fjT45k80vPa+Sufl2/eJ9qg1C9ZLdmlQKueF38k9vxqUklzPcNXojRv7DMKm4KfN/AT1HqcVQmOVG2SLK8AYqKEvHbB5i0sx5dM5A9vwpI51QL56AMeVUKciick3a1gjGxclysA8+QqTyIgME1WQQl+S0hJ4QdAaszLLMBK4LuwxnHOKS2tQqkKhY9T2q762SElpqTi2yu5gyf7C96qX90lrAFWMCSTgbuw7mpi7RufmlC5xnsP8azhKn2t57gSy44LMR+AFKVoq4JXZWlkdxGsKtJhwMBcD9a2fss0EayuoDSchRIMVjtepc3IaBdsacYB5Oal+wTzSCTfujBBxu6VlGVtlc15e+hpy6ndwh0dRgLjCYNUtMvBgmaRU6k7ximXRaG3LQmPJO3e3K5PYd2P0qr/Z0CoZr6K6upQOSy8Aey5rR819TPTobN7qsNpb+d5qvngBR1rOtNTM8vzrsfrt6YqvcafaXiQtbllZT8qoeh9xVm3hhgyNQUSM3ypJ6fX/GleblboCUeXU2HvbWysXuZ3wgGSx5z7D1PtXmNv45v/FnjrStM0uEWuifaFFwssYYzKGyS3pwOBWT4ruZdc1ZdNtJpRpdq3AZjgt68dfaui8BWMGjarZ3EcQdIpA0mB1A6/pXTQjKck1sjOrZRaKHxO0e98T+P7p4EBgUIsKlhtC/TsT6VmnR77RrZGlto1ubb5o3wCQDxt/WvaPEXg64+2NqWlOhE5Xy2jXIZT3HuK474saFPpGjxJvllMqkSHZhVHUEfjXZSpqDlJnIpc6UUeda1Z2UPlIZlmS6/fcJ80DMO/wDsk5rmr/w47QvNZJvUAuVHBAPcj+tdRpBtZ5ULqzzKhWKMj91wTwx645P41qWuizy3N0ILoPHKrKDyAhPRT6D2ocnONgUOWRyvgjx1qPhS4j06YLNprfMY36x+pQ/0717bpV19uuYNQtZEltruDIdehHUZrxTxLpbaYbq7uNNZZETYkrOCoZuM4A5xnNdH8F9VuG0o6NFOrsjmUHHKKRyK4qtOKim9zWlUfNy9D01o7gSMNOf9znMsKnCt/u+h/SpYXR41aDasY4Ixgqe4x2qHbIh8uN9oB5OKsGwyPPU/vD17Bx/j71zrmex1NW3LPnhYz5WSxqJHnKBsKOefWp9Ot42IbB+h7H0p+pSpbfdXawXGB3rSztdkN6kF7cJEi7ny56J61islxJKxVjCD2HGatwWckwN1Iw3HkZ5q9awi4k2NjHrUNOY9jLtYIGGyUN5n1rQWCIQnyVUuvei6thbviMFn7k1BaTCMt5nysfypWUXZhfsQx2pEhkmIPPSpJ4964Cjb04NaAUSgFipWpG8lGX5cp3o5NPIOZmPbWQEgYHEfepLu8l5t7UbYl4Ldj7Vo3XlPFiJgAT2qq2Eh2NgHtV/ArRFe7uzHW13PgA5HqakmgyVUkBhV0lFUYGD6iqNwGEokyT2rFpWLvdkhgPl4AGR0qtDBtkIbA+tStLJGwKtwe1PjmjdwZOGNGl9RakFwi4OSoHbFY62iibeRuye9a9/tf5YgfemKgEIJQilO0nYcXZEf2dXjwKbBD5akccVLFvY4QcD9aSZXXPp6elCStewr9DPkkAuDjIHQ0N5bEcnnv6VKbdc5c4I9agmjDN8vP0qHBpXH1IHkbLKoJHQDvUeIo7lRBMZVKgsShXDd198etdULR73S9NGnXNrD9mUmRJJFjdZd338nrkY/KsrxJ5dxqrTQypK4jRZpYxhZJAPmYfjQ4taii03Y6CGUI3+iW+6NRyzjJq1bXXmNiJYlAHPAwaLGeJphCsEnnNksd4Vakkt7dC8lmWRjg4RuB7V0RWl4sb7Mi2xzpK6gmTP3RwMfjVmxSLYufsybTyHJJP4VGTP5ZONnHChskmo9oeAhHWNyOQQWP1o2AbNFawTMq3amVhkJEPlqxFCsqFFgmOeCd26qVsYI4wvkM7Z+aZRnj6dqvxy5c4lRdvSNm2k+5FKLTG9Ss1s8bmJGI9y3T61dheztYdkrzTSDkBeAD+NVGETyB3ZUbP31bj8B3pqsjhY3eYtksWaPp+dON4Esm1CVJE8/UFmReNuwjBHSqRggYtPJ8pGfKV8fKD3P+0f0q1dyW8cjYFw20Dy1zjJ9ee9Ultp2KzTRxomcqN2SfrSnLXTUtLS+w2zt1nmVdrDbz8o6itVYkyGG9GPqM5qCGSKU7S3zkAAxg5x9akW+KZtkEkjAYXLcD3FEOWKs2Jptjj5sZ+UMcDLMmamiuiqZxmQj5e36d6r7JJIdkMh+UZ+ZsbvX/wDVVi2iggt2dy/nngcdR6e1aRvclozrhZbhvJGUjBLO27Bz6CpIrKIQvsVs4wM+vvWhsVkGyBlHqCcCqt1KsAC/O5P8EY3YPv6VNle7KvpZEFhYwoQGjVyTjcGwM1a1v7Lp1oY7YCWckKHzgMT0Vf6k+9UDeXSqCRGCfuoe31NQ/ZPt9ykzSqnkpxhvlDt3H4fzoUla0dxNN6sZYWm2YyzlWcctKRwPZR2ArVijgLcs9w7HrnCgU22tMx5a4fy1HcdqsmJYY3VfL3t90fdJFEIg2inexGPddQRyLKO4GQ49DXP69qSf8I5f3JDpconlvHswUZuAfcV1CMsUp83dHg9yCK4r4jRRSaPNKjgybxnafvDIoqJ25kOCTlYxfAWkW2o6XqkBZ11SACeNmPyMgGWX/e9K9B8E2Ect/aoiZV8Agj1rz7wZuhvBcGYQwoQ0zEgHH49a9x8DarpuoaeEisvJbOUlzgkHowPfnj8q9bDpQpowxV4t2Oh04LpkracVMkf34lVsSIT1wD268iuZ8dWcN7oyR26PLMpKkMeQp7H0xVXXNWnNyYNdtJh5Eh8m9gJBT6/h6VUm1pPs02y4DyryrPksw7/N3+hrVQ6s5Y02nc83sNFg07Xvs08Ie1WBsc4O45xz6ZNd42naJptlZazBIgkiQC5tCC0bkA8nOO/vXP63qQ1Tc5IjcEZKrgDHp71meNL67fS7WBgPKZAGXbjB9z3pcigmzolTc2k9DzHx7rVxq1xNIzEiRySMkg88V2Hwdsng0p52RIlLFlOPmIP9Dj9K5QWMVzN5bqVZ87c9Ca73w3YS6Xqv2aYHynij65AyBjoenGK8RuabU3cpwjCaSO6gKK3zqx9+tXbVJJJQkY8zPRQKqbmhiPloXT260+PUJAqmI+SynPPBq4pLdlOVx95O0F40EcR84fex0AqOG2ZnZ2cux6hhQ1whUluZTwSvU/jVSTUzBIEMhIPbGSPehvq9hpGhLDtjWOP5VPUkcVBFHJDJksMfWgNPPuyXKgZAXvSRXKxshAII6oUNJ2erAmNwjo25WAPeqVxDHLCdrvx0HrUzTwuW3y7ATx7U9lheJCt0rY4G00pJNbCM2N1R40LFfU561decyJ5bLsUfxVWvLdJcnd8w7YpLe5Zl8phwPlOKhXi7MrSxcSFXwCSMdKRrfdlmJwOhplsJfMMTk5XlcjqKsvDIAu48etaJLsK5FAOojCtnuaq3tpImQSCDz9KsKfJJO7Hp70s2JjkNyBRZcor6mZDEg5c5YdvSrENss0hPAA7UsKLtLMoJB5pBMsbtwVJ7CoSUdWO/YjK7Jmwu4Ul5cRCMKU5pRcFnIC8e9RXbCQBQMN2o5rJ2HbXUasqQx7yPlrPnu5ZSfKi+T1NW1tzwbgnGPu0+R4lQqAAOlS7tWTsPS5krGkvLuc+lOTbv2r0ogTe7nsD6daktUS3uVluIvNhB5j3bdw9M9qi7dh23Om+zXkWj2LaXpVvcpJGTI8kIdi2T69sYrA1NZ455BfWsdtNtX93HGEUDscCrc+oaSQP+JTKQB2u2FUZJYb2ZjawG3iwAIzIXOfqa0k03ozJJrdf19515itzIQ07YXJCqBgmi3a3w5Z3yDuGQMfrTIRIsLGVGIHDSpHk5/lUbNYhMs0kqHrFwuPwrS9tUWE0KCRpw5lVjwuP60IfOd4Y5BAzL/CmP51UN4xuJDFbG3jAAAYYIHQY9amE0UShmZnJPGG3EH/PaoUk9i7W3LSpNaKPPmM0K4yxIUgVX8+KZsKYEh5zcSKTke2etQFptTuliMKRRocbXJILepPc+3arMthLcEpMyFBkxyFNqqfwzSvzfAtAt3CEosubSb7S2Mq4GcD2PapVsWvrlWlWRT127hyPrVIpGIJoXjlRoeD5Q4b369Ks2VzBGFVjkkkAO2KcWvtD2+Eikgng81o2KKoOcNuLD0px2XIxjJA3Z3BePQ4qzZ3eXKSxeVEM/dG7P41FPFFKCxiWNFwNxc9fw6/jVNK11sC8x8SxkNve2iYE/KFL7uPWor5VbaltCS+Mv5anGPr703zAGKwhnKkEGIgg8dBkVLPE6w5WE29weSJSev0HA/Gle6sFrMfp0RCEiIqnUu5zz9KlBPnyKLtGA5KxgDA+tVrFI7eMoWmec9SXDA09d884WNyiscEngPjv9KF8KQnuQXM80caNcrNFbPnGDhpP/AK1T6ascW2QDy1I6kZ/D/wCuadc2p+0NLKsjLkL984H0qYbUw8KIierA5H5/4UcrTbYFeWNFleUgeaRyuQRt/lUEECSXLQpCiOx3Eckcj+lW4x5qlvOjyOSV4A/DFZiStJIn71olkUEsSfmJ9DSe12G7sbKXUOGgDo3lnG1R+ZpxsYXcu0hb2C5x+NZ6XBtwbbejtjIEmBmrVvfQmJm4Eg+XaBjDf1q1K+4+WxVudPmLOY5lOecSL1rzv4gmeCwLSQOY0I3vH91hnv716JdFbg5Z8uBkMAT/APqrn9d0ptVs5hKjtGEAOSVyKXJzaIpS5dWefDUkutOVlLtcIMbiP9avY8enSul8C+KLzRbRYbnc+nPIHII+aM92Q9R7jvXnU8Vz4b1QW10skSJh4jnJC9jXS/25iztzJaeYrgOcoSJAe/tXTRqtO0uhtUjGcbWumeofELxLcNqaBdjwzQpIpB4YY6++a4h9XuN5z8kbHAUDge3NULm/h1IQfYZmXyIynkz/AHkAJOAe+M9KuWBggtVmvbqJmJyIfLLMR9eAK7faX2ZnClGEUrGtpVxZRh7q7d18vkELv3H0A6ZrmNc8QR3k+2NGEYJyOp57+lLrV9b3Ehgt5ZIgo/dhuAPbisPwfotzf6+kTxPdW5cl8HBKjkj+lYzrScuRbD9nFJzkepaf4btk0K3vorQXeoO0bLIUO5cnJP0xgVBOkqeMnS7nEjmNC67gdh9MetZ3xD8R3mg6ObbSbs287p5cywyjfFH0C4HTqK5j4bJOC09wWmkc7vmbBJPcsa5sXKLkoo46dOTvOTPaILmHyzGIgARtDt1X3xWZrNttRGtiZZjztTkv+H9adaJNLG5u51RNu4CMZ4+p/wAKdYeXaw5Vsyy/MxY5IB6VnP3lZlJWZltLNHGrpOYSD90/PRapFI5lnmklfrwMfh0rRktA0knlDc8qbgzDhWHXis6G0nRvMMrs4O07hgYrnlFpq6NI6rQuQys0qCFnPqrdRUtxNcYPysMHqDkUsdks6+aqhJAdrYbpUwKIFjcDcp4Iz/OtLaak9SGIkRFmfcW6jrUDWduxLxny5Oo7VaMUqz/JIF3H7xHykVYlmRoxGyruXjKjrRaNtRNu5mvKRGcgsemT61XR5IJS0luWBHVavtAWAMaMr57nrRfJI8m3DKABk4xSavqw0Wg2HVLeQN5TDzB0z1+lPkeU4csQMflUB0+Ld5jIHU9cHkVC8UqAeTKZFXjy26ke1NOTWoK1ywE89ck5I9e9TBRIMKvzL6UWLwyKwjYBOjDupp52RvvhwwxjrzTStqDI1SLcBho27+9MvZYTKEjTOByamuf3kYdnXAPX0qkGeeUpCo47nvVN20EkmAuQisWQY6VVVwWZwDvq29rO67plG3tjimw2yRAtkhv0qbSloxppGXfzyqhDfLjnFZ1vLJcuNoLVY1d2laTy8naOSOlX9CgAgVtuOM81zpc07XLbsrkkUESwfNw31prWoeI4bI7VNcSfvflBFNVH2Hj5a20eliPMzTAUYoQW9ABUjG3gKC3eZn4DiSMDB745rrLK6tYbKGZZ4knhgaNI8YZZWPLk46YxzWV4iMNxeiSGRZmCKskqjh2A5YUvZ21TFztuzRflm2Q5DbQBu+dv1FV7UfaVDJDNFjoVXfj8fSrLW+VjjIJEYBEkoKrwfb/GnxQPbvHvmU9cMXKp7mqcW2r7FK1hUAHmEttYKMkJtH457/Ss5Vmu3PnbprdW+UeZtHTqcd60Fyhd4LNZIifvsSR9D/jT5Zbe2UxRwwqRgqQhwG7gkGnJJrVjV0VrHPlxx+aoU5wYnyB9SasSSIWiOzKAcPvznHf3NEgnkgWVp4rVMll8uPlh049PxqOGNd5KBHLDKO8py34dBSV0kkDWtyldQ3Ud3HPCpKMcO7DKYPcjtipZ7mIpLHOVuXI+5GhIz2zjpTtYnZ7ea0inK8YmxggNj7ikfmT+FO0qaSXSkRQ0MbIGOQBvPGTnvz+NSklLlQ9bXHafc3cR+S3htYzxiRsdu3/66YkS/aJFB8zjJUcce5p1vdW1rKUtgb65fORDzGCezO3FV7iS8e5C3N5p9pg/KYsysD3x0GfqDVWstWC1ZciwolkCgQ5xu3Hp+NMCQucrdPJz91fm/n1piWpkkZRqMk8uNwd0SMEfXHBqsZUjl+WdnO75WbYNx+pHr3pPTca8i7cGO2h2+Y8Qk+XhDu/L/PWpBJ9nhT7NO7FsDaycD6/4VTjkku7iU7EkSMgYCHeCP9oZB/KrZu44o1FxbX8DE4xIFVW/4F0/WnbswTJo5LlmR1EwY9Sx4J9vapDMqqpZi5PG05IFVFuUijaWSC6ZiMKpU9fqKfb6lHdMQIzCE5JgUMc9ye+fwoTW19RtMinugIp4UZYpSChd+mCOAD261n2cjSQeSsmxh8owQSwHHXt9BU2oq91PIyTySxNtIbIRXbHTPqPT6UzTQkCfZri3YrIQIpnfmM9Sp9PbP0qW3ezBKyuWba1jsTJNMUabooZCWz0ySe2KW3+ZS7OVTPDFgc446UryNFMZ/PaXYdq7yCCewx1qGa8a3QQrAnm5JO5AwOee3SmrW7IpMvR/LndEWAHJIwQT+OKfb28LlXVlKgbiijO4g96r2tysxJdIowBny2OcY7AVNPfeVbb40WWQN9yMbWI7110qkVqRUT6mf438H2Ws6TDcPGtq5CmSYDcFDZGMe3fFeC31ld+G9X2efcJFGx2iM/KRnqM8EV9M6PrNpdxrEkytMoIELsfnHfcCO1cv4q8N6fqMFylw9tbusmUt1Q7kB6sp9KurFT9+L1M6U+ROM9Uec+HdS0S9y+saU80xXJkjmKu4JJ3e5GO1NvjY2ckd5YqZLKRDiG6YMfcZHI+pqrqngS+0ycXNnMzW6SAhl6/8B54P5VV1TVZYbZkv7PysfIGeIjaPbHQcVjOtKMUmrnRC0dndBrt/YPua1MRjK/uwWO5B/dz1OOetZUHiu40yK4NhN9kMibS0f3kPRth7ZrnbgSMvmQBnJG4LjBx7DvV3RvDWo69KZXUxwJwznjA9FFTGTb5noS5trlRFbXt5q0ptLRfJSQ/vW3EvL7sx/lXsnhDSW0q1hjlfIx2PHPrWP4W8GR6avnB8zHn5hkAfUdq7zTZ7aCFTHEs0hJRkT5sH+lZyfNK4noie6EkOYoyAcEb1P9KXQo0awgICmQRjLg/NnHcVDeyS+U8qpHFE3JLHfz/ujp+dZdjFez2qRK7CMgAjOM/gOgqZTcZCS0OjLPdTHZjyYxtLKMH3x61NOW27TH5oPtgj8aqxs1uI45ZDgL8vTHHp7e1T722blzgDcTjP5H+lUncRCUeGVXUbj3B+8P8AGr0MyyOu9eMZYEfe981SNw8wOdqEHJxwT9fSm/aBvxJExB6EdOvTIoVlsJ3ZpXFwo5t2EcYHKv3/ABrPHlucCE5zw6HGPqKlihefe6zJHEMggj5uPaoIo3VjGGIk/vLjn6iiV27kqyL0CsIJGaPDL1O8VXN8A3lz7o9w+XeMiojA8ZLyM3oSB1/wpjyysohjcFSMbmAH5UOT22CyLqeTb27s7BifulDwazpPlBaQlXbpgcipvsSx2/moWQHgtGcY+vY1TeOZyscd1Ow7bkVhj64qZXQRQ/zoYHil+XfLlGA4zx1qxaFSSzqQnUY7VSWCOFt8gkmPTc5yB9AOlWLWOSd2ZQ6r3WlFtsGklqXp4gYVZNpP93HWqaJIs65UKOuBTlLKrK5ZUBwpHY+lVtRdoIWllJOSFHPSqm7u9hJdCe8nVo8wSncOqE1mHUTOxgiIJ6FvSoLuc3EJjjh8nnlx1IqTS7BYG87eGA5IzWbk5yXKWopLUUW6x71bhSvOR0NaFoBFZKc8Y4FJqMcbqGyAxxgVOFWWNEAC7BWkY8rdiG72Kj7mOdhJ9cVdGBb5xk1HNIE2xEcn0oikeKN1ZCR6mqihNmzaRSXOiyRaeiMjWxDhcbjLvHXPPTp2qhrcCSTZzH5ixr5xjxgyY+bGPekVLKGysnn09ZmlQuZA7gE5I28HrVjXbeJrC5FnaG2MCxNjced45Rs9xVRta8jK9noFuHTChiZieYt5Y/8A16uowkikZvmAAxuQfoM81msXWRkgXdwcbBsA+p6frSyWhkSJgvPTcxPzfrWcW1sdFkxl1dJFmSOISbCQhY7AfqP/AKxqNLmaRcRWlq0JbJjXLt+fQVcWERuftAti7/MFZSQBjHXrSrA0P72GSKYnjBxgZ9BUtSepWiM5r+VHkMsEkUUeN3kxZxzxkdau208AgZ7BzNK65LYwVOOg7g4qnLaXksccttFNJsYkmRuCPr2H41mapI8W2e4drSeRv3It8OGP4dRxzUKbi3dFcmhb86SBboXPmROlyVCLgF2KggY+nftUGhzXd3pkUFz5flpyw2/J14DHGW69OB9a56F7mw1i5uNSWZ3uosGRDhd3bOegIPT2712+kIpithHM2zb8jKeFH+9j+VKnJyegNJbliGxUo/mXI2Iu5REoRAAemOn61Sdo2jZgY0B4BC4x+I/nU10nzSB5UEJbbtBxvJ6Env7YFOtwxlYBkmfGGWVCCPTGOtaSdnypEq+9ws4XmYCT94q8bYGAUj6tzn6U540gmDxxQxHJUF0yR79KmMby2+ZlMgj+fEKY2j+dQT3InumkEaRxAkeYeoGOh6ECnZJa7jTbZE0EVsnk2cki+YDzGCGI6556DNPRltWRiXuFfqk2C5PsO/8AnmmuftMuxArbfmDyABj2+Xpn8ab5dshxGGCjPyltzN/n8qV0ndaF7qwXt7PcvKweHT9oKHADlj7sOB/Osq4mSH5J45BKpyGjckL/ALRA5I/Ctm0tWggcwtE0RBPknoT7isUwTfvNhKMxy/lgHqOF3Y6n07ClUctG+oR5dSPTllCy3qXkO523FQ+cA93Hv1z71aubmOGNpWmRUkOWVJQMD1xmrcdpuTN35bzAfc2I4BPYDHPFLJaWwDZj+YsASkO1R9RUKLSHcpvcXVxKm+SWOCI5jfZ80x/v5PA9PWrcEkRdmjlmy44wcsTnnJqNbF7QiISOISCRGVIKA+meoqxHC0a7YkizzlgPmI/Cq95asNNkTTiGPe7RzRTbQTuHD8fez2NJbRyOqMEkCryMqC34Govs+4ozvKJCDhCwI2++amhYORI4UEDaHJyD9D+fWtItpg3ZFmSR4V8wxDCtlWKjt74/rUl3PBqM4ubi0VXZdpmPBHH6VHNvP+uWTaDweOvr6U8RxQSebKWVmBAyvGf93OK6YTRk4JjNQ0HT2mObpgjjcCDhkfsRkYP0rgPE3hxGvRP5sl0oBG2Rzyw4+bK8fQZr0OYG5hLRxbgctIi5G30yP8Kw/sarM4uDOzsMlmk4x6ADoOKqrUTWxMaepzlv4a05oo7i4slhkTBA+9+eef0Aq89jAkiiFUAxwyuDx9K2QluImjGGK87WAJb3q5PJYSW6NZxsM4+U/KpPtjtXNJ8ytoUlYwI7IuoAjkkAwfmOAPTA6EVpwaTNEAWk8skbpAowqj/H+dKCkCMY0CtxgBen+H4VnajNPNG6fbtjoDiNfmI98+prJRW8tWVd9C3cor4ii8z7MMFndcSE+/p296vQpCsSEQtGw6jGV+vrWdo8cxiRZImQ7A21v5+1akKSs3mRhZSp5G8jNWm3qibDZoZbiIs4QRq2RtXj6j1qaGRGiSL5UVslTjqfU46VKxCja8ckEbcuMfLn61HAiqcL5ciqSQVXGTTWjuBBdW948zR+czooOCCN2Pp6VThtZY3YI2xT04xmtx3CRlSjGUj5FzkD6ZpiI7RzSqnykYKr1XI/X8KJRV7iuZkeJWdVkjL9jnBOOxFMuz9mETbhHK527R83NSiCNZhlt4J4YqQCfr6/WtOEMbSSMRRDJ4kYD5fXBqYrmVmEnYyrgvFELe3uFmZhuk2HO32NVdqrk3Lbl7nqR9AOtSfZzbF4zIsceS0boMsGPpirNtGYlDxrEUkHMvU++e9RZt3YbLQoQzlLHy4Y3kjB++FwP171Eby1VSj+ah65Ayv4EdDW68cbWwkeZgzdcJ39zVdLUlkkV4cHoQvB+opuElawlJFFVFzDDJEyYHR8/e+tals5RMO2CRjKcZ9qqfZIVR3lIUbsqF4b8vShXkePZlGjfgPjgH09jVR913E9SeGeFJ5EnzhsEYHes7xFIktzbx4G0Nn5RwQBWg4EMQF0vnTEfIScFR71kIrXl8ZJSAFwIyOhHvRUk7cncaim7jmg+0AiMCMgZweSRUMcaKVjm3t6HoAfStee2SAh1dQSc/LzimT24lhd9wCsM596fs/vE5GYR9ovI4VTHlnnnmtS5jESbIuGP61m2Y8kgupLZ++euKuSTifG7ll7mlF2TvuDV7EkETdZV5POTUt68ciKiHD981HPexKipIx9gOay5Z5POMmAE5G6qc1CNkSo8zOo0y2js7Vd13fpI0JuSkLAJjOMYPfvVLXo2hby7WWY20oWVQ7Z3kj7x96tWl3HBYWJub/ZIULxqIN/yEkEE+hweKy9Rvftd8THN5qYAVvL8sDA6BewFNyio2REVJyuzU012Eyyt5UYIyYWYt29+M+9X0uEC+bL5Vwv3UIkAK+o6VVk8uKFjFGzhTtkCOCMegPWs8TQPCVs2ZpG4xyBnPXHrSUuXQ3tfU0vLl2N5iM653xmYlQPYetVJ5oZZyl1dRWwHKoq5yfpnpUNrFOyul2VnbnImZuPcqP8asQRwoFeG5ghG3fvSIKR+JzkUr81rDtYQpEjg2zSyuBvKKpIUd8jtVC4to9QmEsgktyoGyNsKVxznI4Gcn9K1p3llQxtdyiPjDAfNJn14/nTLiEIi7HlV8EASZYs2PcdO9OcU/dtoRGXU5fVdOf7XbfZLo3C27CaVjjPHbLe2a1prZIp0mhme2aTn5CGU/h0/Krn2BGs5Qzb/MHyuM5LfT+VV7W0E1hC9zIqSNGoKOQScemOlTyJbIq93qRPLn5ipunHAnMZUfiB/wDXqy18kO1xJskK7QMbMn05Ap9tZRCffb3Fz5vUkc5/LrUlxDcTJKs0sEMJ42sP3pA9B2+tOKaT0G2inGwVB5gE0soKoivlgM+x/nViG1lmaMXhMnTEKDyhGff1P41WisbRLZlW0glLNhWRVU5988/jTJbO3+zuotQxX7zElsfVs8fhUrTVjNWdXtYWYvsZSVVXAX8Sf61V+0Wqk5MMt0Pm+Qb2x68cYqpaWKIrMqIA2MjaNxGPck/nWvZW8iIg+dlX5iEYYA+gA/OiLcnogasVFkvZm8xJTbW4xzgc/XHT9apwPFHd/uzHLboSIzltu7+JsdM9F/OtKWB75riImRZIUMhcjAAHcjP5Y71X0mIwQYin8hR0EvBz3OPenyi5r6F62tVdGNpGoHO4pJnn1x+lV7iI+T/o/mNtB3P6H3B/CnswIMb3BJ6llyuOPyNPhiiVdr4dicZAIz79auyew1cz3gJg+UGZQvzRjgA9evY1YtIAsSy7kXJCEKRuUnPVT1q5JYILeRF8oEAjc4wG9R9fwqhBaRqu8WihAuGbnOT3A7/pScbPYd7j7iSJ0e3WTYgxiMQn5vc+tVtrIQoj68MwPysO2RmtK1tFkZVWPfhQQ6bsgf3TnmrV1FCPKW2Mar1YOMnryee/tVKLauwvbQyoFSMO8kQdWHG0YVSfXPb3pBuZncvsZeDGSH+npke9WGe0AJeRUkz85dwCPyHSpIZbbztzxoSD0GWI+nYjijyHeyGRRvNuJZY2HyncvI+h6Us2nBbeOWJ2bcDhVAOPXkds+tWHuYwuWlMaqQMqCR+Jxxim3TWrA/wSkHCJICXPstOytqSm7mP9jvFjkVnCgjOW4DDP5596zmm2sEh/efNhkVBwe4zmtx0kuMrIFjiHAGNozjo+R/LApotESEGKOJnzxk4wB2zn9KycOxpzLqUI0EkbF7qcxjkJ0X6HuRWaY7i1vVmhtwgjOVfaOB6VuJaxW1x5szEYzgBge3/6uaMqYXjAiZpVz5i4YqOuDnGDQoq1mQ21sVrS9+0mJbQs2wnDSfLg+xHWtFJLiA4W6QORgnjGOhwc5qjDbyqdq/u8DngKQT6H3q7siitUJKux6K47+rDPFJSfUGiSJNj7nBJxyUfdgevORinRxzRsrHfsALAHpj1B/pUNvkIxJRu5O3A57n0qVftJtzG0qtaKcqFxuH171SsTcjkmlCCVpH+fkYORj3qKKSOeP5mVUQ8lQTj/AHsfzqw1m5jeUERheHK45yO47fhWXDZyJIXiYFh8xKPtyPfPaldrVoLLoWLtv9JIRlYdWB+6fYEdabLHM33gnlhQylf4c+p70gkXaIxB5cpPDht2D15H+FOkuXLbXjjBHdV+UnHr6VLsPUWzlVZAz7UbOEbI259zROjRXBKBZZGO4NG2DjuMVLEo+zllhjYY5AbOPXcKqKNsm1Y4lhHdW6e4Y8j6UPRJCLkct075jVWyDg7dvH06ZpI5d27Kqzq2W28H64pRdyIJIfMYCT7xVPmQ9PmWqrMUILFSQCNwGcflVcyXW5PK2S6gySIF+VhxtbBy3tn1qowRdsivHIG6pnB4q7DAjHLl0+XqM7c/SqbgktJEsZjY7mz1cDjgdqck73EuyFuLma7hWKQHyQeH6sD/AHS3pUkFskKK8jnO7ltvC+lK1uJF/wBHkZQRl42GCPf/AGhTIFuFOS2/bxtP8Q9Pr7UPV3sGysTyFBG6SFc+o6GofKa1t1JcCNxw2c5H0q6yKtrFcllCN2A9DyD6VQuEDeYqMAG52Z6fT1FN6biWpQl3JOsiuCM8+gFWbxWOANoU9XFVL9ZEhMbjHQqfWrao8sQyCAhG7jgioV9UNrZkMksds8SGMEH+Kn3McfmEgZRxkj0pVbEpRxvTqMU9WTzozcKZEzyinaSPTND2A37W3mOm2K2NpayxBCS0wVm3ZOep4HSsnWInhvM3EMUUgAysSgKB+FWVn0hVIaxuMt0/f5/pVG4EMk4+zo8SYGEZtx+uat7aGcb3L7D7RcqHgLQRqR8q45/vEVciZnhVrSS5itc/PmMAZ6c1HIUjt98g8px1ZmIc+5WoxDHJlmlmXJHzIcD3oV0a3uLIiMxWC6RyG2t/D9Dnv+tPht5IQFCu4PzfMu1D65PemyxReWpVZ5VJAwGAyR3NULu7dJDDp0SysBkyEHZGfcj7x9qltR1aC19DZlupTBsaaPAO4ozHdjpwfTNVb3yrmRY7tBg4+YscnHt2FQWqAoJbrzLm5kOdzZ2r2AxjI+lWB5khX7dsYrkqJJAAv4YzTb5l6gkT+bHCxLIFJHD55A981kaLFdDT4Y4pjEcbt5VSD+fWp9Rt2mtPuBHkyscZc5Oe/PbvT7NFjgjgEqPgbAV64A/zzRK/Nqg9B8SeUHDTiaZm5uFc/IMcA5piTwqyRSIyu3Vycg+mMVEktvFdfZyJZ3PIUAqAO+SetXbNSsuC1tDGSQquAx9zSTu9BtFeXT0khTe5jfd/qxGSCvu3r3q0tr+/WPG9W4VpF2r9OMc1PO6RzKhm27V3KmPlJ9aqiQhiPPidyeuMjHr6GraigV7E3krCfljVyOSccH6Z/lT5dsiq7SFwAD8mAf8Adb0qN5opEAdnITgyE4Uf8BrH1m/V5lt7GES3E/ypIy7QmP4sDsKmU4wQJNly+1Q3UjWtssiW7ECU52ggdifWo4LeKS6cxMckADDAOR9e+KXT9Paa1Xzn3eVnKngenK4q99hiZozPhHwcbJMY9vSmuafvMd1HQcsRUMfNBJwFXdv/ADpyqPNOM4XqThlH+7jpU08ZTau9MYGW3cj3pUHltkyyOG43oQRn6flVPewXII7eOPPlrJufOW3AjHrVmFGdsJJOzoAoAXB/nzRLJ8sfmRgyA4yDtDe9RO8kkpYvFkZJ5Y7vr70N2YE6bIH2gIcA/KeCW9Cc9aglhkeYuxhhLdt2Q/1J6GkguGe5Ajdt+cEkY/4Dn+tWTGSwGxG8z+OTCn8wf1qk7i2KE6IzMsMOF3AqRhsHtkUs0D8Mdqu/dU+X8q0D5ZGH3ELxhHA/n1old1XEQMSk85ABI+v6UcoNlGaVIYSECG443fLgAj36Yqm1iCrPdxxSljyxTlT1HI6Vsx2oFwWxG6nJGCcn/H6VBHEhkbcZGcDChSSSOnIPSplBsadjMdJvKLRyTLtIyjShwQfr1+lM/wBJjkMkkcRJHyjOGb/gP9a1441uPkmjlYBvlK4Jx79Peqtxbg5CIhUH7pXBP581PLpcq9zLlkkO8SW8uVbG1drD6kZH51atWKvj7FKTjhXUZz68GpmhXYTsIdAMhhjdzU7XSIixhhGhGQN5Bx0xwOue1EYta3BtbFeRpGVhKkgbOWCAMc1HcJ5jq6KCuAACACfzqzbRLCxPnAqwAAj4JPv6/WluZ/Ij8yNEXaSFywZs+mPrTcLq8iSsWBAhQMhkGX4xsGeh+vrStvjRiVO5QCDkOOD1+lQCMOolkPntKcsXBH9avpcRwyZhRM42/McA+/t9KlK+7AphWjWJ3byXJ4BUrkc4I9qJI0XEszs6YIypLY/pU8sYlkdz5qSOCA2A+Mdait0cMRuZhyAVY49MUKIMr3gsGby7TdJwDvVgGP0HUCoraPaCFEqM3IU4YMB2K9/r1qfUrR0YeZHHyMlkThfTPXn2qk1rOkYeORmZeiuMr7c5yPwNQ009h30L93KrLGtlBg/7PBJ9B3Aqkm1vMEhl+0OOUcbgw7fWrEFzGxMV7bYJACHfuDHqBu6n6dfSqNw87zZLW5VTwCdoUc8YPSom+u4RXQuWywiSOSQyRIuNro24Bh/CQTxUMyq1yZU27yeYiMfjz1otHDSEnDOcbmiI6e471bitLZmkeZpY07Kw+8PQVcU5KyJbSY6C4hgjM4BYbeChyG9iD0H8qzI5vPaSe0hEaBsFWbO1j/Q+tA817zzPMV4s5DKRlfy7/wA6sXDCQZj+WTd8ygbS4PqOxpOTl8h2SJYnjaNd7PGQeEb+E+gpt47Ox2KQUOXQD5j/ALQ9aekcDbTKrRMRiNAMgnuP/rGqcoeVkDvhVPylTgp7GrcnaxCSbuOmnxEk0YAViA6Ed/aphGC7RNv343RkjGB6VG8cYkMhhZ4WOHyOh9cUj/Mp82XcqkBD3Uf4U1vqIZNGbhYxLHIu1sMx9R6VoCRljKgfMBzhfvCoW2CcNGSVx86jp9am+0rJCNnEi5wfUfStI2ROr3MqVTtKAbWHOasQrH+7a6Dbe4jxux7VDex7JEkBPmyfNtzwPrTfMeQhywO3jaByKy2bTLa00Nl7C0ljBgtdVmhI6xqpGfyrOuIPs995caTxptBVbjG8Z+lbFtdqbW3gNy8atA0DAA4Rs5VuPw96yNXvYTesUlEsqKitKP4nAwTiqlZaszjduxaVLuRjvjUquTukAz9CSeaeksUE6iWVXfGMIOB69OKLIpfKTE21s5WXfwalklUym3DSTFgNxVfu/Spja10aN9CCaberwjzUhk+9FC4OR6k/0pLCxmjYnZJGhQjb0yPTjFJqMUyXcOx8xN8u7aOuOhArRto3KLuiAdVzuGc/lVWvOz6A3ZaDZZV0+FCI2WVzztbOCRVFbgb8SwcR8nGTIw9SfSrVzezRzSxmRI4WG3dt25+hqNIkmhjyFMKnl3X5jnpn1pNuT0YCq73O2UlXQZVEA+4Pp6mprWKZY2AQpGpxuCAnHv1pk0bLKgacSAjgBOQP6VFtZeIo5ck5K5PPNDb6jitDSxCZomBMsiYO5OcD3U9aY8Maq5QhCTkbowc/QVVhuY4hGjbomY4KL1+uetWWieO0Z5UZUYlmdsZH0PWrWomrCM3lxyPK8CDHKrHhsfQiqdzceY6pahPIB/jAy/5D9KaHkuSscQHlE7t8rjcV+lWEgkWZokUeUOWbZnGfQVO4xOXSEuzSEEvGFQD8x6fjSW1v9nmnkvys0rjghcYHZc9selPnkZJmSN9pb5do6/n0q7FG+xhLKyMPunOQfqarcWo+1HnoDBAAV4HJyc96S5CRxq5mUMWzh8jH0FNmEsLszS7do+VdtRPmRQJdnmEcZ4Cj6VXTXcRM08cm4wiOQLjLsDx9O/40kEjtKYpEVJCcqydgPeogsUQVI1bI7q3T6CpSnmyJJHlnb7oweTQr9Si68A8tmaV+uMZzuqjI20qsSKOMZPBH5UqTrGWaT5gvJBypPp1qJrnyQzmGR5zz0BH5+lU7ArlqCMwT5liQkggtIxIH0NOnmjB3KzJjgqG+Ue+Dmqkckk0gkdgCeNqcAH+tXPsZfd5zKgAzjuOKS1VkDELxeWjEM+7OMYG4emQf6VF9ockokUsJJ6yHOR9OlXP9CEieXKA6jJXHH/1jTImLFnRhgH+91+tNoS1I5FcwAm53KMjCfKfw9fzqGdsJw7O+MMAwBFaDqIsPsZ1bB+VT8ue9V5bXziQXIIOVULggntz1qZRZSKkEkcUEbOCWOWXD8nnrjHJ9qdLBNdrGFBGWw6E/e/qKmW3iiViQolVvlULgkUwrI0e4qQobjAOVOPbmhbWC5Wa2W0xtVCmcFhzj8e/4VKc7Q0ZJKnkseP8APvTGiuCm3y1+UE7iOPbnNOg4UAR5lIxgcfzo02AgWJphvV0R3BLDaMY9s1WEgeYLLHwB8hjbj3OfU1YNwG3QsGypxgnhfYetKhUKTEse9T1VRg/SpvcHcWRo503rFNhQMkd/b2qOSWFgsYEhOPlYDB/OrVsGnuMLh1UZBTKle35ZqndM0EhR9jMuQFYbtlS72uF+gsRYxvlSRjh8bSfbilS7uLcRiIrjOcnBJ9jx1FTQyIkckrgs4A4TufXNZE900zYljAJ+4Opxnt2ApvTS4LUvuzxiR7iQu+7cGDHO7/gNMjkSO1fasazBvvMGG3PcDn8qrWlkinzBIVTPJVioX1BHenIBG7HLknkM7gE/QGofMGhWkgWWCSO4iVkYAfJLgD/d4696ZBaT2WxJpElgA+SWQ5IB/hbnkc96vvBEUDyvEigbiVPX3HcHNRTXccjTW7QIAQAE+8zZHPTr+FQoxT5pBzPZFOR0SY7hHCp/iibGR+P+NaLMelrJGIyA+Cchj/Q+9Y0U0i3os5jG+2PdASw+dO4+bqRx+GKsR3oXy4vMCxN84Q+v+yw+nQ1Maije47X1I5SiTgFdrZC+apAJ68EdCaktGgjhZ4w8kyjAy5AXjkMKrNGMOY9ssR++ki4de+M/j2ptxI/AikZhjO+RcMPqO4qOblHZEs8jzqpuGQxdcxgkN7n3FW7FGuYwqlSUACNnqOx561mRXMsQfzo40kl42r8qv9MHg1rWwhTarGTGzC5Xoe+a0pPmd2RMdKVjleNmcqPmP+16kD2rOvmLoZSoeT7qlOh/+samleVn2AvMFGRk4ZcdcccECoEWPby+wN9zB/iHYj9RVTk5aIIq2pPDJLAqEL5Zclgp+YA9xn0NSXDJCsU3ybZCPu9VzVZpkhGJ1JjzkOBnIH8Q/qKa8joDFdQK0M2PnQenRqfOkrILX1JtoQvvJJ5PHRqrwQeZIDsdlJ5xwc07BKOQyb1GCMfeXsfrVu0v7iyEbTQ4kYfKGXOaLJtXFe2xfcy3NpaxWNxBC0AKyxTOEZXz98Hv2rI1s/aNT3QlZmCIksyrxI4HLf8A166GB5IbO3a5vNOjLqSPMg3MRnqTj9arX1jKk8l0s1rN5ar5ixLs+Uj5SBjHPqKuUebqZRlysqRWK21pFbRlNkYO0jCtTdNlb7U2MLyQGHJB/wAavXFlJ9ijJhUMe6sMj1psEIjl8uWKGJR07n60vZ8sk1oac11qSRp5J3PKHZSdoHzMoP8AWpxfRwqV2sZexZs4/CkaSJY5A2zj7rBePxqlBHDDJI4XzQPvyE9D2/Cr2egtyZITc7/tEse1mDkv1+gHYU+XerGENEinozHhvwqxaBIxIyqHcj+I4/WjDXCkKFGB0Azz9aOWyHcrOrTIT8ynPzbcBT75pVjkdCSHYgYzvI49qSe2WMh5yvyj7qthj+NTqhubRXidwvH7oelJRuxkMQgkkRkgVp1GPnY889qlu1mlkEbE/J0Q/wAI/rQrQi5Ec6SBjjDM4CirV3GZHIeSN8AYIyDVK9hGfbx+Vcb4FUxgch+qkVaW4uWmZ22mLdnaAFIPoKAbdXVDM7DoAF4NSxoHgZ9iMnbzTyKFG2iKuQLCJy0meOoBXoPrSJd+WCnykZ7DGMfzq4lvDJBtllZXDcBDnaMdhVZ7bYWDkKpBO9uhH1p2cdQ3VhgnMkjAybCzYUMCS3qBSRxwPLJvj2MeAWUkfgKdbrBcXCzuzRTRcqS+N1TzXXmSFSjsc5VlPP0pXvqwSJIpEtmVItrbuCcYzn27VJEcyL5TsMDlc/qKGmlCKECvCRg5Azn0zT1WHyVYtslJB9apdgZJNaNO4nlAReCoc5zjvUT2sRV/LRSTxuUcrU8jFjkN86cksvLD1pI3YyFo1UlQSobjmndAip9jcFhGzqRzsbgN9KdEnn7iQN45Ybsn64qxctMyBwWO0ZbPamSWvmKphbMgGU7/AIUWQxJ4kRlUBtq9Qx7nuD/Snw8xnbt3emAQ31qCCZZFZACJFGHVjwfcVctVURbiVI744I9jTT1ERmQxxt90PglQTkEegNQgytbs/klIicDByQfpT5JAjNJDbqB0w2AV9xTi4YmZkZQTjJbofane4ySG3Xcsm0kjqRwT7/8A1qje8cSop3c8FiuTx/8AWqzDKtwZI0Uh1HP+1/8AWqOUSLHhNm1uFOASDRfTQlEczRZQuW8sH5Qe3c0z7RExZlLLxgnaDx7VPBbeVC+8kjHBYjIPtUKjanKgDuepHrxUu47kNzpoldZGjLKoJL/xEfT1rMMMsUBV8PGSdpzgAela63G/CmZ9ijucbqhufLmjQKzkMccnG32/nUtLdBqZ08Mskm5TIkijcCvy59RVaZAUSIPIC2TnODWu0rxIdzosh6L3PH+FVGJMpfKgHkbwDx6mplqKO5ntBuCPumUqRgkc9amYBAimPDHO07e351plc5GS2CDgdqrXQRp2KhTGOSM59unTNFuXUq6MyOSTdtRBJvPG0AAcfz68VJD5kjuCIfde2B3HPFOuYwNy7FYDkk9fqB/Slhil8wMrBJCf4E/Uf1FRy3E3bYRIZIIHkJG5gwBDZznsRWZDcwlzkRsWG58ggg46fWtXUACqqIllk74JIx26dOf1qh9ne4UkFkI5cbwSQPUdc1M4u65RxatqUdVje6svtIMbmD95HIVLFtvVcjnOMj8askWz23nFHdZVEibDlTkZ/DI6ioNSJtLZpGuWW2IJkKrkpjvxWBpmoLZ2FqqyOAyjDAZ3Ad/XjjI/Gsm+V2aLS5tUaksoiuVcRDYoIAjfLLnoQD1BqzZXsLyxCN1SQDcm5MqWHUD0Psaxb2R58tDEHIfdsds4z23D8SG/A1QF3cxTIs37skYKthg2O4PUEelYqo4SskaciktTqL6VoZvNmAmSUbgAcfL7DtipYbsJEcgSbc7N2PmPTAPrx0rG0+/g1UyRXFxDHMv8PTfzwwOPz+lQaxN5cK/ZQkJZ8vhsszjqB6cDitOe15oycPss2jcRXMCmNzIisCxzteMepx6dM1djSK3ZpGUsrnaCv3M9iw6445rmra6eTDxgNcn59+Meap7/AOIrRi8+6haRV2wDGWPyjHqD0JH9KKcutrsJRNARuxQSZw2THjGCe4z/AJzU/wBljj04zA7o+cbDyPfb296pSAS2wEUwVT+8fbzt5xuHuKEmRJ2AU70bdu/56ZHb9a3UrP3kZ6sLeV5Jj9oh8psHJ6Bx7e9TvcG6l+aQyKoCk9x2GfanLLKVVZdhA4BUcjPeql9Ht1COOBgyOPvEYDf/AFqq/Kr7i+JnTWNnFcWUR1KGEJEpjjdp/L3qD6c5wT1qlqMk6NPA9usEjNGnytkKi/dA9R3zU0UtrcWVul19pSSBTGxjQOCoJ4OTwRmqt7PuvNxQxwLEiRK7ZYrj5SfrWjSZkr3LcFw+7ymXajcAFc4+lTqjBvnTp1bODimk7lT7TheeDuHFNu5BGy/Z1AXoWY9aV7K7NOpDujUS7VDtJ0Tf1+tS20NxLbYiicA9VUYH4moxMhI3DyvYD71XFMsoYC42Jt6A8VMbPUdyN7eKNA8oJl7gN09qdE77f3S5RjjlsCq8SxhHBIlY91PX2piN5chVkdA33eeBRe2o9y7eLCrRBoOD3B6VXgmVZjGu9FPV/T6U4XqFVTiQ9AW4pFdoHBYRyMeOTxQ3rdDSLkskPGE3Sg8yOvDD2qHyi87/ALzjjI9B7U4tLFzM+d3TkEAUySEMGZrkADkKPT61bQIuWlrEsIdGBIJwvpT44QytuMfAyAx5NVoLlmRGUo2OMYqxJGcs4RVlHPyniquuhNiG2SOaYqxCDPDHg/hRIgjm2h/PQH+7TpZkXEcjEqf4sdKldo9+I3ZOOS1JW2HsUeGk3DHPAVl+7Vm3jIcExJszhuMj3IFEh3kZIkUDBKj+dTySIsKxxNyeQVGCD6GhKzuDY24WGMbYGLIeWIHT8Kb5UcZ8wEhPVjilVgYMKFV84ZieW+lSMBJbiK4yRnnsaN3cEyeyKyo0lu4ZCMAk5GfT6VNG4AXeoUHgjr+tZ9ksdu7JArCNm+VWPT8e1Tyu6RhIj8ucsTzTTdrgy0CSWUqcKScn+IVX8yItiNWGT86nP6GsO5vrgajHIJGVDxsIwHH+FbEKSvGZDCfLxlfmxTjU5tCrWKeobt63NrksnDA9x6GprSWFoTNBu+YfNFzg+9WWhmu4v3IKZHzHGDUGixNZmWNm3yxuSuMYOaLe96g3oSPuS3UuXJOcHPBHb8RTkdm2x3CJ86/KxHU1PI0TIZlCBz/Ceg9Qf8ajUM83l3BJiHzLgng1Vn0BO4lxJMkkSMAFJ/hXHHvUmIvOLQKN3GWBPX1J70/ZHKhTgHrtBOc+uKUSw8wxqV3DBVjwfce9O1hXK2d9wXGWIyAF5GO9Jchz5hWMMMEbh/Dn1peFjyeedu5l2/n61AMmVSgOD97Bz9cVOwxI2ktJmjnRcuMfT0IqtdvLCu21iDFeSP8A65rSg5n4VXbplug+nvSXCoVk80hJicdMg0lHQltmFPLqkgDCzs0UYKKZCzj8elMtr+SGQm6tNqkHcUIZc+vNbpiUx7GU5xlWB4IxWfKzsF8uTaoXuvBHcfWs3Fxd0x76Dor62uGKKfLWLGdw+Yc9qR0IDkNtO4tyuQw7ZrN+xpc3UcWP3ioxDqdrMM8GopGv7CArAHvogc/McSAd13dCPanz90Kxcl8zlFVQmQQc/pmnZkgVHjj3biT/APrH9ayV1uSZMRWV3LITnBj2fL7t7Uha9ukZZ5vJUfcEIyVz2zSjNPYbTJHJN6Xa4dZACGQAD5ev4j3rG1LUfst2kFvcQrOy5M6fPj0GwYyce+Kg1PToFun2ysJGAKO8nf8Auknt71VWZDAFkjFpOh2u6ZC59fb6jPNYub+FKxrGF1djbu4+0MWvbmWRAcOdgTb6MIuhH15qpfQmMCMqVEWHjkST5SPY9fwP406WZfMaW4jkkC4E8R5WZD/EG7fX1qEpcWwaSLMkSKGkVGyHUj5XHv0B+nNZ2urvc1iuXRF2zmETRyKqvbucoy8+ST1jcehP61Z1EwXc0sUVrJHPgl4jzkrjcAe4IJPrWA0gtZGktCBHKquXLHG7HUH3zyO1Jc3k4u47a6uWjmVQ1tc7thUj+B+3Q4zWqaa5SZQu7leeVzcoIySUjLqGx+/j7g+rDH44qe6dcRktugKKRng46qyn88enSnOqTh7ckod4e3JODbyckjnnaT3HTrUc8s76TIk8RV42PG0ZAzgq3oQRwOnSodJXKcia2lmtbrzYJIwodWdVICAngOPRT0I9a1nv1ktxFcKUbJZrdhwjEc8duhNcvCzLKsdygKCNpUJ6SRfxIR7fe9utStNNJdh5Pn80CJZCclW4CuPY4FQo8q0JaUnqdPo+rxiV0ZgrncqB+m/0+hHH1q5ELdWMuJAkhwoA+5n+meK4q1dru5y6qgciJ13EeU6jKt69jXUadrawxv58UR2yeVMGXO044bH+c1FN2aUhVIdYnS2wLCTJVAMiQZ4P+0MdPXiqskEEDLHe3kUahvmdcyFPQgDt7VDHqUrzMlzcmAKN0YVQFdSOv+PpTltWnu/s1qquZCDsOFGc4KmutuLWhy2admbqNYNE6R6t+6dclfszYZu/eqGqzW7apEbd1lt/Iji3bCvbGefQ1NBp9jC6qNVgTcckeWxT8/yrL1MHTdTNrOokaVsowOUORneD/d6GnNyaVyYpXNGzuhLPLEoEpTg5FaETG3CiQIAx+6RzUUKLFM0oWPB7AYpbjypfmdSpU9QaUU4q/U0bT2Lc8CNIpVEJJ4BNT5QAIBHgDBweaqWsavKi7WB6lmNPuBLbOxUK+79K1T0uT1HOUSVRGVkTqQBUkjWxUR3SqUPI28EVSlV4oPMjxk9Qp5NSxMSMtGjYHIPUf40k2Fi09naq0bKoCkZyOajlgGPnYAH7pxUyXBYDzNqpjAwtDSIqKki454brTcV0Em0V7dlX5ipyvAY9/wAKmhhEjnA3k85PFI8zFfJijDDOS1SR74eZEfHYr6UJFXuOs1SSU+XGoY9ugqxcJGkbQj/WkcEnpVFplWbzItwT09Kso4llR5SNp6EimmmrCsyrDbO0WU2nP3gxzTlSVnLYKxLwzDkCrTiGKRwQwJPY5zULXAOYom2hhjB/rU8qWg7gsGJD++G0jPA61JaRGMGWKQcHo3Q1CyGBVkJzgHBHIoR1dd2M7+nYZqtAuWJJfNfywduR1A70/Ehtym1tqtyW659qhRGyg3/MOwFXVkZweG3p0Ujg1S1EZ/zKw+cls5IAxUqmXyVXqu7IJp0kyYIMZU5545FKjcsmDyMjHNEYroVfQWO2EwVAilgcr2Ip8ca7milbynbOzLcZFZ9vcxvOypJiRD16itG5dxbR5RWPpjke9EWrXAsWk6QoGlYmRflZCM5+lQSiOTUIisWIyCDg9BSafEHuSXyOcjJzVqRFWUg7Qc5x0q1qlcnYW4VFmB81QHG1Rt7+9ROCiyZHmsoycHnFSXLea6BCzlOQe4pkMicsE+bOVk6ZPoaHa4xiMgVWCBmb7rZx+fvSM25R+6y5OC4559QasMgQmTKYznYBkH3oYIzERPsjxnBHH0osFypNFKvyP824Z2jmlgTCbJMDcM7T1BqWSY7doGVBGD0I/Gq7RPJMxeHa6jl1PX3zS5exSYRKEkMaSjdyWOOM0L9/BG5WHBzzmlW0V4ZJNmX3cnPbtioolAYxlh8mfx9qnUGOMBIc+a4IyCevFRXkeyMOAQhHr9714qeWRIoiSCR0YZ5rKvGmnVVTzCmPu5x+dD0EiKw+S4Z3coEG1D/s1ZdpI42VT94B+R8pOeoq3bqI4cBcFex7mi4CvBLuWNXzuwTx9KSjZWuK+pjSlCEyBFJyANpG01lX0/lZEoduPvoMK49z2I9RXQSW6NC53fKvzDBznA6Vzt7I5jJChYi24Jjr249fxrOcWtS46mL8koM5hkubVs5j6SRnuR/OoWZmMT2zmRgPk7bl6MjgdD71Zu5yiwzBX+Y7ZdvAIz1x61VR/st8pEkslnP8rEYyefXsaxUVF2NruxmRyqtwEh3Rrk7SxO056q3+NRiGKKUWa5QSMWt3B5yRgoT3B/pXUy6dCgjM7RyxTEN5gHMZ+ornpUjtZZrW+cSWb5KsRnY3YqeoH0puDi7McZqRUsJTapcWl4jeSfus4yIW6Ycdcc81em0m3ltIkni/1ke6B1ZiJAOoB7456VXuEto2imuvMF+gKXUTjKyR9nRh7Uun3gS0mtIrgXFouZoopSEZT6o38x3+tOKVuVjld+8jNtgVkexv2GyJMJJwSIzzz6j37Gn2cbpqBiuGYTITDMHJIkU/dJH6ZHqDVq4doIvJ1C2juCozDMqn50J+YEg5Yc8gcjFZLXYuUxORI6f6PHLjqvTae/TGCarRJEXbNe7P2SZrTCLPGRNFI4+aJgMlfcEZx6ismbyf7LSWE/v42KFRkqEOMEH2bI9uKlmma40/ypvlWA4jmcZMecY3d9uRwex4qpZM4u4omQxJMSjx/wByTbyOeMNgEe+KTXQS0LM05ZEvQELMvzKoABYHoQOucZ9c1IsDG4Dws8ckowrnpgjKE+xGV/CkSzWEM8RX7JPiQeYMhW7qcdDkcVWluVTKSBY4wQm5ARhS315xz+VZTitpFKfY19PmlvbJMEJNGSjJk4yP4SPcc112k3pilhntSm5VA5GfmUd/XiuU0pRb6zC00X7q8JtZHHKrKOh9ux+hrbsdWe11MyEqJYn2yEAEEr0bHoQKUI8mrZnV12R0lpdaRLZyt9g2lgCENwwjx7dx6VQuZV1G9WVIztZViYoPlCgYVR6cVpahrU7SLcWUI+ysu8r9mVlB4zg4+73BqtBcO8sst6yjC7SQgUccqcAVtdN8pzpP4v1NKOAW8x3AmInJFTCTBZgMAjjIqO2uJNsmfmH96mu0boQ0jHAFWmraFkyb4gr580E9fSkuJN7hpCQD3pjM00eFcqq9h3puzdFvUEkcHNDT2QFoTxiD5clz2xxUKZRwv3nPQikhk3AKxAHtT5CqXAZBhgOtVoxIvnzJEKZVABk7h1qo8gDhGYHHT0psbM7Eh8k9c1Q1uC6a12RrsB6FeoonK0bpAlfQuyEwusqSHZnGRV8TgoSSzJ2PpXPaWJxbCK7JZh3rUtZQqMsmGXsO5qYTur7XKaJoN8udn3h0p/7x4mjdTkdMnpT0nCwsI4iCefemrIPlbzCHPrVadBXEh2xphQ/mHglqc1tvV9zAs3BXFOu5ZHAJK5B60W9xuk2ZDnuT1FUrbMLsLfasYgYtwemc0pCqmf7v8OaQIEdyuRnsaNgEqAN9anUBy3YiQB1YhuflouLzEf7pZJOeoHSpVCLKNwOB2xVyExSsEBEeR0HQ/WrS0tcLmZFcOF2sjYPzDcOTVS81BhJjyiikY/GuiuoYzGAMMcd6oNBGyq6kNg9KdmtAbuc9pgW2MmNzZOSrVsJciaMASOrnhQavLaRMGZot7HkCqd9EkbiSJGTbwQvOahRaWuw7sWOKaBkYyD6g1baTzQqsv7z19qrmNWiLgFlK8D3qrDdiHctwCYcY391qtELXqbCIIwEDuMng9aS5hEioQmyNSCR0yarxys7L5D5VhncO1X40eRdkxLg9x1poCSPzPKJgRVjY8ZPSoI95iK7N3XBBwR7UluxikPJY54B6Gi7ZWVXjT5h95c4xTAgEzLburYDMfrUcd3cLDtkwME5wOop8G1UdtoUN97POKkaGFuVYFRyPr6UAPR444kkiY7CfmJbofpVDzmE+6Fl55LAZP5U9oI3Loc5PzBqn08LEsmdhkB2jHelrJ2GmkR+WFjZ0DfN85yOnvSSFY/41GRlR3Jq5c/8AHqwXKO/BwcVVMcYjj3LllHzN6Gh6MRA8J+Wbfklc+gP4VTubjZv81S5KhSvQ49frV+4eGOF2jBkZ8HLjGKzrqUTyxlkBfaQRnJI9jSaC5VaZ4WbYxUr1Egxu4ziuf1h2d0WTMMcoOHA4B9R6elbmoedHbxxxszKX3MHznHSuc1eHfAkSr8hkwT0K+lZVHZamlOzZWmlP7+MgCZcfK3G7/aHv6imXOyLZIE+0QuhaaJDt5HR1PrVq3gW6tBIHLX0Y2Fj1c5wPoMVntYzOfOtgYZgSsi7vuH1x9aiMW1dGjaRc/tGLy41ut6GRSUwhCuccEEcZz1rKu7yHzFE6OsTgC4Vl5U5+8vr60yO9kED293ZRzeUxWRlJ3Et0IHYe4pZNRmRDGltHPZKnltGc5j9Dz705S5ldv8BcvK9hqRTW01usNxB5SHdazCTK7G/hb0+hqDU7WC7iFxaLiFHLSoEw9sT2z3HcH3qHTFiaee2WQ4kjMkTKCCSOqnNaLQYu3WQCMzxqP3SEo3+1jtUJXjoU3ZmdGv2e7t4LqdXhlba08Y27GPR8duozWX4q01tPvjFdxiKWTMbMq8bweG45wf61fmZJ7W402XC31s++JSufMUA5APqOtZ99qkurwWi3yvutUZN4GGJB4Oe/WnZOPmFncq6Vqc89lFaySx4h+QEqPmQtkhs9QDzUup28ttqQt7qdNm1UDDj5MgpIB6rkfhVB/NtZFuLZSjlWljdBkYIOVx34zVad1e1hljkVoQu5STlkYcFCe46Y9qtPSz3M5Kx2+qSLLay3CRJauU+aJWMimVCBIPY5AbHvXORSLNJCLmURQXIcRsVyIpFIK8+hAAzVnR7oXds+WJ89WI4JHmqhyB/vKB1/u1FJIn9m3ECmH908d5DCzbixIAdR+BBpyim7oiLdrEaXJcXNipMbiPzIcnkMpOVz0Jx39q6fTr60tPEWkX1yu22njVrjjPQ4JwPQ9R6Vx5iE2lTTRtEJrCcSAZ+Z0bGCPoRj8a6HSLKz1HXdOKoyab58cpWVwrFZB0yf4SwIz71m1c1bR6HYf2zNbXHm+IIDNEWCTR3gVdueu3tjOMY9KfrV0sjsyFZ/3aCWVRhZCFAdl9jWRaXlvqGqT2GoWdvpeornynRPLBPQpID6grhq0/EdubW9sbVwUEcEasg4BBXBz2znmhaR0OZ/EbaLGjFIXDeuKJbOXb5mV+lJDFtHIG/61K9wUGxssDWi21HbsUZtxcbD82MYHSrVpG2wiYEDv71J5KgeY4wOxqJrsggKMx55z2oSs7yBu6KLKguT5Snrxk1pW8LJ985z6VJbQ2zyFn7jOKmE8ce4bD169qqMerBu5TuGFqmG+Unv3pq3jOqkRM+fXtU80CTKAQS/WlAVNqjjB6ClZ30AgmguPLWTGxWPNR7ZI28xl3ADitO8ud0AEfKjgqKoZeQYCkDriiVrgrksNx54JAII9OtKbiBZMbCR6mn28Xknft5pWhBYuMAnsaavbULLoI48x1kQBk9DUyFSD+7QPnqO9RRAKAnIYdfeqN2Jo5P3QYKeuDzQ3bUPIuiRJAykHeD1JqZF+ZSpPHJxWXZagkk+GiKhe5H3jWqhXeXLDaefl7Uk1JXB3ReUiMgnDE/3u1NuIv3qNjaPUd6jWUOCqjj+8RUjzSNBs2goOCa0TQhLiZvLIXGR+ZFUrEkTYxlM5NTIpuSqBQAOpNDWoimZY1OT70b6lJlyHHzAO3XqDUjRlPl2YBPLdqq2sGYim8ZU5PPNXZC0MZVZBKhGcdx7VaFcJlNvAdrrk9VWs544biPdImR0IPU1oWsbXUeIdqso6N1qrcRyqCzAH1UDoacloFzMkje0cGAF4xztHYVrWN558YKxgDocHkUkCSQ/vcDzF52nuKrXV20N155AVGPO0cVHwgab/u49wxj0I6VUnXITdt9QQeo9DSxXvnLlyGQ9AKkTynZlyqADjNPR7AV4hJscsMIewPakZo0jKIm0nDBh608BypG8/T+9TbncJI0Vdrf3ccEUmtClqOaR5Xj3BlVRnNTeWHUopKk9WHc0KrZ+ZuB2HVvaorwqqM8O5iORx+lPZA0QTsehdm5wQaklVxCHCFWP8I60+3kjc+aBu3DknqDSXl0Cyrv+bsfWlZWuLyKd3cBbbe4CqDg7jkn8KzLIC4ZmYMrH7uF6DsKmvTkyCUknIIHYGpCZSBIi4ULtbjvUL3mV0G+Ibl3gtYh/rFAUn0NcpqbsQzhRz+GSK6e6klbTFBX7km5mI4IH9a5W6QyvOo4RyHQk96mrdjp6Mi0mSOS4MkbLD538IbAVh61HLCyamWluDGs7kNu52+jVStrNrm7nhCBYmYkEDaQRzV+5VbuCFQqlwVAHc44rODbitDWSSkV9TJs51ureJHZWZZGxtV0P9K1hpSQ2tvLhSJIvPVc5yD0Gf6VT1JYpbaeHcvyjBgzuYfQ1S8P3k91aNBAJB5C7X3/wYraLSly9/wAzJ35b7GbrVibW+iltflcnzEK/MFbuD7VNfyn7MLiKbyp+GKtyVbByMj+E1fuWzcm2VgzOnnRTHgKf4h79Ky4oVfyl1EkISdrRrwBzyR9ajk5b26lc10r9DB1C5UTrqdnCY50dZFzjhh1HPY1BDcyST3F6baRFud7JtwIx0yMe2egq1NKi3M2n3JzHMCIz/Cj/AMJz6VS0i4EcrWMgLtBcGSMg5B4wwx78VKfmaboz18yOyQESpcQOWVs42kn0P4cVC4iLCWKNomb/AFiY4HqAver9xJcSxXMEkexRIWOFydwAA9+lUobaacOtuVKAFi7cgH0J/Gld3shSRUiuFs75ZI2HlZz8oxyPbpkf1regRPtFh9jiR/Pz5QdQdwI6E+oORz6isuKzMtqt19m/do3kznquexPcUjzNbad5MuTFDu+zMFO6OTcCVJ9PTNWttTC1i9p6QwXl4EDTWxUMjkfMFPLe/GP0NXbDyTYXCzy+bHErW0J24yjHchx1HIPHvUJunh1HT5GkQ28rxyZ2/KokHzDGOgOeKv8Ahdo18URxzuitL+7CuoAWVVLRn2G4LzxU2s7FX0uaVtpN/HfQxTzWqTToFME1wvnBtuBhSc5wRwSDwKv6Ze3U7eVf7hcWZ8p45Sc7emD6Y/pUMYgGqabd3D6dHaQbEuobgAzg42zKyn52ct0I9sGrV6yL4m8i6kdrg2q29zgc78ZBOe4yoP41jUi1ZopPm0Z6NvyenbtUMbfORxjPSiiuqXQw6EeqXEiOiqQFzjFOiAKrkDrRRUt++0NbD71i8qgfLx/DxUYdhC3zHPvRRT+0NEdrM4BYMc1KpYTBixOT0ooojsgkSSHHAxirNuxDL9KKKFuDC8kOzI4PTii3bKfMM4GRRRVLcHsSynLIwADetQFi8wyenFFFN7oSCa1jGWxzSKvluME49KKKhJXEW8lk64x6VLbrgA5PPXNFFXHcoHcgkDimNK+VYnJziiimBE87iVcH7x5oE7vMFJwB0xRRSu7iZs2J8xdx4ZR1FLvZrkhiCDzjFFFbEjZpTKCHAOOBjiqGp4G0ALsHVSOtFFTLYpFW1QROuzIAPQ1oxnau8cnOOelFFJFMlkQNOnuM1UMjFmQ4whyD3oopsaJmyQJM4YgVDOWVR8xII5FFFS9hdStGv75sk7T27URIDKYzyi8iiip6DY2+jUJkAfeBq+JfKs1+VSXUhuOtFFXDdksw5Iv9HMbMzJISME9K5G+/e/ZRyoDlOPr1oorGv8JpT3GGMLKbkFjKXXOTwe1Q6hO9tcQzDDGOTAB6UUVm9I6dzR7jpZUF1NdxQrHMqq429OvQ1mkvb397e28jxSrEJSFxtYk9CPSiiqlv8xR2ZRXUDcWa3M8QaX7TjKnbweoreF/5ktrMIIw68f7w5HP4UUVrB3Tv5ETVrGL4qkVZFgWKPadzA45HsK5SwT7VqsIkPzLGV3dyB60UVk/4lvM0p/AX9qvYyXo3LMrY4PBGO9V1XzljZdsRxu/djHTpRRWliWWNGklutdi0+STEV22JGA5bAyCfcVT1+IvZIWf77MGwO4OM/pRRTfwf15A1YyLu5abTYQ4G5CACOMbQMGtmKPytZnIw5d4n3OMn72CM+4JoorFbma2La+JNXs9NQR3rNJFO9uszorSCP+6HI3D86kUMnjKaBnZwJ2G5jkkEHINFFQ9UrmySV7H/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A red, protruding vascular papule consistent with a pyogenic granuloma is present on the chest.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_19_23859=[""].join("\n");
var outline_f23_19_23859=null;
var title_f23_19_23860="Polyethylene glycol 3350: Drug information";
var content_f23_19_23860=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Polyethylene glycol 3350: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?8/55/9076?source=see_link\">",
"    see \"Polyethylene glycol 3350: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/41/26260?source=see_link\">",
"    see \"Polyethylene glycol 3350: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F2295346\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Dulcolax Balance&reg; [OTC];",
"     </li>",
"     <li>",
"      MiraLAX&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F2295350\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Laxative, Osmotic",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F2295373\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Occasional constipation:",
"     </b>",
"     Oral: 17 g of powder (~1 heaping tablespoon) dissolved in 4-8 ounces of beverage, once daily; do not use for &gt;1 week unless directed by healthcare provider",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Bowel preparation before colonoscopy (unlabeled use):",
"     </b>",
"     Oral: Mix 17 g of powder (~1 heaping tablespoon) in 8 ounces of clear liquid and administer the entire mixture every 10 minutes until 2 L are consumed (start within 6 hours after administering 20 mg bisacodyl delayed-release tablets) (Wexner, 2006).",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F7814689\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/41/26260?source=see_link\">",
"      see \"Polyethylene glycol 3350: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Occasional constipation (unlabeled use):",
"     </b>",
"     Children &ge;6 months: Oral: 0.5-1.5 g/kg daily (initial dose: 0.5-1 g/kg; titrate to effect); not to exceed 17 g/day; do not use for &gt;2 weeks (Bell, 2004; Loening-Baucke, 2005; Michail, 2004; Voskuijl, 2004).",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F2482702\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F2295374\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder for solution, oral: 17 g/dose (119 g, 238 g, 255 g, 510 g, 527 g, 850 g); 17 g/packet (10s, 14s, 30s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dulcolax Balance&reg;: 17 g/dose (119 g, 238 g, 510 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     MiraLAX&reg;: 17 g/dose (119 g, 238 g, 510 g); 17 g/packet (10s)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F2295348\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F7814690\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Occasional constipation: Stir powder in 4-8 ounces of water, juice, soda, coffee or tea until dissolved and drink.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bowel preparation for colonoscopy: Stir powder in 8 ounces of clear liquid until dissolved and drink.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F2295351\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of occasional constipation in adults",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F2295352\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of constipation in children; bowel preparation before colonoscopy",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F2295345\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       MiraLax&reg; may be confused with Mirapex&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Polyethylene glycol 3350 may be confused with polyethylene glycol electrolyte solution",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       MiraLax may be confused with Murelax brand name for oxazepam [Australia]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F2295362\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Frequency not defined:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal bloating, cramping, diarrhea, flatulence, nausea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case report: Anaphylactic shock (observed with PEG 6000)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F2295357\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to polyethylene glycol or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F2295358\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Electrolyte imbalance: Prolonged, frequent, or excessive use may lead to electrolyte imbalance.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concern:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bowel obstruction: Evaluate patients with symptoms of bowel obstruction (nausea, vomiting, abdominal pain or distension) prior to use; avoid use in patients with known or suspected bowel obstruction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Duration of therapy: Do not use for longer than 1 week; 2-4 days may be required to produce bowel movement.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Self medication (OTC labeling): Patients should consult healthcare provider prior to use if they have nausea, vomiting, or abdominal pain, irritable bowel syndrome, kidney disease, or a sudden change in bowel habits for &gt;2 weeks. Patients should be instructed to discontinue use and consult healthcare provider if they have diarrhea, rectal bleeding, if abdominal pain, bloating, cramping, or nausea gets worse, or if need to use for &gt;1 week.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299899\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6222409\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F2295353\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F2295354\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reproduction studies have not been conducted in animals or in humans.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F2295356\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F2295368\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An osmotic agent, polyethylene glycol 3350 causes water retention in the stool; increases stool frequency.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F2295370\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Onset of action: Oral: 24-96 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Minimal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bioavailability: 0.2%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Excretion: Feces (93%); urine (0.2%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bell EA and Wall GC, &ldquo;Pediatric Constipation Therapy Using Guidelines and Polyethylene Glycol 3350,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2004, 38(4):686-93.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/19/23860/abstract-text/14990783/pubmed\" id=\"14990783\" target=\"_blank\">",
"        14990783",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Candy D and Belsey J, &ldquo;Macrogol (Polyethylene Glycol) Laxatives in Children With Functional Constipation and Faecal Impaction: A Systematic Review,&rdquo;",
"      <i>",
"       Arch Dis Child",
"      </i>",
"      , 2009, 94(2):156-60.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/19/23860/abstract-text/19019885/pubmed\" id=\"19019885\" target=\"_blank\">",
"        19019885",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Co-Minh HB, Demoly P, Guillot B, et al, &ldquo;Anaphylactic shock After Oral Intake and Contact Urticaria Due to Polyethylene Glycols,&rdquo;",
"      <i>",
"       Allergy",
"      </i>",
"      , 2007, 62(1):92-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/19/23860/abstract-text/17156356/pubmed\" id=\"17156356\" target=\"_blank\">",
"        17156356",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Loening-Baucke V, &ldquo;Prevalence, Symptoms and Outcome of Constipation in Infants and Toddlers,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 2005,146(3):359-63.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/19/23860/abstract-text/15756220/pubmed\" id=\"15756220\" target=\"_blank\">",
"        15756220",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Loening-Baucke V, Krishna R, and Pashankar DS, &ldquo;Polyethylene Glycol 3350 Without Electrolytes for the Treatment of Functional Constipation in Infants and Toddlers,&rdquo;",
"      <i>",
"       J Pediatr Gastroenterol Nutr",
"      </i>",
"      , 2004, 39(5):536-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/19/23860/abstract-text/15572895/pubmed\" id=\"15572895\" target=\"_blank\">",
"        15572895",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Michail S, Gendy E, Preud&rsquo;Homme D, et al, &ldquo;Polyethylene Glycol for Constipation in Children Younger Than Eighteen Months Old,&rdquo;",
"      <i>",
"       J Pediatr Gastroenterol Nutr",
"      </i>",
"      , 2004, 39(2):197-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/19/23860/abstract-text/15269628/pubmed\" id=\"15269628\" target=\"_blank\">",
"        15269628",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nurko S, Youssef NN, Sabri M, et al, &ldquo;PEG3350 in the Treatment of Childhood Constipation: A Multicenter, Double-Blinded, Placebo-Controlled Trial,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 2008 153(2):254-61.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/19/23860/abstract-text/18534221/pubmed\" id=\"18534221\" target=\"_blank\">",
"        18534221",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pashankar DS, Bishop WP, and Loening-Baucke V, &ldquo;Long-term Efficacy of Polyethylene Glycol 3350 for the Treatment of Chronic Constipation in Children With and Without Encopresis,&rdquo;",
"      <i>",
"       Clin Pediatr (Phila)",
"      </i>",
"      , 2003, 42(9):815-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/19/23860/abstract-text/14686553/pubmed\" id=\"14686553\" target=\"_blank\">",
"        14686553",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pashankar DS, Loening-Baucke V, and Bishop WP, &ldquo;Safety of Polyethylene Glycol 3350 for the Treatment of Chronic Constipation in Children,&rdquo;",
"      <i>",
"       Arch Pediatr Adolesc Med",
"      </i>",
"      , 2003,  157(7):661-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/19/23860/abstract-text/12860787/pubmed\" id=\"12860787\" target=\"_blank\">",
"        12860787",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pelham RW, Nix LC, Chavira RE, et al, &ldquo;Clinical Trial: Single- and Multiple-Dose Pharmacokinetics of Polyethylene Glycol (PEG-3350) in Healthy Young and Elderly Subjects,&rdquo;",
"      <i>",
"       Aliment Pharmaco Ther",
"      </i>",
"      , 2008, 28(2):256-65.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/19/23860/abstract-text/18462266/pubmed\" id=\"18462266\" target=\"_blank\">",
"        18462266",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Safder S, Demintieva Y, Rewalt M, et al, &ldquo;Stool Consistency and Stool Frequency are Excellent Clinical Markers for Adequate Colon Preparation After Polyethylene Glycol 3350 Cleansing Protocol: A Prospective Clinical Study in Children,&rdquo;",
"      <i>",
"       Gastrointest Endosc",
"      </i>",
"      , 2008, 68(6):1131-35.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/19/23860/abstract-text/18950761/pubmed\" id=\"18950761\" target=\"_blank\">",
"        18950761",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      van den Berg MM, van Rossum CH, de Lorijn F, et al, &ldquo;Functional Constipation in Infants: A Follow-Up Study,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 2005, 147(5):700-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/19/23860/abstract-text/16291368/pubmed\" id=\"16291368\" target=\"_blank\">",
"        16291368",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Voskuijl W, de Lorijn F, Verwijs W, &ldquo;PEG 3350 (Transipeg) Versus Lactulose in the Treatment of Childhood Functional Constipation: A Double-blind, Randomised, Controlled, Multicentre Trial,&rdquo;",
"      <i>",
"       Gut",
"      </i>",
"      , 2004, 53(11):1590-94.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/19/23860/abstract-text/15479678/pubmed\" id=\"15479678\" target=\"_blank\">",
"        15479678",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wexner SD, Beck DE, Baron TH, et al,  &ldquo;A Consensus Document on Bowel Preparation Before Colonoscopy: Prepared by a Task Force from The American Society of Colon and Rectal Surgeons (ASCRS), The American Society for Gastrointestinal and Endoscopy (ASGE) and The Society of American Gastrointestinal and Endoscopic Surgeons (SAGES),&rdquo;",
"      <i>",
"       Dis Colon Rectum",
"      </i>",
"      , 2006, 49(6):792-809.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/19/23860/abstract-text/16649119/pubmed\" id=\"16649119\" target=\"_blank\">",
"        16649119",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10231 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.1.191.153-8DAC4F1F78-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_19_23860=[""].join("\n");
var outline_f23_19_23860=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2295346\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2295350\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2295373\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7814689\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2482702\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2295374\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2295348\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7814690\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2295351\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2295352\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2295345\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2295362\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2295357\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2295358\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299899\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6222409\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2295353\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2295354\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2295356\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2295368\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2295370\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10231\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10231|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?8/55/9076?source=related_link\">",
"      Polyethylene glycol 3350: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/41/26260?source=related_link\">",
"      Polyethylene glycol 3350: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_19_23861="Late decelerations";
var content_f23_19_23861=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F67464&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F67464&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 572px\">",
"   <div class=\"ttl\">",
"    Late decelerations",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 552px; height: 321px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Late decelerations are characterized by a gradual decrease and return to baseline of the fetal heart rate associated with uterine contractions. The deceleration is delayed in timing, with the nadir of the deceleration occurring after the peak of the contraction. The onset, nadir, and recovery usually occur after the onset, peak, and termination of a contraction. In this example, variability is minimal.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert L Barbieri, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_19_23861=[""].join("\n");
var outline_f23_19_23861=null;
var title_f23_19_23862="Alopecia mucinosa";
var content_f23_19_23862=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87485&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87485&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Alopecia mucinosa (follicular mucinosis)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An erythematous plaque accompanied by hair loss within the eyebrow&nbsp;is present in this patient with alopecia mucinosa.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_19_23862=[""].join("\n");
var outline_f23_19_23862=null;
var title_f23_19_23863="Pruritus associated with cholestasis";
var content_f23_19_23863=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pruritus associated with cholestasis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/19/23863/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/19/23863/contributors\">",
"     Raoul Poupon, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/19/23863/contributors\">",
"     Sanjiv Chopra, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/19/23863/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/19/23863/contributors\">",
"     Paul Angulo, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/19/23863/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/19/23863/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/19/23863/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 18, 2010.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholestasis is seen with many hepatobiliary disorders which produce extrahepatic biliary obstruction",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    intrahepatic biliary disruption. One particularly troublesome symptom associated with cholestasis is pruritus, which can range in severity from mild, to moderate in which sleep is disturbed, to extreme in which the lifestyle of the patient is completely disrupted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of pruritus in cholestasis is unknown but several hypotheses have been proposed, including bile acid accumulation and increased opioidergic tone [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Bile acids",
"    </span>",
"    &nbsp;&mdash;&nbsp;One theory proposed that elevated levels of bile acid in the skin of patients with cholestatic diseases act as pruritogens. Observations in favor of this theory include the recovery of bile acids from the skin surface of affected patients in relation to the intensity of pruritus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/2\">",
"     2",
"    </a>",
"    ], although the reliability of the methods used is uncertain. Other studies showed the ability of administered bile acids to induce pruritus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. There are, however, three observations that are not consistent with a primary role for bile acids as the cause of pruritus:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The occasional subsidence of pruritus despite ongoing cholestasis and persistence of elevated plasma bile acid levels [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The absence of pruritus in many patients with cholestasis and elevated plasma bile acid levels [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The apparent lack of correlation between the presence or severity of pruritus and concentrations of bile acids in skin of patients with chronic cholestasis in the most carefully done study that investigated this question [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Furthermore,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/33/36374?source=see_link\">",
"     cholestyramine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/26/12710?source=see_link\">",
"     colestipol",
"    </a>",
"    , agents used to treat the pruritus of cholestasis (see",
"    <a class=\"local\" href=\"#H7\">",
"     'Bile acid resins'",
"    </a>",
"    below), also ameliorate pruritus in patients with uremia and polycythemia vera, conditions not associated with bile salt retention.",
"   </p>",
"   <p>",
"    A related hypothesis implicates elevated plasma bile acids via hepatocyte toxicity rather than their effect on nerve endings [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/7\">",
"     7",
"    </a>",
"    ]. The detergent bile acids alters hepatocyte membranes, permitting the leakage of hepatocyte contents (some of which are pruritogens) into the bloodstream.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Endogenous opioids",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is increasing evidence for an important role for endogenous opioids in the pathogenesis of cholestatic pruritus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/8\">",
"     8",
"    </a>",
"    ]. The administration of opiate drugs with agonist activity at the mu opioid receptor can produce pruritus in normal individuals, presumably by a central action. More importantly, endogenous opioid levels are elevated (via an uncertain mechanism) in patients with chronic liver disease [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/9,10\">",
"     9,10",
"    </a>",
"    ] and many reports have shown a reduction in cholestatic pruritus in patients treated with opioid antagonists [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/8,11-13\">",
"     8,11-13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Lysophosphatidic acid and autotaxin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preliminary evidence suggests an important role for lysophosphatidic acid (LPA) in cholestatic pruritus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/14\">",
"     14",
"    </a>",
"    ]. LPA is a phospholipid that is formed by the action of autotaxin, which cleaves a choline group from lysophosphatidylcholine. Compared to controls, patients with cholestatic pruritus had significantly increased serum concentrations of LPA and autotaxin activity. Furthermore, injection of LPA induced a scratch response in mice. These observations need confirmation, but suggest a potential role for inhibition of autotaxin as therapeutic strategy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of choice for pruritus associated with cholestasis is correction of the underlying hepatobiliary disease. In cases of extrahepatic biliary obstruction in which definitive therapy is not possible, biliary drainage is usually effective in eliminating pruritus. In cases of intrahepatic cholestasis in which definitive therapy is not possible, several measures can be attempted to relieve bothersome pruritus.",
"   </p>",
"   <p>",
"    It has been difficult to evaluate the efficacy of medical therapy for pruritus in controlled trials since pruritus is a subjective symptom that can wax and wane spontaneously. However, investigators have developed a scratching activity monitoring system that allows for recording of scratching behavior independent from gross body movement, thereby allowing for the inclusion of behavioral methodology in clinical trials of pruritus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/15\">",
"     15",
"    </a>",
"    ]. Nevertheless, clinical trials have generally been small and used varying scales for measuring pruritus limiting comparison among them [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In mild cases, pruritus can often be controlled by nonspecific measures such as warm baths and emollients. However, these measures often fail when the pruritus is moderate to severe and often accompanied by excoriations. In such cases, the following options are available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Bile acid resins",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bile acid resins",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/33/36374?source=see_link\">",
"     cholestyramine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/26/12710?source=see_link\">",
"     colestipol",
"    </a>",
"    are effective first-line agents in the management of moderate or severe cholestatic pruritus based upon their favorable safety profile and clinical experience [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/17\">",
"     17",
"    </a>",
"    ]. There have been few controlled trials [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These drugs are nonabsorbable, basic polystyrenes which bind anions in the gut lumen, including bile acids. They lower bile acid levels by inhibiting the reabsorption of bile acids by approximately 90 percent. However, binding of bile acids alone is unlikely to explain their benefit since a potent bile acid sequestrant (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/57/35734?source=see_link\">",
"     colesevelam",
"    </a>",
"    ) was not effective for cholestatic pruritus in a placebo controlled trial [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/18\">",
"     18",
"    </a>",
"    ]. They also decrease pruritus in noncholestatic disorders, such as uremia and polycythemia vera, suggesting that these resins bind other pruritogens.",
"   </p>",
"   <p>",
"    The effective dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/33/36374?source=see_link\">",
"     cholestyramine",
"    </a>",
"    ranges from 4 to 16 grams per day. Efficacy may be increased by administering a dose before and after breakfast in patients with an intact gallbladder to enhance the excretion of the pruritogens, which presumably accumulate in the gallbladder during the overnight fast. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/14/42217?source=see_link\">",
"     \"Lipid lowering with drugs other than statins and fibrates\"",
"    </a>",
"    .) However, compliance is a major problem with the use of bile acid resins. These drugs are relatively unpalatable, induce constipation, and can interfere with the absorption of a number of medications including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29113?source=see_link\">",
"     digoxin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/49/8986?source=see_link\">",
"     propranolol",
"    </a>",
"    , and thiazide diuretics (see appropriate topic reviews on drug interactions).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1650545\">",
"    <span class=\"h2\">",
"     Rifampin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several reports have demonstrated improvement in cholestatic pruritus with 300 to 600",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/16,19,20\">",
"     16,19,20",
"    </a>",
"    ]. It was initially hypothesized that rifampin may decrease pruritus by competing with bile acids for hepatic uptake, thereby minimizing bile acid toxicity to the hepatocyte. Alternatively, rifampin may induce microsomal enzymes that promote 6- alpha-hydroxylation and subsequent glucuronidation of toxic bile salts. However, these effects have not been confirmed, and the mechanisms of action remain unknown.",
"   </p>",
"   <p>",
"    Although toxicity was not seen in these preliminary trials, caution should be exercised with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    use in cholestatic conditions since hepatitis and severe idiosyncratic reactions are sometimes encountered [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Opioid antagonists",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opioid antagonists such as intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/24/35207?source=see_link\">",
"     naloxone",
"    </a>",
"    (given as a bolus of 0.4 mg followed by 0.2",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per minute for 24 hours), oral nalmefene (60 to 120 mg daily), and oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/16/39173?source=see_link\">",
"     naltrexone",
"    </a>",
"    (12.5 to 50 mg daily) are often associated with substantial relief of cholestatic pruritus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/11,16,21-24\">",
"     11,16,21-24",
"    </a>",
"    ]. In an illustrative, controlled, crossover trial of 29 patients, naloxone led to a 27 percent reduction in scratching activity and to a significant reduction in the perception of pruritus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/21\">",
"     21",
"    </a>",
"    ]. A similar study of 16 patients randomized to receive naltrexone or placebo found that the former was associated with a significant improvement in daytime itching (change in pruritus score -54 versus 8 percent), as well as nighttime itching (-44 versus 7 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/22\">",
"     22",
"    </a>",
"    ]. Persistent benefits were observed for at least two months in a third placebo-controlled crossover trial involving 20 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/24\">",
"     24",
"    </a>",
"    ]. Nine patients had a &gt;50 percent decrease in pruritus while pruritus disappeared completely in five.",
"   </p>",
"   <p>",
"    Opioid antagonists are generally well tolerated with the exception of a self-limited opiate withdrawal-like syndrome that usually resolves spontaneously within two days [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/24\">",
"     24",
"    </a>",
"    ]. This problem may be more prominent with nalmefene, which is currently only available for experimental use [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/23\">",
"     23",
"    </a>",
"    ]. The likelihood of a withdrawal syndrome may be decreased with a cautious initial intravenous infusion (such as with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/24/35207?source=see_link\">",
"     naloxone",
"    </a>",
"    given at a slow infusion rate {0.002 micrograms per",
"    <span class=\"nowrap\">",
"     kg/min}",
"    </span>",
"    and then increased gradually until reaching a therapeutic dose) followed by oral therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/25\">",
"     25",
"    </a>",
"    ]. In addition, opiate antagonists may lead to uncontrolled pain in patients who have various underlying causes of pain (eg, postherpetic neuralgia) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/26\">",
"     26",
"    </a>",
"    ]. As the role of endogenous opioids for cholestatic pruritus becomes better defined, the use of these agents, particularly the oral formulations, may become more widespread.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Ursodeoxycholic acid",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/5/12373?source=see_link\">",
"     Ursodeoxycholic acid",
"    </a>",
"    (UDCA) is a naturally occurring dihydroxy bile acid which, when administered exogenously, changes the bile acid pool to a more hydrophilic mix [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. It is unclear if this effect is due to competition for intestinal absorption of endogenous bile acids or to increased hepatic clearance of endogenous bile acids. UDCA is used to treat some forms of cholestatic liver disease, particularly primary biliary cirrhosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/32/43526?source=see_link\">",
"     \"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The effect of UDCA on pruritus, however, is uncertain [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/29\">",
"     29",
"    </a>",
"    ]. Two large trials in primary biliary cirrhosis, for example, showed no improvement in pruritus at a dose of 13 to 15",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. In comparison, high-dose therapy (30",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in three divided doses) in another report led to relief of itching [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/32\">",
"     32",
"    </a>",
"    ]. In the latter study, pruritus disappeared in six of seven patients within one month.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of other modalities have been evaluated in small numbers of patients.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Both",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/13/32983?source=see_link\">",
"       colchicine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      improved itching significantly in a controlled double-blind trial that included 85 patients with PBC who kept weekly diaries to quantify pruritus [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/40/29321?source=see_link\">",
"       Phenobarbital",
"      </a>",
"      has been effective in case series [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/34,35\">",
"       34,35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Case series and a small controlled trial have suggested a possible benefit from selective serotonin reuptake inhibitors.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"       Sertraline",
"      </a>",
"      (75 to 100 mg daily) was effective in a retrospective analysis of a group of patients with PBC who were participating in a trial of UDCA with and without",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/36\">",
"       36",
"      </a>",
"      ], and in a small randomized, placebo-controlled crossover trial of patients with pruritus due to various forms of liver disease [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/37\">",
"       37",
"      </a>",
"      ].",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"       Paroxetine",
"      </a>",
"      was beneficial in a separate report of patients with severe non-dermatologic pruritus (most of whom had non liver disease-related causes) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Phototherapy with ultraviolet light (UV-B) has been helpful in case reports [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/39-41\">",
"       39-41",
"      </a>",
"      ]. The mechanism is unknown, although hypotheses include an alteration in skin sensitivity to pruritogens or a modification in bile salt turnover by mobilizing skin bile salts. In our experience, phototherapy has been unsuccessful in more than 80 percent of patients with PBC who failed to respond to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/33/36374?source=see_link\">",
"       cholestyramine",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Some studies have demonstrated relief of pruritus following plasmapheresis in patients with cholestasis [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/42-44\">",
"       42-44",
"      </a>",
"      ]. However, clinical experience has been mixed. This technique is too cumbersome and expensive for routine use, but may have a role when all else fails particularly when a more definitive treatment is anticipated such as in patients awaiting liver transplantation for intractable, disabling pruritus.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/25/17816?source=see_link\">",
"       Propofol",
"      </a>",
"      , a sedative hypnotic, was given to three patients at subhypnotic doses via intravenous infusion [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/45\">",
"       45",
"      </a>",
"      ]. Marked improvement in pruritus was noted without disabling sedation. The proposed mechanism was inhibition of ventral and dorsal spinal nerve roots modulated by endogenous opioid-like ligands.",
"     </li>",
"     <li>",
"      Androgens (such as norethandrolone,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?3/36/3652?source=see_link\">",
"       methyltestosterone",
"      </a>",
"      , and stanozolol) increase serum bile acids and worsen jaundice, yet they paradoxically relieve pruritus in some patients with cholestasis [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/46\">",
"       46",
"      </a>",
"      ]. How this occurs is not known, but multiple side effects limit the use of these drugs.",
"     </li>",
"     <li>",
"      Delta-9-tetrahydrocannabinol (Marinol) was helpful in a case series of three patients [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The Molecular Adsorbent Recirculating System (a hemofiltration device) has been effective in case series [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/48-51\">",
"       48-51",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Liver transplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe pruritus, refractory to other therapy, has been considered an indication for liver transplantation in patients with severe cholestasis. A functioning transplant cures the underlying disease and produces rapid resolution of the pruritus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/50/27430?source=see_link\">",
"     \"Liver transplantation in primary biliary cirrhosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     AASLD guideline",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 2009 guideline from the American Association for the Study of Liver Diseases (AASLD) recommends the following approach for treatment of cholestasis associated with primary biliary cirrhosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23863/abstract/52\">",
"     52",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bile acid sequestrants should be used initially. They should be given two to four hours before or after ingestion of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/5/12373?source=see_link\">",
"       ursodeoxycholic acid",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      In patients with pruritus refractory to bile acid sequestrants, the following can be tried: rifampicin (150 to 300 mg twice daily) or oral opiate antagonists such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/16/39173?source=see_link\">",
"       naltrexone",
"      </a>",
"      (50 mg daily). Setraline (75 to 100 mg daily) can be tried if other measures fail.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of choice for pruritus associated with cholestasis is correction of the underlying hepatobiliary disease. In cases of extrahepatic biliary obstruction in which definitive therapy is not possible, biliary drainage is usually effective in eliminating pruritus. In cases of intrahepatic cholestasis in which definitive therapy is not possible, several measures can be attempted to relieve bothersome pruritus.",
"   </p>",
"   <p>",
"    The preceding discussion underscores that optimal treatment of pruritus of cholestasis (that is not amenable to correction of the underlying disease leading to cholestasis) has not been defined, although several options have been studied. As a general rule, treatment should be based upon the severity of the pruritus.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For mild pruritus, we suggest general measures such as warm baths with or without an antihistamine (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      For moderate to severe pruritus, or mild pruritus that does not respond to the above measures, we suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/33/36374?source=see_link\">",
"       cholestyramine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/26/12710?source=see_link\">",
"       colestipol",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). As noted above, the effective dose of cholestyramine ranges from 4 to 16 grams per day. Efficacy may be increased by administering a dose before and after breakfast in patients with an intact gallbladder.",
"     </li>",
"     <li>",
"      Many patients cannot tolerate",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/33/36374?source=see_link\">",
"       cholestyramine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/26/12710?source=see_link\">",
"       colestipol",
"      </a>",
"      or find them so unpalatable that they request other treatments.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       Rifampin",
"      </a>",
"      , 150 mg twice daily has been effective in these patients. Given patients' preferences, some offer rifampin as first line treatment for pruritus. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Bile acid resins'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For treatment of pruritus in patients with PBC, we suggest treatment with UDCA followed by the addition of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/13/32983?source=see_link\">",
"       colchicine",
"      </a>",
"      and then",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      in nonresponding patients (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Although colchicine and methotrexate have been studied for treatment of PBC, their efficacy for treatment of the underlying liver disease or pruritus has not been consistently demonstrated. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/19/34105?source=see_link\">",
"       \"Overview of the treatment of primary biliary cirrhosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If none of the above is helpful, we suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      (150 mg bid) (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). In nonresponding patients we suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/40/29321?source=see_link\">",
"       phenobarbital",
"      </a>",
"      (90 mg at bedtime), although it has the disadvantage of causing somnolence during the first few weeks of use (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      We suggest an opiate antagonist in patients who do not respond to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      or those in whom we are reluctant to use",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/40/29321?source=see_link\">",
"       phenobarbital",
"      </a>",
"      because of its sedative effects (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). However, patients should be warned about a possible opioid withdrawal-like reaction and these drugs should not be used in patients with known opiate dependency. As noted above, the risk of a severe reaction may be decreased with an initial intravenous infusion given slowly (such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/24/35207?source=see_link\">",
"       naloxone",
"      </a>",
"      given intravenously at an initial dose of 0.002 micrograms per",
"      <span class=\"nowrap\">",
"       kg/min",
"      </span>",
"      and then increased gradually until reaching a therapeutic dose) followed by oral therapy (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/16/39173?source=see_link\">",
"       naltrexone",
"      </a>",
"      given orally at a dose of 12.5 mg per day and increased gradually to a maximal dose of 50 mg per day as needed). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Opioid antagonists'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Optimal therapy is uncertain for severe pruritus or pruritus refractory to the above measures. Several measures described above have been effective in case reports and can be tried in individual patients (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Other'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest referral for evaluation for liver transplantation if the pruritus remains severe, incapacitating, and refractory, and there are no contraindications for liver transplantation, even if the severity of liver disease may not otherwise warrant liver transplantation (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/61/25559?source=see_link\">",
"       \"Patient selection for liver transplantation\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23126505\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We are saddened by the death of Marshall M. Kaplan, MD, who passed away in September 2012. UpToDate wishes to acknowledge Dr. Kaplan's past work as an author for this topic, as well as his work as our Section Editor for Alcoholic and Metabolic Liver Disease.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/1\">",
"      Jones EA, Bergasa NV. The pruritus of cholestasis: from bile acids to opiate agonists. Hepatology 1990; 11:884.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/2\">",
"      Schoenfield, L, Sjovall, J, Perman E. Bile acids on the skin of patients with pruritic hepatobiliary disease. Nature 1967; 213:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/3\">",
"      Varadi DP. Pruritus induced by crude bile and purified bile acids. Experimental production of pruritus in human skin. Arch Dermatol 1974; 109:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/4\">",
"      Kirby J, Heaton KW, Burton JL. Pruritic effect of bile salts. Br Med J 1974; 4:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/5\">",
"      Murphy GM, Ross A, Billing BH. Serum bile acids in primary biliary cirrhosis. Gut 1972; 13:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/6\">",
"      Ghent CN, Bloomer JR, Klatskin G. Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and topruritus. Gastroenterology 1977; 73:1125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/7\">",
"      Ghent CN. Pruritus of cholestasis is related to effects of bile salts on the liver, not the skin. Am J Gastroenterol 1987; 82:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/8\">",
"      Bergasa NV. Treatment of the Pruritus of Cholestasis. Curr Treat Options Gastroenterol 2004; 7:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/9\">",
"      Thornton JR, Losowsky MS. Plasma leucine enkephalin is increased in liver disease. Gut 1989; 30:1392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/10\">",
"      Spivey, J, Jorgensen, R, Gores, G, et al. Serum met-enkephalin levels in patients with primary biliary cirrhosis correlate with severity of disease but not pruritus. Gastroenterology 1992; 102:A892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/11\">",
"      Thornton JR, Losowsky MS. Opioid peptides and primary biliary cirrhosis. BMJ 1988; 297:1501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/12\">",
"      Bernstein JE, Swift R. Relief of intractable pruritus with naloxone. Arch Dermatol 1979; 115:1366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/13\">",
"      Summerfield JA. Naloxone modulates the perception of itch in man. Br J Clin Pharmacol 1980; 10:180.",
"     </a>",
"    </li>",
"    <li>",
"     Kremer, AE, Martens, JJ, Kulik, W, et al. Increased serum autotaxin activity in cholestatic pruritus (abstract). Hepatology 209; 50:376A.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/15\">",
"      Talbot TL, Schmitt JM, Bergasa NV, et al. Application of piezo film technology for the quantitative assessment of pruritus. Biomed Instrum Technol 1991; 25:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/16\">",
"      Tandon P, Rowe BH, Vandermeer B, Bain VG. The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus. Am J Gastroenterol 2007; 102:1528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/17\">",
"      DATTA DV, SHERLOCK S. Treatment of pruritus of obstructive jaundice with cholestyramine. Br Med J 1963; 1:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/18\">",
"      Kuiper EM, van Erpecum KJ, Beuers U, et al. The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial. Hepatology 2010; 52:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/19\">",
"      Podesta A, Lopez P, Terg R, et al. Treatment of pruritus of primary biliary cirrhosis with rifampin. Dig Dis Sci 1991; 36:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/20\">",
"      Ghent CN, Carruthers SG. Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial. Gastroenterology 1988; 94:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/21\">",
"      Bergasa NV, Alling DW, Talbot TL, et al. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial. Ann Intern Med 1995; 123:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/22\">",
"      Wolfhagen FH, Sternieri E, Hop WC, et al. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterology 1997; 113:1264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/23\">",
"      Bergasa NV, Schmitt JM, Talbot TL, et al. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis. Hepatology 1998; 27:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/24\">",
"      Terg R, Coronel E, Sord&aacute; J, et al. Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study. J Hepatol 2002; 37:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/25\">",
"      Jones EA, Neuberger J, Bergasa NV. Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions. QJM 2002; 95:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/26\">",
"      McRae CA, Prince MI, Hudson M, et al. Pain as a complication of use of opiate antagonists for symptom control in cholestasis. Gastroenterology 2003; 125:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/27\">",
"      Batta AK, Salen G, Mirchandani R, et al. Effect of long-term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis. Am J Gastroenterol 1993; 88:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/28\">",
"      Poupon RE, Chr&eacute;tien Y, Poupon R, Paumgartner G. Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy. Hepatology 1993; 17:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/29\">",
"      Talwalkar JA, Souto E, Jorgensen RA, Lindor KD. Natural history of pruritus in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2003; 1:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/30\">",
"      Heathcote EJ, Cauch-Dudek K, Walker V, et al. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1994; 19:1149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/31\">",
"      Lindor KD. Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. N Engl J Med 1997; 336:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/32\">",
"      Matsuzaki Y, Tanaka N, Osuga T, et al. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis. Am J Gastroenterol 1990; 85:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/33\">",
"      Kaplan MM, Schmid C, Provenzale D, et al. A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis. Gastroenterology 1999; 117:1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/34\">",
"      Stellaard F, Bolt MG, Boyer JL, Klein PD. Phenobarbital treatment in primary biliary cirrhosis. Differences in bile acid composition between responders and nonresponders. J Lab Clin Med 1979; 94:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/35\">",
"      Bloomer JR, Boyer JL. Phenobarbital effects in cholestatic liver diseases. Ann Intern Med 1975; 82:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/36\">",
"      Browning J, Combes B, Mayo MJ. Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol 2003; 98:2736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/37\">",
"      Mayo MJ, Handem I, Saldana S, et al. Sertraline as a first-line treatment for cholestatic pruritus. Hepatology 2007; 45:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/38\">",
"      Zylicz Z, Krajnik M, Sorge AA, Costantini M. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage 2003; 26:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/39\">",
"      Hanid MA, Levi AJ. Phototherapy for pruritus in primary biliary cirrhosis. Lancet 1980; 2:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/40\">",
"      Cerio R, Murphy GM, Sladen GE, MacDonald DM. A combination of phototherapy and cholestyramine for the relief of pruritus in primary biliary cirrhosis. Br J Dermatol 1987; 116:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/41\">",
"      Bergasa NV, Link MJ, Keogh M, et al. Pilot study of bright-light therapy reflected toward the eyes for the pruritus of chronic liver disease. Am J Gastroenterol 2001; 96:1563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/42\">",
"      Lauterburg BH, Taswell HF, Pineda AA, et al. Treatment of pruritus of cholestasis by plasma perfusion through USP-charcoal-coated glass beads. Lancet 1980; 2:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/43\">",
"      Cohen LB, Ambinder EP, Wolke AM, et al. Role of plasmapheresis in primary biliary cirrhosis. Gut 1985; 26:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/44\">",
"      Alallam A, Barth D, Heathcote EJ. Role of plasmapheresis in the treatment of severe pruritus in pregnant patients with primary biliary cirrhosis: case reports. Can J Gastroenterol 2008; 22:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/45\">",
"      Borgeat A, Wilder-Smith O, Mentha G, Huber O. Propofol and cholestatic pruritus. Am J Gastroenterol 1992; 87:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/46\">",
"      Walt RP, Daneshmend TK, Fellows IW, Toghill PJ. Effect of stanozolol on itching in primary biliary cirrhosis. Br Med J (Clin Res Ed) 1988; 296:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/47\">",
"      Neff GW, O'Brien CB, Reddy KR, et al. Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease. Am J Gastroenterol 2002; 97:2117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/48\">",
"      Macia M, Avil&eacute;s J, Navarro J, et al. Efficacy of molecular adsorbent recirculating system for the treatment of intractable pruritus in cholestasis. Am J Med 2003; 114:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/49\">",
"      Doria C, Mandal&aacute; L, Smith J, et al. Effect of molecular adsorbent recirculating system in hepatitis C virus-related intractable pruritus. Liver Transpl 2003; 9:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/50\">",
"      Bellmann R, Graziadei IW, Feistritzer C, et al. Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis. Liver Transpl 2004; 10:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/51\">",
"      Par&eacute;s A, Cisneros L, Salmer&oacute;n JM, et al. Extracorporeal albumin dialysis: a procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol 2004; 99:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23863/abstract/52\">",
"      Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis. Hepatology 2009; 50:291.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3607 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-2E861B2D37-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_19_23863=[""].join("\n");
var outline_f23_19_23863=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Bile acids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Endogenous opioids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Lysophosphatidic acid and autotaxin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Bile acid resins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1650545\">",
"      Rifampin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Opioid antagonists",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Ursodeoxycholic acid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Liver transplantation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      AASLD guideline",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23126505\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/14/42217?source=related_link\">",
"      Lipid lowering with drugs other than statins and fibrates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/50/27430?source=related_link\">",
"      Liver transplantation in primary biliary cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/19/34105?source=related_link\">",
"      Overview of the treatment of primary biliary cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/61/25559?source=related_link\">",
"      Patient selection for liver transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/32/43526?source=related_link\">",
"      Ursodeoxycholic acid in the treatment of primary biliary cirrhosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_19_23864="MRI of hyperacute ICH";
var content_f23_19_23864=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F81767&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F81767&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 530px\">",
"   <div class=\"ttl\">",
"    Hyperacute intracerebral hemorrhage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 510px; height: 593px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAJRAf4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5/wDH1/e/8J94kSO7uAP7TuQB5pAH71vesL7dqH/P7P8A+BB/xrV8e/8AJRPEf/YUuf8A0a1c5QBe+3ah/wA/s/8A4EH/ABo+3ah/z+z/APgQf8ao0UAXvt2of8/s/wD4EH/Gj7dqH/P7P/4EH/GqNFAF77dqH/P7P/4EH/Gj7dqH/P7P/wCBB/xqjRQBe+3ah/z+z/8AgQf8aPt2of8AP7P/AOBB/wAao0UAXvt2of8AP7P/AOBB/wAaPt2of8/s/wD4EH/GqaKzuFQEsTgAd6GUqxVhgg4I9KALn27UP+f2f/wIP+NH27UP+f2f/wACD/jU2haBq2vXIg0bTL2/lzyttC0hH5CvSLL9n/4gai+620F7WHjm9uYkb8gc/pQB5j9u1D/n9n/8CD/jR9u1D/n9n/8AAg/4179afsreJp7VWudU0i0n7oHklH57RWbqf7Lvji2LGyudHvVHTbOyMfwZcfrQB4n9u1D/AJ/Z/wDwIP8AjR9u1D/n9n/8CD/jXpV/+z58SLSPf/YSTjOMQXcTH8t1YOofCTx/YMFuPCerHIzmGHzR+aZFAHJ/btQ/5/Z//Ag/40fbtQ/5/Z//AAIP+NTat4f1jRwP7W0q/sh0zcW7xg/mKzACelAF37dqH/P7P/4EH/Gj7dqH/P7P/wCBB/xqjRQBe+3ah/z+z/8AgQf8aPt2of8AP7P/AOBB/wAao0UAXvt2of8AP7P/AOBB/wAaPt2of8/s/wD4EH/GqNFAF77dqH/P7P8A+BB/xo+3ah/z+z/+BB/xqjRQBe+3ah/z+z/+BB/xo+3ah/z+z/8AgQf8ao0UAXvt2of8/s//AIEH/Gka+v1Xcb24x04nJ/rVKnj/AFJ/3h/WgC8LnU2UMLufBGR+/P8AjSifVD0u5/8AwI/+vSIf3SBeu0dabjDeme4oAf8AaNTzj7XPn/r4/wDr0faNTzj7ZNn/AK+P/r01sNySCR+tBI+UtQA7z9TIJF3Pj/r4/wDr0n2jU8Z+2T4/6+P/AK9IQSPkOB3zSfeIGSB7d6AHi41M/wDL5P8A+BH/ANej7Rqf/P5P/wCBH/16aRkHHUUmSoXgnNADxPqZHF5P/wCBH/16PtGp/wDP5P8A+BH/ANekYbgMj64ppxt+9j3JoAebjUwMm8nx/wBfH/16PtGp4z9smx/18f8A16dbQT3RVYLeSYngbVPWu10L4S+MtZZUg0qWIEbsyrjigDh/tGp8f6ZPz/08f/XpTcamOt5N/wCBH/169pX9nbxBb2X2vVbpbeAEBtil3GfYDpWhqH7Od7ZSWStqVuy3LABnbaAPxoA8F+06l/z+Tf8AgR/9ej7VqX/P5N/4Ef8A16+mH/Zs0JR5beLLYXZ/gLDGfzrIf9nYJqi2b6rAqtyJmkAB9hQB8/fadSxn7ZPj/r4/+vR9p1LA/wBMn/8AAj/69fSrfsszkny9Wi2Y4PNYt7+zVqsRmW31e2MsK7mQk8D8qAPBBcan/wA/k/8A4Ef/AF6PtGp/8/k//gR/9evU9V+A/i+wtftEMUdzFjcCh4I9q4LV/C+uaPhtQ024jj6bthxQBlG41MDP2yf/AMCP/r0efqf/AD9z/wDgR/8AXphIDYzgjjBGDS88FenvQA77Rqf/AD+T/wDgR/8AXoE+pn/l7n/8CP8A69MKlRnOR6DrQV+VSO3Y0APM+qAZN3P/AOBH/wBej7Rqf/P5P/4Ef/XphAyCCTj1pQcsAScigBwn1Qn/AI+5/wDwI/8Ar0efqef+Pyb/AMCP/r037z4xxRjDYHSgB3n6n/z9z/8AgR/9egz6mP8Al8n/APAj/wCvTQOoJJ96TAAwDz3IoAcbrUgcfbJ8/wDXx/8AXr1f9mO9upvHt+stzPIv9mSHDSE/8tYq8iI2zgc9Opr1X9l7/kf9Q/7Bkn/o2KgDgvHv/JRPEf8A2FLn/wBGtXOV0fj3/koniP8A7Clz/wCjWrnKACiiigAooooAKKK0tJs7aVvN1KaSG1HA8pQzyN/dUf1oAz1RmztBOOT7VpaDpt3quoR2ml6dcaneP92CFCxPvgc4r3P4V/s+al4tRNS8S+doeikgw2oT/SJ19Tn7v1I+gr6s8H+DPD/g6x+y+HNLt7JCAHdFzJJjuznk/iaAPlbwj+zR4n19IbrxRe2uhwdraOMSSgfRcKPxJPtXt/hL9n3wD4fRGn0xtWuV6y6g+8E/7gwv5g163RQBW07T7PTbVLbTrSC1t04WKCMIo/AcVZoooAKKKKACiiigCO4giuYmiuIo5Y2GCkihgfwNeZeL/gT4C8S+ZI+jrp10/wDy309vJOfXaPlP5V6jRQB8Y+Pf2YfEGjwzXXha8i1q3X5vIdfKuAPbna35j6V4Jf6feadeSWl/azW11GcPDMhR1PuDzX6k1xXxE+Gnhzx7a7dYtAl8oxFfQALPH/wLuPY5FAH5wUV6r8bPhLrHgLV2mS3e50OTAjvY0+UH0cfwn9D2rysjBwetACUUUUAFFFFABRRRQAU8f6k/7w/rTKeP9Sf94f1oAvBcwRf7o49aXAOAV59KaBmKIkHAUc04fePPHY5oAbxnBHFJkjvn2p2VQYzyfWgHHUcdqAAYAOetNZhjPSnArgAnP0FNDZb5QOPWgBRwPnx7UoBPcAeuaBjIBB3HsO9dVoHg28vAlxeQmO3cgRxkYMhoAxdE0TUddult9Mt5JWJxlVyK978E/AG1tbaPUvHF9FaW55CyuFz+dJD4p0/4eeHha6HHAutMMSyuuRD7D1Neb+JvF2ua7L9sv7qec/wvcHj8FoA94n8SfC3wXLt0q1bVLiEY/dgeWD65PX9azNU/aOumVo9N0mGCPojhi7Y/lXzZFeuZWmuGaQA/d6L+VW7rxE8wCxQxpgYBVQKAPWT8cvGuoasTY3MUUhXYI3RdmPXB7+9V7nRviH4oP2q6vI2IOVV7kcZ7gZ4rxqa8lJ3MQpPf0p8Wr6hDJmK8mXjs55oA9Zuvhp4uR1e61G2G/wC66ybsmoH8E+Kxu3avHI8JA8uRzkH2zXGaT4x1GBcS3Mzkfdyx4p+reLtQlnBW8kGV+Y54NAHePa/ETRIRKNRIRf4kus4/WtKw+J/xG0dP9T9o2/6yV4xIXHua8dTxHqYieJbmRo5DkgnIqxpXizU7QhUuZQpPIJoA9z0f9ofWbR8arpcLw/xRhCv5V0Wl/Gjw1epPBrNi9xHcnJQqu2IeleKv8Rbh7V4HsbK4eRNjPJEMge1cdOsVwxkjcLIecA4xQB9UXnwy+HXxAsfP0G5S1unGQFYAg+4rwf4ifBvXvCNxL5aG5tOSjqM5Fcxo+p6lp04+z3DqwPy/MRzXsXhD4yXlsg0/xZb/AG4LjZ5xxxQB86spSTy5FKOvBVuCKGA3Z5Jr6p8b/DTw/wCPdAl8Q+GPKtbrbveBGHBr5j1bS7nS5mjuY2wG2hsdaAKTZ28Yz6mkJB9vf1p3BA/lSJkZJXpQAZ3D+97U4Hd04xTBkqe30oDcYzn8KAFYk/dBIpBn+EAH3NPHA4z600kH5gOfSgCNhicfTvXqn7L3/I/6h/2DJP8A0bFXljZM6k+nSvU/2Xv+R/1D/sGSf+jYqAOC8e/8lE8R/wDYUuf/AEa1c5XR+Pf+SieI/wDsKXP/AKNaucoAKKKKACiipbaCS5lEcKlnPQDvQA6ytLi+u4rWygkuLmVgkcUSlmcnoAB1r7H+A3wHg0GO08QeM41udZwHt7NxlLX0LDu/6D61d/Zv+Dtt4V0u38Q6/bB/EFwu+NJU5tFPYf7RHU9q95oAKKR2VFLMQFHUmuL1vxksTTR2IB8vje38X0oA6jUdUs9Oi8y8nWMZAx1OfoKxtQ8aaXaqwjZ5pQAQirjP515jdeIDqN4DLcGbyc7iDwx7HHtXNXus4mEk0rb0lGxwOB7GgD1h/Hl217HFFYwCJzgO0pP07Vf1H4g6PpMf/EykYSquSIV3g+uK8Gu/ETrNLH8255chl64x6elVbvUxeoWmGJWQoADkKemaAPfdF+J/hzWdLu76xuHEdsQrCZChJPSmN8TtFjvVtZSwlcZTadyt9DXg2gWNtYWd3C0u1mIBQjgH3rn7i7/s+4UtH5jbsh8kbef0oA+qbXx3osqlprgQLjILHIIrVtfEOlXiqbW+glLAkAN6V4F4T0eTxIJLqYGKOPiNAfvHvWpqngS80q2fUdNvp2aIHzEHytyeCDQB7ncahBBBHM7bonOA6cinWt/bXTlYZAzDtXinh7xNfpZ3WnXsudo3At94HtTbPVLpb7/R7h1mHT+pNAHu9Fc7Y63OgVb+EFAobzo2yD+FatlqdpeyPHbzK0i5yh4P5UAT3lrBe2stteQxz28qlXjkUMrA9iDXyH+0Z8Df7CSbxL4Ptz/ZY+a6soxn7OP76/7PqO306fYVR3EMVxBJDPGskMilXRhkMD1BFAH5X0V6p+0H8OZPAfjab7FbsuiXxM1ow+6n95Pw/kRXldABRRRQAUUUUAFPH+pP+8P60ynj/Un/AHh/WgC8pIhjwf4RSDg59aFIEcZBAOykZjgHv7dqAHHhiM8+9NIOM5PvTl6nt6ntQ2MckE0ANGWTPHtTkUtgIpLE/nSgEsqBSS3Ax3r334K/DC0jsz4n8YbUsIvmigJ5c9uKAJvgz8IYDpv/AAlPi9hbWUY3xRyDJf8ACs74peNrXzUj0yNbaGI7Yo0HzN7+1XPin8RWNwYYr2SaFPktbWMbEiHbI7mvD7m5uJr0zSlpbhjkD0oA6R7WFIDqPiC6QtL88UAfcxP+1WHcyXus3AFupIHCgdFFX7DwzcXMqz3ykK4yNxzg102hWMdqmxVOc4JoAwLPwszRZuZSDjoKsweEU3ea8jEHoK7JsKrbQBtHepbLZJG24fN6UAc5a+GLBwRcRF1HrxSaj4O0lo8w+dbyY475rrIbMlcMcDsKWWFk5KEn35oA83Hg1p5GW3uVYqMlScGk03wdPcrIZ5xHtOFB5zXYXlizyebH99fmHarGn/vArZG5z83pQBxo8E3HmbVkBQdfmo1nwXJZJHIm9onHUc4NejyWcLDIIBzy1RSSrAPKa8KRj+BhkUAeW2nhi5mlVHYqnt1rrIvCdstsRhWcDpnBrqY2dYiyyQyx+y8ikeRA65jBZhwW6UAeY63psmltvBcxA8Z6g10WmXena9pUdjqMaw3YHyXJOMfWuh1qzjurKSFkxkccZrza40rUbOdhAjzIOTtGcCgDqdI1zWPBGoNGLhmtJBs8xGyjCvXYl8KePvh39hlVY9ct8srhcFz9fSvnm01EhHtrvfJbNwY3/hPqKveH9dufCurJLbyb7Y8hm5GPSgCp4y8G6h4buyLiCTym5DgZGPrXM5wvIJI6DNfYvgnxX4e+I2gHQfEEUW5h8jgbdp+tfP3xh+HF34F11xtZ9OlOYZgOCPrQB5374GccGmjDoDxkdcUq5wc5z2pWAI/woAQqDjBNCAqcEHH97FBBGMZH9acGOwqzdKAIpMi4HHY16n+y9/yP+of9gyT/ANGxV5Y7lpUyDwD1r1P9l7/kf9Q/7Bkn/o2KgDgvHv8AyUTxH/2FLn/0a1c5XR+Pf+SieI/+wpc/+jWrnKACiiigAr6k/ZU+EnnvF4z8R2/7pTnTreRQQ5/56keg7e/NfO3hbSRrOuaXpsas9xeXKRBV7KTj86/S7SrCDS9MtLC0QJb20SwxqB0VRgfyoAt0jMFUsxAA5JNLXF+PdeW2tJrSE5faCcHBzngUAc54v8R3GqXhhtmeKzhYqUDbWkbsfpXEtrhaPdJ5ZUKQ6KenPX6Ua3eszpFIrhnIZWA43emO9c20jNLJIVTbGWD7xx9BjpQA6W4MNzHJbKVByJP72PX6VjXbSssSAsoMhbJ70rzGWYMzKAVKMRn5h2phfzpSysFgXCpuPQ9zQBo3MIdRMTEGIBfAzg+lMkiCyP8ALGTKWyE54xxUH2wBwEwzycgY7jrVJZWeeeWcswHzAjNAFvRnnurW6ExwrSgM4OQvbmsvUo/NCwswcRuVLAfw/wBa3reWCHTwsZ2SStuOzuuPXtWJqVyFtJSOQrcbRk/nQB7l8JLizPhmDyh+/TKt7iu8NuZ7OeAmQRt8yEkZYf4V478Ekmh0vzwTJl9oXPQHnNeyaW76lPKZgqQquxVTqD6+1AHlPirQL2x1NrvTUWTeuXOc8Y6e1ctZ6yZLpYrsNb3EQ6L0Yele+eILAS2C21vEzzx/MMrjIrxbxvo6yR+ciLHKMKsn+0O1AHdabqI1Lw80MShJGO5SG7D3rCl1C8tdWt76zkGYto2yNjPrWZ8PdUFhqS2V2SokjCguPunPQVseLtOjtNduGt5EeOTaVXjC+uBQB7FoupQ6tp8V3bn5WHKnqp7ir1eHeBtSu9M1y3Fv5jLdybGhZsIFz1HvXtsU0c27ynVtp2nB6GgDmviL4K0zxz4dm0zVIl34Jgnx80L4wGH+ea+CviD8OtY8G6peQXELz2kDlftSqQh96/R6uM8beFrHxPY6lol9CPLv4C6OBgrIOM5/KgD83qK3PGXhrUPCfiG70jVYjHPA5UHs47MD6Vh0AFFFFABTx/qT/vD+tMp4/wBSf94f1oAupgxx9fuig4+uD0pUOIo8nA2jFLxjrz296AI/lJHLflTn3Nxxx60KTt3EDNaPhvS5da1q20+1jLTTuFUfjQB6h8BfAUWu6sNV1qSK2060/efvRxJjsM1t/F/4hRXE8tppcKQWkJ2RIhxnHfFdl47Sy8GeHdL8PWY33YjDXA7KcV84a241HXZdpwit8xJoAqrKzO9/eNvcn5VJzWt4O097+/kupEAHXcelZ0UEeq6olvEMQJgcd69S061htrZIkVURRgYHWgCK6tswbVOOKbbRhYgFbPH51f1CMNAnln5l61BbYcL5eFPfNADEj+cAjAPer1rBsJkU+3SnJEr8AYA7+tWowzY9BxigBssywp/tGs25vGcERAn3q1cqXckZOD6VW+zqXAGeevtQBn3l/KkDfumLAYo0xm+yoWABJyCKlvrZTE67mbHU9KIiFSJVjGMdqANkOvkB/wCdLaFZI5N8C7T/AHxnNNVAtp8xOwcj61FZXjOcDBJ44oAkktUtAJbcHyz/AKyLHT3ontx5StGdy53Kf6VbG4qdwOSMGqEv2yxI+fz7Zv8AlmB0oAaZOuS8ZPGcZxVyOd4LdkDxkt3CAE1DCouoXljySvWNz8y1FMfNVXGA68FaAOY8U6DDcobqFTHcDqVHDVy2mWSXtw9hcgmQj92B3NentiSExlucc8da858UaVeadffa7UMBnIZeqmgDPs7vUPC+sBWaSIxnkZwQK+nPA+u6d8WvB0/hfXCraikZe2nYZJx0/GvnK7vG8TaaPPCnULcYZscuKPh9rl7oGuQzWUm25tz5iZOMgfw0AZ/j3wtqHhHXrnTtShZTGxCN2YdjXPLgLkfeFfX/AI40F/il8LD4kuLW2h1eNC6R2zb+B/ePr7V8iXERilZJBhlYqRQA3OQOPzNH3sDg+9IBj7wx70oBU4HT6UARvnzkyT0Nep/svf8AI/6h/wBgyT/0bFXlbf61PXBr1T9l7/kf9Q/7Bkn/AKNioA4Lx7/yUTxH/wBhS5/9GtXOV0fj3/koniP/ALClz/6NaucoAKKK3fBGh3HiPxTp2mWkDzvPKoKL1255/SgD6B/ZZ+FT3VzY+MtRcLFBKXt4scsQCAfz5r62rn/BdjHpOlLpdtbLBbWiqiYGNxxzXQUAUdavVsdOmlLhW2kJk/xdq8N1q+LoySzefNH88m373X1rr/iprKl47WORlZHxla8o1C+kOoBEUJJLlWbp+NAC318Xu7feHdDwcdyehFZep3BeRns8KGwHjY8sfWmXd+BPFFLtDQAq38WT9aoTyxySGRiW+XkJwwHagBjvGJYA5MYcneh6KPWs8sXt0jZv3SsWRvr2zSzSrJbA4RWbKI+fun3qzYeXhEbIjbnYxxhh6UAJao4uYAELHlsHjjHYVHNLKizQwswbbjBHTmrF9MRfRSu/zkY6dB9aq2lp9ovnDyMkQO8Ked3pigDRvFjtkhLqNzxK+D8v1rKmWZ7lYIowSQDgH7wPrWlrErJdwElZONwDLk7R61J4Ulhub27TZ5lzIigKRjHPagD3PwDpT6fp1uqIka+SJHYKBuPpXd2brFazfZo1ZyQWCccHv+Fc54aeePR0a4ypVNpYjdjFalvLkYcv5bYw3Qk/4UAat0ysvmldyqNjMP4fc+teS+PNIuJtQieOcxW8WWII4I9c16g0ojluopQSykMuwcSe2KwPFEcrWDqiESRDdxyG55FAHk2gWQmkje6cea5JhG7PIPUVFrk1zZX1yCZS7LuLFgSnHUVhXV5dx3ck8DeWgYsF6YGelWo4b7WovMG+RSdoIbPzfWgDW8N3PmWTOz8wx5E+SSp7Y969D8A+K0i1A297JueVV3HPIzwCR/WvC459R0e6PnqWi3mPA4Ax7V03h15Uu5bkkKrBVfGCdvYUAfUw56UxokaRJGUF0ztbuM1zfgHWG1TSgsxAmi425yQO2a6egDwr9qb4fN4o8NLq1gi/btORpMAcuncV8Qniv1Nu4FuLWWF1DK6lSD0Oa/Pr4+eCT4J8f3dvDGV0+6/f2x7YPUfgaAPNqKKKACnj/Un/AHh/WmU8f6k/7w/rQBcGTHGP9kdqdkZJ6j1oEZMMRB42jrSeU2c9u9ACBc89c96+jv2b/B0WlRP4v12AmMKVtVZe/rXknwp8JSeMPF9np20+SWy5HZe9fS/xj1NtA0q08O6KAllBEEITrnHegDyn4ga3JqGp6vqs+PPiJVBnjHavH7uOSOOJVz9ouTuYfWux1gNMlraFxumky5z296yFiE3jSOMbWVCFGD6UAdB4a8NHT7dJHIa4kGSPSukZW8rERww657VNEwjXLA4Y4+lWliV+SCWHOBQBThBCbJOcjqKZAriYAADPHTrV+eMs4AYAY9KkjQoOfp0oARFKtsPIpTxkEjaPwpZVCEbSc+tNmJKHnOOcYoAZNIsaEsflPQd6oed5qEKuAD1pk83O9wWYcVVjlYbnlAVOxJ4oAmYs2VQb2Y9MZpVVjKqHgdOKhhu4xcf6I5beMFwOlXbGICfIJLKOpoAlvGkEYhjKlQOcml02MKmQvzdzVaYAXBaRgWJwPrWigeONVGzB9KAHT3HlYLng8VnXzmaMiCVtnVlHXNXpVRwUcgg9Qao3CfZ5FlhOxQOoGQaAKcV24mXYR5w43eo960bWXlzIBg8EY5qkYmDCfy1XccgipWxLJviYiUdR60AWo9qShQdy9c0saW0jypeIZImGAB2qSxR7iJwygSDofWo/K33KqN2V68cUAeea7Gvh3xDHdWsebfOSG/iHpS+ILWCC70/XtPj22Vw3zKTnae4ruda0u21qKS0kRBIR+7l/ut6V5LdG406G70y5LFFfpnofUUAe9fA/xKPDvjP7BMp/srVQF2k5AY9K8+/aC8Jnw38Qb4RRBLW4/fQ7Rxg9qyvDF/cy6Uo3YuLflOeeOhzXtXju2b4ofBG01i3jMut6R8syryxA6/pzQB8t845OfrSMQnfLHtT2j+cqylSp6GmN8uRjOe57UARnJlXIwcHvXqn7L3/I/wCof9gyT/0bFXljD5489MGvU/2Xv+R/1D/sGSf+jYqAOC8e/wDJRPEf/YUuf/RrVzldH49/5KJ4j/7Clz/6NaucoAK+n/2PfDkBvLnWLmJRdN8tu7dQo+8RXzJbxNPPHEgJZ2CgD3r9Cfg34Yi8M+FdNhWA/aZYVaR8Y2DHQ/U0AeiJGqM7KuC5y3vSyMERmYgADJJp1c949mSHwtemQkbl2jHXNAHkHjG5E1zeStEp3TsY8nOea4XVZQ7QAbEPK5zjePc+tbWryeVc+SZy8MyglXPfHUGuXuH89w1wMqerAZANAFO+nKSgWsRRSuGBGS3Y1VUuYIvIKrg4weTgmrnlSPH8iMsycoSegqokgLSrIjhiD8o4/OgCOVwQNoxEpwRsxnHem28ifaS8TSr+8AZc5GO5BpxdzZCJG3KV+83r6VRSUleW+ZSQ23g/UetAG7MVku1QIjQqmA5OM+9TQyBSZAAjqBgkYyP6VRtZEJXf86yjYOP19jV2V4452F1G2P8AVHZ0GB0x+tAGJqdwWmmKn5sDk549cV33w10RIryxvJo97SAsvPH41w08D3N3HAm7aoym0dV969j8C2jXmkorhYyo27VXAGR196APSLWRl2AnETAscAbc1YgmM1xGYVCxp1V+Ax9arWywmCSAYVI0AXA4Y+lWoGIjaMBVZONzD7o/vZoAUPPcXU/IVx8iMvJGexp8sio0kMr7pNoTDDjH19aXyZt6RkBHL7gU53cZBqQmCNFcE75HIJUd++R7UAefeI/CFreSfboVPnMCMIP6VZ8KeFrTT7K5iYspaRSrE4A9ePWu+jgW5ufl+9kEqOMD1rH1+3COYbPcm1t0j56mgDzrxr4eihsdSkSJTcbuQW7DoT6VwekXIZYECHdA2GVDxk9M+teg6/JdSQ3rmZpDIvzdxx3NeeaWTZXgSZ41YnLkjHB6ZoA9i+Gt28F+mTtEuVmDYyp7c16zXhC6jHYaVFc24DFny5AwxA6D6V7L4dvjqWjWt2SpMiZJXpQBouwVSW6d68A/a08LLr3gZNZsF8yfTJNzFR/BjDDPt1r39hlSPWuX1W3j1DSZdOmUmO58y3kRlBXkEZIoA/NydHeFLggbGOzI9QKr11OpaNJpmsa74duOJrSRyhPdo8/zWuWoAKeP9Sf94f1plPH+pP8AvD+tAF5QRbxkH+EcUkjEpgliexFLHny48A42DmrOnQG5uoo0Us7sAAKAPqX9lnwwdK0i88S3iKsflEIzD25rz3xh4hutc13UboTMlu8hCgd+a9p8RTy+CPgXZ20XFxcIsZwOm7rXzsVKlEZTuJyc9KAOX8TXbrqSJA2SickVD4TEr6yJ2yxj5JFVdfyL+R+xOBXXeB9Ma1sBLMh8yY559KAOoS7LxrsjkLnqCOK0bZ2KqzgqR2Heo7eMZHGB6CrO9Y0KhWOewoAkJIBYDg0xi2B85A71EkzFwrYUjoGPNSJKpBbGSODQBLkgDb+tNkG5T1zigZZlIAHtTJHJYhSOOKAMdrc4b+E7umetQTxoUZQvOcAGtS5xhmIJIHbpVK3K+csjEsV/hPagCxDaRW8kaqBuAy23tVuVSvKMQT2FR2cocu4zgnrTb9sAIAWbOffFAFaJFnuwzk8dq1U2O2DkOn5Vn2MoadmwBjgAVfLBGzgtnqDQAEAgkgY9Kgnj/dspKjcOKmdiwJwOOmKY3zYGcY6mgDMmSTyEXO4Ke54pli6pKwGwlulaLIrYXeT64FUJ7aS1ujuTKkZH0oA0bW5aKcbVCqP4Qa1bO4SfLFAu7rjtWC2wxR4JGTnI61d0l1LOiN1PJNADri2Kuzo2BnIFeffE3TyZ4NShQFJBtkwO9emSMu9wEPH97oax9Vsk1LTr22WPcGQsDnoR6UAeVaJJ5eqRxKxHmjkZr3T4F+Ijo3jePTLll/s/VEMLoegftmvn60RoLlJHBDwSbSO/XvXdLcSW7LeWx2TRMs0Z9xQBa/aC8Df8Ih42ungQpp94fOgPYZ6ivLGPB219h/Gi1j8a/A+w13y1a6iiSQt3HZq+O3VlYg0ARsf3qZ64Nep/svf8j/qH/YMk/wDRsVeWOMTL9K9T/Ze/5H/UP+wZJ/6NioA4Lx7/AMlE8R/9hS5/9GtXOV0fj3/koniP/sKXP/o1q55FLMAOpoA7P4O6Mmu/EfRbKTiEzB5D/sryf5V992eoJNHNHZuXMexVUdh0ANfGn7MNkk/jW7uGTc0NswX0G7ivsHwPZR2Mt0kNqIFlxKecn0GaAOurzb4rX8y3dpZDb9naNnfLDk54GK9JrxT4lzSzeJyJIUkCRFRzggZ4oA8zv5h9qYkFGg5wRn5c/rmqUjb4/M2quTuGARn8KtXYhjvJMlncja2T90juvqBWfczO48uMvGqjcGByWHuaAGyySnDBz+8YtnPTH9Kh1ls+XdghZHjHUZBI70+JzbsZIwnmDKtgZHPrUV9sW3VQG3AHC9vz7fSgDNiZCpIBUOMorHP1NVIrZluJQC2wkmM9hVuxBklCFiGUFm3DIHt9KuOn+j2zOSXZt2EX7h9ffigCraZQxxuAZOq5H65q4x3y/LIHEWPvfxEdarmOa2vSPMGdx2bxwffFQ3fmLOkqsghYHAXv7UASQP8AaNY325ZVbChSeB6j6V798OYY102QhflYkEdQWHp6V4ToRMmoLI8ab4zlF/rX0D4NV4NJiZFUyPl9zMNhJHJ46UAdDK8UkRIJwG4I4H04q6LiO5ZfNWOPjCpn+Y71Sjt/ssX2HcDISGyOV55xmpJiGnj3gJEwBXGeD7mgDQ3SpbQ7433hiNwGD17H0xVS5ZZp8CNgsTHdu4CjPJqaQfaIvNSZ0VF4DHO1h0496ZLB+6xKqR+bHl9x4z60AasLQrKpckFkGD9Ohqpqlqs1sV8tRJKxJDnt9aA+YFGS8qphccY9PrTdRlf+zczoplBySxxgUAee+MIkWyuZATCsAzu7EelePabqCSX0zENsLDaCRg59a7j4h+IUttPuLOHdG7HIU8kZ7j1FeZaPNiRGR23s2AuB94d6AO6uLp725t4psQ2qfIV6ZI716t8GdZa6gvNOwBDAd8RPUgnmvHfOK2u2WQLI5+ZQu8KOoyexNdP8LvEI07VYg8g3SSeS6gY/OgD6HrmfFbNaz28xby7Z8iVycBTjg10w9qzvEFot7pF1A6IwZDwwyKAPiH9oTT20P4ow6tHg298iTA4+9jAbP6V5Vrtmthq1xBG26IENGw7qwBH6EV9AftJ6JNP4Y0zUkQMLJzBJs52A8c+navENdi+1aDpOqJk8G0m9mTlfzU/pQBz1PH+pP+8P60ynj/Un/eH9aALq5MUfGMKPxrrvhfY/2j4z0uHkqZVzge9cnExVI9wyu0Yr3H9lbRJLzxuLwx5jhXd8woA9O/aYv2iTQdIhcqijzWA9uBXht5dySymSZgxVevpXo/7QV8t78Q3RHBFtEE45ryfU5BHasFOC7bBgUAYdvajU9figY7owd5NeqQW6RQJsGEAwM15z4SUW3iKYSc7RyTXoovFZVDMFOMAetAFhSdmUI298daUJuOORjkHPJqqLjLfLtJHUVbSaMoW79xQBFJEGY5OCOc0tsNrYPJbualZUkVWGKiUBZCCcMOlAFlHw2FzkdahlYx3wV8+W4/WnbiwG7gegpshXIPcdjQBHfL+6zwGHQCsu23sjlQS/cGtnAZgwPGe9VJFZbuRJX5YZB9KAF0w5Lg7eOfl7U2+dpX2K67j0z1pbRXinKnGD0I6UkyZvsuOV6GgB1lbiJSeWbvUxfc+WT2wDU0jGTlkA+lNcMThVOD1K9qAI2HGB2pygtkMQT15p3ylCikjHt1pwOXVuOBjmgBSSMYwq9z606dfPjxIAxA4yKdCMyNnn69BTyDngcfWgDIVGyY1cBT1xVzTlVJiqjKAdc96meARsH2LtPTHen2oPICqCeeBQBDduWm27h5fekhA3RYGMnHXrUdxtEhB4Unv61IoKwBQicNn3oA8j1y0EfiLUrcEjJLj61u6W4n0+3kYbsDYRVXWxFZ+MoLiRziR9sisOgNTWIW2u9RsQQyrJ5sbD+6aAPo/4OL/wkfwo1jw7dOsjwh1TPQAjIr5I8T6fJpmsXdpKMPE5Uj8e1fQf7PmpS6f8RxaynZb6hbkBSeGI6Vx/7T3h1NI8eS3FugWK5USYAxjNAHir8SR+uK9S/Ze/5H/UP+wZJ/6Niry2QnzFr1L9l7/kf9Q/7Bkn/o2KgDgvHv8AyUTxH/2FLn/0a1YlkMzZ/uqW/IVt+Pf+SieI/wDsKXP/AKNaq2hWUkun6xdrgR21v8xIzyzBQP1oA9o/ZJt/tGp6+vIzCgyO3NfWejOE1qe2QsUSBdrdnxxmvmH9kNDBpniu+wMRpGA2eQee1fVelQAiO7AAaSFQcdPU0AaVeEfGQSW/itCZzHHJDxkfe9hXu9eJ/GC5hu9XQQIGlhHlsTwQe2KAPIrqZ4ZXMsMziM8BugB61Zk1KC7u2jykQ2HaGGOMdhVmbUWtbjy5oCTxheodqqS31vLcSNNaW+8EMcL39BQBSmUfPHHgByGXceeO1R3LieHc6+XKeGjzlSPX60XV6ZWWMFo+OuBz7Ul4Wt12sV8wY27vp2oAppllzCyqwUAPjhvY1ctJBNDJCjKqr80g64981QZAQyJuEEvR8YGaktLpYppEm2KvQAjBPHfHagCxfMsmx2C52kc8Aehqo6SG2/fKCiICpDDOPXHpWmNr20YULiRcouSQuOtc818kOpyWrDZlCMHIB/8Ar0AWLSby1DMcMGBwvBUH+le8+Atbi/s7YGjEfEUityMdiK+fYysyEZzLGQRgYO2vR/BFxLY3cZjMaR3CZk385Hrj1oA94vZIGlVbfhwm8sTx+X0pLlGEUczbmwnDngHjjNN020D2tq6uJpZSMugx8vv7VppaxbJpBGzW+SEXG7d+H1oAqWsbG3gRmjCk7nQHgE/0qeITNAYdqvGH2jjt2J9KfEreTgxqcMG5G0Dn+lWUt0VZhJIDuAYtuzxQBC1mAIzKx8zOVI4A9vSsbxNdCK1lS6eICM7mAHOccfWq/ifxNb6Wk0Kt5soIMfmc/wCRXjni/wAbXN20ljas+9ztLLghc9RQBx3ibUf7T124EUxKMekgxt9Rn0qCNgxMP7p+ig4wPzqquSm+XYGfgsecEHpVmBXZy8bom04Xj7x+hoA0be4uEuRFE2FQ5k2/dk//AFVu6ZaXCTw30JyiyAYxtHXvWdpdtPFCd7KWLAAgZ5rSu72SGwdAqxqJQHA5PPfHYUAfTvh+/h1LSLa5tz8jIB9COCK0TyK8x+DOqlrKbT5XUDPmQqTk4716dQB5N8TdHg1XSvE+hR/628sXmXIGA6jIP6V8U+HYpNQ0vVtIbdvWM3cS/wC3GDn/AMd3V+jetWsMkDuYt0hRkyBycjvX58eK7Sbwd8VNQt8bPKuicDuj84/JqAOGp4/1J/3h/WrWs2L6bqlzZygBonI4OcjqD+RFVR/qT/vD+tAF6MApEM87RX2T+yron2Lwvc6jLFzIcI57gda+P9Og+0S2sQGS2BX3/wDDzTpPD/wvto2270tWkAUY/hzQB8x+NLltQ8aa5fAhlWdlz6AH0rib8+ZqenQAFvMk3cCtkyl3u7hyRJNM5b86ybNhP4wiA+5BEWPOKAKthDLdeMZ441GwNhiDgCu5SzwNuWYKcYrgfDsZu/EN3sZlQsW+XpmvQLXzItpkyG9O1ADDZtGT5TFR3J5NKomchUlT5epPetMSbtvAz3p22PllC5oAjjL/AGQbuvrSwPvYDcAR1OOtPmJ27AfrUdovzlSwx15oAsFfmG7AxUcxDYHG3pmpJkLEFuvYDvUbK2zcANgP8VAEcJYSspHA7+lSasmY7W8jTOPkcgVAwZZTjLdyBV+2uUkt5IeNp7HsaAK0aApuxls5x2prqPMDMgB7c9afGWjYqzcDpinTrHcIyyBhgZyDigBtu0jMSwIJ9uKlyQ5Uhsn34qC1z5YjUsSO9SEOxIK9O460AG4ZyW5zjml2neSFyB3ao5VY8jqKmVvmG7O4D86AH5KkEHg+1ABb7pJJ60jScE5AJ45oQMAdmfw6UARiZ3zG6kDOMVdtowu7AOAO1RR4TqPm7mp5ZwE2QLwfvZoAzrk5kI6A/jTYFBYAn73GDU7oGI3KM9uaguJGR9sQye/GcUAcV8SbLbbRXWQZFOM4rFjmxqOmXYJKTp5bD3rtPF1nLqGgTBOXj+YgjtXBW3l3HhsYbF3ZyhwPVaAPQfBeptpHjTRL3d8kFwEcH0PFepftb6KLrQ7DV4gSF+VjjseRXhyzmWxedDg7RIpHXIr6k12IeMfgMkj4kkeyV9x5+YCgD4TlGJV2nivUf2Xv+R/1D/sGSf8Ao2KvM9Qi8m9KZ+6Stemfsvf8j/qH/YMk/wDRsVAHBePf+SieI/8AsKXP/o1qZafufBWoSbyDPdRQ7R3ADN/QU/x7/wAlE8R/9hS5/wDRrVVuJnHhS0t8EI108n1IUD+tAH0r+x7axv4S8RyPgs06KFPQ/Ka+ndNGLCAYAwg4FfNX7N+mX2h+BriG8jAfV50ltfLO7ICnqe1fSOiu8mlWrSIUfyxlSc4oAu18/fFC5WTx4Y02rGIzuOeNw7mvoBzhGPoM182eLpI9T1eeS3BmkdmV5I+qEMaAMLU4m8hJJJoXVVPLnawPse9Zkwgmto2UMobuwwD7+1XGWP7JPbXMe6TedrMeD/8AXrO09IlM6TCUxIOEbgGgCH7PGAVikAQLwep+tNubdiV5BJXcTnv609FaaJkt4Y12Hcqq3O30/Cq11G6SOkr+Wc4GOQw7igCLc7Q7AciMnaVPykd81UhSaKf5QFZhvJzkgfjVhY1OnzCRY8p98Akbuew+lUbrMsizHasJ4CMSSAOlAGnHPFLb7Q6OrglmIzgA+nauP1t5IdV8yPO1WyPm7etb9nKqucrG7twqHI//AF1la9tWVdkRM5OCrDt7UAS6dOTdxmXcMkHLfxLXf+H5jDciQBGQtwvqO4FeX208yxbg+FU5OD+ldz4Lns3lltr2MAnDLjOUJ7igD6J8Daz5ml2qrOhQg4/dYKn0z6V10lwwPz/JvUjeB+grxTT3u7K2aay8yUIxDKWxlD3AqpJ8WLu3n+y3Fr5ag4JZs4x0I96APbblokhVH2OWOMq3A9Sa4Tx54zs9ChMAZWuplwuwn5FAxn2zXGyfEj7RG6IQZCCrKRsCsRw1eU3txLfX7zzzPvXks2TmgDW1fxHdaxcNLJu8lcKQzZP0FY75WYzqTtAwffuDTS6iCWTdliwBA7+maIiIWCKhaQEEmgCRVVo4uXbcPM6dPUkVr6PErTRzMjyOXDGRsYwPTNZcbGNUkVihLHI9F9Kkij8iRCHcxynLKOir7UAdc9/aKRtIRwTKWVPlPqDWTbJcX2pnZISGbftzyF9vaspYpJL9Yg5fAIXngV0OntHZ+S8sbRzOuFdGyB26UAegeCb5NF1CGWRgIxIFGPv7T6+2a98UhlDDkHkV8oWE0r3rCNgY4gPmHzd+vvX0z4TvBe6BaSDqqBG+ooA1zyK+I/2vvD50v4h22pIpEWo24OSc/Mhwf0Ir7cr5/wD2wPDz6t4Jh1KFAW0t/MZu4Vjg0AfKPi23kuNO0fWuTHdw+S7H/npFhT/47trnB/qT/vD+tdNY+bqHgK/tgdw0+5S6UE8hWGxsfjt/KuZH+pP+8P60Adl8ObZbnxPpaNzl0GMZzzX3D8S9S1rRfBITQNCfVWkh8qYpKE8hNuC+OrY9BXxB8OJvI8R6dIWwFkQ59Oa+8fHk8h+HOpzWszRO1mSsijJ6UAfIV3Y2un21vDDdfaJH+d2UcAntXIx3Ai1TU5xjKx7VJrZmuttgk7dUjPbqfWuHmnd7cgHJlfJoA634bIClzLJuDM3HHWu6k+bnJzjGazPDOmw2nhu2RIX+1sd7S54HtitiESEDcijPX3oAjjfbFznB4wRUU0rRRlDHjuSKtqoViflyOzVW1CIOp2Al2HAoAqJcSSD92a0dOib5mlyGPY81n2KzRxgSRbRnBJ4zWpA5kJzwRxx0oAnbdgkFfQHvTVCuCWb5u4p0pj4DjcCOg7GoVZsjHyj0IoASbIC4IX+dc1Z6kbXWJYpydrN36V05U7RGy7wW+bPXHtXDeLZ1fVm+zxbIU4C9TQB2iMsilixK9h608LgduenOcVzmi6kGiSGQnIHGau3MpyFX5T1GD1oA21k2gEY3gYOOpoV9x5BAPp1rBFw8DIZSMddw7VsQypKgeJ1LEfwnOaAJlYI5GeD60wyeW2EXex6jrTDukCqItxPT2qZHhhDfIFbo2OpNABHDIzAzBQhOQKsELjCEgDtUQZnPA+hFNJBbB3HFADzJztLDIpsjqOd+DTWUFMY57Y61AIzzvQsfdqAHyS7j8gLEdTjGKrpHJJJndgHv0qZIWILE7VPYGphHmMbCoQ+vagBsiKo2gEgDa3fIryfW7caN4hniUlre4B5IwDntXqyt5jhUb5V4z61yvxI037Vpq3cQ/fQ9cdxQBi+EG+2WD2q/M6Erj1FfU37OU66j8NbjSpiWNtLJCUbqAa+QvCly0WpgcoZBlcetfSX7MGrPF4h1zSJWB8wC4APXPegD52+LOjvoXjy/s3j8sJI2B7V0n7L3/I/6h/2DJP8A0bFW7+1ppjWXxCiuCuFuY94PrxWF+y9/yP8AqH/YMk/9GxUAcF49/wCSieI/+wpc/wDo1qpamNmjaUvZhI/5kD+lXfHv/JRPEf8A2FLn/wBGtWfqV0J9O0yIHmCNlP4tmgD6o/ZC8y68NTieaRxDdDy1cEhRjkA19LxoI1CqMKK+fP2OIVh8EXhWdZWkn3uneLjA/OvoWgCtqVzHZ2M08rBUVTkmvnDWLhhdXq2coJlkO0hRnBPNe6/EIgeEr7O4jaOh968E1FHSWNV2IsnyDI5Jx1NAGPIJTKFjhMq7TgDgA9yaxXgkW/Rgzb1H3WzyK1L17qyikiZXkVDuYq2Bg96o+fPCYRavGZHYkAnt7mgBjCJS8iKFuXIxsU5Hv9KeFhVZXKkr5eQS25lf2o1C5MizqYtr5VCVP659ajkKSXUT7niyvQn+Iew6UAZ08RC7llaRgQXDDkHtVAysGMsCCPg7xjIJ+lXZRIZHeRt37zDEjbmsu5QvNtEZUJnax6Z96ALVqVZlVlCgdSeSARwKzvEBcTCKNJHZVUxtnOB3Oa0dNWNgsbQhi6nc4bG0VT1tkF8sayIAq7QMHao9/egDGuPktYsOoEvbrzmr2nynYoSV0lTD7w3FU7hY1jPk5kxjjB4+hqfSyrSfu1JfAwAeQO+aAPRrHxLMZkaeZS2wAZb5ZRjuPWsnxPNA96J2QSJI/wAyABcfSsOPMc6rtWONmJUSc54qVbotFMskgIIwvY57fSgCyx8hgTE5j3fLvIwahy811PH8yLIcgdsjtmnWhDMxK7goUbmPB/yabNIwdfNQqEy27OMf/XoAjhDLOS65lkbawXjJFTCTfK0cikZXDfw8+uarI4aAyyDcuc5PBJzU0TxCaQThgojxuU560ASxMoHlkI5jP3u7fjU5jd5WaQlNy7voB/SpoVgEUamTnoVAzye5NSSnygj72aRQwUFeceg9qAFsYD5rLhfmjyCOMD60+adTKpLM0qx7A3OV9PrUdonzBACXCj5H7fU1qW9r9nRGTy3mUkqCfuigDT8MwG2TJKCacZJ6E5r2j4QXUZivLQTmSRArFSc4HTNeJi8Dy2Yw6M4wSvB47ivRfhNMbPVIpPJEfnZibJ/hzx9eaAPbq4z4yWA1H4X+JbfClmspCMj0Ga7OsDxXewQwLYXLBRqEckEe7oX2kgfjQB+eHgWRGv72zlUsl5ZzQgA4+baSv6gVzg/1J/3h/WtaGKTS/FJt2yjw3JiYDrw2KqaratY3t3aupUxTFMHqMZoA2vCxYanZbeB8vT6191+NbW+vfhO8FhMLd2tFLyHnCgc18NeCU87V7NcEkFRj8a+8fFJWD4U3vmbgPsGOvP3aAPirWXSHRZV3En7qkfxVyNnF52oWUOMsWGRW94icppNpEuMlu/asrSAW8SWQAB2uCaAPYYCbeJIyMEAKRnpU6sCuByc8EGqN8Ga+byn+XAOe1MR3TLNIpA5yBQBYlleNgpc4z1x/OnrKGB8z889KjguVnHzsCv8AKmS24kyFcbfbigBDJ5gweQDwc8VLCJlxsUMM4J7VU+z+U3ylivYVahuCDGr5+vpQBenj/eYQErjkg96hSR13BmHtk1JKBKNpY7j0IqsBsOwjLe9AFwbfkLuc1wmulZL6QhcfNiuzuZAsLSHqi9K4WWZZLwsWPXIFAEfmCC9hRWBx+ldLqAHlRSpjkcmuRLbrssRk59a7VY1l02PGDleh6igDKeTcx+YYxWdYvJHeb4JzGwPRjxWiIVLkDIJ79qq3MIt7xMYbnk9jQB21nM72wfeDkfNzSQs2SwAYH1qjp0hZV2Y561bJ2yHdzjoAKAHbm3Eg8ep4xTiWKoGOGqJ2+XDnBNPUglScH6dqALAdtvIX8RSKMhjkc9KB8w++Bj9aTgsMAqf50AIQCvIBz6VGE+TZn3JzUjDaWJUknjA60sabcF8fRuooADiNG7Ljg1TvoRcWU6SHKNGRj1q1cMsgUL06A9RUF5+7tZ9hztiJoA8UgdrHUo3BOIZcH6Zr2b4YTrB8UtDkF9NYx3J+/GP9Z/sH2NeR2lubwakMDKgvzXWeAr0Jf+HLqVziG7VWYnkc0AeoftpW4Gq+H58DLRuue9edfsvf8j/qH/YMk/8ARsVemftn4ceGZAchlcj8q8z/AGXv+R/1D/sGSf8Ao2KgDgvHv/JRPEf/AGFLn/0a1c82dq5HHauh8e/8lE8R/wDYUuf/AEa1ZDwt/ZUU38IlZP0BoA+sf2KZSdA11GLH98mOOBwe9fS9fLX7E1+gs/EdizASF45VB9MEGvqRSGUEdDzQBzvxBfy/Ct4wwMAfMeg5614HMd8vml2KwvuQ/wDPTPevcvipIsXgjUHkdUQbclhkfeFfPtzb6hNbH7C48v7wUjC5xnvQBLfxu1wJdwLKcskgztHbp1FZN9FFMC24IwXfvUAAmrbK8UMcrSOXztKhtwBPr7VWlW4WQQiJCrbiJG+6R9KAKN5BLhZSC27PAA2sP73FPjPlSu7QFnVckOuMg06QyCXydzwIefLHK496arlPtCby0bR8qT+WKAM+ZTcxBB5qYycA5BB6Cs25V5AyxBmx3J2jP41q2camGa4urhY2DgAr1yOlUb3zGdpNxw7k8HOBQBV063Mi4t0YO5JPr71ga7cbrsgMWaMhc9B+VdJql4bDR5GFxtcSfuiBy3HSuFjlEpluJmKnJyuep9aALOpXDi7VCfmUggKcBvarGnxpIrFMKdxYsflI9vpWTaq9zL5ZYhi2UOOa6/S7B1tf3gi80HDZ6c0AaEBSVQJWCORlMDIB9DTZoRCFB2lWOTsHLmrMFsXiG94yjgjJOChFQA/uNk7tIM5QA/d9c0ARmMMFwZItw27WHK4PSnzoZtzgxoEwvzHkn6UhVJY4ZIH891ySANpz75pCBJsa4g7bA3T5qAK4BLDfGTg4Az0/KiMkARMmFHI7nn3qxcRtbTGBmByvmYB4cdBz/SjzW+3q6SAbVAVeooAv2rIYw7R9T8uOOnr60lp5bpK80mZMkdMYHtUccU8SyOJty7i+f6CrMixm33bIw2A23dzg9TQBPbSDzVQKCZEHIPJx39xSm+SdQkuBCo2yOx4z2xioLmVpYLaOJdsRIIcKB8vpmrcEUaQG3GCSfMAx94Z7/SgDa0l0hhSWR1kdVBDHI2Y6Cu88OXXm6jYvcMiGKRWAzjPOTXBafFHNEBEAJN+drDg/iOgrq/D0VvBqttHIieYxIV853e1AH0QjBlDKcgjINcf8UY1Tw/BqRTc2m3UV2B3IVvmA/DNdJou7+yrXzDltgzmsj4jwmfwLraAkH7K7DB7gZoA+AfiFq9t4k+JeoX+l2otree7AjjA54IGT7nrVf4lQLbeNNYhUk7JlBJ9dgz+tU/B9odR8aaXbZIM14ik+nzU/x5di+8X67cK+9XvZNrDuoYgH8gKANHwPcC11C1kyNysjdM96+6fEtyup/Ca8niYYksc8fSvgPRZfKuISrBcoM19vfC25OofB+WJkQyLbuu1uMjHBNAHxt4qyxsFOAoFN8KwGbxAigZIGQal8XAG+tgRj52XjkDmpPBzlPEDqp27kK9KAO5+0CNnA2yKxwQe340Q3LNIUWPAH41JaWhsyxh+dW/1iOev0qRI0UjapjOeN/agCGSJXyVDof50n72DG9fl65zk1bHk4cEGV/U8LUIA6SAEevpQA5b1VADsfUZWmzXEW9HBX/dU5qT5HHyMGYDp1zVeLT5LibkC2XqzEc49hQBrW8hmi2jg+gHSnBcnaThu+ajtLVIOI5ZGhPQt1Jq0Cu45OIx1JFAGN4ou1s9NYDbvk4AHWuEgkYSgscZ5rR8R6gb/VDtI8mL5VAqnDEjOI0LEt0zQA+ytzNdkIAcnrXoFjapFZpG/JxzWdommraRh5Qu7GR7VpCV2trkj7o5wByaAKd1ZoGcKuR1AzVDUYALZFmRg3/LNh0rWSTDKygszL3p5t1uE2v0HQZ6UAY+lXB+VTwc49K2GJ8zByfTPesW5he1uy6r8nbFbsR863jk43EY4PSgCNwC+FwpH97tUqMMD5CoPVuuaa8bYCuV3eoqWIMQOCoX9aAJUjIHQ7ffpSDdyT1HQ0rkSLtUMo9TS4UoqgE49KAJACUwBz1I70wt5hxkBh0yKXfzgMFI71FcI0m3DdO9ADpGSFSo79azp7q2jLC6LMGQqQnUVKUOSZX/EVXFmjSrtBKBs565oA8xt3+w63cwOcRyhhk9cVo+FFkaFYLOH7Tcrc5hix99geKr+OYQni3ZFgZHStX4UyTJ4w04QHbMt2u0gZxzQB6J+0vc3194Q8HXGt2MtjqgRklhYYAwO1cZ+y9/yP+of9gyT/ANGxV6d+2hIdvhqNjlsOx/L0rzH9l7/kf9Q/7Bkn/o2KgDgvHv8AyUTxH/2FLn/0a1RaWguvDOqwBVMsDJcg99o+Vv51L49/5KJ4j/7Clz/6NapvhzaNqPiQacj7TeQSwgYzuJQ4H4nFAHX/ALNviCbQfHymJC6TRNvUHsBmvu7Q72PUtHs72DPlTxLIuRzgivzQ8P30uia/DPtxJExRlP5EGv0G+Cuof2n8MdBn7iExkem1iP5AUAb/AIssotQ0G6gnTchAYj6HNeMzQJFJKqMEiGVTackkd8d694vIhPaTRMAQ6kEHvXzvq7rZz3DRwtG/mbTk52kHHFAFNLcbPJkZY4j9/K7d5/pWdexJalk8hpLeM9JXwD9Paob7UbiIqkqBYiDIVb5g3OOtUtQvvOESRxs6uSFXdy9AFiW3Eblg0cgBB8nOeD6mor+OOSH7RbpGYi/zMSMgdwKybq6nS1kOFAdgMvwwI/pVKWee5s43echZX2EImFGKAJbmZfN8uLDpvP7vGAfQmsyR4mcnDDb85Ibge1PmLo0rRtG4X5SShByajeQmBiVKKsZQbAMsfegDm/Fd59pfyoWPkoPvkglj61jSQyfZzs4Rl6kctWvPZ+dhYgSzEj5ucj1qex08uFlLBfKbGG6n6UAGg2e1Y2ccjnI4K/U11MMA/dsXXeCASe/ckjvVQQiKCYD96rcvJ2VvbFWLZQZiVmSSNMA5+UjI4x70AakKxXVhdBFaNg67GCcn/Cs1FMcx3yPlkKMWGCPYGt7RHksZ3jZ1aOSI+YVwzZ7ED1rMvMRzszTecuSRhcMo9x60AZACsRH5bvu6YG0Nj0NWoJcl0dl8sDKhxyuP4c1UlfiPcwD7j5ZLYP1/+tRDlmXzo/3Z6+rH60ASzR+VIGmiZomAO5Odv40xH8wwjySV3DcEbkinNLPcRurv5anjrgAjoDQPLE8bR70+UBjg7c+goAtRs7Tyvw0ZJwhPOAKjtlfYsnBjAJyBwfakaPDssaYJO5drYyO9FuZPLnLA4k4AU4GPYUAbXlu1nFMrL5HVUVen1qxabIr6XYJHTy8qc5Ck9ev8qyYl8qNYSromOGDdvQetbdi0UsD/AGjDSA/eZ8Y/x4oA09Pcs8bRxZIbac4BBPf6V0Phi2VNXs4hMrSxzBn2jgc/pVbSIbeSL9wZEUAOEI646n61u+HoopvEGnKmfOmn3Ox64HY44/CgD3hcBRjGK5T4r36aZ8OtfupBlUtHGPqMV1leO/tW6s+mfCG/jiwGvJY7c5/uk8/oDQB8dfDAw/8ACbWU1yQsUQeZiTjG1Sa5dmLo7Mclmyf1re8HwsV1i7C5FtYytk9ASNo/nXPj/Un/AHh/WgDW0siOe3YkcqK+3v2fo0vPh/JOHZmkDRFDzjAr4btgDLbbuBgfjX21+y9cLJ4LnhCsDHL1zwRQB8q/EGzNlrU0RBVYrt1IPUc1V0B1tfFMTnlWXjNekftOaE2l+MruVU/dXOJ1Pqe9eT2U5XVNPuMjqF570AewRbJGKkDnlSeopWtmBbJBPYmmWoaRg3C9Cee1WJLpYnwvzDHWgCqYHDbcdeuOlKbVerx+bjp2qb7cvZeT3oF4oGApHrigCvJbyYGyNFA67OKtJE20CZ8r129/zqYYKgjADdh1p2RjGBj6UANwWU5XGO2azvEUrpp7pExGRitMKoAwuT9ajv4FuIcHAz1oA8zt7ZzKTgYA6Yro/DmjlWE9wpA7cVrW+jxxTb9wPsBWqiDG37o96AK8zbEyoyp4wetVZmdVfaQGdePatB4w7DOdo6nNULnDl0XGBxmgCG2neZUyVjKjb8verkJDEoxB9zWZaqQuzkFT24rWt4wDuHf1HWgBHTB/eLlMYwRwaZZqsEToFG1myParcg3HbgnHahFCsAFAOOaAIgC7/MQyjoAKkIbPcDtinhcH5QMd8d6bIH3LtXg9STQAPuJUBuO5NOwQvBAz3oOQAT93p9KGCkkA8DocUANjEZJLYPNQ3U4ZSqgFemQOlSCJirZPXpSrBtAPyjPWgCtDFJIGU5UgcE9MVMkYjVVwcFuSDUksqoNqrk9qozPKULxgblB4zQB5xrxF142cjOxM57muq+AVodQ+LOnIv+qSUyY+lccs+db1G4JxtU8+tetfsh6YLrxZqerMuY7SA4Y9NxoAqfte6iLvx7a2yuWFvDtxngE1zP7L3/I/6h/2DJP/AEbFWT8bNUOq+Pb+d2DMZWHHTitb9l7/AJH/AFD/ALBkn/o2KgDgvHv/ACUTxH/2FLn/ANGtWf4a1KbR/EGnajbECa2nSVc9Mg1oePf+SieI/wDsKXP/AKNaucoA634qWqWnxA1kQqFhmmFygHTEih+P++q+wv2Yr9X8C29mHyhjFxGN2cZJVwPoQPzr5C8bA6noug68hBEkAsZgB92SIADP1Uj8jXp37JviiW18Z2+kSThY5A6qjD7ytgkA+xAP4UAfaleLeOrKSDWLlfKWNSTIM/xc17TXOeMNFGpQpcqxElupITHDe1AHz/dWsMrGSeLZ1B3NhiR6VnSW8UM0bzcQAEDB+f2OO31rp9UtJWuJniyxVicbMsPbntXNXjqhmUHa4G1lZd27Pb2oArXgtl0+XzH3TH5kUJkZ7c1zsYMlt58rRgg7EXJxnuQK2m3gJDPJsgXgueoPt7VnNbI6TA7o13FxsI+bHegDHk8wybSHJLfNg5BHofQ0zCs7JsaFMAFMZ/WpDgu0cUbyDP3w3B70hfMcsI3JJnflehz2NAEMUcNowlVD5WOQTkgUkce5QwVlyxIZRnAqeGA3MgDlUEfRtuAK2VCRbkVQGyMFCMNx3zQBibCtthS+8seVb7317VcgDjY0cS7OCWI6Y/xqV7RAyNGjR/KWZAckjucdvrVeSUxqIXjMxQkIxznH8sUAaulnaSrxhpizONuCAD+tVbi0EtyCp5XkyDgMe4xVzQLiGG+jmBZdg2iR/wC9SySBdQMk8LSAFlYA4UH1FAGLqFm2AA8QkxkBlwD9KhEbQp9xJEVSApOCD65rVu5o7mMJMrKvmZ6DIHfFUZ4ckbWEmHICuMbk9aAK0CRQqYmky2CWI6EemfWhcCNRyyupG3PftU20QRJDcQu8fIwDwp+npTLSNS5hRSoUFjubG70xQA8IfJjSHYz4J8tmxtP9asRwFXilXBDKPuH7x9hUUI3OkksfII75GPc1btV3tI7rHGm4qi9+OetAFwIsj4Jyx+UEj7p9K0odLmXzJU2xIoBUsckEdaqaeHS6hjt1TZIASw52nPGc1uWcAe5lacM5UkkscICenFADVnvInhETL5MqFPnPIbPNesfCjSEknN48ah4sEurbg7f0rzCBGYskUUrSqcFFUFQx/pXv/wAPdHfSPDkC3BBu5gJJSOBnsB+FAHTV8uftt6yq2Ph7Rkf53ke5dfYDaP8A0L9K+oyQASeAO9fnn+0B4nk8VfFPV51k8y2tZPsluB0Cpwcf8CzQBzem3BsfBeqkfevpo7ccfwjLn+Qrnh/qT/vD+ta+vJLYW9ppUuVaFfOkX0dwD/LH51kD/Un/AHh/WgC+mVW2fHAAr6r/AGVdbjhlvbGWTaswBT0Jr5RU5jjHOdor1L4MeKDoHiS0uD80TMI5F7D3oA+hf2ofDB1TwtFqsKAvZ5D4HO018bW0cksTJGD50DbgPav0juIrPxFoMkTFJrW7iKnuORXwT8RvC134E8aTWcwIVHLK3Z0PQ0AdN4Z1ePUdNjmQ5kQbJFPBBq/IjzEZYqnXArzayv20jXIrmDAtbk/MvavTFZXVWUcMMjB4oAi8lAD2H15qaBY8YZ2prgBskADHWnQqSAV7dCehoAuW7FieNoHFTrhgcHBH97jNVbYE5BU568nirQKsgDcHPegBsfyvgjj1zT5M7OSCPSopMmQeWMKO9E+REWU5OKAFYdOV56D0o2/Lg5IrIeWSMkkM+fTtVmC7OxfMBxQBLeXPkY2qQo6g1UnuEmUuoIOM+1XJ0W6jADgsOelUpbVkRs7TuHbtQBX08pKS24Ng9q0/tKRqEJJrHs4xDGRGWznkVZjiLybUZj3NAGvHKjhcEnPTnpTigXjPPrmq9opVigG5fWrJB3j5ctjpQAqE7jtx6UgOMhhkCmgMxxkKPQ1IXz16igBu4Km8554+lDYcKMnPam7g3Y+wNC8NluSP0oAlU8bSBVS5MgOAvIPJHpVkPkH07Ux5GTsuCKAK0VuxVshlTruNR308cFtLIBlY0JLHrUrTEocnHvmuQ8X6hLNNDpFu26Wc/OR2WgDiZpysFzMMEzOSPpX1F8ANN/4R34H6rrUilZr1XcHHO0DAr5ysNFk8QeMNP0CwRj5sqwgegz8xr7D+K/2fwZ8Hjptoi+UkK26jp260AfEHiO4N1rcznJyxOTXoX7L3/I/6h/2DJP8A0bFXmF22+8ZiSSSeten/ALL3/I/6h/2DJP8A0bFQBwXj3/koniP/ALClz/6Naucro/Hv/JRPEf8A2FLn/wBGtXOUAdV4MiOtpP4aYoHvD5lqztgLOoO0f8CBK/iKy9F1G+8L+JLa9g3wX1jOGwRgqynkGsyGV4ZkliYrIhDKw6giu08cCPX9Js/FdtCsUkzC1v0Xp56r/rP+BgZ+oNAH394E8S2ni7wpp2tWEitHcxBmAOSj/wASn3BrfPNfF/7JPxDGgeJH8MalIRYao48hieIpu34N0+uK+0KAPLfH3hySK+e6t5VCSAtszycDkAV5pOkcTxMyNCXPKSdVHqM9q+h/EekpqllgYW4i+aJ/Q14XqaP5159sBkXcyMG4INAHJ6kI4ribycRqcne3zFz1OBWZds6RIXRD/CYw3UHnitlfKidiofyojyh6uT0x6VnyW53D7ZEPtCP+6QnamD60AYv2dWinbcURsFY84YH0qiq/v5d+3eFxhh90VtvbhGC3KJ5gy/XlR9aozwmdJJkiycbmQdQPXNAFTTFxIwmlLnAUbBxzWi22TyhOZI2B2lwOE9M+tZcPlxw4K5cgMOTxVtjLJboUJDoRuHXj3oAtNJm58lgYlX5A/wDf9aS4UxsolBx1weSO2OKZFCNRZiFWFsYGTgj3A71XkS4s70Az+fGr4yf4sfyoA07GW2N4xkO5VkAVTgnnjNR6gqFCpDRsjEuV5YsKqMTBdJLKI0IkDhEHb39K19QtvtEqPZ7jG7eawJ79/c0AYNravcofNDLEp3Bs4P4VYkVBaFIiVU5LFuStXryIjYUAZdvReAD/AI0kdrJIkkMiIW2ghAOVP1oAybiKWSziInJ4x82MsKaEdZ1kIcSDAZ85H0rRmhmml42s0SbJCny5x0//AF1LBEksSllVHbC7QcHH1oApQvJLFIoUqjZXAOBWjYxBgsjxr5aqoBJzgjqR70k9nLbzRyBXkBwqMTgD8K1be2eVXkk8qJdu5XXkgZ5yKAM1ESMF4pG8vdgSAZbP/wBeukt9t/Gbgo/yxkFduTnFZthaXMUqpJbxO4bcxJz16Ej6V0+kWIl22zN++cnYqnAGT146/SgDpvhbow1O9jvJcmNY8uue/avalAUAKMADAFc74D0I6Foiwyqgmcl22+nYV0dAHE/GfxEfC/w013Uo5RHcLbtHCc/8tG+Vf1NfBPw8s47/AMVRS3qNLb2ySXkwz1CKW5/Kvob9tjxAywaDoEMg2uzXUyA88cLkfifyr5y0OabT9A1e7iOwzKtmCDgkNywH4A0AY+pXkuoX9xeXLbpp3MjH3JzUI/1J/wB4f1plPH+pP+8P60AXFyI485xtHSrmlXptbxSQAknBqnkiOHPTaKdt3DJ7dPagD7R/Zq8RyXun3GlzXPmCIBo1PYe1R/tT+AG8ReGk17T4i9/poJkVerxd/wAq8J+DviF9M1ywuN7qA4RhG2M819xfutQ00iVcwzx4YN6EUAfmoXM2nbOSYzlfavSvBV2b7RYpMqXT5GGa574n+GJPBXj7UdOkU+T5hlh9GjY8VQ0XUToN+rA77C5PzgH7uaAPUHiZsOcLjj2pzSKCuGBI69qgtbhXhwj7omGVPWkBQYzk5OM0ATm4LyYUcU/aSBkAEdOahnkSCM7SOOcjrTLEmUb3yxP8IoA0OcbWIGR2qJx8mwZBHf1ollEbBdjbe59KYZEJOyTnqBQBRkcK+xi2T3rPfzLfP3vLJ6elaV/B50TEEB8ZGagtWEsO1x844OaAGW90qlfU9MGr0zebb5GBjrjvWJc6fOtx5sJAHcZq4Lryoz5gGMevNAC2BKEYUctzkZrWLgAjAU+w61l6PtI3DkMatO4y+Gzk457UATxzEADJHPHFTp87Hlsj3qsZkgUYyZMU9JS8Z2Bt3cCgC0CASWwSR37U8kcdjjt3rKNxIjFVYMPRqt20u9ST19PSgCYggbtwx79aXccEKVOfWhR/ESMenWmSMvO1guO3XNAEN5KYiFCHB60yOZAh3fN7VI7K6DzQCD6VC4iViecDnnsKAM/W7+PTrJp5CAQPkX+8a4mCZYrS71TUGP2ucEQqOq+9O1J/7b8QOzSFbC3PAPSs2+aXW9Zhs9OXzN7iCFV/iJ4oA9z/AGSPBr3eq3njC/B8iAGK3LD7zfxNWL+0r47fWfEcmm2FwZLK3+QKOhbua9q1Yf8ACrvghb2EGEu0gEbMOMO33jXxVrN7Jd38srNu5Jye59aAM+TIkXd155r1L9l7/kf9Q/7Bkn/o2KvLXH7xD6g9O9epfsvf8j/qH/YMk/8ARsVAHBePf+SieI/+wpc/+jWrnK6Px7/yUTxH/wBhS5/9GtXOUAFdL4NvUL3ejXkgWx1JNh3dFlH+rf2we/oTXNU5GKOrDqDkUASus1jeFctHPA+Mg8qwNfoL8A/HMXjr4f2dy8hbUbNRbXgY/MXA4b/gQ5+ua+F/FkQvVt9dt0QQXgCShBgJMoAYH6/e/E16D+zB49PhDx5HY3kyR6TqpEMxc4CP/A+fqcfQ0Afd9cF8Q/DktzGb6xj8wA5mhA5P+2PcV3oIIyKCMjB6GgD5ovrW13NFBc7iSGZgM7yO2etUNXtgYN7zSO+4MUZfk9AAa9U8c+DZLS4l1LRyqWzj99bhMnJPLKe1eeTQyCyEltGI0V9m53IZ8duaAOTvba3ksPJZVEsZ+bPIwewP1qi8DWwUAmTfhSu7G0+lblzb28xLbJCAxXYZMbW+vpUaxokLCaOFZhgpubK9eOaAMK5sQ6+eFKTMDypyoxxz71UMn2XYJSADhWUEnP09K3riISLukBkaUg7WJVSc9selUruApOVli2ZJVyBnPpQBmqvlXPmR5JU9AN2FNWhthlkLueVwXA3gE+1Q2+6ISJCpb5txYHgY7GrUWwW4dGfd9w5TIIoAsLaxOqjDPkKCc5YdycelW9QiiF7Mih5mjx5Zx9wfUdaitZlQTGJgiyqo3M2XA9hV/VY7db4ukjISgZkJwOnX3oA5+Z0SUOfMuFXOHA6n6e1aNo7+WJLlWUNzuLfO470x4IEhkaGNgezKcjn0qu11cMFWYsdiBRhdqn3zQAy/lN1dNdIkmfulR1AHcCrNrEAoUhZFcfMXB+X0/WqswlIabErPHgGUgDOfStjT4FIZ2nCFeA7N8rA9R9aAGFZ7k27zQ+Y6jMQjl4/FaWwcQpN9oWUTZ3Iu3ktn09K0BDMGVm3SQBR8+Mk89Bj+dMe1ke6XYxMoXhPvY568UAbFiHubaBmi2O5ADYzvb3HWvWvh94X8gLqeoxAXRyEBXHf72KofD7wfcbIL3WSGC4ZIiuMnsc9a9NoAKbLIkUbySMFRQWZicACnV4h+1P8AEJfCngxtHsZF/tXV1aIYbmKL+JsfoPrQB8o/GnxN/wAJZ8Stb1JJfNtvOMMBByPLTgY9jgn8ay9ZiOm+GdNsZCfPuGN66/3VI2p+fzGs3QLA6lqkMBIWPl5GJwFQDJP5Ck1zUX1TU5bp+FOEjX+6ijCj8gKAM+nj/Un/AHh/WmU8f6k/7w/rQBdXmOP2UUAkknPA/WhCdsfH8AoIPQ/jQBv+D7n7Ne/uySykMvsa+7vhnrUPirwdCt2oldFEcqt0Nfn3pk4gvI3J4zj6V9bfs4+JLS3jnsJ51QyYIDNQBR/a+8Hy3Wk6f4isYs/Yh5M+0chD0NfMOmyxyJ9mnwY5Dwx61+kOvabba1o13YXkQmt7iMoy+uRX53ePPDN54U8S3Wn3UDwKJGaAv1K54oAv6RqVxpF59gmkMkD/AHCT0ruLVWEal8Ox54PSvLYJVvoDHIMTjox6g11fhXXHI+waiQs8fCPn7woA6mbfLJtHQHnitCArGhCjp3xVFJFxmMc9yashy0DAnp0z3oAc0iOx8wH0qpP+7bcrZVec+tVhMMMjZ3jv0xSjPlqpA560Aa8bCeJG2ryOKrvbbXMsPy/3hjg1FaXKqpX+FTjmrxUMdxBKY4OaAICiEbmH4mql1bxSbjtI4zirczhcLjgcjvVWaUsjNkZwQfegClp0gWAggD5uoqZjGdxJ2Ac9c5pmkKDGw7Zq61qHYYGQO9ADYwLiNpFXcsQ7Vagbeo4xkdRxSQZgkfyo/vrtOTxU8CAIAWBIH5UAUbzCOAEAJ96dYuQCdnzDjrUE+WlJOQAeD61ZsQ28lsYoAulmVM5UGqLuwk3g4FWJCZm2p90d+9V5yFz02gc57UAO8z9yVI5PtXKeINYd7wWOmtvnYYcjkVW1PVZ9Qu30/S2KoeJJs9BVPUPsmg2fk27iaduWlYfNQBmapOdPtmsoCRM/+sJ5r1n9lPwPJrXiv/hIbqIf2dpvEZI4eU+n0ryXwj4e1Lxp4mttK0xGe7uW+ZuojTuxNfevhvRtN+HPgSKztgiwWcW6R+nmPjkn6mgDyr9qzXVj0mDSlYHI8x1H6V8fsSWIxn+lekfGTxRN4g125uS2fNbgZ6KK81Yg4wcn2oAJQBIgHJwc16j+y9/yP+of9gyT/wBGxV5bJkzJkY4Nepfsvf8AI/6h/wBgyT/0bFQBwXj3/koniP8A7Clz/wCjWrnK6Px7/wAlE8R/9hS5/wDRrVzlABRRRQBv+GbuF0uNJv5AtneD5WY8RSj7r/0Psax7q3lsrySGUFJomwfqO4qCtYStq0UcEvzXkY2xSH+NQPun+lAH2f8AsyfFGPxj4bTRNWnUa7pyBBuYZuIh0YepA4P4Gvb6/MDw1rmoeGNetNV0mZre+tJNyNjv3BHoehFfoJ8IfiLpvxF8MRX1o6R6hEAl5a55if1A/unsaAO6IBBBGQfWvO/HHg9ZS15bRK8QO+RMnKjuQOhr0WjHHNAHzVravboYoI1mhZ8JGU5HvisRY9pKNExIBIJGSp9CPSvofxJ4L0/WCJEH2acc74x1/wAK8l1fwhq+kXcwktjLb5B89k3hh3GRzQBwmoIxWFo1wwG0spqheSWs0+XV8ovybTwzCt7VbSaSUra27mFSB83O3Pce1Y5tpik8hb90HAB2cZz0NAFEFbadZUPl7m24ZeCSOea0DCLmwMqW7gSfdZOxHHOOgqndQKL4Mzh1bAZUz8vYcGtZAsUItXuHjAcLwuEI9/egCtb20JhE6sYDGCH7k46ADtWx4gSC7i092BjkaHar9FJ9OKrNawF5GjEWVO4ojcEetdVf2jz+GdMns7eJGTJCsQ2OexoA477BPFEts8gk8oAoFf19ajnsZ1tXDQRzDoQCTsJ9D0rSSNkecyXKuu4KyJGqkN9fSo8m7jlijhmnZpApigJLr74HGKAKUMdvc2jRRySw7cBoWXo3qDRIwtYUhOIl3AqrKcMf9o+tehaF4A17UISs1uLSKbhpJMcAdDt9a73w38MNK01kn1NjqV0mMNKoCgj0FAHlGnaFqesm1TTba4dHPzO6FURenB717D4O+H9loUET3Ttd3SncS33Afp3/ABrs4okhjWOJFRFGAqjAFPoAAMdKKKo63q1joelXOparcJbWVshkllc4CgUAUfGnifTfB/hy81nWJljtrdCwXIDSN2VfUn0r87PiH4tvvG/iy+1vUWO+dsRR5yIox91B9B+ua6347/FW6+JGvKtuGg0KzYi0hPV+3mN7n07CvOtMsHvZHOQkESl5ZD0VR/XsKAJ7W6ax0q4ERKzXY8snH/LPv+ZwPzrLqxfXAubguq7IwAqL6AVXoAKeP9Sf94f1plTCNzatIEbyw4UtjjJB4z+BoAtKR5MYIGdox70gG77xI9KVRiKMk4G0c+lCjjg5PXJoAQ+/H0ruPBWutYXMMo5lhIJGeCK4cc88E+lTW8slvMssOd47HvQB+iHw38UweJNEikSZXmVRuAGKwvjT8LtP8f6LJIieVrUCE204PUj+E+xr5l+Fvj650K8hnt5m8ncPNiz0NfZPhPxHaeItNiuLeSPzGXLRq2SKAPzp1bT73RtSnsdQglt723crJG4wcjvVmCVLuNd3yzJyrg4r7W+NfwjsPiDYi5tStprsCnybgDAk/wBl/b3r4o8QaJqXhrW59O1aBra8hYhlb7r+6mgDr9F104S21EeW44Dno1dYrJsLK2RjIxXl2m6hHMDDc4OfXtV631a7064KIGltT1GckD2oA7gpvudxPyMOSKbdyCFNud3HAI61V0e6tNR5sLrzeMtHJ8jof61piNGYNIQxXjntQBnW0bI6NL8u7oK3YzmLA/I9qrOEYBSAPTvUrn5FDYP0GKAK8jr5hVWJYdcimSqpUGNgRg5FWJ44yhYDHtVaSVIonmkwNowcd6AKuiMZQwGBsb5q02myzbBtT6c1m6Rbzm0aYhAHbcEDfNirbHb87BufSgBVLctkbQelKtwFkByAv0pCQVB6n27Um1eQ2BnkigB126vzwo9qW2XamCB7ZNY+qajaWRDS3se8ciIc1mSeJpb5wtjbsFJwGI/WgDp73UILRWaWUQ4GWP8AhXKX+tXepq0OnxyR2zcNK4wW+lV5rST7buv5C5HIY8gVV1rxFtH2e3ALAbc+n0oAla8t9IszHCczkct3zWBZ2+o+IdZt7Cyjee9uXCRooyeaZpOnah4h1eDT9NjkuLudwigDOCe5r7e+Cvwk074f6atxcBbvXZlzNcMPuf7KegoAtfBT4Z2Xw98OorokusXA3XVyRzn+6D6CvOf2g/iRGwl0PTZMLGf37g/pXc/G/wCIUfhvSZdN0+QHVJ1xwf8AVr618UeI9Vmv7yUuxbJJdieWNAGff3DXN1JI33e3PNVhuVjxwe9P28Bhx65oAw2QflPrQBExJlQkHODXqn7L3/I/6h/2DJP/AEbFXls3+vXp0Nepfsvf8j/qH/YMk/8ARsVAHBePf+SieI/+wpc/+jWrnK7DxJZpqHxZ1izluFtkn1meMysCQmZmGcCsifwvrkMzxnSb9yjFdyW7sp9wccigDGorV/4RzXP+gNqX/gK/+FH/AAjmuf8AQG1L/wABX/woAyqVSVIIOCOQa1P+Ec1z/oDal/4Cv/hR/wAI5rn/AEBtS/8AAV/8KAHsYtXiLErHqSjkYAWcD+Tfzqx4J8W6z4J16LVdBuWt7qP5XUjKSL3V17iqo8O64CCNH1MEf9Or/wCFM1PTdTgQT6hp13bgnaZJYGRWPuSMZoA+9vg18W9I+JGmBUKWetwr/pFkzjJ9XT1X9R39a9Lr8utF1W/0LVINQ0m6ltL63bdHNE2GU19ifBr9ojS/EUUGleMXi0zVwoVbp2CwXB9Sf4GPoeP5UAfQNIwBBBGQexoRldQyEMrDIIOQRS0Acdr/AIB07UvNe0d7KZ+pj5U/UVwOofDbWbRkU3CXkQO4eXHgZ7ZH9a9vooA+ZL7wbqw1Rf8ARSPmw/y5I/D0rah8F6hJBK6QxTSM2VjEbDZ+Pc177LBFKQZI0YjoSORT1UKMAYoA8Z0f4Xy3Ukct1HHBChxiTIkb16dq7qLwZClrFa+eEtY+AkaYyPQnNdbRQByY+H/h5RhLRkHGQHOD9a1tH8OaTo53afZRRPjBfGWx9a1qKACiiigAooJAHNeQfE/49eFvBXmWtnKNZ1dSVNtauNsZ/wBt+g+gyfagD0zxHrumeG9In1PW7yK0soRlpJGx+A9SfQV8LfHT4v3/AMRtTNraeZaeHbd8wW2cGU/35Pf0Haub+JXxI8QfEHU2uNaumFqrboLKMkQw/Qdz7nmsTRvD11qUZuHeKzsV5a6uW2J9Bn7x9hmgClpWnXGqXqW1qoLNyWY4VB3Zj2A9av6xdwW1sdK0yXzbRXDSz7cee47jvtHb86hvr2GGJ7PSnkFowHmSMArTH39F9BWVQAUUUUASQQyXEyQwRtJLIwVEUZLE9ABXY+J/D+reGvCsVnqts9uZbpJWVlwd2xsAn1AJ4r139mL4au9xH4r1eEq6/wDIOikTgn/nqc9h29+e1YP7T3j638RaxF4f0wxyWelSnzrhQP302MHBHZeR9c0AeOJxFEc5+UcGjdweme/tVu10nUruzhmtdOvp4mXCyRQMynBIPIHrUn9gayCc6PqP4Wsn+FAGeMEjaDj1qVR2xwe+auf8I/rA/wCYTqRPqLV/8KcNC1kZxpGpf+Asn+FAFW2uXtbjfAQGHUeteg+DfHN7pdzHLpd08MqkFo81w50HWTgf2RqXPU/ZX/woTQtaiffHpWpK68hvsr/4UAfd/wAL/iPZeLLFIbmVItSQAMpON/uKs/Fb4b6T8Q9FNtfL5N7GCbe6QfMh9/Ue1fGHh+41+zuFlOnalDMuCHFrJz+lfSPw6+MciWsVn4osNQQqAouBayH8xtoA+W/G3hPU/BmrPY6zDJGUYhJwhCSD1BrFhu5I23KSQOma+8/Emv8AgHxTpjWWtyxXdu44ElrLuX3B25Br5i+IHwn0uzaa68FeIFvIclls7iGRXUegYrg/pQB5pETI5lil8qQDrnGDV+08V6haL5VyiXEeMBh1rOXQ9bRiraVqAYHnFs5B/ECpW0PViP8AkFahn/r1k/woA7zw54j0+8hVWmCz/wByTg1vyXKOhAK5HOOteSLoWpllZ9I1HI7i2kGP0rVstO1mNh/o+pqPe2kPH5UAd1d3KxqjuQg/hIp3h+yj8WTyW63KwyRnhW48yuSks9QcoJLTUmVDnH2aTn9K0tJu7VdtxC+xyAyMGxx60AbnjPR5vDtxbW7lDcydUjOSF96z5L6WFwY1bp0bvXQWBsI7Ka81C4FzcSjiR2yVrlLzV7OIyiWRXIOVIPagBbm5vrpVNtbmKTPIXo1cpr9/qKXDQCUqAPmx2rR1HxZKy7I5P3aj5QoxiuVur8zu00hOWoArqVDb5t0rnua1bbXJI7dVCBAnQVTs7S5vpo47K3mnlY8BEJruND+DHjzXZ1a30ZreAn/W3LbAPzoA4q71e5uD88mEP5VufD/wHrHjvVFg0uCRIAf314yEqg9vWve/h/8AszR210l34xvUuChyLaDO1vqa97EmgeDtJEEZtNOtIl+WJcLn8O5oAwfhZ8N9D8B6SsWnW5kvGH727mUeY5749B7VT+KHxMsvC1rLbWbrPqRXAVTnb9a87+IHx0lb7RZ6BAIocFTcSHn6ivnHxN4mmvJ5GWVpJ3+9ITQBZ8eeKb3WtQmluJTJeSH53J+6PSuOX5fvZ3DqPWm5YnLHJJyT60AHktk0AWTzHuJGT0FV3UEjjkd6N7E4bPsO1NwGJJPzZ70AJJjzkw2eDXqX7L3/ACP+of8AYMk/9GxV5bLjzkx6HgCvUv2Xv+R/1D/sGSf+jYqAOf8A+a+/9zN/7dV94+LvGuh+E3tItYupBd3hIt7W3geeaXHLFUQE4A6npXwd/wA19/7mb/26r7E8Z6Trmk/FbTfGuj6M+u2g0p9JubSGVEmg/e+YsqByA2SdpGc4oAv3fxj8EWdtaXF1ql1FFdj90x0y6O472QrxHw25GG088dK7PRNVtNb0u31HTnke0nBMbSQvExAJHKuAw5B6gV518QNK8ReMfB/hd10I2Wow69bXtzYm5iYwQRyvli+QpO3axAJOTjnFdZ8TtLm1vwFrOmW8V7NJdQ+VsspUjmILDO0uQvTPBIyMjIzQB0cc8MkbSRyxtGucsrAgY6801rmBY0kaeII5wrFxhj7HvXzNa/Drxe3hea3fw9bPpcOrWdw+nrDb6fc6raxK4kSZIZGiyGZcZYbsEn+EVe8aeB9X1qys7LQvh9HpOkSWt2Fg8uynuILh8beZXKQo2Acx/MMHGCRQB9HyOkaF5GVFHUscCvDP2yf+SRw/9hOH/wBAkrCvPhRr+rxwf21oi3clv4A/suEzXMTFNTV2Mag7+oyMN933o/aLs73Tv2afC1jqysuo2xsIblWcORKtuwcFgSCcg8gnNAHx9SUU5CAw3DcvcUAemfDn41+L/A5hgt706hpUfH2G8O9APRW+8v4HHtX058OP2iPCniplttWb+wdROAEupAYnP+zJwB+OK+Int7aVN1pPhu8U3B/A9D+lVZI3icrIpVh2oA/U6KVJo1kidXjYZVlOQR6g0+vzj8AfFHxX4HuY30bVJmtF+9ZXDGSBh6bSePqMGvp3wL+054X1aER+KYJtDuwOXAaaF/oVG4fQj8aAPf6K5PSviP4M1WEy2PijR3UYzuukQjPsxBrai17SJYhLFqtg8R53rcIR+eaANKiuP1X4m+CdKYrfeKdIRsbtq3KucfRc1514r/aa8F6TGy6Kt5rVxj5fKjMUefdnwfyBoA91or5L/wCGtb7P/Io22P8Ar+b/AOIqG5/az1VoiLbwrYxyf3pLp3H5BR/OgD66rmfG/jrw74KsGuvEOpwWx2kpDu3SyeyoOTXxn4p/aK8fa4rR217b6RAwwVsYtrY/32y35EV5VdXN/rF8095PcXl3IfmlmcuzfVjQB6/8Wf2gfEHjFpbHQml0XRDldkb4mmH+246D/ZH5mvIdK0u+1e6Fvp1tJcSnkhRwB6k9APc05YLa0YG9bzpAeYYm4/Fv8Kfca3eSWslpC4trJyN1vB8qtj+93b8aANie00rwxOVvJLbWtSCgiKCTdbQt/tOPvkeg496wtX1W91a4E1/OZGUbUUAKqL6Ko4A+lUaKACiiigAr1/4AfCqbxzrkd9qkTLoNs+X3ZH2hh/Avt6mqHwY+FV9481JLm6SSDQYXxLN0Mp/uJ7+p7V9F/Fn4gaR8J/CNppGhWsC600JitbZMYtVx99v588k0AYf7QvxLg8FaIfCfhqeL+15ohDM8PAs4cYCjHRiOg7DmvkTOYmz13D+tTalf3Wp39xe6hPJcXc7mSWWQ5Z2PUmoB/qT/ALw/rQB99fswOsfwF8Nu+dqi6JwM8C5mrc0j4s+DdY1mPSdP1K7l1CR1QQtpl0hUt93cWiAUH1JArF/Zc/5IT4Z/7ev/AEqlrV8M+HtUsvjF401y6tdml6jbWUdrP5inzGjQhxtB3DBPcD2oA6Hw54x8P+JtR1Sy0DVLfUJ9MMYuvs+WRC4Yrh8bW+633ScEYODW/XjvgDS/FNt8UPG2o3/ha40fTPEK2yw3K3ltJ9mMELJkqrEksxBHHHep/H3gTxC3hW2uNL1W+8SeItK1S21OwW+MMJJRsPGGUIoUqWJz6UAet1Wur2KC3upRvma2QyPFAvmScAnAUcknHA714H4O+F3izT/Eum22oMP7GgR9bN08yuU1WW3WJl253ELIXkBxt9/XH8E/DPxPpguUvNL1JNX/ALMv7K4nQ2i212ZUcoWlD+bMWcoQZFBXuQBQB9I6bqEV9YWl15c9t9qQOkN1GYpRkZ2sjchh3FZ6+KdMPi648NmV11KCzW+cMuEEbPsHzeue1fKnj7SW8J6fZ2/jCwsL64/4Q9bG0tp7+JZNNuQrKXSMk+YSw4KZOeOOtdbc/CzWNf0hJ7rQRcY8CWdjZedIiMl+ij5drMCrDnkgDqM0AfQ9vrum3Gv3WiQ3StqlrCk81vtOURvutnGOfrWhHLHIziN0YocMFOdp9DXz/afDvW7bxncXraGRqGoeG4bS21dXib+z9QW3KPLI27dnOBuUNnj3xzvh74YeLrbw9rFrYWGpaXrM+hNp8zE2kNrcOHU8NE5eR2AceY4BAYgmgD6ItfFWl3Xi2bw5BK76lDZi+bC5Tyi+zhvXI6UyPxn4ffxdd+GBqSLrlrb/AGqa2dHXbHhTu3kbTwwOASfyNeYfB7wZf6L8Qp9XTwifDWjyaHFZ+U08Ls1wsgLEhGJyQOp64554qHxX8ItQ8XfE/wAT6rcXE+j208dotnqMDK7yIIXiuItoYMoZWxkj0IzQB3I+LngltAt9bTWWk024uzYxSx2dwxecLuKBAm7p3xj3qWX4qeDYvC7eIW1gnSEufscky2s7NFNgnY6BN6HA/iAHT1FeT23wq8SR6FpOl21lPpsVv4ym1ES2tzCJLayK4SVCSRkDGFwW9RUt54I8ZWvwd8W+FB4efU9c1HUmdtTW9hH29Gff9obfJlSAioU46gjPzGgD37RtTtdZ0u21HTneS0uE3xM8bRkj1KsAw/ECvze03T9ZuYYvs1nczJ5aldiE8Y4r9G/Db3UmgWDajZPYXfkqJbZ5FkMbAYwWUlT07GvMfhX4o8FWfgXwz5l5ZRahFpNrHOdvIcQqDn3zmgD5k0b4deO9YQC10m7iQj5fOBUN9M0l/wDBzx9bsBLo9we52LuH6V9qHx74XFv5x1i12DoN3P5VmD4qeF3mKQ3ofaMsTwAP60AfKPhf4C+MNamPnwi0t8/M7nFexeGP2adLs5I5dXvmuCMEqorv5vjF4WSBmjuSWBwFK4zXN6v8edOgR10+1aeQ/cY8AfWgD0nw74L8P+HkX+zNMtopFH+s2AsfxrQ1XXtM0pC1/eww+xbmvmHXPjf4gnEqQyw28Z7g8ivLNe8az3sjtc30ty55IBoA+mfH3xusbCGW10EGW5IwJm6L718y+JfG099qM019czXs7HJBb5RXI3+sz3fyLmOM8cdfzrOUFjyScUAXtS1Oe+ch28tOyqaoEZIxz70oIywOfSk5z2496AF4DZI/ClBBJ+bn2oJyOCMjuabnGc8Y9KAHbh0OPx4o2++TTduTkjJPpTgOCox60ARNkTDPXB4Feqfsvf8AI/6h/wBgyT/0bFXlZx5qd+DXqn7L3/I/6h/2DJP/AEbFQByuq30Ol/Gm8v7osLe18QPPIVGSFW5LHA+gr60/4aX+Hn/PzqX/AIBn/Gvjjx4of4ieI1bJB1S5Bwcf8tWrG8qL+7J/30P8KAPuD/hpf4ef8/Opf+AZ/wAaP+Gl/h5/z86l/wCAZ/xr4fEUJONsn/fQ/wAKPLh9JP8Avof4UAfcH/DS/wAPP+fnUv8AwDP+NH/DS/w8/wCfnUv/AADP+NfD/lwjqsn/AH0P8KPLhzjbJ/30P8KAPuD/AIaX+Hn/AD86l/4Bn/GvL/2ifjF4T8eeAYtI0Ce7a8W9jnPnW5Rdqq4PP/AhXzf5cX92T/vof4UeVF6P/wB9D/CgCDYv/PRPyP8AhRsX/non5H/Cp/LhzjD/APfY/wAKPKi/uv8A99D/AAoAg2L/AM9E/I/4UbF/56J+R/wqfyof7smP94f4UvlQ55WQf8CH+FAFfYv/AD0X9f8ACpIo4Sy+bNhc8lVJp4jiJwFkP0Yf4VNHYNJ9y3nP4/8A1qAI2t7XDFL1OOgaNhn8garlFB/1qH8D/hWkNImLBfs0wZugLdf0pJdKkibbJBMp9zj+lAGbsX/non5H/CjYv/PRPyP+FaqaLO67kt5nX1U//WpkmkzIxBtZ8fUf4UARWEOnO2L+6niHrFFv/mRV2SHw9FKDHdahcJ6GJYyfxyaz3tlT70UwI9//AK1MEcX92T/vof4UAaDX+nxM32TTrfBGAbh3kI/QCqdxeTTxCJp41hByI0Xav5AVGYoR2k/76H+FHlRDqsmP94f4UAQbF/56J+R/wo2L/wA9E/I/4VOYouyyY/3h/hR5cPpJ/wB9D/CgCDYv/PRPyP8AhRsX/non5H/Cp/Lh9H/77H+FHlRf3XP/AAMf4UAQbF/56J+R/wAK6/4b6b4SutYE3jfXlsNOgIYwR280j3H+zlFIUep6+lcv5cX92T/vof4UeVFj7smf94f4UAfWPiL49eC/CuiQ2vw+gi1CRY/LhjMMkEVrjofmQFvw69zXy74o17UvFGsz6rrl/wDar2Y/M7AjA7AADAA9KoCOHniT/vof4UvlQ4+7J/30P8KAK+xf+eifkf8AClIAiIDqST0GanEUXPyv/wB9D/CmTRIsW5AwO7HJz/SgD6o+B/xx8G+D/hdouha1NfLf2nn+aIrYuvzTyOMHPPDCu6/4aX+Hn/PzqX/gGf8AGvh0xxhE+WQkjJ+YY/lQY4wfuPj/AHh/hQB9xf8ADS/w8/5+dS/8Az/jR/w0v8PP+fnUv/AM/wCNfDrJEDyr/wDfQ/woKRAj5X5/2h/hQB9xf8NL/Dz/AJ+dS/8AAM/40f8ADS/w8/5+dS/8Az/jXw8yQhwCsmP94f4UpjhzwshH+8P8KAPtyT9pH4byOjySX7uhyjNZElfp6VJ/w0v8PP8An51L/wAAz/jXxGsFuRwJP++h/hTPJiweH4/2h/hQB9v/APDS/wAPP+fnUv8AwDP+NH/DS/w8/wCfnUv/AADP+NfD4jhYgBZAfdh/hTmhhUgESZ/3h/hQB9vf8NL/AA8/5+dS/wDAM/40f8NL/Dz/AJ+dS/8AAM/418RJBA2c+YP+BD/ClNtGCPlkK+zj/CgD7c/4aX+Hn/PzqX/gGf8AGj/hpf4ef8/Opf8AgGf8a+JGt7ckBDJ75Yf4U/7NZgDc8mf98f4UAfbH/DS/w8/5+dS/8Az/AI18e2XiMwWkMJWICNFXvk4H0rIa0gUE5kK/7w/woit7Vx96QH/eH+FAHRP4nhYDJB9st/hUP/CTKCcLHjtnd/hWIbW1QguzlfZxn+VSCytGUlTNnsC4/wAKANN/ErMP+WQ9sN/hVafW5pThbhI1PUKG/wAKoJZRvkASbv8AeH+FQyQRoxUpICP9of4UATSTiQfPc7j6nd/hUatEBzMuR3AP+FM2QFeFl3f7w/wp3lQBclZM/wC8P8KAHq8POZU+uG/woMkX/PYfk3P6U14IViDYkz7sP8KFgiMe7bJ7fMP8KAHGSPHEyfTaf8KbuiI5lTP0b/CkWCIoSQ+R23D/AApqJA3DCRT6bh/hQA/dHuz5yED/AGT/AIU4vEcnzU57Yb/Co5IoVxjef+BD/CkMcAXI35/3h/hQBIrxjI85R6cN/hS74sAecnvgNz+lQpHE2Bhw3puH+FL5UO8riT/vof4UAOd4jIrK6gAe/wDhXqn7L3/I/wCof9gyT/0bFXlXkx7gpWQf8CH+Feq/svf8j/qH/YMk/wDRsVAHCeOv+SjeIv8AsK3P/o1qxW64FbXjn/ko/iH/ALCtz/6NasYdcnmgAwByOtIenNLjIz2pc4HH50AKi9yOKCAFxjPNIOmQc4puR/8AWoAXocDmlHrtoUAg9PypuSOhxQA446ikAUtjkmrNlZS3T4QYX1bivR9F8I6VpFjDf+JboW4kG6NcZZ/oKAON0TwvqOsTLHbQOA3PSvQPDXwhluZRJqTmG3U/N5vy/lVi6+LEGlBo/CmmRWyKuxZbgbyT6j0rhdT8S+ItfZ5LzUJZQSSdrbQPoKAPZV8EeCPD7L/aWsWcrscgRncVHvTJ/Enw0sl+0WzzNcWx2/Yig2XA/vbu1fPsrzBWWSdmz1BbOa2tGHhY24fUvPWZesa9G/GgDs7z4naWuvyX1roFsqKu2JG5C+9Nl+KtpqMD2+q6FaSKw+WVVwyVnQ3vg9JlaKwkeFxyjNll+lW7i58LujPbWPlwx/eDHLNQBY0H4k6HpRMc+jGaE9e26uog+IngPUIBDd6U1mJMhWQAlD6k15vPqHhaJ/3OnTNEeQC+ST9aoSSeHJ5xm2mt0JwQX3GgD2W2j8B3dlbyT39hKu4rKFJEq+hx3qDxB8OPC95aC+07UbNIehHmjJHrj1ryKXRtIKMNPu2lkJ+RhwR7GqM8F9pzukc7SL12s1AHY+JPhJqmm+XLp+bq3lXerLzxXn2oaZe6c5S6hePnGWFdP4f+IOvaHexzR3Ukgj48tzuXHpivSYPiF4b8ZWxs/EFhFb3Tf8t1XABoA8DAyRgUuNpJbGfSvRfEHw6uzb3F/o/+kWkZy3l84HrXnc8ckTlJQVZT3oAXCdwRTCQO2PpSZJ68eppeex/GgBBRj2IPrTfpzTlJ5A6EUAIMDGRTiPm6YFA69qc3C8tz6UAICpbJBx6Uy4P+j/8AAh/I0vPbimz/AOo9tw/kaAHZykfQALTGJJ54FOyCkYI6KKaW6YJwaABSC3z8DtTu+4DpSScqBgcd6VmZlA28GgBshLEZAxUjM/ACjpTZUPyAHOOtPK/xDrQAqpuHWmBRhitD/cwMU9FZ3CR8euaAGpE5APSnvAVIJOWqZyIuCckVHy/OTzQAmMc4BPrULSOH68GnzAjAU5PpSJGACTnFAEJyhOCeaeqF+SNo9TU6w+YBt6VFMHT5JRx7UAOGUT1WmSDK5PBPTFAO5QARgdqlChlyc4HSgCJIjvHOR3Bq0zEABBxVaPc7krwBU0bAMcvzQApcq2VYg0R3YLFHTcfWjGMsvzGoQ+3MgXHtigCw0cbPlOD3FRldrkgYHamScgNyCalDDAU5I70AV23McvynpVgMEVQOhpzR7VyOUPf0qF/nGWwMUAMbLSkDpTjGCfnxntTY2xuYYxTepLs2M0AOcBRjqfSmnlcY5p5HAbPNMEgWQnqD60AIUC42nnuaReWJJNKdu7K857U5s8BhjPSgAic55GRzzXqv7L3/ACP+of8AYMk/9GxV5ZEMNjt2r1P9l7/kf9Q/7Bkn/o2KgDhPHP8AyUfxF/2Fbn/0a1Y3etnxz/yUfxF/2Fbn/wBGtWOGOcnpQAgAOeRSHp0FKDt+bHPajOeTQAh57Y+lKeMHj60buxyAaUYHTke9ADSMnGeK6Xwh4UutfufkVhCvLHHan+CfC8uv6im4+TZIcyTMOAO9emeMvF9jpmhx6L4ei8i2gG2SfbtaY/4UAcXrMVh4cvmt323HkrlFToW9zXP3E9zr1wZ7ydlRB95jwg9FFRWzW+pXEk2q3DW9suT8vJY+lS2tjLqhC2CNHZKcFm6n8KAMi48t5/LtgzjOFLDk1YWzvnbalvNkcYUV6bo3hjRtJ00vOJpdUY5V3+4o9MV6b8Mdc0HSLpReWMbtMdh3jOPegD50XwzekL5g2M/IG08VFqPhjWNPj82Wylkt/wDnrGhK19M+Pda06WS4GlWkSbTyUUHiuD0nxNqNtO4t7gRxNw0bKGU/hQB4jbW9zNOq28bNITwAOfpU2oR3tlIyX1vJA5GPmGK+pvhzfeGNQ1yOTVdEtvtm7CyxrtXPqRW3+0p4b0q58P6ZdCyQMswAdBg4I7+1AHxrDFLKB5UbN6EUsltOp+aN89hivW4tFims55oLYLDGQpKCn2tpYSeWm5G4xzxg0AeR26zBmKK6uKv6dYapqU+LOyubth12qSPxNehXXhhvMLRxiRQcny2ByK2NCuLnTLRrW1ee3hzkqg2k/U0AeR6np17p0mdQtpYJB/CwwKsadp8WqW7GCUQ3qnITs1eqazD/AGnaEXKmRG7v96vKr+0n0TVyyA7F5U0AbPhXxjqXhvU/KuZphATslj/hda6HxdpVh4q1W2fw9GiNOm4ovrXG/aINZTypmCXJ5VunNM8P6vd+GddhnP8AroGyoPTFAGRqumXGmXckN1GyOrFSCOlU1yc88V7JqUUfjuczSJDHLOuVZOPm968z8Q6Dd6BfNb3kbqQeCRxQBkEY/pQFx2peTyQCKU85KnIHrQAzABHNOYk4yM0Eg8kUn0OaAA+h602Yn7Pz13D+RpwJxg9PSmz/APHv/wACH8jQAMv7tDjPyihQCuDj6UrY2J82DtFNRFP8WD60ABBBwafGRuCnj61GCQSMkk96kVwDg9exoAkf5XGBSh8DcRTEVjnefxp8MLuxLH92KAI/LkZww4qTJWTjg9zUjkggKCwFQO26RUVSC3agCYgOwNbGleG77UigjUrvOB71Y8P6cst9EhgaY9SMcCvWdFt4rS5SRU+YDAX0oA4mX4R65AI9sXmq/O4HpXVeH/hRb2A8/XZ1Kkf6oda9OTUJbbTQZSdp6ViarfxTwBlclqAOJ1jwDYzzbNN+Vex9K1/CfwLjuLgXepXazRqM+UnU1uabPbiPcWG4+tdZ4W1NdKu47qO43rnlCeKAPnj4leC4tP1822n20kGWwquMZqnP4Av7C3jnvFOxlzjFfQXxg1XRtb1Cwl2CO6Qg57moNNe31SQ2dyA42AAEUAfMV9BDbuUiBx34qKO0twAWI5r2jxRoOi2d3Is8KBs8GuOi8ERa3etFpt1HFL1VXOAaAOe0XR7WRiTMqg/3jVy+0ay+zMsLq0g9KseIPBWs+G0SS8Tdb5wXjORWrp3htLmyS4hdmVh27UAeY3kEkUmxuBUAbaTnriuy8S6H9nkMbht3Y1yLxNDIY2G4D1oAbbzOG9U7irk8MMib4m5PUVRUmN9vr6UqOVkwDQAKAcqRgildCzAEDYKttGk0RK8SCqiMwJRgdwoARkJBI/Ko2RvL6AjvT9/lu3PFMclsFT8vegBqMAoIHWnYJbJb8PSl2HO4HC037o+8MnvQAsfyydcjmvVv2Xv+R/1D/sGSf+jYq8tjYEhcDp1r1L9l7/kf9Q/7Bkn/AKNioA4Tx1/yUbxF/wBhW5/9GtWKAR7VteOf+Sj+Iv8AsK3P/o1qyHwSCB0oAZ9evalHJ3MeKXjdwAKQ5B/oaAAkEmtzwl4eufEOoC3tonkxy2OwrItoHuZ0jjBLMcYHWvYNOun8EeEpY2VI726Xj5fn2/WgCz4p1Oy8J6LDpOnBBIFBkdTklvQ15DqV7d6pO0905cD8AKZqN7LfXRJLYZudxzVnT7CbVdRh06yX5WYBm7AdyaANzwX4UbWA11esIbMHCjP3jX0X4D8FeHbbRZb1QkoVOSegYV5f4jt9P0m3trXRpjLFFEEcju/ciur8IahKnheS2jJVM7n9zQBj+JYC2pyNCp2+lVtJ+VJ/MVQ2MjPWtUXqt5qTEEOeuORXNa9dxW8OyB888kUAZNxqs0F3P82QeOtU7e9aJy/3i3WqzhpZc4GXNdBoen27EG5YBc8g96AE03xA1q4MQeNwflbb3r0a/wDHF34i8F/YdY2SzROAr4xxWBHaeGJJkjuZ7y3z1kiUEAV2HjPw34d0X4eadJ4eeW6N3Lua4mbLt+HagDH+FV55+o3ellY2ts5wR1rpfFHhbw1YKzy2zNOxyI4jgmvJPD9/JpGuW10jMoMuxwOmK9I1q8mk1SCVnzCSMN7UAUdN0Hw1d3JtvNv9Nvm5jErfKT7GsTXIbvTri4sLtt0kXKSkcsv1r0G70+3u7RfMAPo3cfQ1za6NdazJdWpaSWe2+6W7r6ZoA5TSo7eeKR7y6KFRlCfWsLV9OTVGKSqd/ZyOorU8QaXc6e5R4njZDkqe1WLby7jTVnwfOjPzHPUUAec+IvBep6TareiMvbk5GzkgVjSXcd9Z7blR56fdcdfxr1iXUpXZpVcFB8roeRj0xXHeNdIsvL+2WMXkyNyVU8GgDm9D1u40qdHViQpyBmvZA9p8TPDxt5Ni6nBHuRh1b2rw+a3LxCVFwR1xWr4V1u60e/hurViskTBuD1oAydWsJ9NvJLa6jZJI2IwRiqiEYNe7fEXRbbxl4bt/EmkKougn+kqg6H1rwpgyMykfMODQAg6/L09KVsYGRik6YPQ045Zc9celADMnpRcf8e3tuH8jQBnGRzST/wCo/wCBD+RoAaxAEfGTtFHXGBkUrKSE7fKKQA5x2HegBVwWwBgipNhft8w64phBUbgeTUquyDcOT3oASKJpJApJx3q1cvtQRR4xUXmkx4QfM1RkEH5j+dAEsJkkdYgAuTgmvW/h54H0O+eB729WSfIOwVz3gXwK2uWj3l7N9ntU5GerV3fhHSIdN1WOSIsVRuPpQB3HiTQtJ0C2RtIt181hhjjmsvTreNodwT943OK2NYuEmmEjD5cY5rGW+Nnc7gqlG/SgC7e6h/xKnglT5l4FcczkrtjYs5PSrusakZXYJjB64qv4eijNyZZecc4oA0bDS2KhrgsCewrdstBlOx43KoTxk1LFdQCMyMy8dBU8WpG8gEQfYoPUUAV/Ffht4ZLS4vEDDjBFYFxqH9k6uJlG1CuBWj4p8RXMl3a6dATKq4yTXP8AjEtPagAAOo60AeXeMvEF5qevSrJIfJDcEVv3Gnb9Gt7zT7lluFUEhTXI63CLTcZ4yGY/eNWtJ12S0svL3+ZngA+lAGq/jq/fSZ9L1BmlyMfMc1a+FmvPBczWMjB435UN2rj7qwuLxnuFXJznHpTrWT7HJDcWx23SHkA9aAPRPG+qfZf38toJADjOOK4XTbP/AISTVvM8vyof4sdK7yY3Ov8Ahp4o7YtMy5zjPNZ3w8XTkSXT79zDqCtwCOtAHIeJ/DbadKZoMvCtc0FQucH/AOtXvet6NFc2jpD8zAcrXi+r2n9nXcqyJt5oAoWrFCRnI7GrEsZeMSx8sOoqi2cFlb5TV/S3VJlVzkNQBSmiDZZTz6UkYxH14Nal3pzRyPMpHlGsnIV2B+7QAjZ3AdR6UFhjaVo6klO1Iz5+9y3tQA+NVMo256V6r+y9/wAj/qH/AGDJP/RsVeWxH5lGOcHNepfsvf8AI/6h/wBgyT/0bFQBwnjr/ko3iL/sK3P/AKNasfkNxwCO9bHjn/ko/iL/ALCtz/6NasgYI+YnFADehNA5NGdw45Ira8H6DceIdbgsrfG5m5J6AUAeifBjwzbgXHiHWU/0O0QsgI4duwrlvGGuSa1qV7cyksgYhF7KPSvTfiRqVp4e8I2nh7SZ4y8Q/fMp4Y968ZvVMiQRQgln+ZlH9aAKFttggeZ8eYfuA16H4N8NX1pokupTwtEkgypIwWrmvB2kpqusNLOhNnafO69jjtXq9/4rbVUit75UjtIV2xJF8qgDpmgDipzcoh3xkJ7jiuv8I6gJ9MuLY4WVRlf9qsm/1iXyxbM0fkf3QKz9Mnayu96H5W/lQBd1K9+zySKxIzzXMzTPOST93sKu+JJRLcgxHjqazgSMAgZPagCW14b5+COlXGvyo2p+FUSpeVRGpYn07VoWemEtulOfX0FAFi0meVBvIBPT3roH1KaDR7ewZ2CRMXHPH4VRsbS3WaLYfMyegFSarbyqfMdNiMcDnNAFCRme6tYv45ZA3616X4gvLXT4rWG4wlyyABR0+tef+FYTeeMIXADR2oz833ePWuk1USarryvM63DBuEQcKKAOwtL8yWSRIFY4644FUtUtbh1a7t7l4rkLwEOA9T2g8iMNsKonbFYGpeK7SQTRpHKrKcE/3aALUGvLqNslv4ktV2D939oQZdT71hGy/s29uLB3WS2l+ZJF647Va06KV2F1BslRx8ysetR+JLQ2uoRyEttZA3XpQBzeo2y2c5QNu9fce9U7mFL20NuAFOflrcvLy0ux+8BE4GMnvWTYKF1MCUDaDk49KAOB1awudFu3MikwPwfSswIYplkz8jV634omsNa02e0isdlwnKS55/KuA0TSY9Usb23kuoILm2QunmHG/HYe9AHRfDbXbvT9TXSf7TFppl6wEoddwI9qPjN4TTQdZE9kubOUAqwHXNcXIzNaxOuFlgbqOvFfQHgiWP4lfD280m+eFryzj3Q8fvDgetAHzQcg80DPcHmreq2MunX09tOpV4nKkGqwPFADeqgZps+fIwf7w/kafgjnnHc02cYg/wCBD+RoAGYGJF77RTU44PQUMvEee6ilQBhgdaAHgHbnHFOt8HPHFCna3I471YhKKjcdelAEMSjcSDjFXdGsX1XVYYFUk7hwO9UkU5PbPQe9ew/C3w3FpNmdXvMPcuMxqaANxbOe1soLONCgUDIHepre4nsLiJposLn0rXN/56maVAHHNZurX5vLY4AOOgFAHUajLHe6cskIG7HIri765UKYwxDVraFcolgyynD44zXM37B75z6ng0ARx5RjubOauWsggDM34VTj7qR0q/plm93IWkBEYoAdbtLdOdpbbWrpMU0VwfmJUc4NXIEtLFAYhvY9hVa5e4Pm3MqeVEi5x0zQBDdXMct08ipiRPSqWp3MYiiN8QiE5JqroV+l7JcTN8saH8653x7qCOvktJhcZGKAOR+IOoRalqvlWRH2ePgEd6Xw1pwmG5gCw6A1gWoae52kZ54NeneDLS2EyKZF391zQA+ysILTTrr7TOi3Dr8iV5hds9rfMHJVw2fY17N4k8LO12LyDJjUZIzXl+ueRdahIHTY68A0Adt8PfHbW0kNjLFHtkO0NjkVieOCdI8Xi5Vcl2DAr6Vylp5dreCdtwdeVx613uma9pep2xbXIM3SDCk9xQB2cNyZrW2v7ZgQ6gOuelcT8ToLQLFKihpXGWwOla9he2hXOmyZjJwYyelXtJsrC81gy6inmRp/AaAPD22btpyv1pqAIdyk8GvR/itoltDdre6ZAEgP8Arzkv8AL8q4J7GgDZIaWzB8wkelY7KV3Ky8Z61oaQ5mVom4btUWojZIN4xigCkpXHTio1fy85XPoafKvGf4T6U1TwAOaAHxsSd3Q16p+y9/yP8AqH/YMk/9GxV5bEuW4r1L9l7/AJH/AFD/ALBkn/o2KgDhPHX/ACUbxF/2Fbn/ANGtWMAcYJ/Ctnxz/wAlH8Rf9hW5/wDRrVj5yOfWgABIbCjnpX0N8F/DqeHPDF54m1BVV2iPk7x1rxXwhpralr1pAkZk3uAwr3v466nH4e8H6XoOnttaRQWT+6KAPF/F2ovquttOIY7eMtkKp+971T09RJLe3DEKI02Lk9TVJc+YWY5Kjqaz98h3AMdpOcUAemfDpYrXw3qN1JnfM4jQdj60y7RdzlcgHrXqPw08G6XdfCW1/tK7WzvJ5zNG7/3e3Fc74i0DTtItpGe9iuJS3ybOhFAHnzFyuHJJHRvQU83Um0KCDx1prkeewQ8E1HNw4BAPrxQAEhpMMd3HU01dxyTzjpSHIZsfKD0zzUsPygjjmgDQ8PQrK3IySeRXX2WmTXWmTmCP5I5AzRjgsvtXK6HKLVn3DI61ufbp2jHlyEdl2nkUAdXqf9jWGkR3kcc3mTDZBDswEPfJrg7q4aS9UOcbAScHjNbPiK5mkbT7J5mkhgj3sCe9YOjWzanrAj5VGbHAoA3fC1hNaaJeajIDFHcPtVv71bPh4oL9pw42KME1seMvLsdDttJgUlVUEsD0NUPCdrAYSGBKkc56E0Adhatb3dudko9gO9cv4p8Oi6srhbPyhK3JYHFdNBaBIAIWHPoPu1WvdO2WTs0jc9T1zQB5DpL6pFKmn20wBRuRnk+1emDw9NJp6y6rG6yOuAA2a4TVYJdJ8RWt3EY3EbBgAO3vXeSeJEvoFmS4jIGN0YzQBj/8I5I80Vq8KmSQ9epC1h6jol5pOqzI9rI6txGwH3q6ZvETW+qNLbBXAXr3ArodN8QRanPHbXKx7TzGw5agDx2wEyapIXjKsh5VuPwrnviDpQ0vVI9RsFK29wN23H3W716b8UtLXTdV+2WufLnA3AdjXKXUR1jQprOQ5ZB5kJPUHuKAPMLWcmVwcYfk123wm8RHw542s2ZisMhCOR0IPY1wrp5U+Ocq2CPSrDyNHMrxvtkQhwaAPR/2htDXTvFgvIVxDeASAgcc15O2c7QRivoj4x48TfCPw5rkMYaWJBFKV7Y9a+dmwXzj8KADrgZPFJPj7P77h/I0vUg9hST82/H94fyNADSeE9doqa3TDk/jUR+6n+6KmR1RcnvQBPFGXfC85p2oKYFVQKsaZCzOH6IKi1WQfaVT1oAZbRma7tUXqXFfRDWRi0SyCZV9gzXhnhGyN74q0+3HVpB/OvqXxH4XvVFqsBXyQgzzQB5lPLcxyNk5j71DaufN+Tv2rrdZtbTT9PeIsGnPvXIRfu3BzQBcuJlCsjttb2rKkmz8vf1q5cYPznms24C7sjg+lAEiSEZI612Xhsh9OfONxrjrchVKsOTWzoV5JZqykZU9KAOvm0+NdOE8JAlTnBNc5411PztBRIXAnbhlFaIL3NuQ0pCt2BrnjpKJdyO7mQDkA0AZEbJpehxq3+slOTXD+MI5JGWVm+VunNdD4guzJdGMj5Eridd1Rr2VVRSI4+KAINKt55bkiEZA61uWcV3ps63ay5KN8yZp/gNUkumy4XI5JrZuLa3k1PCvvAPOO9AHq2gajFqmkK8kZA24avMPiFpVvaPJNapndz0r0/wYkZtPJC7YyKyPGulxRQSo5UhuntQB4dDMojLOAWHGDUB+aJ5A+AOiirmrWb2c7oF3K3QjtWM2+NwucA0AdP4AnSDUi1zJhX6AmvW7PSGMclwnK9ePSvBEUQ/vVc7hzmvX/hT4ze5lGn320pjaGPegCxrOl3WoW8jW6iWMAgqe1eK6rbSWV48NwhXDHHFfQmpxT6fqLPAxFvI2eOlcn8VNKsZ9Ljvoiq3GPmx3oA8jtWdLpGJKjpW5qsIeFXAyCK59pGGGI4U10Fs/n2gGaAOdJ/eMCcAdBQDkY6Z71PqMBjn+XkHrUUf+1QAQ5RsZyDnmvVP2Xv8Akf8AUP8AsGSf+jYq8sQEyA9FFep/svf8j/qH/YMk/wDRsVAHCeOf+Sj+If8AsK3P/o1qxhw3FbPjn/ko/iH/ALCtz/6NasfbubBoA9n/AGctFF14pju5AHSFc7feqHxlvhr3xCvoxIsMVt8gJPcV3v7OtolpoV/dlNrLGSJD24rwfW7p7zXtTuHYuzzthvXmgCmuUE3O5s7Qav8Agrw/c+I/E1jpNqhMk8o3HPCrnk/TFZyDMAUnAySa7j4eSS6Ppd5qcJKXk/7qKQdVXvigD074kyNY3aWFu+21s41gh2ng4HJrzPUL2S4O0sTjjmkutRubrcJJHlI/iY5qtHExIJzz2oAktrTzCDwo9SafcWbxN0+Xsc5BqAllDA4x2qxay/KEfLL9aAKMgbaM4PNTWoMnyIQfXFLOVCsAOVP5ipdEkWDUId/KlvmGOxoAZExRjxyeMCug0k7kU44Byay9cthbXk6xsDETlT7Vo6EQ0TKcgqmRjvQA/Vpd/nSEZOMbq0/h2Ejd72bBWL5qymj+0WrHcuTnPPStHwEGktLyFCFYHlmOABQBo63ryzGUFVPnt94feA9K63w7CkenRtj5tucV58+lNeayMDepYBSp4zXqVrbeRZxwjClQAw70AJG0m1g2VLnjPpTru4KQNFHtZunNOnZnfHlnfjCn2qNbVmDLvxu7d6AOR1i2tooZGuJWMv8AdUZzWbpelXEdq91GrC3PVXHNegtZLFE5jRfMK4VmGcH1qjZWsospY7ybzZWByR0oA8/fck8gC5ZVySvORSaBO0WtW0imTIP0xWjqcbaZfuxPzOnBU1V0GNv7UhchpCz5INAG/wCKdTW5HlSqHCjljXEaXGRfpIg+Tf09q0vGUuNee2ts7CRuB7VHMYbS3VRlyRnjigDzz4haYuneIrhISPLlPmLj3rBf544mx14JFdx8Tow39l3GzZ5iY65riNu1JY8nKnIoA9v+Hcp134G6/pO4NNZv5iqeuP8AIrwWVdrOp6qxFex/s4asll4wexulD2epRGJkb1riPijoB8P+L9RtlQrCZWKA8cZoA48DBx60lx/qOn8Q5/A0Gi4/49/bcP5GgBcjZGD/AHRQI9zKqjvTchRGePuirWno0txkHgUAbkKGK3VTwccVjXnM/wAw5HIrcDOxAZc4FYV+xlvRGowxOBQB2nwws2n1dbliU8vkP6V63c+JNTEjI14ZIxwK4jwvato2hJ56ASzDOTVmS45BXigC5eTy31195mbvVmHT22nzDtY9BVCyuxHITxv9a0UvBJKvmE0AEunAWxckkrWFKoMu4jiusiY7mA5iI6GsDVIhFOdvIJ6UAWNMtVuIn4y4HFMUtFuzwQelX/B0qRazGkvKOMVL4usGtNWYxjML8jFAFzSA8sAdWA9ql1KKKOymcf6wCsy0cJbosbYf0p2ovMYXjYEMRQBxiWiSWt5dznJQHivMXbfcPtGAWP4V6jczxQ6TeQPkOwPNebabbGbUXTcNueCaAGWiT28x+zylGPU+tb/hu5J1NFmk+YH5s96y9UhFrNtzz7U2zhf7RHIrNuJoA+g9PvIoLBfKkG8isTX9SilIjlbe9QaNbSyaTGwBLYpJdHkmPmbfnFAGBNp8Mt2puAqq3rXIeKdC+w3bNEcxnkGvSl0Jri8jadzhe1U/iPbQ/wBnJ5MWJFGOlAHjssh6DGBwa0fDDMuqJ5chTack1UuLN1lQMvytzSRN9muUZG68UAen6f4svbnVFsSPMt043Gq3je6FzGbWIbu/FR6TGljo7XW0eZJ/FT7ZImvYip8wv1oA8zu0ZHaIrhqv6Ox8ooeMVe8dWRsdXGON3OKytKl2XRQ96ALWqxFIw6isgjH7zPPpXTX8YktiF5IrnGRtpyDgfpQAxCQ4GeDXqv7L3/I/6h/2DJP/AEbFXlUWAw6N15r1X9l7/kf9Q/7Bkn/o2KgDhPHP/JR/EX/YVuf/AEa1ZMWQ4weDWt45/wCSj+If+wrc/wDo1qzrYb5kTjr1oA+p/hlssvhXqE69BbMWGPavmENu85iPvSMQfxr6g8PxtZ/A2/bADfZjxjtXy+GMqxqwAUMTkfWgBHTIKqfmVMmvfvC3gZtZ+GWiX9vPHCPMdXLHg14XDgrezYwgAXNeq+HdW1UfC6zgtzKtlFcsdyqdpJ9TQB0WmfC+a5jbZdCQgnPl81k+LtA/sKSO0SIgumSzdSai8K+PtV8PXyyW7qfm5RxkGu31r4j6D4nEH9vaA4lXh54JMMB6gUAeNXEDjDcY6YNVoA0ZZWHAPU13/jDTdEV5ZPDt6Z7HYGHncOrelcJaq29s9uxNAFeT/WH0p1qubsAHnGabdHc5KggZ7U+1IS6TB6jrQBp6hGZoQ5OTjGM0umujJC8hOY2wMHA/GpFIeM5AyOKgtyEWaFwoyMg+9AF2J/Ku5opSBk5GKu+Fm8m7vYmDFX6Ad6xNS5W2u1J5Gxs+oq7o106XsZjwwbhlNAHpfhq1jt3WVVQg9j/Ca6YswZZOWcn8DXCeG7iYX3l28BaFjl2LZxXoUKh4U+UEqfpQAioDbvI+5ZCcAU3YvnoCQWA+8KkkByFIIB/Kqly/kjYAPMPQ0AW1JaUggBgeB2NUJo33zjH3uMqMDFSLLM0oDhX47cGpI5ULKRkt0IPagDl9c0tbuJMRLvj43dyKl8L2K/2uHVF2wLyMVQ8TajdWF+IYRvhk5JP8Ndd4J00jS2vpyQ8rcjHWgDyTxCPs3i29LglN24A1UvQzL5rlQnbB6Vd+IFzGfF9wkZzg4yKyp3EcGGILNztoAxPG0yT6TayknfFwABwa568VCbaZcZljww966+aCO80e6icYZVLLx0NcUoZtL6gtDJnp0oAm0K9n0rVrO+hLL5Ey5I7c17j+0/pSXmkaH4hhXP2iBS5HfjNeBzM6CRUyEcBiPUivprU4z4x/Z+sZo0DzWke33G0UAfKJGCD1z2pLjAt+P7w/kaldWjdlwQykioZ/+PfPbcP5GgA27lXI6KO9XtIOGJ7ZqowAgQ4Gdoq3pxIXGMGgDYMxXLAjpWVpcBvNchAPJcVLdttiPODim+GZVh1uzMowhcZI7c0Aet66siGCEncqIOlQwW0sqqRGStd1rmgWkcVtc29wsqzID1rV0nS9NaySOWZUkNAHmc9sYyCyFafEvzBhkY9a7m+8Oz3F75dg6TbecGsvVtNEduwKBJ0+8ooAq6fcq67W4xWZqRCTOSevStLRY1IJkXgd6oan5Ul6wUZWgBNCLSXKsOMHrXQ66rS2wZWLsOtc3pMqx3RQHGTXZW7Ax7GT5SOtAHEXE0iNFKhwUPNbk9+J3hd1BDris7WrQQtMucBuRSeG5UktHhmXMi/dNAEGv6SI7K4mdPkIyK8l0sF9XMMfdsCvaNcklk0mVCScDpXiUkz2mrGXBTDdaAOkvfDlw90DIC3etjRfDUrToShKg+ldf4ZK3GgidonmlYYBUZrc0xTDFzDKWP8As0AT2tqY4I4kTaijk1csbQ/NhdynvURvgUMZhkUD7xxVOXX0tpFVS0cI79zQBp3OnncoCle+cVk+INOjurVtygqo5NbVlrqX26IfNkcMa5/xnPJbaJNBCdzvyWHagDyvxDbW0MTR+anB4wRmsHw9o/8Aa+qmOI/uxzms3V3YykAl3J5zXofww0WSO3F3KdqH1oAu3dksektaqfnXgVT0bTpIGSWdvunNdRewwu0igfNnrVKOIKG3sACMAUAc38TY4JrSK4iiLNjBavN0cxyxkfer2fUYFuvDV3CFDunI9q8X8orIysfnBPFAHRW8mVDdcjmsS9JW5YDhT2rS0mQMmw9RWfq8W2bOTigCqvEoOOOa9U/Ze/5H/UP+wZJ/6NiryiFT5m7ORzXq/wCy9/yP+of9gyT/ANGxUAcJ46/5KN4i/wCwrc/+jWrOsTi4j55zWj454+I/iH/sK3P/AKNas21+edewzQB9X3s66Z8B7i6KZmmtxGOeua+XbeNg0QIwcFjxX1NYpBc/BW5a+jMqx2v7uJegPqa+ZnLpL8w+7GeOmBQBWj2jTrncDh34r2jw74wXR/hlZeHfssclvMxllZvvDPp+VeLNkWFuM8SSZI9Oa73VBsgtUVcDyhwPSgCxqdpBdQ+bbkg9Queaw45HRxkkbeKu205G1ADt7nNVJcC7KrxGT0oAc08j9ZMg9eKfbEozbBye5qylg8m0qvD8A4rUvNKh06A/anxc7c+XjpQBzN27mNlkHftxREcIpxyvrTpVy+eNp5GTUX8RGPwoA14nV0VlOCaSSM7lkA+6ecVDZSbkZSwyO2K7vwLoI1xrtVwSsf3aAOUhhSawubWTmVf3kZrORJYkSTGMelauq20ul6q0UwOVyvA6inWaxSQSWzKC/VWz0oA1NAv086GeEmNxgSJnrXoJ1WcoAkZC+jdxXk2nJJp92smFkiz8wNdrb3izeWQ/7s/doA69NSfarMhVMc85qnc6vDuDgk/hVFroSwhEIBQdsCqEzRpCNxJyeSMcUAdDFdpNGNu4N1/CpLGdJZW8mQHB5IriJL+aR1trWYrJn53HRV+taceu2Om2rW1s6iQcmTOfxoA1NeltYr+I3QygOSCeTVbxZ8RIbPTfs1icSldqqOi1514g18XLsIWkkRTksxySa5qSTzHLNks3IB60AaDXLyzvc3Db5X5560yMSTzAMSE9aW3t3lK5Q/TvWxDH9jh3sQso6KR0oAt6FZWqXJXV52gtpImHyjJY44rz+C1RL3ULKV2XO4px19K6GW+kuLjAYvj+If0qz8QvDd5pWmaLr8tu8cV2NpJHcf8A1qAPPpciKNupU7TX0T+zPdjUPBviHR5pMlMuEPJwR2FfPKOs1zOp+VG+Ye1ev/sxTNYeOZ7eSZR9sgIA9QKAPI/FlkdP1+/tsfdlOCRjvWHNkQEH++P5GvWf2htKbT/GbzCERwznKkd/evJ7n/Un/fH8jQAfeRFXrtFX9PViv86oEMVjAwPlFaumgiE44I65oAZfqDGRnGKq6Yd2o2ylsIWAJ9KtamoCZB6jpVG0Hl3Ue08k9KAPqPU/D5s/Del3FrOZYDGOQc1zf2ySxnJZWf0zVvw/4iuLbw9ZWlyDJCVAAPapdVhS5haVMDjOKAI9P8QTWVybiFmR27ZqLUtYkvXdjy79TWXZxi4JXPIq/bWbeb908UAX9LQizcSADjNYDbftT49eldZBp0oiMjNtXHSuXuIo/tzkN3oAqzRCGZZl65rpLS9aW0Xa2SKw7oB1wo4HemWszW7hUb5T1oA0dXV7mDco+YVV0SMM5ywVhWvZQ/bbiO3Q4L1n+JbKTQdUSFhhX5zQAs52zuHddvvXmXje0gWR5LfDHPIFega5YySWaz2zbsj5gDXDjTZLidw7YJ7NQAeDNQ163twNM1O3tk/uTYNd3Za94ijOLi7tS/XeEGDXjOrwz6besuGCg9jXSaFrhSAG4XeAMcmgD0678S6nNppCRxGX+JwOtcjPrl20mZlRsdRiq76rbOgaOQqD1XNc9q+pRxzZtW475oA9P8L6vZqHkvJBFx0ziuN8U+K5pLyaG3z5ByAx5riW1SaaU75iEHappJri8hEcUJEf97HJoAm8P6VLq+pOQpKqck+ter2Kpp2mLGr8jtXJeDozp1udp/ev1rcnlydxoAuCUoDI+MntUUNvLfyZUHYKLe1kumViCEro7G0EA+UhVIoAzIrMhZLeHOZFxk14t4i06bS9bniuVIbPHvXtWoaiPtiQ2/BU8kVy3xe05pLW3vBFyRgvigDzbS3MU+G/iqxrKnAfAIrOjcxyIrZ9zWtfDfbAdRigDFg5fLEgYOBXqv7L3/I/6h/2DJP/AEbFXlUPyttPXnmvVf2Xv+R/1D/sGSf+jYqAOE8c/wDJR/EWP+grc/8Ao1qi8O232nVYUxj5hx2qXxz/AMlH8Rf9hW5/9GtWr8NbNbzxPbwM5XcwGQOlAH0l4qaHRfhDdRoMu9sAFB6EjrXypLcO9pvkyXcYLV9KfHyePTPBtrbzOgkZAiD+J6+ZLoFLWFOmecUAa2hWEmt69punxsFjaRdx/ujPJr3jxJZ+E/EupwWnh+/FpNbRi33zDCSMBXkHwyRhf39zj54YDgjtVozNBcFlPuTQBpeI9Em0DUfIuJImP96JtymsaZg2W2fN2Iq1f3jXroXByBj1qL7MxTK5YHuD0oA6TwdrlpaJPaX8BuLeVcg/xRt6ioPEpa6C3Hn7g42jJ5AHrXM+XMsoCqTj0GK07W1nuXZV54zj0oAziOQAQfpSbFJzJkH19anmiMVwFBBI4OKiZMls5LDpQA6DmZSGA/Gve/2d7X7RfakrKBmPGa+f4wxlRTtOTzmvpX9my1ZTfzqf3eAuMd6AMr4reDmWaWaLGdvJPWvD51nspioyCnXjrX2N8Q7RJbY7lOGXt618weM7Xyb51VcA/lQBjwTLdgEAxyf3c/ero9ChKSKjJmJjgZP3TXMWLRq6qy5zXqfgWG0nYCSJSOnzCgDMvYtMt7sQapuimAysiMdrD8Kzr6HTILOW5Ina2U/KWkIJP0rvPHujDQ7BdT02NbiL+KGRQwX3FeLeL9dl1byQ6ouOCqjAFAFe91p23RWqBITzkHn86yHuJXU7mbGeD60oUABQAMDrTUHU9umDQAu07d3UntWtplnbRZmvGYuBlQKz1GCAy5xzmlllJxnIz6UAbFxfxKSbZRC3cg5Y1l3F7JcSYIYA8ZJyTVZhmQ44HrVm1twyhm3cGgDS0O2SANPNtIT5gPetS71mfxBod3pmpXMksDDdCh52MOmPSsaSUJE0anAx1o01vs84ZMZBB570Aed4aK62SZ+U7SPeux+GmpSaV8RtFuBJsHmhCfYmsPxxAINdleMbVkw44xUEcgW5064Ehi2yLl16rz1oA9y/an09mubW8CAJ0BJ5r5xuseQMHOGH8jX1Z8erJbn4caNdRyG4CxKxnkPzPkV8p3WPI+X+/wD0NAEtq4ieN2Qv8orUgbzZC8S4Q9qxhnEe087RxW7pJzGSV2460AZ+pqfO54GKNEjM+q28RBYlgAaj1ObzLpgDx0ro/hnaxTa8hnHyocigD1e70y6tIrNGU7NgIrT09RPFKoIDAYwakj8SRieSO9iDxqNqe1YU93KbppLVCqE9qAK9o5g1V42A612+mpPcQmW3hUqn3q4GbJuvOcEH1rrdD16O3sJIY5PnYYIoATXdZePKqny9DiuWDCSQse9dNL5bWrAgO7/pXO3yeQcBcZoAhvpVACRNWbMXiKsDnmnS98/eqizOD8xNAHYeHr5k1OzLHGWGTXp/xJ0ey1jRYZrT57lEzkV4laTmDy3Od2eK9/0K3ceGrclcmRckmgD5/XV2025NtLnIOCpp1zHb3LGd28s9RjvWp8WfDiQ3LXtueRywFcZomoRzgw3DbhjAzQBzniYvNckxneFOCtZzusSKqE5bt6V0euaW255bXLMvJxWBaWxvDJGeH7e5oAcxkSAZ27vaoLa2kvp/LQbj3qaLTb2ZvJVHyDjkV13h/SW0+Ah4/wB6e9AGfYeHIgo89TuHNbsEIj2wpGoUe1X40cHJHHfNPCqXGwc96AI7W2CFmUc1r6bpnmDzZiNvpVA/umJz0pZLxxja/wAvpQB07SW8EQLlVUelZepaoJIjFbsdx6GsSSR5Sd7kr6U+zgdpAUGcUAXtMgMUm6cbnPNXPETf2v4fmsgAWQZX2pty4gtQ5H73pS6TCdxkk43jmgDwm8hktp3jk4KHHNaVu6z6edw5Udq6D4k6THY3/mxcrIMmuU0qYIjIwxmgCkBmck9Oa9U/Ze/5H/UP+wZJ/wCjYq8ylidZiw+6c16b+y9/yP8AqH/YMk/9GxUAcJ45/wCSj+Iv+wrc/wDo1q6P4Ruq+JrZWwSXABrnPHPHxH8Q/wDYVuf/AEa1P8Iag9hrlpNEDuWQHA780AfRv7TFvZ/8IHpl3ND/AMTBZBHG4Ynj3r5ouIz5sXRhj1r6Z+PX+nfCiznmTbKXSQKTzjFfNcDLJdp8pOFoA7H4Uwvcy6zEnRoCT+FXngt4j++LhiP4V4Nbf7LtpHf/ABAu7S45ieB96AcMPT2r0r4g/CqC0ia+0WVngJObaU4eP6HuKAPEntomB8l/pxiqpMtq+8BiAfSr95A1nKyL/CeRTob5HXZcQhx2zwRQAtvqsMuBdQxOe+4bT+ddPJrmmXGji003TI7C7Iw0qPu8wfjXG3djvPmQKzLnr6ULZzxpvQNgdSRQBBOjRzuHznNRYw55qw6l1YtjPrVdlIww6UASom+5i3LyemDX1V+zrpk1r4Wnu55A3nyYRR2Ar5c0tWuNRhiXG8kDpX238PtL/sjwlp9r/EIwzcdzQBW8dlhZMyrkheK+WPHE032yQSgKO9fTXxM1COy06Qu6g7Dgd6+VNZuotQvJyG4YcmgDEinkVMqFYDsa7Dwf4h+zXUak7D6npXPXVkI4LeVQcMuMVkLM0MyMpICmgD6F8QX0d7oMgc8OnUHIBrwTWocxh8gMr49Ca7Twxq0V3BJbNIQxHGT0Ncz4jtmjuJVfDFTndQBhMuR3BHSm4OccZ+tTKu6MMeVzRsHJ6elADQCyncRn1pDGNo5+apGVh8uRk1EvzLyx+U8g0ATQxB5QGUlR2q/FFM6EooVF7niqgu5Y1xGV4745qM3M8u4Zbnt6UASu2ZtuQfX0FXLFRLPlRlQQM4rLUHgZ5PHFbemxyLJFDGuZGYbQO5oA5Pxoklx4lMJ5KqFGe3FYTB47No2HEb5/I11Hi4fZvGzeZ8rArnNYmqxBLy8QkEHnPqKAPpP4gwi++C2hGB1ZBbK5PrxXyfe48ph6SdPwNfVPg0jxD8GZIL2J7aewgbyEYH94uOtfLGpjY0ynqJf8aAGR/fhJ6BQa6KzlWa2kKLgBa5l2PlxqvXaK3tLYDTpApwcc0AYswLTMEG5s8iuz+HZ8nXI24J9K41yY5Sy9TXUfD/L6mN+Qc/eFAHrWo2wmDOAA/XAqrBPLbLtkUfWtzS0ieFxK4I7GpH0mGaMtHKr47UAZECrMDuAcntUY0zy5y4+X2qWXT57dmkiDKB7VEb2fH7wZI70AbNnZyRQ/aJVIQc81zmt3iXczeVxt7Vux6v8AaLUQyvtQViapao6tJbkAe1AGA7CQ9drCopUPBJBqNyQzK/XPWnpGZSMHgUAaunwNPcW0YXJLCvpqwtDbeG7dGByUGPyrwT4eWUl/r0EaLnawr6a1S0mj0+3XAAUAGgDy7xN4biu9DuxP/rHBIJr5h1ywOk6iyrn5T1FfZniqMDTCcZUjqK+XPFUEUmpzrIM8mgDE8P6yst4I5tpVxtbNdH4a8NxQa6DcRFrYtvUgdc1xM+lBLlJICVwc5FexeBdRNyLS2l2Fl4yaAKPibSYoLhZrNSif3cVgSzuJt7YGO1ej+LbSVJuVGzHavM79gbtlbIAoAkacSPkHg0wkq4KHikQLt+Uc0tujbyH6UAOMvzfWmqoL560+dBvCqKQALnnmgCxBFE8gLnCjqKtebGjYh+VR0rOifCndTzIoPNAE26SWX52zzxW4jpFbR55asKyePzS0h47VctZvPmIAOwHigDB+Ktv5WnW87nl+hrytTskDDvXq/wAWLlZ9Nt4COUGa8kjfOd3QcCgC9KzMox0r0j9l7/kf9Q/7Bkn/AKNirzVg5jXivSv2Xv8Akf8AUP8AsGSf+jYqAOE8df8AJRvEX/YVuf8A0a1Q+H3SLVLd8ZIYHn61N45x/wALH8RZ6f2rc/8Ao1qo6fhbqMknAbjFAH1L8Y2W6+C0E+Db4WMjAzur5m04gTFsEnZ2r6f8RxjV/gXIu9mMVurgEdMV8tWMhEzA/wBwigD2j9mnVLTw9L4i1q+SRh5XlIUOCM+h9a9C1vUrfxb4eA8OXl891Zgl4biQmRge/vXiPw/Jl8M6hCpPyyAsB3FaPh7V7nRNajuIJGjmibKsOMj0PrQBXuI5hOVn3bs4wwwQaqyxZVjzvBwDXo9x4/i1K+xrGkafcW5PJVNsn1zVvVIfBavE1ol1KJxuKbsLH9TQB5Kr3MKlcMQeSM9KntNQmEq4che4PSu61xfCENti1kupLkjkxn5B7Vwl/HF5mYnAU9KALur3VvdAvDEkKEYOw/ePrishVAjG1iSOgpzcpggnFMxg/KRQB2/wb0pNR8dWAuOI4m8xs98dq+wL/VbawsGnZgqqOBXxt4C1JtL1D7QrhZenNdf4z8eTXNmbeCZjuXB9M0AR/F7xzJqd89vaudn8RzXmtg6KqyTY2lvmHfFQTs0kvms2STzmm4aaTZGfyoA7LXptOa2gXTdxjCZw3UGuMuGR4vkHIPIPWuq+w3en6RFPcWKbZ+EnkYZI9lrlLvZ5rbSN4PPpQBJZXJglVkBArX1K5a/j3jAcrgiufIwMjoe9SwySL94h6AAHagUjOO4o8wdR196a7ZbIGM9qbu5AOPfHegBzckEH60zgggDHPNSBAT8vfpnpUcuEPLZ9cUAOfaeSxB6AAUsILTLGDhT1NRB9oxt4PcipIGzIpCg4PO0YzQBs29mEIKxMy54x3rvfClsllN/aV/DFawxLhA4yXb1rl/Dd/PZ3qXIVmWPkRuMim+KvEFxqty7ysEd+Ni9B+FAEXx+jsbmXSdV00RjzV2SvHxlhXl105a4BOTwK6zxqW/sfTYc5yxOK5q+gePVLaFAuW2g9+tAH2C2pzS/CCxkuYLeJxYYXyuM4XHPpXxTrB3STMB1l/wAa+tfirqSeG/hZp1phGeezWPb6ZFfId2xaDJPV8/zoAY3EaEf3RWvp5/0CTcOMVkEnYgAyNorUsCRYS5Py0AZt0Bx654r1P4WW8FvHvvLcyrIMB8dK8schww/Kvd/hFqaw+Dbq3eKKSc/cLDmgDuIvCKNYtPY3YO/nYT0rDNpdWU5QZ3DuOlWtEvgIGhvZGhnb7p7VTv7XVhKRDOsiHv3oAu2+rwRo0OoAc8cUkmnW1yvmW8i7D2Nc88SRTBLpWaY+tWJbK8RN6FlTsBQBeudAZoswlc+xqpNpF3YW2+6jKxHuai0+a4SXMkrgrzzT/EGvXmsqlrK6rbx+negDk9RjWKcsR8rdKrITuypx6VpX0sVxiFRwneodJtDqGq29nDyWcA0Ae2fs+aBJLK+oXMRCD7pI617xdxCe3dGHHY1i+FNNj0Lw3Z2sQAbaM/WrPiXUBp2lSTsyqFXJoA83+JevR6PpT25xvPAr5r1O4kmvDJt3bzXZeONZuPEmrNsJMStgVhXVqEAXbyooAxLy3BjUDqam0aV7K7jcOygH1qxaqtw7l/lVO9LdrE8WYzwO9AHrNjdRanpXmSNuZV71554hghFwzIm05qx4R1sW0ZhmP7s8Zq/4vjimtY5bPaynkkUAcyoCqhUDmlYAuCn41BwQBu5FPJaPBHegB0xUkcgGogOD3NMkA5YAk0sIZscfNQA8FsZIFIzAjkc0OjSSYDYxSNCuMluRQBoWmnmZBLJwvoK6CCxC26m3ALntWVYJM8A2PlK19MmaJ+M8d/SgCt8SfBj33hQakJdtxCuTGO4r54cbGKsOQcEV9NXN676ZqBaUyLsPHYV82ah82pTkDA3GgDRsIkmTMjhVVTgE+1d9+y9/yP8AqH/YMk/9GxV5pE+COMrg8fhXpf7L3/I/6h/2DJP/AEbFQBwnjn/ko/iL/sK3P/o1qy7UkTjafetTxz/yUfxDn/oK3P8A6NasiLht2OKAPsD4bn+2/hXc2bFX32zRhR1zivlCRDa6lLC67WR2Ug9ua+jv2aNVL2NzZSbTGnzAA8814/8AGfQpPD/ju/QqyxSymaPPcHmgDT+DbRvHr0Eyl/3W4CmaoqOc8KR0ArL+GeoCz8StGzCNbyMxjPTJrp30q4k1J7eaNg6MQc8CgDnysi4Zecd80+W9mKBW3D+tXdQtxZ3BjPUnBA5rQkstNOmJLJM8c+eU60Ac0HZlIZm2+gpyjJUA5I6ZqeeOJQTFuK54NVwxUgEgAc80ASAHymBHOaYMAjBzjtinKVJySQT2HepY9pTjGO/rQA6CVljBVutPLs5yxLetRIjA4Hze9K7bAQOPY0AMnYNwDj+dLazNbkMqbqlsbZphkKWJ64GcVcmiiG0BX+XtmgC/Bc/aYCtw5kO35S3JT2Fc/qEYD7gPwFdPY20MljJI7MrDgEdPxrA1FFik2/eyemaAM8spA4IA71JG27JUfjU8tp+7LIAM9h0qGMDJViQ36UADAsccUqxhhjaCc0+XG0nGSKjY/Mp6DHJNAD5EZeN6D2FTWltEpDyHeRzVRMSz7WOM8AirLW8sQ4+YUAasn9nzBCpdOMFSMjNNWG1gyyvvxznHArBaV4wRtx+NKTLJF95jntmgDVutT4VLcYOcjmobKzubmQyFXkf+6Bkmn2MEECLLPtZh2Jq3Bqc8t5ixd4h0BTigDO+I2n3VhqOj2V3EY5HjEgVhjANYmh251Px3ZWyoPnmRMDnvV/xprM+p+KI2v7h5DZw7N7HJHtW9+zjpB1b4im8cb4bNWuWJ9ulAGz+0/rLPrlrpK4ENpEqjHrivBrj/AI98Zydw/ka774za8/iDxteztjaHKqAOwrgZv+Pb33j+RoAfCnmKMnACirunuPIlQcgDpWeCcRjOBtHTvV7S3UXDL2xQBQmHOOmf0r0r4ZzCS3aHftYdMGvOrxAt03YZ6V3nwmtPNmlcN93nAoA9GS6QoYrtcsPuvTI7hxNmG7JdeimodUKsVyMHpiqD6fNneMr6GgDflmMo827RVlHQ+tQR6xcxOd+1l6AVg3CXxADuWUVAbafG5mYgdqAN66uGuAXYqvsKwbm4UsVjznvUSM4ckk496c6A8gYNAEakEYPBrpfh5FDH4ihmYfdbNczwrZxk1qaLcm0uPNU4PpQB9Rv4igjgjMkgwq8c15V8SvGk2oxSWVoxMZ4JBrg7zxRd3AMW47elUjM5QkPyfWgBlgfL4B571YRvNlcZBLDHNVIZPI3MRkmptJt/NuTMGyf7tAEOnpbwvPE6l2aobgx+Q0SRFTnrWrcQ5uSYY8N3NZ9zISWD8EUAUBbuiBQMA1dgnaO2MJYke9NVwQBnk1EyEPhuhoAYIsPk96V1P96pldI2AYZFPmSJyrLx60AQwpuPJFK4Kt8lW3aGOMbRzWeZCrMTzntQBPBAzyZU5JqRrVVf5s471ViuJY2BUbama98wnj5qANO0kSIHBIjqCbUmctDbn5T3rMIubk7FOFNbOnaX9mTdLySOtAFuAtB4ZvgWGWQ8mvAL9h9qkGf4jk17/qM1nF4avjMTvCnaBXz/AHDLJJI3bdxQA9ZAVAPpXp/7L3/I/wCof9gyT/0bFXlSEtIoA6A16r+y9/yP+of9gyT/ANGxUAcJ45/5KP4i/wCwrc/+jWrHwRzWx45/5KP4i/7Ctz/6NasgHIB7igD074Da+dL8YW8buyxTDyz6c163+0v4Yk1Xwta6zHb4urQ7JGXnch6E18y6PfPa3iSRkhwcqRxivs34f6rbeMvBcK3CmQPCbe4WTkHjGaAPj/RbaTUInW1IS8tP3inPJx6V6qfFD+K/D9m4hjg1GxXy7p1PMq9mrzvxTpE/g/xreWkiMqxSlR2yh6H8qNJvxoniJJCSbS4wGAPBBoA6G7RjJuLbgOcjvUbpNIo8tCPXdXcXHg57O6t3vJo1s7hRJFKrZ+U10NnbeCdNtit5JJfTnkhWP5UAeU2+k3F022MFj2AqtLA8MpimUBl+9XoWteKdLhjeHRNHhtYzxvZtzV53eSNcXLO2TuPHNAEbjzMbByO3tT1AOMA4HftSFgoES5Ddz6VPAoWF49xxj86AHB2kwi4DDoKhlDuSWGT69KWFT52B1PFaGoWE9pFGzbxvGQW6YoAg07VLjTm/cNtHcEZBrqLXxNp91FjUtJt53BzvjPlnHocVxpZXBDL8/QEVHOnlDdgY/nQB6bq3iHR7/wAJvpem6LFpsolEhnEhcsK5CbTlu5GmRlfGO+Km08w/2TISMSnG0AdqyZWure4Y7MxdQehoAs/Y2TOcnBzx2rPvCHuQUAH0q3Jq7tCUXr06VnoHVvMc9e9AEsrAKBkH1xUPzMec4HQ01pW5G1ST3Iqa1bMqhmUA9RQA+1W2ldFlYRNn7wroYtW021sJLR7c3bP1cHbisrUtHKwrNGcB+RzWQYJUbZkPkclTQBPd+VJMTEMDsG6in2thc3rAWwwM9R1NQxpszuDEH1HSrcDXakC3DBT3PGaAEutNuYptk/BHUNV17iPRtMN86EADbHn+I1u+D7mEahG3iCDztOiBaYN3H1rkvFOqL4t8Tn+zrdbbRrZj5UOeAo7mgDk9QW4Wye8uCN985O09QK9/+B2lnwv8L9b8QXLCGW9QxQ7upAHJrxTZN4u8V2OmafCGXesKIo7Z5r3z46Xlv4W8A2OjxARLFEsCRg8s2OSRQB8x6tMbm/uJ3ycuec1n3RP2fGBjeP5GpJZMpj+Jjk1XmGLfn+8P5GgB23dGvbCipbORY5Fc9c9ajXH7sEEjaKVj1QDHpQBa1VQXEg5BFdP8JL/7JrwjZgFfjBrlWPm2YGfmWm2kkls6zQkiVTkEUAfRN1bxy6p+9Xamcg9q05obEYaWXKgdBXkmjeKrzVkihnm2yJx9a7GKZtiednIoA1by40xCVQkH3qiJUckQqGz3qG+NtcLlE+cU22cxwfKoU9KAKF1GIpjuwBTSIjESDzVjUI1Uq5O4mq0v3BtX5aAKaAs+B1qcqwODgVBID5i4yM1aSImdEZsjvQBJaQ56jOe9SzxCLk5xXVaXp0F3bYgK7lHNZep6c0e5WODQBlwWcl6B5LZHpV22s57C4QoOvaqWlvLp13uOSmea2ZNTtnlWUsd/YUATlX81mkTBIrn5omnuXGwgZrfnkuFniuZMeQexpt3Om/dGq7G70Ac/LZyROpA4oeJur81oXE6SKcnAFZcbMGYhty0APWOMOCefalncIeFGDTGkK42rzTZyVwTzmgBskgMeMUsMIZNzLzUTnYuQM5qVJW2jaefSgBkkbZyRxTIBHHLmQcVcgjllb5u1Q3CqH+fnFAF6C+s4eQMt2qC71Ka5JWIlVpkNpDKu9cZHakuIWit2cABB1NAFHxLfx2nhySNyGkk45ryPqPbNb/ii/N7cmKMkxJxXOgZbbuxigCWM/vPlHGDzXqn7L3/I/wCof9gyT/0bFXlkfDDDE9a9T/Ze/wCR/wBQ/wCwZJ/6NioA4Txz/wAlH8Rf9hW5/wDRrVjdDkVs+Of+Sj+Iv+wrc/8Ao1qxjyTigByMQ6nuK+kv2btf+WfS5m+SRdwGe9fNQ4zzXc/DHW30jXbZ9+2MttYjrigD2j9pTwqmo6Lb65bhReW7eXcICNzJ2bFfOif6VYGFuJoeV+lfcJ07QvEWlMbi0Se8mtjEbpmOUUjjjpXxV4k0+bw54lvLOQN+6lZDkY3Lng/lQB2uh61ca74YhtjKxuLD5Su7nbUczzFFI27DwGNcbYz3Ol3a3+kMWHV17MPQ16x4asNO8aaPPf6ZcR2s1qN93ZufmX/aX1FAHHSE7yoy5PXHSo1AjUlv9Zjj2rT1k26uBZhvLPG88FvwrNljwMgce1ADtOt5LuZY1Unedua0ta0p9KdEmcCQDO0Hmtr4W2Md9rcETZwz849qg8cwM/iG9C7tschTDHJFAHNWwMt5GF4J717j4rt7ey+EdlbSJFc3bYdpiOVHoK8NgHkXSsx5Br2HRhH4m0e2tjNyF2eXnpQB5Fb2/wBou1RejHtWl4m0p7GeOJlKMI9wHrXTap4euPDGrKJ4gVByCOjCuk8RwWfifw5E8YWO/tl4x1YehoA820ZpFto3jCkoeQ1JPqC+dMJVB9DV+xspYRH5u1CSRzwKxNRRTcygYBU4GO9AFU7GlLYxHnO2pBG1zMmMhPSoYYWkukQjI74rovKjhiRUTlSM0AV9V0qOC1jdchmGeaxLdgJlyoAFdlqsQltkZMH5ea5e5hwfQ+mO1ADtTupMBkJ244Haqdhavd3GRnYecL60OWdxwdvSp7SaewffANuDkHFADprKZSSmSQeVq3aXk67YmXgdiKvWmuJc/LfxKQTy8a4NWtTl8P6XpzX9xqLFyD5dqE+YntmgDD8ca0kej22k2IZbyY7psdAtcrey/wBk6WIoWAnmHIHUCnRXTSXE+rXahS2Qqt6dqybZLrXNZhihVpJ53CRoB05oA9q/Zd0GJNQ1PxPfFBFYRHyy5wN5HWvO/jB4om8TeKpneTzIomKrg8da90+IFhb+A/hJaaJZuBcOoe4ccFpCOR+FfKsrhnfJLMxzk0ARkdSOKbP/AKjGc/MP5GnYyuSelNm/49v+BD+RoAAxHl4H8Ip7DecjgnmmsCIkP+yKTc23DfhQAsUjI+Ox61PCBuJUnFVkyG9x2qzaNvdlHBoAn0+RoNQV4zjJ4+tekw6pfCBC9uzHGAcda8uDlJD13Kc16j4Q1Jr6wUKylkHQigDX0q8nDAz2hAbuRS35Yy8HCelWJLq5kwrEbR7VH5ZZiznK0AZMjStLg52inmZiNtWZoWlbFvzTLiF4MZH1oArvuZkz0Bq+8aookDckVUSNn5A4p7yLtCncCKAOt8EIP3rK53+lbF2baaQeb99TyDXI+EdRFlrMRkP7pjg13vjTS1txFfwriGQZyKAOY1e1VvmhT5e9c1e2xiuImVeCea9N8B2NvqVzIt6w8vHGa5nxrpX2XVpIoARCD8pFAEWqXUc1pb2u0jgciuZvbWZJCiTNt+tdBDD+43SH5lHGayY5GluXBGaAM+NHRCpbNOQiNctVm6iZHG4EZqeHTnOHcZU9M0AVI1MrBui1avbNvIV05HtW9ZaaslsTsGRUUtjIiFVBHsaAOdh2RjEgyTT1jjJYgYbtUNyojuisuQaRXy+3P0oAtwHhlZsMe9W00pXiLFgxPvVGJA7YJ/GrKQXHPlyHaKAKcunXMEmIeQT0rL8c6p/Z2lLbFgJnHIrqRdNpttJd3nKKp25rxDxBqcmr6xPPM5K5+X0FAGezswJYkGmqoD5K/ie9KH35wORTHcsRwcelAD42JkIAAHNeqfsvf8j/AKh/2DJP/RsVeVR/fGODXqv7L3/I/wCof9gyT/0bFQBwnjr/AJKN4i/7Ctz/AOjWrHH61seOv+SjeIv+wrc/+jWrGwBg+tACEEE8VcsJjDcKw4xznNVMknOcU5F+fqR/WgD69+B/i5Nb0kaZdNEssaYV+hP1rlf2l/CC3VpB4isVBmi/c3aqPyavK/hb4gTRvEVrNPuMO7ayg4zX19Ha2XiXS2tngU2t5FtdM+o659aAPhPSr5rO4AbmFuCK0xJLpeoR6lpUjRgn94qnqO9Xfih4RuPBnie8sJ43EAc+S5H3l7Vz9heBiILjOOgNAHpmxNRtEvLNPMjcZZV/hNZ00MgUscAdMGsLQdZuPDV6NhMlpIfmX0rvLy0i1W1F9psivARl1U8qfSgCv8P9RfTNat5oyAElGT7Guh8cWh/4SmV05W5IkU9jmuFBfT75XbIDHkeles+EraLxJYQSTAvdWr7s56oKAPOvFVh/Z17HCwUOyh8Dt9ar6Zqs+k3KyWzMFHJAq34tuW1TxVdMg+UPsA9AO1Z91BtUgx7dvU5oA9V0zxDp/iOyjhvZoo7jgDzR/Wm6p4bvrEia1dGgPeJ85ryy3YeTtwD7mnNrWoWytbxXE0aemaAOr1SMtZRrMMv5mOuDiuYuYgl7J5PzAdN1XfD9/uu7Y6k7PC0m1t3PXvW5No0EGp3IDK0O7Kt7GgDkLFJ/7Q4UMzEDGK1/Fun3Gl6nHbMeTGsjcY61flt49MYzNtKg7h3JqLUNZg8ReYJ5hFcKmIy/fHbNAFe2LOFjXpjoe9EllGSvmk7mOMAdBVHTLiUP5Mh2sOAateJL9o7WO0jGAvJcfeY0AYuoxpHqCxwnKg9QeKvGBJYcvIN/pis/TLOWZw8i4JOQDUuqa3a6YkiW2LjUOiIOVWgBdVnt9BiSW6A81xmOPu1cpi41C4e+vwoBO5EJ6CrlrbPNM+oatMJp25y5yF9hWJrmpLPmC34jU8sDQBBrV+b6bC4WFeAB3r6H/Zw8AHTbY+KdYgBndStjE4+7/t4rkPgd8LP7dca54hR49LhOYYiv+vb/AAr3L4ieJrPQfDjp53lz+VsgSPjaMdKAPFf2g/Fn27UF0yF9/k581x3avDm5OO/rWjrN+99eyzTMS5YkknJrNJ4I9aAHFcAAYPvTbgYt8Hru/oaUeo7Uk3/Hr77x/I0ANY5VB22ilRQSN5HtTSDhMED5RSkHgkdKAJnTZ84OQalgESDfI+JPT1qLI8raeT6VXJO/p+dAF53XlwAauaPq76TcJNBkxk/MKz40B6jnvUhCopAHHegD2TQ72PXLdfsC75mHKit8WBs7ZkvF2vjpXjHw/wDEj+FvEEN0Mtbk/MK911K8s9dZNRtZg8bjJQHpQBmaJZB5JZSdsa+tZmuSI8p8rlQetdFsQWMgh4GORXL3REi7V4INAF3TxClrmUgE1ox6Xb3luTFtL44rGt4yxSPaWzW3pds6XyJCWDdxQBzdzZTW1wV2kFTkGu+8PeIF1XSjpWov8wGEJrG18n7YVYfNjmsaMbZQ0QwQeooA3b67uNBl8mInk/Kwra03XbW7iVNRRWkx1IrkL24kkZRO2761FvVJkZDmgDc1N4pr8pAv7rsBVC105hqahFJBPSl0298jVla4TMZ4rUhuhBq7zIy7D0BoAzPEFoRfxKFx6irOtoLayhKEA45IpmqXAnu2fzAWPT2rL1K5Bt/Jlck0AaGmam64VTzWtNFNqEO8NtZfSuU05QpUq2a6yCX7PYtIOeKAOR1mH5j5hG4d6radGrOGfoKNRuWnumwMkmnwKNu4Hkds0Aa09pE8XmR5U1HYeZAGechYF5LGq/8AbCW8DPdACJf1rzjxZ4vuNSdoLZjFa5xgHrQBrfETxrHqS/2dYRgRJwWHevNihVT61MoAYkH5j1zTMAsc5470AJHuXgkAHrSnAJwaYQGfCGnOoCYHUdaAC3AMv3ucGvVf2Xv+R/1D/sGSf+jYq8ojX5wRXq/7L3/I/wCof9gyT/0bFQBwnjn/AJKP4i/7Ctz/AOjWrGOTx1ra8cHHxI8Qn/qK3P8A6NasYvls7efagBD+lKG4xngUjYIHIBpd3qBxQBPaTtbyBgea91+EPxSfT2Sx1iZmtiNoyev0rwMkZ5zUsc7RkEMTjke1AH2/4q8N6N8SfD4jupFbauYpkwZIvr618l/EPwDqngfUDHejzLKRj5FwnIYe/pWj4F+I2reGr1JIpnkg43qT1FfTPh7WvDXxL8OyQy2UUhkXE0T4yp9RQB8bWl4ABHc/Mh6NWzpN5eaTd/aNHlJRvvxHlWrq/ip8JNT8HzS32mxPf6I7HDKMtF7EV5na3csDAxtkA9KAPW11zRfEtqI7n/iWaugwFk+5L+PavWvgT4W1IX0s9wm2yEZG7cCGJ6Yr5oS4h1QKrKN/fsR9K0dN1rXtBuYxo2u6hbQKwPliU7SfcUAe9N8I9X/4SieeRB9jeZpBKOwzXnfjCzWw1q8slO4xt1PevR/hf8Z7R74weJ72RLhlCkycIatfFbT9Ev4Zta0e4tpkZPmCEA59qAPDnlWHAkT6YpsdwJZPmjyB0zTbeQJeZk2mMdS1Gv6zpdhLs05xcSOuWGOENADtVJt1towQrlt4GegrRm1eW/DSRH50XDD6Vyetzw3bWlzZyyzSog3AdAfSozfaiblZYIlhTbiQY4agDellvJ4NxZmRj1zUcNjOzBeAx6ZrIPiLUI4Xi+zx/Z16MOxrIk1u8uiNzFWzgbTQB3NtbiC7AnlVQMZZjjFM8V+INNNzHBoyS3TKoDSMOC3tXLonnuXvJ2ZQMHmp/ttlYptQcgcCgBZ59XusRyP9ngPVV60qw2mmw+bMwEueCeS1ZN3rMjsyox56Gsl5ZLmQAlpHPG0cnP0oAv6vq0tzlEwkWeg716V8HPhRP4kuI9V19XtdEjIZQw5mPoPatX4SfBefUPI1nxSpgsThorZuHk9Mj0r6B1rUbDwxo8YGyKKBMKh+6B6CgCHX9csfCWjQPH5KQQJthhyBwK+TfiJ40uPE+qSTSnbCGIRF4xWh8VfGT+INTLQEpCmQBng15rI7SNuY5NAA/wAzEnk0zBJxjmnAil388dPegBvA4FNm5g/4EP5Gn54PHPemzkG24BHzj+RoAbJjy4z/ALIpUZ2H3QcUjDIj/wB0U4fIpbsaAEUkfMAc1KVDjJGM1DuIIycAVKjM/Tp60ATWlx9nfMg3L0pHdJZiY/lB7U0Kd3qaYDw2RyKAHuqrGVY5FbvhfxHc6LdRjLPbk8gnisGMeYvzjFPAYPjHy0Ae/wBpqcF/pxvLRxgj5kzWeqiSB58ck9K8n0HXrrSZSq5aI9Vr07RvE+j6xZiGRhazj1PBoA29NgCqrt94962tHbyrmSbIdwOKy9NPzBUkSRO2CK6DSNJ2X6zz/u4D15oAzJkN5cSylfnPY1h30JtmYk4PoK9E1F9MS/VUKhCOorkdXt4jqDeT86N0oA5stG6hnJJrQEKQWqzBCwNZ03+i3pV8bfStB9TP9nlYUBOcAUARzwzQmO4C5ibsaz9RmPnAo7AntTfEmq3FjbWovWEav0FVZ5xtSdWV0IzQBMrM5BVju71JNGzEb8k1nQagpVmTqDWhFfxlA0kir9aAEMhtlz3NbzXoGhlN2HIrlr/UrJcvJKCo9KZN4u0v7CIACX9qAFVmAcg5c1YElvp9kZr2cBjzszzXJ6l4mjCbbNcGuYu7q4un3TylgexNAG34q8Sm/wAQ267YR6d65gMmctz9alwoHNN2bz04FADFTc+7oKZKxLBF4HeppD8nydarlTt3Kee4oAVcFjtxnpTCxOVbqO9O4CbsYOaQnGDjk0AOhO1sEDmvVf2Xv+R/1D/sGSf+jYq8qUksCRXqv7L3/I/6h/2DJP8A0bFQBx/iGxfVPi7qenxOqSXeuS26uwyFL3BUE/nXtP8Awynrv/QyaZ/35kryb/mvv/czf+3Vfenjq712w8PTXnhldMa6t90sq6h5mwxKjEhdnO7IXGeOtAHzL/wynrn/AEMemf8AfiSg/sp66f8AmZNM/wC/Ele1+B/EPj3xX4Cg1yKPwvb3F+sUtmHE5SOPLeYZBnJPC4AIHXJqX4d/EqLU/CdzqnjO90TSfJ1KfTorsXHk2t75eP3kJkOdp+YYyfun8ADw8/sp66f+Zk0z/vzJR/wynrv/AEMmmf8AfiSveNf+LnhjQhrZvXumGlJayOYY1cXCXAyjwkNh1xkk8YwetO1f4s+G9NGoFjd3H2W6t7FPIRSLqeaPzFSJiwHCnLFioHrQB4Mv7KuvL08SaYP+2MldF4S+AXi7wxqC3en+JdL3r/C0MmD9ea9Gj+KunavJ4al0m5e0hvdVl026t7q1DyJJGu5kZlk2oQCDuBcYIqz4e+MGha7q2lWdnp+txw6tPLBp99PaqlvdGMEuyHdu2jGOVHNABc+GvF95beTeS+HpFK7XCidQ49xXkfiT9mbUtV1Brqx1HSNN3HLRxLKyn867f4a/GttZ8N6Kuv6XfjXdStb25gkt7XbbXRtzIWjiJfJYIq57Z4zWj4a+NNndeBdG1vXNKvra+1OUwW9rAqYuWBbJiZ3A2gDlmK4PFAHkafsra/G25PE2mq3qIZKvn9mrxKyhX8SaU2BjPkSV7BF8Y/D93Y6JLpVlrGp3erNKsVhZ26vcR+UcSGQFgqhT33HPbNS/C7xnqXiT4M2vivU0tjqL291KyxIVjJjkkVRjJPRBnn1oA8Xl/Zk16Xyy2v6TvT+LyZMmrf8Awzp4oEQiTxNpyxj+ExyEVZuf2j9Qj+HceoJo9p/wk6zBp7Rg/kpaELtn+9nBMkaDnqT6Vv8Aj74y614d8b+KNIsovD7x6ObQQWly8ou9QM0asUhC5BYFsdO60AcTcfsyeJZm58UaaB6CGSuR+IPwWv8A4ceHotW1TVrK9t5bpbciKN1cFlY5ye3y/rX0jf8AjDxPF8VdC8OQ2ekx6bqVp9tYz+Z9oiRAPMQ4O3dknHGPWsD9ra1mvfhlaW9speZ9Uh2qBkn93Kf6UAfKVhd2FmxCkFD+Iqa81e0NsUjIaUHknsPaqUPgjWpQxhtpGVV3H5Tit3TPhH4h1C3jnS2bY4yH7UAcpe6pHJb+TbJh26n2rKVwrgA/XPevXNP+Cmrs832geUI1yD6/Suk0H4BreQxXN/dhIz2C4JoA+f5bpwzDfhewFNTzrhlWJHkY8dM19W6X8AfDMcplu55pechQQB+NdtbeCvB+h2gjj020THOXOW+uaAPk7wj8MvEfia58m1txEoGS8nG0e9e9eCPghpGjWyS63emHUVOVu48EIfoa6HxZ8QvDfhezb7JDE9wwwDGQMn3xXg/i74s6vrErKsv2eIHpGcDFAHvfi7x9oXhKMQR3j311Cu0NKQd5/DgV86ePPiFe+I533StHbAkrHmuH1HU5ruUySSNI5PLMcms9nLnLHNADp5WlbLcVGBnOe1Lxnk0nb1FAACT1NGDnkZowM88e9O4HHrQA08AdqS4IMHH94fyNPAGenFMnP+jkY/jH8jQB7V8OP2f9V8c+CtN8Q2utWFrDeCQLDLE7MuyRozkjjkrn8a6cfsqa5t2/8JHpn/fmSvXv2aPtH/DP2gfYvK+1eXd+T52dm/7TNt3Y5xnGcVJ4H8WeOtb8aa9o2oW/hpINDljiu2g88NIZIy6+Xk464zn3oA8bb9lLXW6+JNMz/wBcJKcv7KmvKm0eJNM+vkyV7V4W8X+Kv+FjXnhXxNDoVy8Wl/2iZ9JEwW2YvtEUm8nJI5GMHAzjnhvwo+IGt+Ltf1qy1fSEsYLSRhFIEmG/CQnaN8a/3y3zbWxIny8MaAPGR+yvr2BnxJphI7+TJTT+yrrvbxJpg/7YyV794x+J2keF9an0uax1bULq1sm1C8+wW6yLaQDPzyEsuOh4GTRYfE/RtQ1rStLsbLV7i61GxttSj8q03rHBOQFaQg/IBnLZ4A6ZoA8D/wCGV9d4z4j0zI/6YyU4fss68D/yMemf9+ZK9wsvi7oEniGbR9QtdR0q5jt5rrdeLFtMcSlnJ8uRmUhVJwwU1zA+MV1qviW1j0vTrzTtEn0W81JJ9RswHm8tcpLGBJ8yEc4OCfbNAHmw/ZZ17dn/AISPS/8AvzJSf8Msa8G3DxHpgPtDJXrh+Neh6Xoekyan9t1C7n02LUrp7O3SNYYmwA7K8nGeTsUu2ATir3iL4z+HNDub6NrTWL2Gxhtri4ubO2DxRwzgGOQksOOR2zzwDQB5Lp37OPi2wmDweLbDjopikxXXj4U+NTaiCXXtGcDv5UoP867Twp8Q59d+JfibwydHuUtdLNv5V4q/KRJEXzJk/KGx8mAcjripfHPxV0Dwbqr6dfxX11cw24u7kWiIRbwlsBn3uue52rubAzigDzp/gv4sfltb0fPY+XLUqfB3xYse06xopPqY5c16DN8UdIbXH0zSNO1rW2hjhlubjTbUSQ2yzANGXYsDyp3fKDxn0Nc14I+MH2vVX0zxJY3aS3OvXOk2d5b2uLUFDhEdi2d556Aj6UAcldfAfxNcuXk1rR93r5ctLafAjxNb/wDMa0dx1AMctenaD8V9B1vWbCytrfU47bUppoNP1GaBVtrySLO9Y2DFuxxuUA4OKzPiz8TrrwH4s8MWX2GGfSr8SSX8xDGSCJGQF1wcYAYk8HgUAeY69+zn4m1ycSX3iLS22/dURSYWlsP2c/ElrF5Z8QaVKnTDRSV0f/C89SudO+IOo2GmWRstCjhm015N+bqOSUoHfnoQNwxjgitrwN8SfEXid/EVnbReHr2awskuoNRsHmaz8xv+WMhPO/AJ+U9qAOLi/Z88QRwtGmr6MN3fypc189+K5LrSta1XR52jeawu5rR5I8hXMbshIz2O3Nfcvwc8Tat4y8B2Wv65DYQS3rO8MdnvwsYO0btxPzblbpxjHvXwx8U8/wDCzPF+Of8AidXv/o96AOfkmmkAEjnb6ZpqhuoYAU1MhORTDIDkYPFACkJuPUmkGNw60oPy8CkwSMg80APIGcsaDMu3C/epjA7CeppkPzAluDQAhLg+maUfIh8w8mmZ/e85welOcHq3IoAbkhcHBzSA9d2B6UFh/EMDtSOCT93IoAkQFXXng5r1T9l7/kf9Q/7Bkn/o2KvKoh84HU/yr1X9l7/kf9Q/7Bkn/o2KgDn/APmvv/czf+3VfoXqVol/p11ZyMypcRPEzL1AYEEj86/N7xdfTaX8Utav7UqLi11maeMsMgMs5YZH1Fegf8NL/EP/AJ+dN/8AAMf40AfVt58N7eb4Y2ngm11rVLKxgjWFrm3dVmljGcoxxjBzzgDOMdM1peE/BdtoWgx6RfXTa1aQsDbre20IEChQAqKiKoHXtnk18gf8NL/EP/n503/wDH+NH/DS/wAQ/wDn503/AMAx/jQB9YeIPhjoeu+NdO8RXnmh7O1NobNNogmTbIq71x1UStjGO3pWLF8E9Bi8DW3hxby9c2t+NShvZhHJIJgAo3KylHXaApUjBAr5p/4aX+If/Pzpv/gGP8aP+Gl/iH/z86b/AOAY/wAaAPqSy+FdlGdHe81CSeTTdRfUUENpBbRuzRrHsKRoBtwv1JJ56CuG8EfCvxJpvjrw9Lcs9p4Y8PT3Mtpbzait1xIGAWMCFCoycnezccD38U/4aX+If/Pzpv8A4Bj/ABo/4aX+If8Az86b/wCAY/xoA+ovD3wj0jRIfB0UN9fTJ4YW+W3EhX98LoNv34A6bjjGKzU+CliPDGl6NLrV3OmjXDTaXLNbQP8AZ1YktG6lCsqnPO4dhjFfN/8Aw0v8Q/8An503/wAAx/jR/wANL/EP/n503/wDH+NAH06vwnjiuNHvrLxBe2Gr6e0wF3Z2ttEHilxuj8oR+WBxwdpPUnJrovB/gmy8LfD6LwlZ3NzNZRxTQiaXb5hEruxPAA4LnHHavkD/AIaX+If/AD86b/4Bj/Gj/hpf4h/8/Om/+AY/xoA+oL34O+Hbr4fnwufMQtaRWTakqJ9qaKOZZVUttxjco4xUviH4SaFr+o+Kb2+nu/tOutaS+bGVV7OW2QpHJC2Mg885zXy1/wANL/EP/n503/wDH+NH/DS/xD/5+dN/8Ax/jQB9WSfDqSbxtpPie48TatJfadAtuseyEJImBvDfJn5yMnBHJOMUz4yT2ttYeHJdQIFqusJvJ6cwTAfrivlb/hpf4h/8/Om/+AY/xrA8bfGnxf4z0mLTtcms3to51uFEVuIzvUEDkH/aNAH1LL4g0mztwk8tphz8vlAEY9GqtqHxD0K3fbbmOOFFxtzgZ9q+MP8AhIb/AGld4wTkjc3+NMk1y6k++EI9Mt/jQB9cTfFOweOSOHy0PaRzxXNat8amgLKiRSIo2jB/Wvmb+05j1RCPTLf40x7+Rjkxx/r/AI0Ae06j8YNTlVhA5jz/ABDiuO1Xx/q95MzT3cjk8Ak9q4Q3bE8oh/E/4003Gesafr/jQBp3upT3TbpWJbOeTVFmJOWOTUYuSD/q0/X/ABpPtH/TKP8AX/GgCUADqCaOFqL7R/0yj/X/ABpftJ/55x/r/jQBJgYzjmj9BUf2n/plH+v+NJ5//TJP1/xoAkwPwoGNpqP7Rxjyo/1/xo+0f9Mo/wBf8aAJB+dJcD9x/wACH8jTPtH/AEyj/X/GmyTF49uxQM5yM/40AffX7Ln/ACQnwz/29f8ApVLXX6N4Qt9I1zxRqtpeXIutfeOSXO3ELJGUUpx755zzXxD4M+OPjLwf4as9C0WeyXT7Tf5Yltg7Dc7Ocnvyxra/4aX+If8Az86b/wCAY/xoA+qfh98Nf+EL1O6u7fxJq1+t27S3Md2sLGeQ/wAbuEDsR2y2BXfqiqWKqAWOTgdT6n8q+F/+Gl/iH/z86b/4Bj/Gj/hpf4h/8/Om/wDgGP8AGgD6A+Mnw+8Q674gur3whG8UmqaW2m30w1JYI3U7gBJG0LlhhhyrKcZHHWuv8G/Dq18PX1hqL3k819BoNvoUgXCxskQHzjjcCSPWvlD/AIaX+If/AD86b/4Bj/Gj/hpf4h/8/Om/+AY/xoA+i/D/AMCND0prRZdRvbu3tra8s1hMUMe+G4Uq4dkQM7YY/MT6cCrelfBy2tGtTfeI9X1AWmlTaNarMkKiG2kXaANqAkqO5J/Livmn/hpf4h/8/Om/+AY/xo/4aX+If/Pzpv8A4Bj/ABoA+kp/gnpKNpc2nahLb3dnp8emvJcWdvdrNEn3WKSoVVx/eGOOMVe1P4RaVqFr4ihm1G/A1uytLGdlEYKLbgBWUBcAnbzxj0Ar5f8A+Gl/iH/z86b/AOAY/wAaP+Gl/iH/AM/Om/8AgGP8aAPrjRvAy6N461HxFp+q3SJqUMEd7ZNGjJMYYjHGwYjcuAc4B5P5Vn+MvhfYeIvE48QQXn2LUntxazF7OC7jkQHIOyZGCuP7w7cYNfK//DS/xD/5+dN/8Ax/jR/w0v8AEP8A5+dN/wDAMf40AfU0HwzOm69Jqfh/xLqmlG7it4tQhijhdLvyUCK2GQ+WxUYJTHsBSWvwo0q3+xbb6+P2XX38QrnZzM3VDx9z9fevlr/hpf4h/wDPzpv/AIBj/Gj/AIaX+If/AD86b/4Bj/GgD6f8O/CPTtE1XSJE1W/uNJ0aee50zTJAgjtpJSSx3BdzgFjtBPGe9dF4i8E6b4g8UaVrWpF5TYW1za/ZWVWhmjnXa4cEc8V8ff8ADS/xD/5+dN/8Ax/jR/w0v8Q/+fnTf/AMf40AfUes/CLRNRj8TRRz3Nnb65aWtk8NuEVLeO3xsEYxxwAOc+1Wk+GtpZatrF9oWq3+knVrRba6hthGY2dRgThWUgSY4PY5ORk5r5S/4aX+If8Az86b/wCAY/xo/wCGl/iH/wA/Om/+AY/xoA+wvhv4Qj8C+GItCttRvL+0gdmha6CbolODsG0DjOTzk5Y89K+CPirIE+Jni/8A7DV7/wCj3rtf+Gl/iH/z86b/AOAY/wAa8o1fWbjV9Zv9Uvkie7vbiS5mIBALuxZsAHgZJoATefL3j8qiZ9mMkZaojck8eWmPTn/GmmYH/lkn5n/GgCVmYSLg0DcZPkOM1GLjH/LKP9f8act1tHEMf6/40ASsjAfe/CkjC8knk9qi+1HnMcZz9f8AGmiYD/lkn6/40APckPzytCnc+OcU37Rz/q0/X/Gl+0/Nnyo8/j/jQAjNl8MOBUqsBgr+VMN1n/ljF/49/jSG5yMeVHj8f8aAJAP3u/PJzxXqn7L3/I/6h/2DJP8A0bFXkwuCOkafr/jXrP7L3/I/6h/2DJP/AEbFQBe8Zf8AI365/wBf0/8A6MaseiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAr0j4Df8jfef9eL/APoyOiigD//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT and MRI studies were obtained less than six hours from symptom onset in a patient with spontaneous acute intracerebral hemorrhage. The CT scan shows a hyperdense hemorrhage predominantly in the left frontal lobe. On MRI, the central portion of the hematoma is isointense to brain parenchyma on the T1-weighted image and hyperintense on the T2-weighted and T2* gradient echo images, consistent with hemorrhage containing oxyhemoglobin. On the T2-weighted and T2* gradient echo images, the periphery of the hemorrhage is hypointense, consistent with deoxygenation that occurs more rapidly at the borders. On the T2 weighted image, tissue adjacent to and surrounding the hematoma is hyperintense, consistent with vasogenic edema.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_19_23864=[""].join("\n");
var outline_f23_19_23864=null;
var title_f23_19_23865="Epidemiology of burn injuries globally";
var content_f23_19_23865=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology of burn injuries globally",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/19/23865/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/19/23865/contributors\">",
"     Michael D Peck, MD, ScD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/19/23865/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/19/23865/contributors\">",
"     Marc G Jeschke, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/19/23865/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/19/23865/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/19/23865/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burn injuries are among the most devastating of all injuries and a major global public health crisis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Burns are the fourth most common type of trauma worldwide, following traffic accidents, falls, and interpersonal violence [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/3\">",
"     3",
"    </a>",
"    ]. Approximately 90 percent of burns occur in low to middle income countries, regions that generally lack the necessary infrastructure to reduce the incidence and severity of burns [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/4\">",
"     4",
"    </a>",
"    ]. In this topic, we use the classification of countries by income adapted from the World Bank for the World Development Report [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic reviews the epidemiology and distribution of burns worldwide. The global costs of burns and prevention strategies to reduce the risk of burn injuries are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17716?source=see_link\">",
"     \"Global costs of fires and burns\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/48/9992?source=see_link\">",
"     \"Prevention of fire and burn injuries\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unintentional and intentional burn injuries vary across age groups, gender, income and global region.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Site and setting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most burn injuries occur in a domestic setting, with cooking as the most common activity [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Pediatric burns occur more commonly in the home (84 percent) and while children are unsupervised (80 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/1,8\">",
"     1,8",
"    </a>",
"    ]. Adults are equally likely to sustain a burn in the home, outdoors or at work. Burns to adult females occur mostly at home, while burns to adult males occur mostly in outdoor or work locations [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. The elderly are most likely to sustain a burn in the bathroom, followed by the kitchen [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Incidence",
"    </span>",
"    &nbsp;&mdash;&nbsp;The worldwide incidence of fire-related injuries in 2004 was estimated to be 1.1 per 100,000 population, with the highest rate in Southeast Asia and the lowest in the Americas (",
"    <a class=\"graphic graphic_table graphicRef66105 \" href=\"UTD.htm?3/43/3772\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/12\">",
"     12",
"    </a>",
"    ]. The incidence of burns in low and moderate income countries (LMIC) is 1.3 per 100,000 population compared with an incidence of 0.14 per 100,000 population in high income countries [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/12\">",
"     12",
"    </a>",
"    ]. The incidence of burn injuries severe enough to require medical care is nearly 20 times higher in the Western Pacific (including China) than in the Americas [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/3\">",
"     3",
"    </a>",
"    ]. Infants in Africa have an incidence of fire-related burns that is three times the world average for this age group [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A population-based survey of over 170,000 households representing nearly 350,000 children and 470,000 adults during 2003 in Bangladesh showed that the overall incidence of non-fatal burn injuries was 166 per 100,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/14\">",
"     14",
"    </a>",
"    ]. Approximately 173,000 Bangladeshi children suffered moderate to severe burns each year, which is an annual rate of 288 burns per 100,000 children. 90 percent of the burns occurred at home [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/14-16\">",
"     14-16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An estimate of the frequency with which children are hospitalized throughout the world for treatment of burns is a rate of 8 per 100,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/17\">",
"     17",
"    </a>",
"    ]. In a rural community survey in Ethiopia, burns were the second most common injury to children under 15 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/18\">",
"     18",
"    </a>",
"    ]. Burns were therefore the leading cause of admission for injury to pediatric hospitals, and ranked third as a source of outpatient visits [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The frequency with which children are hospitalized throughout the world for treatment of burns is estimated to be 8 per 100,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/17\">",
"     17",
"    </a>",
"    ]. In a rural community survey in Ethiopia, burns were the second most common injury to children under 15 years of age. Burns were therefore the leading cause of admission for injury to pediatric hospitals in Ethiopia, and ranked third as a source of outpatient visits [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It was estimated that approximately 11 million people sought medical care for burns in 2004 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/3\">",
"     3",
"    </a>",
"    ]. This number exceeds the combined incidence of tuberculosis and HIV infections, and is just slightly less than the incidence of all malignant neoplasms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Prevalence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burn injuries rank in the top 15 leading causes of the burden of disease globally (",
"    <a class=\"graphic graphic_table graphicRef77885 \" href=\"UTD.htm?3/39/3708\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/21\">",
"     21",
"    </a>",
"    ]. Burns are more common in lower middle income (LMIC) and low income countries (LIC) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/3\">",
"     3",
"    </a>",
"    ]. The three regions with the highest prevalence rates are the Western Pacific Region, Eastern Mediterranean Region and Southeast Asia Region [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/3\">",
"     3",
"    </a>",
"    ]. Region for region, LIC have a greater burden of fire-related burns than HIC. The prevalence of burns is higher for women (0.09 per 100,000) than men (0.06 per 100,000) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Intentional versus accidental",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of burn injuries worldwide are unintentional. Less than 5 percent are deliberate self-burnings (DSB) or the result of abuse, with regional exceptions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. The highest absolute number of DSB cases and highest ratio of DSB to overall burn hospital admissions occur in India, and the highest incidence of DSB cases occurs in Sri Lanka [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/25-28\">",
"     25-28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the US and Europe, DSB account for less than 1 percent of suicide attempts [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/26,29-32\">",
"     26,29-32",
"    </a>",
"    ]. In higher income countries, 37 percent of DSB was associated with mental illness",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    substance abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/32\">",
"     32",
"    </a>",
"    ]. In lower income countries, the data are difficult to discern. A review of 55 studies of DSB found that the most common motivations for self-harm were psychiatric illnesses (Western and Middle East regions); personal (India, Sri Lanka, Papua-New Guinea and Zimbabwe); and political (India and South Korea) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/26\">",
"     26",
"    </a>",
"    ]. Assault, usually by a spouse, is most often caused by throwing caustic chemicals or flammable liquids at the victim's face or genitalia, or ignition of clothing (eg, dowry deaths in India) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/33,34\">",
"     33,34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A retrospective review of 7139 burn patients between 1979 and 1998 in a US burn center found that 184 (2.6 percent) were self-inflicted [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/35\">",
"     35",
"    </a>",
"    ]. Self-immolation with an accelerant (53.3 percent) and ignition of clothing without an accelerant (20.1 percent) were the most common methods used. Burns related to child abuse are discussed below. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'High risk populations'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;In locations with seasonal variations of temperature, burns occur more frequently in the colder winter months [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/1,9,11,36,37\">",
"     1,9,11,36,37",
"    </a>",
"    ]. Burns also occur more commonly when meals are prepared, particularly in lower income countries where there is exposure to open flames and non-electric appliances used for cooking, heating, and lighting [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/2,38-44\">",
"     2,38-44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Flames and scalds",
"    </span>",
"    &nbsp;&mdash;&nbsp;Flame injuries and scalds are the most common causes of burns in children and adults worldwide [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/8,23,45,46\">",
"     8,23,45,46",
"    </a>",
"    ]. Based on information collected from US burn centers between 1995 and 2005, 46 percent of burns resulted from",
"    <span class=\"nowrap\">",
"     flame/fire",
"    </span>",
"    and 32 percent from scalds from hot liquids [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/33,47,48\">",
"     33,47,48",
"    </a>",
"    ]. A retrospective review of 127,016 hospitalized burn patients between 1999 and 2008 from 79 US hospitals found that the most frequent known causes of burns were:",
"    <span class=\"nowrap\">",
"     fire/flame",
"    </span>",
"    (42 percent); scald (30 percent); contact with hot object (9 percent); electrical (4 percent), chemical (3 percent) and other (12 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In many households in lower middle income countries (LMIC), especially in rural areas lacking electrification, open flames are common, including floors of huts with open hearths used for cooking and warmth, candles, and small kerosene and naphtha stoves and lanterns. The fire risk from these sources is increased by lack of enclosure for open fires, floor-level location of fires and stoves, instability of appliances, nearby storage of volatile and flammable fuels, flammable clothing and housing materials, and lack of exits [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/2,39\">",
"     2,39",
"    </a>",
"    ]. Serious injuries from kerosene stoves have been documented in Egypt, Ethiopia, India, Nigeria, Pakistan and other LMIC [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/27,38,40-44,49\">",
"     27,38,40-44,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Scald burns occur from hot tap water baths, hot foods and liquids, and heated cooking oils.",
"    <span class=\"nowrap\">",
"     Flame/fire-related",
"    </span>",
"    injuries overall are the most frequent reason for admissions to US burn centers. Seventy percent of",
"    <span class=\"nowrap\">",
"     fire/flame",
"    </span>",
"    burns and 81 percent of scald burns are sustained at home [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adults &mdash; Burns secondary to flames and fire are the most common cause of burns in adults. Flames account for 35 to 42 percent of hospital admissions related to burns, while scalds account for 15 to 18 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Children &mdash; There are regional differences for the most frequent cause of burns in children. In the US, the number of scalds far exceeds the number of flame burns in children age 0 to 4.9 years. However, flame burns outnumber scalds in all other pediatric age groups in the US, based on the National Burn Repository report [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/22,48,50\">",
"       22,48,50",
"      </a>",
"      ]. In burn centers in the US, scald burns account for nearly half the admissions of children less than five years of age. For children under two years, flame burns cause only 5 percent of admissions; contact burns are more common in this age group, involving over 20 percent of admissions.",
"      <br/>",
"      <br/>",
"      In some lower middle income countries (LMIC) such as China and Iran, flame burns and scalds occur at approximately the same frequency in children under the age of 18 years [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/51,52\">",
"       51,52",
"      </a>",
"      ]. Three pediatric hospitals in Mexico found that the majority of emergency room visits for burns in children under 10 years of age was due to exposure to boiling liquids, most commonly overly hot bath water [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/45\">",
"       45",
"      </a>",
"      ]. Over 75 percent of children under the age of 18 hospitalized for treatment of burns in Taiwan were injured by scalding liquids [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/24\">",
"       24",
"      </a>",
"      ]. A retrospective review of burns in 650 Ghanaian children age zero to five years found that the most common cause of burns was scald through spillage or immersion (45 percent), contact with a hot object (33 percent) or flame (19 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/53\">",
"       53",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Clothing ignition &mdash; Clothing ignition is a common cause of unintentional and intentional severe flame burns, such as bedclothes and loose fitting cotton garments [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/38,54,55\">",
"       38,54,55",
"      </a>",
"      ]. Women of the Indian subcontinent wearing loose flammable saris made of cotton or synthetic textiles are vulnerable to fire deaths when their clothing is ignited while cooking near open flames, particularly if the cooking source is an open fire pit or a small kerosene stove on the ground [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/56\">",
"       56",
"      </a>",
"      ]. Ninety-three percent of burn injuries in rural Ethiopia occurred inside the home where open fires used in the common room often ignite clothing [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/18\">",
"       18",
"      </a>",
"      ]. Ignition of grass skirts in warm coastal areas of Papua New Guinea account for nearly half of hospitalizations for burns [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/57\">",
"       57",
"      </a>",
"      ]. On occasion, the small stove is used as a weapon, thrown by the assailant at the victim, igniting his or her clothing [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Occupational&nbsp;risks &mdash; Work-related injuries account for 20 to 25 percent of all serious burns, with the most common being",
"      <span class=\"nowrap\">",
"       fire/flame",
"      </span>",
"      and scald [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/33\">",
"       33",
"      </a>",
"      ]. Food service industries (eg, restaurants that use deep fryers) are responsible for 12 percent of work-related injuries [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/58,59\">",
"       58,59",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Flammable fuels",
"    </span>",
"    &nbsp;&mdash;&nbsp;Flammable fuels are often the agents of fire acceleration or heat production in incidents that result in flame burns. In one US study, the unsafe use of gasoline was implicated in 87 percent of patients in whom the cause of the burn could be identified [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/60\">",
"     60",
"    </a>",
"    ]. Liquefied petroleum gas (LPG) has replaced kerosene in many households in LMIC as per-capita income has risen and availability of smaller and more affordable LPG cylinders has improved. In Delhi, LPG-related burns were responsible for over 10 percent of admissions from 2001 to 2007 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     HIGH RISK POPULATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most vulnerable groups for burn injuries are children, women and the elderly. Lack of supervision of children, frailty and comorbid illnesses of the elderly, clothing made of flammable materials, parental illiteracy, congested housing, pre-existing impairment of a child, and low socioeconomic status are important risk factors for burn injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Children",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants and toddlers to age four years comprise almost one-third of all burns, based on a retrospective review of 139 studies on the epidemiology of burns worldwide between 1974 and 2003 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/1,62\">",
"     1,62",
"    </a>",
"    ]. In some areas, such as Brazil, Ivory Coast and India, burns in this age group account for nearly half of all childhood burns [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/8,63,64\">",
"     8,63,64",
"    </a>",
"    ]. In the US, fires and burns were the third leading cause of unintentional injury death in 2006 for children one to nine years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/65\">",
"     65",
"    </a>",
"    ]. The number of burns decreases from age four until adolescence. After age 15, incidence death rates begin to increase again, presumably because of greater exposure to hazards, experimentation and risk-taking, as well as employment [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the US, the crude rate of non-fatal burns in 2008 was 156 per 100,000 in children under the age of 18 years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/65\">",
"     65",
"    </a>",
"    ]. Burns are the fifth leading cause of unintentional non-fatal injury in US infants: the rate for infants and children to three years of age was 358 per 100,000. Ninety-three percent of young children were treated and released from emergency rooms, suggesting that the burns were minor. A retrospective analysis of almost 10,000 children who were admitted to a US hospital in 2000 found that 67 percent of the children hospitalized for burn injuries sustained burns of less than 10 percent total body surface area (TBSA) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Compared to high income countries (HIC), children under five years of age in lower middle income countries (LMIC) have a disproportionately higher rate of burns [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/66\">",
"     66",
"    </a>",
"    ]. Even in HIC, children who live in poor districts are at higher risk of residential fire-related injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Child abuse &mdash; Burns account for 10 percent of all cases of child abuse [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/68,69\">",
"       68,69",
"      </a>",
"      ]. The child burn victim is almost always under age 10 years and the majority are less than two years old. Scalds from immersion into hot baths or splashes are the most frequent burn injury. Contact with heated objects including cigarettes, iron, curling iron, hair dryer and heated kitchen utensils are commonly used in abuse cases.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The medical evaluation of children who sustain burns includes seeking evidence of:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Healed burns from subsequent injuries",
"     </li>",
"     <li>",
"      Multiple simultaneous burns",
"     </li>",
"     <li>",
"      Bruises shaped like hands, fingers or objects that suggest burns, hits, or bite marks",
"     </li>",
"     <li>",
"      Sexual abuse",
"     </li>",
"     <li>",
"      Inconsistent history from parents or guardians and physical examination",
"     </li>",
"     <li>",
"      Doughnut shaped burn pattern on the buttocks",
"     </li>",
"     <li>",
"      Sparing of the soles of the feet",
"     </li>",
"     <li>",
"      Pattern of burn similar to a cigarette or other heated object",
"     </li>",
"     <li>",
"      Stocking or glove pattern burn",
"     </li>",
"     <li>",
"      Waterlines on skin",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Elderly",
"    </span>",
"    &nbsp;&mdash;&nbsp;The elderly, as defined by age greater than 60 years, suffer a disproportionately higher percent of hospitalizations due to burns in comparison to the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/11\">",
"     11",
"    </a>",
"    ]. A prospective study from Egypt between 1995 and 2001 found that burns in the elderly represented 2.3 percent of all treated burns and 7.1 percent of all hospital admissions related to burns in an area where the elderly comprise 5.8 percent of the total population [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/11\">",
"     11",
"    </a>",
"    ]. Most of the burns were caused by flame or scald (92 percent), occurred at home (79 of 97), and in the kitchen (40 of 79) or bathroom (30 of 79). Burns were more likely to occur during the winter season (43 of 97) and spring (27.8 percent) than in the summer (12 of 97). The majority of burns occurred in elderly individuals from a low income family (85.5 percent). Most of the burns occurred during the day, when the elderly were left unattended.",
"   </p>",
"   <p>",
"    A retrospective review of 759 burn patients admitted to a US burn unit between 1990 and 1994 found that the most frequent cause of death for elderly women with burns was cooking, related injuries resulting in clothing ignition [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/70\">",
"     70",
"    </a>",
"    ]. Cooking on a gas stove, isolation, slowed behavioral responses, mental and physical disabilities, and inability to access assistance were contributing factors. The medical, economic and social burdens of burns will increase as the proportion of the elderly increases in both higher income and developing countries [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Gender",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gender differences in burn incidence vary by age, region and national income category. Although some countries, such as Egypt and India, have a greater proportion of burns among girls, a higher number of cases in boys have been reported in Angola, Bangladesh, China, C&ocirc;te d'Ivoire, Kenya and Nigeria [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/9,14,51,62,63,72-76\">",
"     9,14,51,62,63,72-76",
"    </a>",
"    ]. The global trend has been that young boys are at highest risk of burns; thereafter, the risks are higher in older girls and women.",
"   </p>",
"   <p>",
"    For example, in rural Ethiopia, burns occur more often to boys than girls, but it is women who are more frequently burned than men [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/77\">",
"     77",
"    </a>",
"    ]. Young women comprise the majority of victims of deliberate self-burning (DSB) in India, Zimbabwe, South America and the Middle East [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/25,26,78\">",
"     25,26,78",
"    </a>",
"    ]. Males are more frequently victims of DSB in Italy, Spain and Bulgaria in Europe; Korea and Hong Kong in the far-east Asia, and Australia [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/26\">",
"     26",
"    </a>",
"    ]. No gender differences were identified in the US.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Socioeconomic factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Socioeconomic factors that increase the risk of burns include [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/79\">",
"     79",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Non-white ethnicity",
"     </li>",
"     <li>",
"      Low household income",
"     </li>",
"     <li>",
"      Crowded household living conditions",
"     </li>",
"     <li>",
"      Low maternal education",
"     </li>",
"     <li>",
"      Unemployment",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In metropolitan Oklahoma City, Oklahoma between 1987 and 1990, the overall fire-related hospitalization and death rate was 3.6 out of 100,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/80\">",
"     80",
"    </a>",
"    ]. When the data analysis focused on the area characterized by lower median household income, lower property values, and poorer quality of housing, the fire injury rate was much higher, 15.3 out of 100,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Census tracts with low median incomes in Dallas, Texas had the highest rates of injury related to house fires, over eight times that in tracts with high incomes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/67\">",
"     67",
"    </a>",
"    ]. Although there are multitude high risk behaviors in low-income neighborhoods, one important factor is the frequent absence of functioning smoke detectors. From 1991 through 1997, the prevalence of operational smoke detectors was lowest in houses in the census tracts with the lowest median incomes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Longitudinal observations of patients admitted to a single burn center in New Delhi suggest that overall socioeconomic improvements led to a reduction in the frequency of injuries severe enough to require admission to a burn center. In 1993, the per-capita income in Delhi was US$",
"    <span class=\"nowrap\">",
"     450/year",
"    </span>",
"    and 1276 burn patients were admitted that year; by 2005 the per-capita income in Delhi had risen to US$ 1542 and the number of burn-related admissions declined to 695 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/61\">",
"     61",
"    </a>",
"    ]. Although unproven, the observation is that the gradual decline in fire and burn incidence and deaths across the world can be attributed to improvements in living conditions and income.",
"   </p>",
"   <p>",
"    A retrospective review of 173,504 Danish children injured between 1998 and 2003 found that the risk for burns (1.9 times) and scalds (2.4 times) was higher in the lowest income group compared to the highest income group [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Environmental and familial factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Childhood burns are largely environmental and preventable [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/1,53,79,83-87\">",
"     1,53,79,83-87",
"    </a>",
"    ]. The risk factors include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Lapse of supervision",
"     </li>",
"     <li>",
"      Walking barefoot",
"     </li>",
"     <li>",
"      Storage of flammable materials in the home",
"     </li>",
"     <li>",
"      Cooking utensils within reach",
"     </li>",
"     <li>",
"      Flammable clothing",
"     </li>",
"     <li>",
"      Lack of enclosure for open fires for cooking or heat",
"     </li>",
"     <li>",
"      Lack of water supply",
"     </li>",
"     <li>",
"      Large families",
"     </li>",
"     <li>",
"      Single parents",
"     </li>",
"     <li>",
"      Pre-existing impairment of the child",
"     </li>",
"     <li>",
"      Sibling with a burn",
"     </li>",
"     <li>",
"      Illiterate mother",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      father",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Comorbid illnesses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epilepsy, often untreated in LMIC, is a frequent initiating factor of severe burns [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/88-90\">",
"     88-90",
"    </a>",
"    ]. Burns precipitated by epileptic seizures occurred in 44 percent of adult burn injuries in a community survey in rural Ethiopia, and 29 percent of adult burns admitted to the hospital were precipitated by epileptic seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/77\">",
"     77",
"    </a>",
"    ]. Victims in Ethiopia are often left to burn because of fear by potential rescuers of contacting the disease by touching the victim [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/91\">",
"     91",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Physical and mental comorbid illnesses including blindness, deafness, arthritis and diabetes are associated with burns, particularly in the elderly [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/70\">",
"     70",
"    </a>",
"    ]. Religious traditions that require fasting have also contributed to the increased risk of sustaining burns [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/92,93\">",
"     92,93",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     PROTECTIVE FACTORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Maternal education",
"    </span>",
"    &nbsp;&mdash;&nbsp;A case control study of 740 burned and normal children identified maternal education as a protective factor that reduced the risk of childhood burns 0.6 times that of illiterate mothers [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/86\">",
"     86",
"    </a>",
"    ]. Preventive measures to reduce the risk of burn injuries are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/48/9992?source=see_link\">",
"     \"Prevention of fire and burn injuries\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     MORBIDITY AND MORTALITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Morbidity and mortality vary with age and region [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Disabilities",
"    </span>",
"    &nbsp;&mdash;&nbsp;For those who survive the burn injury, there is the added burden of a permanent disability and economic hardship for the victim and the family. The Global Childhood Unintentional Injury Surveillance pilot study conducted among children age 0 to 12 years in Bangladesh, Colombia, Egypt, and Pakistan, found that 17 percent of survivors had greater than six weeks of temporary disability, and 8 percent had permanent disability [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a retrospective survey of the mothers of 650 burned Ghanaian children, 113 (17.4 percent) of the burned children developed a physical impairment and 5 (1 percent) developed a physical disability [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/94\">",
"     94",
"    </a>",
"    ]. The risks of developing burn-related physical impairments were significantly increased when the injuries were associated with protracted healing, burns to the",
"    <span class=\"nowrap\">",
"     head/neck,",
"    </span>",
"    burns involving skin removal, and wound infection.",
"   </p>",
"   <p>",
"    The rate of permanent disability due to burns in approximately 173,000 children in Bangladesh was 5.7 per 100,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. The annual incidence of burns severe enough to restrict activity for one or more days in Ethiopia was 80 per 1000 children [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/18\">",
"     18",
"    </a>",
"    ]. In one study, two-thirds of 68 elderly individuals who were living independently before the burn injury were forced into skilled nursing facilities after hospitalization for burn care [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/95\">",
"     95",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;The worldwide estimate for deaths secondary to burns is 300,000 annually (",
"    <a class=\"graphic graphic_table graphicRef50206 \" href=\"UTD.htm?0/47/764\">",
"     table 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/3\">",
"     3",
"    </a>",
"    ]. Mortality rates differ by gender, age and region (",
"    <a class=\"graphic graphic_figure graphicRef71014 \" href=\"UTD.htm?20/17/20765\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef58202 \" href=\"UTD.htm?35/43/36541\">",
"     figure 2",
"    </a>",
"    ). For example, injuries resulting from exposure to fire are among the 10 leading causes of death for the age group 15 to 29 years, but not for any other age group [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/3,96,97\">",
"     3,96,97",
"    </a>",
"    ]. Over 90 percent of fatal fire-related burns occur in developing or low income countries and over half of these occur in South-East Asia [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/98\">",
"     98",
"    </a>",
"    ]. In the US, the age-adjusted death rate from fire and burns has decreased from 2.99 per 100,000 in 1981 to 1.2 per 100,000 in 2006 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Overall mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;There has been a decline in mortality due to fire and flames across the world [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/99\">",
"     99",
"    </a>",
"    ]. Between 2000 and 2004, the Global Burden of Disease Project noted a 6 percent decline worldwide in fire and burn deaths, from 5.1 to 4.8 per 100,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/3\">",
"     3",
"    </a>",
"    ]. During this period of time between 1982 and 2002, fire and burn mortality in Australian men declined from 1.5 to 0.7 per 100,000. Similarly, the fire mortality rate in Brazilian women decreased from 1.1 to 0.5 per 100,000. Other countries observing reduction in fire and burn mortality from 1982 to 2002 include Canada, France, Mexico, Panama, Thailand, the United Kingdom, and Venezuela [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 90 percent of all burn-related deaths occur in lower middle income (LMIC) or low income countries (LIC), while 3 percent occur in high income countries (HIC) (",
"    <a class=\"graphic graphic_figure graphicRef75894 \" href=\"UTD.htm?16/6/16493\">",
"     figure 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef62440 \" href=\"UTD.htm?22/17/22813\">",
"     figure 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef50689 \" href=\"UTD.htm?26/4/26701\">",
"     figure 5",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/3\">",
"     3",
"    </a>",
"    ]. In the US in 2006, the mortality rates for burn-related deaths in children up to four years of age was 1.24 times higher for girls than boys [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/65\">",
"     65",
"    </a>",
"    ]. For children 4 to 20 years of age, the mortality rate was nearly identical for boys and girls (0.7 per 100,000 and 0.65 per 100,000 children).",
"   </p>",
"   <p>",
"    Mortality rates for fire-related injuries are twice as high in males as in females in the 15 to 59 year age group in high income countries (HIC) (",
"    <a class=\"graphic graphic_figure graphicRef75894 \" href=\"UTD.htm?16/6/16493\">",
"     figure 3",
"    </a>",
"    ). Comparing these mortality rates in this age group to the low income countries (LIC), female deaths occur at a rate 2.3 times that of males. The discrepancy is greatest in South-East Asia and Eastern Mediterranean Regions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/3\">",
"     3",
"    </a>",
"    ]. Nine percent of all deaths among Egyptian women of reproductive age were caused by burns [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/100\">",
"     100",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The gender discrepancy in fire-related mortality rates is present in lower middle income countries (LMIC), but less pronounced in younger children. Between the ages of 15 and 19, women begin to suffer a disproportionate share of fire deaths. Women between the ages of 15 and 59 in LIC have a fire-related mortality rate of 15.6 per 100,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/3\">",
"     3",
"    </a>",
"    ]. In India, approximately 65 percent of burn deaths occur in women, most often caused by kitchen accidents, self-immolation and domestic violence [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The 2004 fire mortality rate in infant girls in Africa was 35 per 100,000, higher than that in LMIC in Europe (3.5 per 100,000), the Americas (2.2 per 100,000), or the Western Pacific (0.4 per 100,000) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/66\">",
"     66",
"    </a>",
"    ]. Similarly, fire-related mortality rates in boys one to four years in the Eastern Mediterranean LMIC were nearly twice that of boys age one to four years in European LMIC. Moreover, fire-related mortality in South-East Asia was nearly six times that in the Western Pacific LMIC for boys under the age of four years.",
"   </p>",
"   <p>",
"    A cross sectional survey of nearly 1400 households in Tigray, Ethiopia, showed that 1.2 percent of the population is burned each year. Over 80 percent of these burns occurred at home, and 90 percent healed without any complications. Only 1 percent of the burn victims died [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mortality rate from deliberate self-burning (DSB), noted mainly in young women, ranges from 44 to 73 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/26,78,101\">",
"     26,78,101",
"    </a>",
"    ]. The high mortality rate is related to the extensiveness of the burns.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Childhood mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rate of childhood mortality from burns is nearly 11 times higher in low income countries (LIC) than in high income countries (HIC) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/3\">",
"     3",
"    </a>",
"    ]. There is a differential in mortality rate based on gender and childhood age (see",
"    <a class=\"local\" href=\"#H23\">",
"     'Overall mortality'",
"    </a>",
"    above). Unintentional injury is the leading cause of death in US children age one to nine years (10.4 per 100,000) and burns are the third leading cause of unintentional trauma death [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/102\">",
"     102",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Racial and economic disparities exist in the US and other HIC [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/67,103-109\">",
"     67,103-109",
"    </a>",
"    ]. Burns are the leading cause of injury-related death in US black children between age one and nine years and the rates are 2.7 times higher than in white, Hispanic and",
"    <span class=\"nowrap\">",
"     Asian/Pacific",
"    </span>",
"    Islander children [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/102\">",
"     102",
"    </a>",
"    ]. The higher mortality rates related to burn injuries for black children remain higher throughout adolescence.",
"   </p>",
"   <p>",
"    Worldwide, the mortality from fire and burn injuries in children living in high income countries (HIC) is 3 percent of the overall rate of death from unintentional injuries, and is over 10 percent of the death rate from all unintentional injuries in low income countries (LIC) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/3\">",
"     3",
"    </a>",
"    ]. In absolute numbers, the proportion of childhood deaths due to fire and flames in LIC is twice that in HIC. The burn-related mortality rate was 0.6 per 100,000 in 173,00 children in Bangladesh [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/14-16\">",
"     14-16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Elder mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;The fourth leading cause of unintentional injury mortality among people aged 65 years or older is burn-related injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/65\">",
"     65",
"    </a>",
"    ]. The elderly and the very young are at a higher risk of dying in a residential fire than any other age groups [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/110\">",
"     110",
"    </a>",
"    ]. The death rate due to burns is disproportionately higher for the elderly in comparison with the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/111\">",
"     111",
"    </a>",
"    ]. Elderly burn patients treated for scald burns had relatively small burns (mean 7 percent TBSA) but high mortality (22 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23865/abstract/95\">",
"     95",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burn-related injuries are a major global public health problem.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The risk of burns is highest in low income and lower middle income countries. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In high income countries, an increased risk of burns is found in minority populations, and in lower socioeconomic households. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Flame/fire",
"      </span>",
"      and scalds are the most common type of burn in adults and children. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children and elderly are at the highest risk of unintentional burns. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'High risk populations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While most burns are unintentional, child abuse, deliberate self-burning and personal violence are not uncommon. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'High risk populations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Approximately 90 percent of all burn-related deaths occur in lower middle income (LMC) or low income countries (LIC), while 3 percent occur in high income countries (HIC). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Morbidity and mortality'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For those who survive the burn injury, there is the added burden of a permanent disability and economic hardship for the victim and the family. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Morbidity and mortality'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/1\">",
"      Forjuoh SN. Burns in low- and middle-income countries: a review of available literature on descriptive epidemiology, risk factors, treatment, and prevention. Burns 2006; 32:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/2\">",
"      Peck MD, Kruger GE, van der Merwe AE, et al. Burns and fires from non-electric domestic appliances in low and middle income countries Part I. The scope of the problem. Burns 2008; 34:303.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. The Global Burden of Disease: 2004 Update. World Health Organization, Geneva 2008 www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf (Accessed on April 02, 2010).",
"    </li>",
"    <li>",
"     Murray CJL, Lopez, AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020, World Health Organization, Swizerland 2006.",
"    </li>",
"    <li>",
"     The World Bank. World Development Report 1993: Investing in Health, 16th edition, Oxford University Press, New York 1993.",
"    </li>",
"    <li>",
"     Center for Disease Control. Fire deaths and injuries: Fact sheet overview 2008 www.cdc.gov/HomeandRecreationalSafety/Fire-Prevention/fires-factsheet.html (Accessed on September 26, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/7\">",
"      Attia, AF, Sherif, AA, Mandil, AM, et al. Epidemiological and sociocultural study of burn patients in Alexandria, Egypt. Eastern Mediterranean Health Journal 1997; 3:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/8\">",
"      Rossi LA, Braga EC, Barruffini RC, Carvalho EC. Childhood burn injuries: circumstances of occurrences and their prevention in Ribeir&atilde;o Preto, Brazil. Burns 1998; 24:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/9\">",
"      Hemeda M, Maher A, Mabrouk A. Epidemiology of burns admitted to Ain Shams University Burns Unit, Cairo, Egypt. Burns 2003; 29:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/10\">",
"      Davies JW. The problems of burns in India. Burns 1990; Suppl 1:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/11\">",
"      Mabrouk A, Maher A, Nasser S. An epidemiologic study of elderly burn patients in Ain Shams University Burn Unit, Cairo, Egypt. Burns 2003; 29:687.",
"     </a>",
"    </li>",
"    <li>",
"     WHO. Global Burden of Disease 2004 Summary Tables. Geneva, World Health Organization, 2008. www.who.int/healthinfo/global_burden_disease/estimates_regional/en/index.html (Accessed on September 20, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/13\">",
"      Hyder, AA, Kashyap, KS, Fishman, S, Wali, SA. Review on childhood burn injuries in Sub-Saharan Africa: A forgotten public health challenge. African Safety Promotion 2004; 2:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/14\">",
"      Mashreky SR, Rahman A, Chowdhury SM, et al. Epidemiology of childhood burn: yield of largest community based injury survey in Bangladesh. Burns 2008; 34:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/15\">",
"      Mashreky SR, Rahman A, Chowdhury SM, et al. Consequences of childhood burn: findings from the largest community-based injury survey in Bangladesh. Burns 2008; 34:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/16\">",
"      Mashreky SR, Rahman A, Chowdhury SM, et al. Non-fatal burn is a major cause of illness: findings from the largest community-based national survey in Bangladesh. Inj Prev 2009; 15:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/17\">",
"      Burd A, Yuen C. A global study of hospitalized paediatric burn patients. Burns 2005; 31:432.",
"     </a>",
"    </li>",
"    <li>",
"     Demamu, S. Community-based study of childhood injuries in Adamitulu District, Ethiopia (Thesis). Addis Ababa University, Department of Community Health, 1991.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/19\">",
"      Wold FT. Accidents in childhood. Ethiop Med J 1973; 11:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/20\">",
"      Tamrat A. (1981) Accidents and poisoning in children. Ethiop Med J 1981; 24:39.",
"     </a>",
"    </li>",
"    <li>",
"     WHO Fact Sheet: The top ten causes of death 2004 www.who.int/mediacentre/factsheets/fs310/en (Accessed on June 08, 2010).",
"    </li>",
"    <li>",
"     American Burn Association. National Burn Repository, Version 5.0 2009. www.ameriburn.org/2009NBRAnnualReport.pdf (Accessed on May 02, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/23\">",
"      Forjuoh SN. The mechanisms, intensity of treatment, and outcomes of hospitalized burns: issues for prevention. J Burn Care Rehabil 1998; 19:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/24\">",
"      Tung KY, Chen ML, Wang HJ, et al. A seven-year epidemiology study of 12,381 admitted burn patients in Taiwan--using the Internet registration system of the Childhood Burn Foundation. Burns 2005; 31 Suppl 1:S12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/25\">",
"      Gupta RK, Srivastava AK. Study of fatal burns cases in Kanpur (India). Forensic Sci Int 1988; 37:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/26\">",
"      Lalo&euml; V. Patterns of deliberate self-burning in various parts of the world. A review. Burns 2004; 30:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/27\">",
"      Ahuja RB, Bhattacharya S. An analysis of 11,196 burn admissions and evaluation of conservative management techniques. Burns 2002; 28:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/28\">",
"      Street JR, Wright JC, Choo KL, et al. Woodstoves uncovered: a paediatric problem. Burns 2002; 28:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/29\">",
"      Cave Bondi G, Cipolloni L, Parroni E, Cecchi R. A review of suicides by burning in Rome between 1947-1997 examined by the Pathology Department of the Institute of Forensic Medicine, University of Rome 'La Sapienza'. Burns 2001; 27:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/30\">",
"      Thombs BD, Bresnick MG, Magyar-Russell G. Who attempts suicide by burning? An analysis of age patterns of mortality by self-inflicted burning in the United States. Gen Hosp Psychiatry 2007; 29:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/31\">",
"      Modjarrad K, McGwin G Jr, Cross JM, Rue LW 3rd. The descriptive epidemiology of intentional burns in the United States: an analysis of the National Burn Repository. Burns 2007; 33:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/32\">",
"      Poeschla B, Combs H, Livingstone S, et al. Self-immolation: socioeconomic, cultural and psychiatric patterns. Burns 2011; 37:1049.",
"     </a>",
"    </li>",
"    <li>",
"     Pruitt BA, Wolf SE, Mason AD. Epidemiological, demographic, and outcome characteristics of burn injury. In: Total Burn Care, 3rd edition, Herndon DN (Ed), Saunders Elsevier, Philadelphia 2007. p.14.",
"    </li>",
"    <li>",
"     Snehi, Y. Female infanticide and gender in Punjab. JSTOR: Economic and political weekly 2003; 38:4302. www.jstor.org/pss/4414126.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/35\">",
"      McLean AD. Burns and military clothing. J R Army Med Corps 2001; 147:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/36\">",
"      Cheng JC, Leung KS, Lam ZC, Leung PC. An analysis of 1704 burn injuries in Hong Kong children. Burns 1990; 16:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/37\">",
"      Shani E, Bahar-Fuchs SA, Abu-Hammad I, et al. A burn prevention program as a long-term investment: trends in burn injuries among Jews and Bedouin children in Israel. Burns 2000; 26:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/38\">",
"      Sawhney CP. Flame burns involving kerosene pressure stoves in India. Burns 1989; 15:362.",
"     </a>",
"    </li>",
"    <li>",
"     Barss P, Smith GS, Baker SP, Mohan D. Injury prevention: An International Perspective, Oxford University Press, 1998 1998.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/40\">",
"      Grange AO, Akinsulie AO, Sowemimo GO. Flame burns disasters from kerosene appliance explosions in Lagos, Nigeria. Burns Incl Therm Inj 1988; 14:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/41\">",
"      Gupta M, Bansal M, Gupta A, Goil P. The kerosene tragedy of 1994, an unusual epidemic of burns: epidemiological aspects and management of patients. Burns 1996; 22:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/42\">",
"      Marsh D, Sheikh A, Khalil A, et al. Epidemiology of adults hospitalized with burns in Karachi, Pakistan. Burns 1996; 22:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/43\">",
"      El-Badawy A, Mabrouk AR. Epidemiology of childhood burns in the burn unit of Ain Shams University in Cairo, Egypt. Burns 1998; 24:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/44\">",
"      Mabrouk A, El Badawy A, Sherif M. Kerosene stove as a cause of burns admitted to the Ain Shams burn unit. Burns 2000; 26:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/45\">",
"      H&iacute;jar-Medina MC, Tapia-Y&aacute;&ntilde;ez JR, Lozano-Ascencio R, L&oacute;pez-L&oacute;pez MV. [Home accidents in children less than 10 years of age: causes and consequences]. Salud Publica Mex 1992; 34:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/46\">",
"      Sanghavi P, Bhalla K, Das V. Fire-related deaths in India in 2001: a retrospective analysis of data. Lancet 2009; 373:1282.",
"     </a>",
"    </li>",
"    <li>",
"     American Burn Association. Burn incidence and treatment in the US: 2007 Fact Sheet. ameriburn.org (Accessed on June 08, 2010).",
"    </li>",
"    <li>",
"     National Burn Repository 2005 Report, Dataset version 2.0 file://www.ameriburn.org/NBR2005.pdf (Accessed on September 20, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/49\">",
"      Nega, KE, Lindtjorn, B. Epidemiology of burn injuries in Mekele Town, Northern Ethiopia: A community based study. Ethiop J Health Dev 2002; 16:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/50\">",
"      Shields BJ, Comstock RD, Fernandez SA, et al. Healthcare resource utilization and epidemiology of pediatric burn-associated hospitalizations, United States, 2000. J Burn Care Res 2007; 28:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/51\">",
"      Yongqiang F, Yibing W, Dechang W, et al. Epidemiology of hospitalized burn patients in Shandong Province: 2001-2005. J Burn Care Res 2007; 28:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/52\">",
"      Lari AR, Panjeshahin MR, Talei AR, et al. Epidemiology of childhood burn injuries in Fars province, Iran. J Burn Care Rehabil 2002; 23:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/53\">",
"      Forjuoh SN, Guyer B, Smith GS. Childhood burns in Ghana: epidemiological characteristics and home-based treatment. Burns 1995; 21:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/54\">",
"      Kalayi GD, Muhammad I. Burns in children under 3 years of age: the Zaria experience. Ann Trop Paediatr 1996; 16:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/55\">",
"      Kalayi GD, Muhammad I. Clothing burns in Zaria. Burns 1994; 20:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/56\">",
"      Durrani, KM, Raza, SK. Studies on flammability of clothing of burn victims, changes therein and their wearability after a borax rinse. J Pak Med Assoc 1975; 25:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/57\">",
"      Barss P, Wallace K. Grass-skirt burns in Papua New Guinea. Lancet 1983; 1:733.",
"     </a>",
"    </li>",
"    <li>",
"     Baker SP, O'Neill B, Karpf RS. The injury fact book, Lexington Books, Lexington 1984.",
"    </li>",
"    <li>",
"     Fatal and non-fatal injuries, and selected illnesses and conditions. In: Worker Health Chartbook 2004, National Institute for Occupational Safety and Health, 2004; NIOSH publication no. 2004-146. file://www.cdc.gov/niosh/docs/2004-146/ch2/ch2-1.asp.htm (Accessed on June 08, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/60\">",
"      Barillo DJ, Stetz CK, Zak AL, et al. Preventable burns associated with the misuse of gasoline. Burns 1998; 24:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/61\">",
"      Ahuja RB, Bhattacharya S, Rai A. Changing trends of an endemic trauma. Burns 2009; 35:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/62\">",
"      Adamo C, Esposito G, Lissia M, et al. Epidemiological data on burn injuries in Angola: a retrospective study of 7230 patients. Burns 1995; 21:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/63\">",
"      Vilasco B, Bondurand A. Burns in Abidjan, Cote d'Ivoire. Burns 1995; 21:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/64\">",
"      Gupta M, Gupta OK, Goil P. Paediatric burns in Jaipur, India: an epidemiological study. Burns 1992; 18:63.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control. Web-based injury and statistics query and reporting system (WISQARS&trade;) 2009. webappa.cdc.gov/sasweb/ncipc/mortrate9.html (Accessed on April 02, 2010).",
"    </li>",
"    <li>",
"     Peden, M, Oyegbite, K, Ozanne-Smith, J, et al. World Report on Child Injury Prevention. World Health Organization, Geneva 2008. p.78. whqlibdoc.who.int/publications/2008/9789241563574_eng.pdf (Accessed on April 02, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/67\">",
"      Istre GR, McCoy M, Carlin DK, McClain J. Residential fire related deaths and injuries among children: fireplay, smoke alarms, and prevention. Inj Prev 2002; 8:128.",
"     </a>",
"    </li>",
"    <li>",
"     US Department of Justice. Office of Justice Programs. Office of Juvenile Justice and Delinquency Prevention. Burn injuries in child abuse. Portable guide to investigating child abuse. 2001. www.ncjrs.gov/pdffiles/91190-6.pdf (Accessed on April 29, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/69\">",
"      Pressel DM. Evaluation of physical abuse in children. Am Fam Physician 2000; 61:3057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/70\">",
"      Ryan CM, Thorpe W, Mullin P, et al. A persistent fire hazard for older adults: cooking-related clothing ignition. J Am Geriatr Soc 1997; 45:1283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/71\">",
"      Dissanaike S, Rahimi M. Epidemiology of burn injuries: highlighting cultural and socio-demographic aspects. Int Rev Psychiatry 2009; 21:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/72\">",
"      Ghosh A, Bharat R. Domestic burns prevention and first aid awareness in and around Jamshedpur, India: strategies and impact. Burns 2000; 26:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/73\">",
"      Bhalla SB, Kale SR, Mohan D. Burn properties of fabrics and garments worn in India. Accid Anal Prev 2000; 32:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/74\">",
"      Gali BM, Madziga AG, Naaya HU. Epidemiology of childhood burns in Maiduguri north-eastern Nigeria. Niger J Med 2004; 13:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/75\">",
"      Ndiritu S, Ngumi ZW, Nyaim O. Burns: the epidemiological pattern, risk and safety awareness at Kenyatta National Hospital, Nairobi. East Afr Med J 2006; 83:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/76\">",
"      Mashreky SR, Rahman A, Chowdhury SM, et al. Perceptions of rural people about childhood burns and their prevention: a basis for developing a childhood burn prevention programme in Bangladesh. Public Health 2009; 123:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/77\">",
"      Courtright P, Haile D, Kohls E. The epidemiology of burns in rural Ethiopia. J Epidemiol Community Health 1993; 47:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/78\">",
"      Mzezewa S, Jonsson K, Aberg M, Salemark L. A Prospective study on the epidemiology of burns in patients admitted to the Harare burn units. Burns 1999; 25:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/79\">",
"      Edelman LS. Social and economic factors associated with the risk of burn injury. Burns 2007; 33:958.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/80\">",
"      Barillo DJ, Goode R. Fire fatality study: demographics of fire victims. Burns 1996; 22:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/81\">",
"      Mallonee S, Istre GR, Rosenberg M, et al. Surveillance and prevention of residential-fire injuries. N Engl J Med 1996; 335:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/82\">",
"      Laursen B, Nielsen JW. Influence of sociodemographic factors on the risk of unintentional childhood home injuries. Eur J Public Health 2008; 18:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/83\">",
"      Petridou E, Trichopoulos D, Mera E, et al. Risk factors for childhood burn injuries: a case-control study from Greece. Burns 1998; 24:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/84\">",
"      Daisy S, Mostaque AK, Bari TS, et al. Socioeconomic and cultural influence in the causation of burns in the urban children of Bangladesh. J Burn Care Rehabil 2001; 22:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/85\">",
"      Karim, K. Alam, I, UlHasan, N, et al. The socio economic factors of burn injuries in children. Burns 1975; 1:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/86\">",
"      Delgado J, Ram&iacute;rez-Cardich ME, Gilman RH, et al. Risk factors for burns in children: crowding, poverty, and poor maternal education. Inj Prev 2002; 8:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/87\">",
"      Forjuoh SN. Burn repetitions in Ghanaian children: prevalence, epidemiological characteristics and socioenvironmental factors. Burns 1996; 22:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/88\">",
"      Minn YK. Who burned and how to prevent? Identification of risk for and prevention of burns among epileptic patients. Burns 2007; 33:127.",
"     </a>",
"    </li>",
"    <li>",
"     Barss, P. Health impact of injuries in the highlands of Papua New Guinea: a verbal autopsy study (Dissertation). Johns Hopkins School of Hygiene and Public Health, Baltimore, MD 1991.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/90\">",
"      Fauveau V, Blanchet T. Deaths from injuries and induced abortion among rural Bangladeshi women. Soc Sci Med 1989; 29:1121.",
"     </a>",
"    </li>",
"    <li>",
"     Tekle-Haimanot R. Neurological disorders. In: The ecology of health and disease in Ethiopia, Kloos H, Zeinb ZA (Eds), Westview Press, Boulder 1993. p.483.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/92\">",
"      Al-Qattan MM. Burns in epileptics in Saudi Arabia. Burns 2000; 26:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/93\">",
"      Al-Qattan MM, Al-Zahrani K. A review of burns related to traditions, social habits, religious activities, festivals and traditional medical practices. Burns 2009; 35:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/94\">",
"      Forjuoh SN, Guyer B, Ireys HT. Burn-related physical impairments and disabilities in Ghanaian children: prevalence and risk factors. Am J Public Health 1996; 86:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/95\">",
"      Alden NE, Bessey PQ, Rabbitts A, et al. Tap water scalds among seniors and the elderly: socio-economics and implications for prevention. Burns 2007; 33:666.",
"     </a>",
"    </li>",
"    <li>",
"     Peden M, McGee K, Sharma G. Fire-related burns. In: The injury chart book: A graphical overview of the global burden of injuries, World Health Organization, Geneva 2002. p.27.",
"    </li>",
"    <li>",
"     World Health Organization. Injury - A leading cause of the global burden of disease 2000. whqlibdoc.who.int/publications/2002/9241562323.pdf (Accessed on June 08, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/98\">",
"      Atiyeh BS, Costagliola M, Hayek SN. Burn prevention mechanisms and outcomes: pitfalls, failures and successes. Burns 2009; 35:181.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. WHO mortality database 2009. www.who.int/healthinfo/morttables/en/index.html (Accessed on December 22, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/100\">",
"      Saleh S, Gadalla S, Fortney JA, et al. Accidental burn deaths to Egyptian women of reproductive age. Burns Incl Therm Inj 1986; 12:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/101\">",
"      Rashid A, Gowar JP. A review of the trends of self-inflicted burns. Burns 2004; 30:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/102\">",
"      Bernard SJ, Paulozzi LJ, Wallace DL, Centers for Disease Control and Prevention (CDC). Fatal injuries among children by race and ethnicity--United States, 1999-2002. MMWR Surveill Summ 2007; 56:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/103\">",
"      Park JO, Shin SD, Kim J, et al. Association between socioeconomic status and burn injury severity. Burns 2009; 35:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/104\">",
"      Friesen, B. Haddon's strategy for prevention: Application to Native house fires. Int J Circumpolar Health 1985; 84:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/105\">",
"      Bjerregaard P. Fatal non-intentional injuries in Greenland. Arctic Med Res 1992; 51 Suppl 7:22.",
"     </a>",
"    </li>",
"    <li>",
"     Muir BL. Health status of Canadian Indians and Inuit-1990, Epidemiology and Community Health Specialties, Indian and Northern Health Services, Medical Services Branch, Health and Welfare Canada, Ottawa 1991.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/107\">",
"      Shenassa ED, Stubbendick A, Brown MJ. Social disparities in housing and related pediatric injury: a multilevel study. Am J Public Health 2004; 94:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/108\">",
"      Flores G, Tomany-Korman SC, Olson L. Does disadvantage start at home? Racial and ethnic disparities in health-related early childhood home routines and safety practices. Arch Pediatr Adolesc Med 2005; 159:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/109\">",
"      Runyan CW, Johnson RM, Yang J, et al. Risk and protective factors for fires, burns, and carbon monoxide poisoning in U.S. households. Am J Prev Med 2005; 28:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/110\">",
"      Marshall SW, Runyan CW, Bangdiwala SI, et al. Fatal residential fires: who dies and who survives? JAMA 1998; 279:1633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23865/abstract/111\">",
"      Gulaid JA, Sacks JJ, Sattin RW. Deaths from residential fires among older people, United States, 1984. J Am Geriatr Soc 1989; 37:331.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 822 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-AA4CF5E739-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_19_23865=[""].join("\n");
var outline_f23_19_23865=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Site and setting",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Incidence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Prevalence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Intentional versus accidental",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Etiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Flames and scalds",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Flammable fuels",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      HIGH RISK POPULATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Elderly",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Gender",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Socioeconomic factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Environmental and familial factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Comorbid illnesses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      PROTECTIVE FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Maternal education",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      MORBIDITY AND MORTALITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Disabilities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Mortality",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Overall mortality",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Childhood mortality",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Elder mortality",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/822\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/822|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/17/20765\" title=\"figure 1\">",
"      Burns epi mort IC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/43/36541\" title=\"figure 2\">",
"      Global mortality by age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/6/16493\" title=\"figure 3\">",
"      Burns epi mort HIC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/17/22813\" title=\"figure 4\">",
"      Burn mortality in MIC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/4/26701\" title=\"figure 5\">",
"      Burns epi mort LIC",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/822|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/43/3772\" title=\"table 1\">",
"      Estimated global incidence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/39/3708\" title=\"table 2\">",
"      Estimated global prevalence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/47/764\" title=\"table 3\">",
"      Burns epi deaths",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17716?source=related_link\">",
"      Global costs of fires and burns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/48/9992?source=related_link\">",
"      Prevention of fire and burn injuries",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_19_23866="Overview of stress fractures";
var content_f23_19_23866=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of stress fractures",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/19/23866/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/19/23866/contributors\">",
"     Kevin deWeber, MD, FAAFP, FACSM",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/19/23866/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/19/23866/contributors\">",
"     Patrice Eiff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/19/23866/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/19/23866/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/19/23866/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;As defined below, stress fractures are due to loads that stress (either compress or stretch) a bone but would not individually be expected to cause it to break. Stress fractures may be the result of a small number of repetitions with a relatively large load (eg, a military recruit marching for several miles with a heavy backpack), a large number of repetitions with a usual load (eg, an athlete training for a long-distance race), or some intermediate combination of increased load and number of repetitions.",
"   </p>",
"   <p>",
"    An overview of the classification, risk factors, diagnosis, management, and prevention of stress fractures is presented here. Specific stress fractures are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/4/19527?source=see_link\">",
"     \"Stress fractures of the tibia and fibula\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/61/33747?source=see_link\">",
"     \"Stress fractures of the metatarsal shaft\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43812?source=see_link\">",
"     \"Stress fractures of the humeral shaft\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/54/873?source=see_link&amp;anchor=H29#H29\">",
"     \"Proximal fifth metatarsal fractures\", section on 'Stress fractures of the proximal diaphysis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fracture &ndash; Fracture refers to the breaking of a bone. Complete fractures divide the affected bone into two or more pieces, while partial (incomplete) fractures do not extend through the cortex. An example of an incomplete fracture is the \"greenstick\" fracture, in which the convex side of a long bone is disrupted, while the concave surface remains intact. These are most common in children.",
"     </li>",
"     <li>",
"      Stress fracture &ndash; A stress fracture occurs when a bone breaks after being subjected to repeated tensile or compressive stresses, none of which would be large enough individually to cause the bone to fail, in a person who is not known to have an underlying disease that would be expected to cause abnormal bone fragility.",
"     </li>",
"     <li>",
"      Insufficiency fracture &ndash; An insufficiency fracture occurs when the mechanical strength of a bone is reduced to the point that a stress, which would not fracture a healthy bone, breaks the weak one. The condition that causes reduced bone strength typically does so throughout the skeleton (eg, osteoporosis, osteomalacia, or osteogenesis imperfecta), but may be more localized (eg, demineralization in a limb due to disuse).",
"      <br/>",
"      <br/>",
"      Insufficiency fractures due to osteoporosis, pseudofractures, and radiolucent lines seen in the bones of patients with osteomalacia are reviewed elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/55/11128?source=see_link\">",
"       \"Diagnosis and evaluation of osteoporosis in postmenopausal women\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/7/14458?source=see_link\">",
"       \"Clinical manifestations and treatment of osteoporotic thoracolumbar vertebral compression fractures\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/54/27494?source=see_link\">",
"       \"Epidemiology and etiology of osteomalacia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pathologic fracture &ndash; A pathologic fracture is due to a localized loss of strength in a bone from a disease process immediately underlying the bone. Examples of pathologic fractures include those that occur at sites of bone tumors (primary or metastatic), bone cysts, and infections.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stress fractures are classified clinically on the basis of their risk of complications, particularly of displacement, nonunion, or fracture propagation. The distinction between \"low-risk\" and \"high-risk\" stress fractures is based primarily on the fracture site. Stress fractures at low-risk sites are unlikely to have any of these complications and are generally amenable to conservative management. In contrast, high-risk stress fractures are managed more aggressively, often surgically.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sites at LOW risk of complications &ndash; Fractures of the second through fourth metatarsal shafts, posteromedial tibial shaft, proximal humerus or humeral shaft, ribs, sacrum, and pubic rami are considered low risk.",
"     </li>",
"     <li>",
"      Sites at HIGH risk of complications &ndash; Stress fractures of the pars interarticularis of the lumbar spine, femoral head, superior side of the femoral neck (ie, tension side), patella, anterior cortex of the tibia (ie, tension side), medial malleolus, talus, tarsal navicular, proximal fifth metatarsal, great toe sesamoids, and the base of the second metatarsal are considered to be at high risk for complications.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY OF STRESS FRACTURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone remodels in response to a mechanical stress. The rate and amount of remodeling depends upon the number and frequency of loading cycles a bone is subjected to (Wolff's law). An abrupt increase in the duration, intensity, or frequency of physical activity without adequate periods of rest may lead to pathologic changes in bone. These pathologic changes result from an imbalance between bone resorption and formation. During periods of intense exercise, bone formation lags behind bone resorption. This renders the bone susceptible to microfractures. Under continued loading conditions, these microfractures may propagate and coalesce into stress fractures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of stress fractures is less than 1 percent in the general population. The reported incidence in athletic populations varies with the type of athlete. Among military recruits the incidence ranges from 1 to 31 percent, among runners 13 to 52 percent, and among participants in collegiate team sports 1 to 8 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Important risk factors for developing stress fractures include a history of prior stress fracture, low level of physical fitness, increasing volume and intensity of physical activity, female gender and menstrual irregularity, diet poor in calcium, poor bone health, and poor biomechanics (",
"    <a class=\"graphic graphic_table graphicRef79279 \" href=\"UTD.htm?35/11/36027\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Prior stress fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;A history stress fractures is a strong predictor of future stress fractures, according to several prospective studies. The relative risk is over sixfold in distance runners and military recruits with a history of at least one stress fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Among track athletes, 60 percent of those who sustained a stress fracture had a history of stress fracture. The one year recurrence rate in these athletes was 12.6 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Physical fitness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Decreased muscle strength and endurance are associated with an increased incidence of stress fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/5\">",
"     5",
"    </a>",
"    ]. Muscles play a supportive role in bone health; when muscles are weak or fatigued, other musculoskeletal structures absorb greater impact. Specific factors associated with higher rates of stress fractures include &gt;1 cm decrease in calf girth [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/1\">",
"     1",
"    </a>",
"    ], less lean mass in the lower extremities [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/6\">",
"     6",
"    </a>",
"    ], less than seven months of prior strength training [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/7\">",
"     7",
"    </a>",
"    ], and poor lower extremity muscle strength [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/8\">",
"     8",
"    </a>",
"    ]. Rowers with lower knee extensor to elbow extensor strength ratios also had a higher incidence of rib stress fractures in one retrospective case control study [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although joint inflexibility has long been cited as a possible risk factor for stress fracture, its role remains unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/5\">",
"     5",
"    </a>",
"    ]. Among several prospective studies looking at ankle dorsiflexion, one found restricted flexibility to be associated with stress fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/10\">",
"     10",
"    </a>",
"    ], while two found no association [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/6,11\">",
"     6,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Activity type and intensity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific activities predispose athletes to site-specific stress fractures. As examples, throwing athletes have an increased risk of humeral fractures, while runners are at increased risk for pelvic and lower extremity fractures, primarily of the tibia and metatarsals. Gymnasts have an increased risk for stress fractures of the spine and foot. Stress fractures of the ribs may be seen in golfers and rowers.",
"   </p>",
"   <p>",
"    Weightbearing bones, primarily those of the lower extremity, are at greatest risk for stress fracture. As an example, tibial fractures accounted for 49 percent of all stress fractures seen in athletes, followed in frequency by fractures of the metatarsals [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Non-athletes who abruptly increase their level of activity may also be at risk for stress fracture. An example would be the patient whose activity was restricted by the pain of arthritis who resumes walking after joint replacement surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Gender differences",
"    </span>",
"    &nbsp;&mdash;&nbsp;Females are at greater risk than males of developing stress fractures. Relative risk ranges from 1.2 to 10 depending upon the population studied (eg, athletes versus general population) and the fractures considered [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/1,14\">",
"     1,14",
"    </a>",
"    ]. Women have 51 times the rate of sacral stress fractures but 3.4 times the rate of pubic ramus and proximal tibial stress fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the reasons for the gender discrepancy remain unproven, higher rates of risk factors, such as decreased bone mineral density and disordered eating, likely contribute [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/1,15\">",
"     1,15",
"    </a>",
"    ]. Menstrual irregularity is an independent risk factor for stress fractures in women [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/3,7,14,16-18\">",
"     3,7,14,16-18",
"    </a>",
"    ]. The combination of decreased bone density, disordered eating leading to poor energy availability, and amenorrhea comprises the \"female athlete triad,\" which places a woman at greatly increased risk of stress fractures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/3/36919?source=see_link\">",
"     \"Amenorrhea and infertility associated with exercise\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Poor physical fitness may predispose some women to developing stress fractures. Studies of female military recruits show that many women begin basic training at lower physical fitness levels than their male counterparts [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. The dramatic increase in physical training may overwhelm the bone's capacity to compensate via normal remodeling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Bone health",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lower bone mineral density, as assessed by quantitative ultrasonography or dual-energy x-ray absorptiometry (DEXA) scan, strongly correlates with an increased incidence of stress fractures in both men and women [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/3,6,17,21-24\">",
"     3,6,17,21-24",
"    </a>",
"    ]. Vitamin D and calcium are essential for bone health. When the amounts of these nutrients are inadequate, bone is weakened and is potentially more susceptible to fractures of any kind.",
"   </p>",
"   <p>",
"    Case-control studies show that lower calcium intake is associated with an increase in stress fracture incidence in women, with a relative risk of 1.1 per 100 mg decreased intake [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/17,25\">",
"     17,25",
"    </a>",
"    ]. Conversely, ensuring adequate vitamin D and calcium intake appears to reduce the risk of stress fracture, according to a randomized trial of female United States Navy (USN) recruits [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/26\">",
"     26",
"    </a>",
"    ]. Daily supplementation in this study consisted of calcium 2000 mg and vitamin D 800 IU. The importance of vitamin D is further supported by a prospective, nested case-control study in female USN recruits in which women in the highest quintile of 25OHD (ie, vitamin D) serum concentrations (over 40",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    had half the risk of stress fracture compared with women in the lowest quintile (1.5 to 19.7",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/21/3417?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment of vitamin D deficiency in adults\", section on 'Optimal intake'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A family history of osteopenia or osteoporosis correlates with a threefold higher risk of stress fractures in adolescent female athletes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/21/33113?source=see_link\">",
"     \"Prevention of osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Disordered eating",
"    </span>",
"    &nbsp;&mdash;&nbsp;Restricted caloric intake in female track and field athletes, gymnasts, and dancers correlates with an increased incidence of stress fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/6,28\">",
"     6,28",
"    </a>",
"    ]. Disordered eating deprives the body of the nutrients needed for bone and muscle metabolism, in addition to other health risks. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=see_link\">",
"     \"Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Anatomical factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;A systematic review found that extreme foot arch morphologies (pes planus or cavus) likely increase risk for tibial stress fractures, but no definitive conclusions could be drawn [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Biomechanical factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific biomechanical characteristics during the ground contact phases of running may predispose athletes to stress fractures. Preliminary retrospective studies show that increased tibial striking torque [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/30\">",
"     30",
"    </a>",
"    ], increased tibial shock and vertical load rates [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/31\">",
"     31",
"    </a>",
"    ], and earlier hindfoot eversion [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/32\">",
"     32",
"    </a>",
"    ] are associated with higher tibial stress fracture rates.",
"   </p>",
"   <p>",
"    One large prospective study showed that a shorter duration of foot pronation during landing was associated with increased risk of tibial and femoral stress fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/33\">",
"     33",
"    </a>",
"    ]. Neither maximal pronation angle nor pronation mean angular velocity appeared to increase risk. This suggests that how far the foot pronates during contact with the ground is not as important as how well the subtalar joint controls the duration of pronation. Further studies are needed to clarify these risks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Age",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of stress fractures is greatest in patients aged 17 to 26 years, but this likely has more to do with increased activity than age, per se. One large prospective study of Finnish military recruits found a twofold risk of pelvis and lower extremity stress fractures in 21- to 29-year-olds compared with 17- to 19-year-olds [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/8\">",
"     8",
"    </a>",
"    ]. Decreased bone density may play a role in the effect of age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Footwear and running surface",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recruits who begin basic training using old shoes have a higher incidence of stress fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/34\">",
"     34",
"    </a>",
"    ]. A systematic review found that shock absorbing shoe inserts probably reduce risk [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/35\">",
"     35",
"    </a>",
"    ]. Two retrospective studies found no association between running surface and stress fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/36,37\">",
"     36,37",
"    </a>",
"    ], but one found that running on a treadmill reduced tibial strain compared with over-ground running [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Other risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stress fractures have been attributed to various other factors, despite little evidentiary support. As examples, white race, moderate alcohol use, low body weight, short-term use of glucocorticoids, and low-dose depo-medroxyprogesterone acetate for contraception have NOT been shown to cause stress fractures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/21/9562?source=see_link\">",
"     \"Drugs that affect bone metabolism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Overall approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early diagnosis is essential to avoid complications and a prolonged delay in return to activity. Often history and physical examination provide sufficient information for clinicians to manage low risk stress fractures without imaging studies. Imaging is needed when high-risk stress fractures are suspected or a definitive diagnosis is necessary. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Clinical classification'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H23\">",
"     'Imaging studies'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough history will often provide the diagnosis. The clinician should inquire about likely risk factors and solicit a detailed description of the pain and any antecedent physical activity. Particularly important are recent changes in activity level and participation in athletic activities. Often, patients describe starting a new training program or significant changes in their training regimen (eg, boot camp, addition of hill runs, change to a harder training surface).",
"   </p>",
"   <p>",
"    A dietary history is valuable for both men and women to exclude eating disorders and dietary deficiency of calcium or vitamin D. A menstrual history will help to screen for potential hormonal deficiencies.",
"   </p>",
"   <p>",
"    Clinicians should look for risk factors by inquiring about the patient's general health, past and current medical conditions, medications, alcohol and tobacco use, occupation, previous injuries, and family history (especially of osteoporosis).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Pain description",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients classically report the insidious onset of localized pain. The pain is initially related to activity and increases in severity with increased activity. Eventually the pain is present during less strenuous activity and ultimately during rest. Occasionally, the patient experiences an abrupt increase in pain at the site of milder chronic symptoms indicating that a repeatedly stressed area of bone has completely fractured. Less frequently, a patient's initial presentation may involve the acute onset of severe pain, resulting from a complete fracture at the site of a preexisting stress fracture. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Definitions'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tenderness of the affected bone is the most sensitive physical finding for diagnosing a stress fracture. Tenderness is usually limited to the site of injury, unless a complete fracture is present, in which case the area of tenderness may be wider due to bleeding and inflammation.",
"   </p>",
"   <p>",
"    In one common scenario, small muscle tears (ie, shin splints) precede the development of a stress fracture of the medial tibial border. In this case tenderness may be present along several centimeters of the tibial shaft, but the fracture site is often most tender. In superficial areas there may be subtle soft tissue swelling over the stress fracture, and occasionally mild erythema, or even bony callus in chronic, severe cases. Defects of the cortical surface and bony crepitus are not present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/4/34890?source=see_link&amp;anchor=H24287212#H24287212\">",
"     \"Overview of running injuries of the lower extremity\", section on 'Medial tibial stress syndrome (shin splints) and tibial stress fractures'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When the fracture site is not easily palpable, maneuvers to stress the bone at the area of pain may aid diagnosis. The fulcrum test may be useful when long bones are involved [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/39\">",
"     39",
"    </a>",
"    ]. It is performed by placing one hand under the area that is painful and applying steady pressure while the other hand applies steady pressure at the end of the same bone. This creates a fulcrum effect that stresses the site of suspected injury. Increased pain at the area in question during the test is consistent with a stress fracture. The fulcrum test is neither sensitive nor specific, and imaging is needed to make a precise diagnosis. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Imaging studies'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Some clinicians use the hop test to help diagnose femoral neck stress fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/12\">",
"     12",
"    </a>",
"    ]. The patient is asked to hop on the affected leg, which may reproduce pain at the fracture site. However, the test is neither sensitive nor specific and confirmatory imaging is necessary to make a definitive diagnosis. Given this lack of precision and because performing the hop test risks converting the rare tension-side femoral neck stress fracture into a complete fracture, we do not recommend its use. For patients with weightbearing pain who may have a femoral neck stress fracture, we assign non-weightbearing status until appropriate imaging can be obtained.",
"   </p>",
"   <p>",
"    Biomechanical evaluation of the affected region should be done to identify factors that may have predisposed to injury or affect healing. In general, the entire affected limb and its attachments to the axial skeleton should be evaluated whenever a stress fracture is suspected. The examination should assess:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Leg length discrepancy (noted in 70 percent of patients with lower extremity stress fractures [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/6\">",
"       6",
"      </a>",
"      ])",
"     </li>",
"     <li>",
"      Joint range of motion and ligamentous stability",
"     </li>",
"     <li>",
"      Muscle strength and flexibility",
"     </li>",
"     <li>",
"      Limb alignment (eg, genu varus or valgus)",
"     </li>",
"     <li>",
"      Foot type (eg, pes cavus or planus)",
"     </li>",
"     <li>",
"      Gait analysis in shoes worn during physical activity",
"     </li>",
"     <li>",
"      Core muscle strength (eg, abdominal, back, and hip musculature)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Use of a tuning fork's vibratory energy to elicit pain is an insensitive sign of stress fracture. Likewise, using ultrasound energy to elicit pain at the location of a stress fracture has been shown to be only 43 percent sensitive and 49 percent specific compared with bone scan and should not be relied upon for diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Imaging studies",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Approach to stress fracture imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Often history and examination provide sufficient information for clinicians to manage low risk stress fractures without imaging studies. Plain x-rays should be obtained initially and are helpful when positive due to their high specificity, but they are very insensitive. If plain x-rays are negative but clinical suspicion remains high, and a need for definitive diagnosis exists, MRI is recommended because it is both sensitive and specific. Bone scan is highly sensitive, and confirms the diagnosis in all but rare instances, but is nonspecific. CT is preferred if extensive bony injury is suspected because it provides greater anatomic detail of bone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Plain radiographs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiographs should be obtained but are typically normal for the first two to three weeks after the onset of symptoms, and findings may take months to appear. Periosteal elevation, cortical thickening, sclerosis, and a true fracture line are all examples of positive findings (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef62977 \" href=\"UTD.htm?34/7/34942\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69856 \" href=\"UTD.htm?8/42/8878\">",
"     image 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef73240 \" href=\"UTD.htm?22/36/23118\">",
"     image 3",
"    </a>",
"    ). Although such findings are specific, plain x-rays have poor sensitivity in the detection of stress fractures. Of note, periosteal elevation on plain x-ray correlates closely with high-grade stress fracture on MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Magnetic resonance imaging'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Bone scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radionuclide studies (three phase bone scan) have traditionally been used for diagnosis because they can show evidence of stress fracture within two to three days of injury and have high sensitivity. However, the specificity of bone scan is low. Approximately 40 percent of positive findings occur at asymptomatic sites [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bone scans can also be falsely positive with shin splints. Areas of increased uptake may represent subclinical sites of bone remodeling or stress reactions. Increased uptake can also appear in the setting of bone tumors, osteomyelitis, or avascular necrosis. Although rare, there are reports of false-negative bone scans [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. Because of these limitations, MRI is supplanting bone scan as the diagnostic study of choice when plain radiographs are negative and confirmation of suspected stress fracture is needed. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Magnetic resonance imaging'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Acute stress fractures appear as discrete, localized, sometimes linear areas of increased uptake on all three phases (angiographic, soft tissue, and delayed phases) of a technetium-99 methylene diphosphonate bone scan. In contrast, shin splints are typically positive only during the delayed phase of the scan [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/44\">",
"     44",
"    </a>",
"    ]. A system to grade stress fracture severity based on bone scan findings has been developed (",
"    <a class=\"graphic graphic_table graphicRef58048 \" href=\"UTD.htm?36/11/37051\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     CT scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT is useful if extensive bony injury is suspected because it provides greater anatomic detail of bone involvement. CT can also show fracture lines in long bones. In the setting of a negative plain x-ray and a positive bone scan, CT can differentiate between fracture and stress reaction, or other conditions of the bone such as tumor or osteomyelitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnetic resonance imaging (MRI) is quickly supplanting bone scan as the study of choice for confirmation of the diagnosis of stress fracture. Many studies indicate that it is as sensitive as bone scan but more specific [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/43,46\">",
"     43,46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MRI appears to be useful in distinguishing between shin splints and stress fractures, and is better at differentiating pathologic fractures from stress fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/47\">",
"     47",
"    </a>",
"    ]. When an intraarticular stress fracture is suspected, MRI better distinguishes bone injury from ligament or cartilage injury. Additionally, MRI is noninvasive, does not entail ionizing radiation, and in most centers is less expensive than a bone scan.",
"   </p>",
"   <p>",
"    Though more specific than a bone scan, MRI findings must be interpreted with caution, especially when no clear fracture is present. Asymptomatic tibial stress reactions are seen in 43 percent of asymptomatic runners [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/48\">",
"     48",
"    </a>",
"    ]. Findings such as isolated bone marrow edema are nonspecific, and can occur with bone tumors, avascular necrosis, and osteomyelitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/42\">",
"     42",
"    </a>",
"    ]. Correlation of MRI findings with the history and physical examination is critical for accurate diagnosis.",
"   </p>",
"   <p>",
"    With a stress fracture, MRI typically shows a fracture line that extends through the cortex and into the medullary canal. Early in the process there is an increase in signal intensity secondary to edema surrounding the fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/42,49\">",
"     42,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A system to grade tibial stress fracture severity based on MRI findings has been developed [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/46\">",
"     46",
"    </a>",
"    ]. Using this system, the presence of a fracture or cortical abnormality on MRI, as opposed to edema alone, is somewhat predictive of a longer symptomatic period. However, further study involving a more heterogeneous group of stress fractures found this classification system to correlate poorly with recovery time [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound (US) continues to gain popularity as a diagnostic imaging tool for musculoskeletal conditions, particularly as image resolution improves and clinicians gain experience. Preliminary observational data suggest US can display several findings suggestive of stress fracture, including hematoma, periosteal elevation, hypervascularity, and cortical defect over the area of tenderness [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. In a blinded case-control study of 37 consecutive patients, the sensitivity of ultrasound for detecting metatarsal stress fractures was 83 percent and the specificity 76 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/53\">",
"     53",
"    </a>",
"    ]. Further studies are needed to determine the effectiveness and appropriate role of ultrasound in evaluating the patient with a possible stress fracture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several disorders can present with localized musculoskeletal pain. Tendinopathy, muscle strains, joint sprains, nerve entrapment syndromes, and compartment syndrome share some features with stress fractures. Bone stress reactions probably represent precursor lesions that will progress to stress fractures if the sites are not protected from further insults. Among runners, medial tibial stress syndrome (ie, &ldquo;shin splints&rdquo;) is the most common example of this phenomenon. Neoplasm and infection represent the most worrisome diagnoses in the differential list. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/4/34890?source=see_link&amp;anchor=H24287212#H24287212\">",
"     \"Overview of running injuries of the lower extremity\", section on 'Medial tibial stress syndrome (shin splints) and tibial stress fractures'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4290459\">",
"    <span class=\"h2\">",
"     Tendinopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Overuse syndromes frequently are due to tendinopathy, a condition characterized by chronic pain in the affected tendon. Onset is usually insidious. Tenderness is localized to the affected tendon, which can sometimes be difficult to distinguish from the underlying bones. Pain may be reproduced by passive stretch and resisted contraction of the affected tendon. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/10/2215?source=see_link\">",
"     \"Overview of overuse (chronic) tendinopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Muscle strain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Localized pain may develop acutely or insidiously as a result of isolated trauma or repeated minor injuries to one or more muscles. Tenderness and pain with passive stretch or resisted contraction of the involved muscle are indicative of a muscle strain. A localized hematoma",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    palpable depression may develop at the site of a sizable muscle tear. Although radiographs do not reveal a fracture, this is also often true with stress fractures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/4/34890?source=see_link&amp;anchor=H2791029#H2791029\">",
"     \"Overview of running injuries of the lower extremity\", section on 'Labral tear'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Sprain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ligamentous injuries are typically the result of a single episode of trauma, though repeated injury may lead to a subacute or chronic disorder that could raise suspicion for stress fracture. Tenderness with sprains is generally localized to the area of the affected ligaments. Stressing the ligaments reproduces or exacerbates the pain, and may reveal ligamentous laxity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Nerve entrapment syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to pain, other neurologic symptoms, particularly paresthesia, numbness, and weakness, may be clues to the presence of a nerve entrapment syndrome of the upper or lower extremity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/44/8906?source=see_link\">",
"     \"Overview of upper extremity peripheral nerve syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42233?source=see_link\">",
"     \"Overview of lower extremity peripheral nerve syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Exertional compartment syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compartment syndromes are caused by increased tissue pressure within a fascial compartment that compromises local circulation and neuromuscular function. In susceptible individuals, the compartment pressure increases with exercise, resulting in exercise-induced pain, tightness, distal paresthesia, muscle weakness, or numbness. Symptoms usually resolve within several minutes of rest. There may be no symptoms or diagnostic signs at rest; provocative testing and compartment pressure testing may be necessary. A more detailed discussion of exertional compartment syndrome is found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/35/28215?source=see_link\">",
"     \"Chronic exertional compartment syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Medial tibial stress syndrome (shin splints)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Shin splints are an inflammatory response of the connective tissue of the lower leg to repetitive loading. Unlike a stress fracture, the patient with shin splints has no discrete bone tenderness. Instead, diffuse tenderness over the middle to distal third of the tibial border (usually medial but sometimes lateral) is typically present. However, if overuse continues, shin splints may progress to a stress fracture without a clear demarcation of this change, and distinguishing between the two can sometimes be difficult clinically. Like stress fractures, shin splints develop in people who suddenly increase their level of physical activity. The change may be in intensity, frequency, or type of exercise. The most frequently associated exercise is running. Shin splints are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/4/34890?source=see_link&amp;anchor=H24287212#H24287212\">",
"     \"Overview of running injuries of the lower extremity\", section on 'Medial tibial stress syndrome (shin splints) and tibial stress fractures'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Neoplasms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone pain due to neoplasm is generally characterized as being focal and constant. Painful benign and malignant neoplasms of bone can generally be differentiated from stress fractures by imaging studies. Lytic, blastic, and mixed lesions may be appreciated on plain radiographs. Malignant tumors may arise primarily from bone or be metastatic. The approach to diagnosis of primary bone tumors and bone pain due to cancer are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/53/35673?source=see_link\">",
"     \"Bone tumors: Diagnosis and biopsy techniques\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/41/21146?source=see_link&amp;anchor=H12#H12\">",
"     \"Overview of cancer pain syndromes\", section on 'Multifocal bone pain'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteomyelitis can cause localized bone pain and tenderness. It can occur at any age and at different anatomic sites. Among adolescents and young adults, osteomyelitis of long bones is most prevalent and may present in similar fashion to a stress fracture. Bone infection that results from a contiguous soft tissue infection should be readily recognized in the extremities, but may be more difficult to differentiate from a stress fracture in the bones of the pelvis.",
"   </p>",
"   <p>",
"    Hematogenous seeding in older children and young adults generally affects the ends of long bones, while in skeletally mature adults the vertebrae are most often affected. Laboratory tests and imaging studies may have some value, but it is NOT possible to exclude osteomyelitis on the basis of noninvasive studies. The clinical features and the approach to diagnosis of osteomyelitis are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/34/4649?source=see_link\">",
"     \"Overview of osteomyelitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20087?source=see_link\">",
"     \"Clinical features of hematogenous osteomyelitis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h1\">",
"     TREATMENT CONCEPTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h2\">",
"     General approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a stress fracture is strongly suspected clinically or is confirmed radiographically, early intervention is needed to reduce pain, promote healing, and prevent further bone damage. The sooner treatment is begun, the quicker the patient returns to full activity [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/54\">",
"     54",
"    </a>",
"    ]. Conservative management is recommended for low-risk fracture sites. Surgical consultation is necessary for patients with fractures at high-risk sites or for whom a lengthy rehabilitation process is untenable, such as a laborer whose livelihood depends upon a timely return to work, or some high-level athletes.",
"   </p>",
"   <p>",
"    Conservative management consists of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Acute pain control",
"     </li>",
"     <li>",
"      Protection of the fracture site with reduced weightbearing or splinting in selected stress fracture locations",
"     </li>",
"     <li>",
"      Reduction or modification of activities such that pain is not present",
"     </li>",
"     <li>",
"      Gradual resumption of activities if pain-free",
"     </li>",
"     <li>",
"      Rehabilitative exercise to promote optimal biomechanics",
"     </li>",
"     <li>",
"      Risk factor reduction as indicated",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In some cases, therapeutic ultrasound may be of benefit. Details about treatment are provided below and in reviews of specific fractures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/4/19527?source=see_link\">",
"     \"Stress fractures of the tibia and fibula\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/61/33747?source=see_link\">",
"     \"Stress fractures of the metatarsal shaft\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43812?source=see_link\">",
"     \"Stress fractures of the humeral shaft\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/54/873?source=see_link&amp;anchor=H29#H29\">",
"     \"Proximal fifth metatarsal fractures\", section on 'Stress fractures of the proximal diaphysis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h2\">",
"     Low-risk sites",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fractures of the second through fourth metacarpal shafts, posteromedial tibial shaft, fibula, proximal humerus or humeral shaft, ribs, sacrum, and pubic rami are considered low risk for fracture propagation or nonunion [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/55\">",
"     55",
"    </a>",
"    ]. These fractures usually heal with conservative treatment. (See",
"    <a class=\"local\" href=\"#H43\">",
"     'Conservative treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    As an example, tibia stress fractures commonly occur at the junction between the middle and distal thirds of the diaphysis on the compression side of the bone (posterior medial). In this case, a brief period of relative rest followed by gradual progressive exercise over several weeks is appropriate therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42\">",
"    <span class=\"h2\">",
"     High-risk sites",
"    </span>",
"    &nbsp;&mdash;&nbsp;Expert orthopedic or sports medicine consultation should be obtained for a stress fracture at any site with a high risk for nonunion, complete fracture, or long-term disability. Such sites include the pars interarticularis of the lumbar spine [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/56\">",
"     56",
"    </a>",
"    ], femoral head [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/57\">",
"     57",
"    </a>",
"    ], femoral neck [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/58\">",
"     58",
"    </a>",
"    ], patella, anterior cortex of the tibia (ie, tension side), medial malleolus, talus, tarsal navicular, proximal fifth metatarsal shaft, great toe sesamoids, and base of the second metatarsal bone [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43\">",
"    <span class=\"h2\">",
"     Conservative treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although conservative treatment is generally preferred to surgical intervention in the management of stress fractures, each patient should be considered individually. An elite athlete or laborer may depend upon an early return to activity to remain competitive or earn their living. Such patients should be considered for more aggressive rehabilitation or for orthopedic consultation earlier in their course than those whose career or livelihood is not threatened by a longer period of rehabilitation. A patient may also require early surgical intervention if there is evidence of nonunion (ie, cyst formation or sclerosis surrounding the fracture) because such fractures are less likely to heal by conservative measures alone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H44\">",
"    <span class=\"h2\">",
"     Pain control",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ice (applied locally for 15 minutes every three hours as needed) and pain medication (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    or low potency opiates) are used to control acute pain. The effect of nonsteroidal antiinflammatory drugs (NSAIDs) on fracture healing is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/49/17177?source=see_link&amp;anchor=H23#H23\">",
"     \"Nonselective NSAIDs: Overview of adverse effects\", section on 'Possible effect on fracture healing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Excessive analgesia may mask pain, making it difficult to gauge appropriate increases in physical activity during rehabilitation [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/60\">",
"     60",
"    </a>",
"    ]. It is prudent to use as little analgesic medication as possible and to strongly discourage using analgesics as a means to increase pain-free activity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H45\">",
"    <span class=\"h2\">",
"     Protection of the fracture site",
"    </span>",
"    &nbsp;&mdash;&nbsp;The forces exerted on the injured bone must be reduced such that pain is eliminated in order to allow for bone remodeling and healing. As examples, high-risk femoral head and tension-side femoral neck stress fractures should be treated with crutches and complete non-weightbearing as soon as clinically suspected and continued until orthopedic consultation is obtained.",
"   </p>",
"   <p>",
"    Other pelvic or lower extremity stress fractures should be treated with reduced weightbearing if walking causes persistent pain. In many foot stress fractures, protection with a Controlled Ankle Motion (CAM) boot, hard sole shoe, fracture boot, or leg splint eliminates pain with walking.",
"   </p>",
"   <p>",
"    Bracing may be helpful in some instances. Use of a calf length pneumatic brace for tibial stress fractures reduces the time until pain-free return to play. Bracing of the spine may be indicated for some stress fractures of the pars interarticularis; orthopedic consultation is recommended for such injuries. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/4/19527?source=see_link\">",
"     \"Stress fractures of the tibia and fibula\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H46\">",
"    <span class=\"h2\">",
"     Activity modification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Modification of activities that place stress on the affected bone is critical to the successful treatment of stress fractures. Pain is typically used to judge the efficacy of activity modification. Simply put, activities should be limited to those that are pain-free. Failure to do so may prolong healing time and increase the risk of completed fracture or nonunion.",
"   </p>",
"   <p>",
"    Active individuals will not tolerate long periods of inactivity. It is mentally untenable and leads to cardiopulmonary deconditioning and muscle atrophy. Instead, patients should be encouraged to engage in activities that closely approximate their desired activity but are pain-free. For instance, runners may walk briskly, use elliptical machines, or perform shallow-end aquatic therapy or deep water running. Cycling and swimming are excellent alternatives.",
"   </p>",
"   <p>",
"    As healing progresses, exercises involving increasing amounts of bone stress can be added gradually as tolerated, using pain as a guide. Should the patient experience any pain at the fracture site, the activity should be replaced by an exercise that places less stress upon the healing bone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H47\">",
"    <span class=\"h2\">",
"     Rehabilitative exercise",
"    </span>",
"    &nbsp;&mdash;&nbsp;Athletes, laborers, and patients with biomechanical problems predisposing to injury should participate in rehabilitation supervised by a knowledgeable physical therapist, athletic trainer, or comparable professional. The key principle during rehabilitation is protected, gradually progressive exercise that allows for adequate bone healing while promoting cardiorespiratory fitness, muscular strength, and flexibility. If supervised rehabilitation is not possible, education, home exercises, and close follow-up with the treating clinician are advisable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9471818\">",
"    <span class=\"h2\">",
"     Therapies of uncertain benefit",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H48\">",
"    <span class=\"h3\">",
"     Therapeutic ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound (US) has been shown to accelerate the healing of acute fractures, but evidence for its efficacy in stress fractures is mixed. One double-blinded, randomized controlled trial showed no benefit in 43 tibial stress fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/61\">",
"     61",
"    </a>",
"    ]. However, two randomized trials, one blinded and one not, in Indian soldiers found US treatment dramatically reduced the time until return to full duty (mean treatment duration 15 days versus 75 and 24 days versus 39, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. These protocols used 1",
"    <span class=\"nowrap\">",
"     Watt/cm2",
"    </span>",
"    of ultrasound energy for five minutes a day at the fracture site, in addition to usual conservative therapy. Further study is needed before US can be recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4290467\">",
"    <span class=\"h3\">",
"     Extracorporeal shock wave therapy (ECSWT)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reports of successful treatment of stress fracture with ECSWT in humans is limited to case studies [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/64\">",
"     64",
"    </a>",
"    ]. Controlled trials are needed before the effectiveness of ECSWT for the treatment of stress fractures can be determined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4290481\">",
"    <span class=\"h3\">",
"     Medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;A small retrospective cases series of subchondral stress fractures of the knee showed markedly faster healing by MRI assessment at 3 and 12 months in patients treated with the prostacyclin analogue",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/53/37716?source=see_link\">",
"     iloprost",
"    </a>",
"    compared to those treated with the analgesic",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/50/42792?source=see_link\">",
"     tramadol",
"    </a>",
"    . Controlled trials are needed before the effectiveness of prostacyclin analogues for the treatment of stress fractures can be determined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9471850\">",
"    <span class=\"h3\">",
"     Electrical stimulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Capacitatively coupled electric fields were not more effective than placebo in healing posteromedial tibial stress fractures in a randomized controlled trial [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H49\">",
"    <span class=\"h1\">",
"     RISK FACTOR REDUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Underlying causes and risk factors for stress fractures must be addressed to optimize healing and prevent future injury. Referral to a clinician with sports medicine training or experience managing stress fractures may be beneficial.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H50\">",
"    <span class=\"h2\">",
"     Disordered eating",
"    </span>",
"    &nbsp;&mdash;&nbsp;A careful history and examination can identify patients whose eating habits predispose to injury. Those with the \"female athlete triad\" (disordered eating, amenorrhea, and decreased bone density) are at particularly high risk and should have treatment by a multidisciplinary team consisting of a mental health professional, nutritionist, and primary care clinician [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/66\">",
"     66",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44023?source=see_link\">",
"     \"Eating disorders: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H51\">",
"    <span class=\"h2\">",
"     Decreased bone density",
"    </span>",
"    &nbsp;&mdash;&nbsp;We perform bone density testing using dual-energy x-ray absorptiometry (DEXA scanning) in patients with any of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Stress fractures unexplained by excessive activity",
"     </li>",
"     <li>",
"      Recurrent stress fractures",
"     </li>",
"     <li>",
"      Family history of osteoporosis",
"     </li>",
"     <li>",
"      Regular use of glucocorticoids",
"     </li>",
"     <li>",
"      Disordered eating",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Those with low bone density values should be treated with weightbearing exercise (as part of a graded treatment plan), calcium, vitamin D, and other indicated medications. Additional laboratory testing may be needed. Secondary osteopenia and osteoporosis are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/35/42553?source=see_link\">",
"     \"Evaluation and treatment of premenopausal osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Dietary habits that promote higher bone mineral density may decrease the risk of stress fractures in susceptible individuals. In a prospective observational study of 17 female runners, higher intake of calcium, skim milk and dairy products was associated with lower rates of stress fracture and increased bone mineral density [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H52\">",
"    <span class=\"h2\">",
"     Poor physical fitness",
"    </span>",
"    &nbsp;&mdash;&nbsp;An assessment of past physical activity, the activity that led to the stress fracture (frequency, intensity, exercise selection), and future activity needs can help patients develop a fitness plan that promotes health, but avoids recurrence of stress fractures. Consultation with a knowledgeable fitness specialist may be helpful. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/46/28394?source=see_link\">",
"     \"Overview of the benefits and risks of exercise\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H53\">",
"    <span class=\"h2\">",
"     Anatomical and biomechanical factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biomechanical evaluation for factors, such as leg length discrepancy, muscle inflexibility, excessive foot pronation during running, and pes cavus (high arch) or pes planus (flatfoot), should be performed. Runners should be counseled to replace running shoes before the tread becomes worn or cushioning is lost (approximately every 500 to 650 kilometers, or 300 to 400 miles). Gait analysis in runners can help identify problems and assist in the selection of appropriate running shoes. Consultation with a sports medicine specialist can be helpful. Running injuries are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/4/34890?source=see_link\">",
"     \"Overview of running injuries of the lower extremity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H54\">",
"    <span class=\"h1\">",
"     PERIODIC REEVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should reevaluate the patient every one to three weeks during the healing period. Those with high occupational or athletic demands warrant more frequent evaluation. Pain should progressively subside with treatment. If symptoms persist after several weeks, compliance with the treatment regimen should be ascertained. Compliant patients with persistent pain may need more restrictive activity modification, further protection of the bone, and a more gradual rehabilitation program. Imaging is needed if there is no clinical improvement despite six additional weeks of conservative management, including the additional measures described.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H55\">",
"    <span class=\"h2\">",
"     Follow-up imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once radiographs, bone scan, CT, or MRI confirms the diagnosis of stress fracture, the clinician rarely needs subsequent imaging. Radiographic healing lags behind clinical healing, and both bone scan and MRI may remain positive for up to 12 months following the original injury. Clinical response to treatment should suffice as confirmation of healing for almost all patients. Additional imaging plays a role only when the clinical response to treatment fails to progress appropriately. In this case, repeat imaging will determine if the fracture has extended or developed an area of nonunion. CT images the fracture line in long bones better than plain radiography, bone scan, or MRI. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Imaging studies'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H56\">",
"    <span class=\"h1\">",
"     ORTHOPEDIC CONSULTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immediate surgical referral is recommended for high-risk fracture sites, which have higher rates of nonunion and progression to complete fracture. Orthopedic referral is appropriate for patients who cannot tolerate a lengthy rehabilitation process, such as a laborer whose livelihood depends upon a timely return to work or some high-level athletes. Should conservative treatment fail, surgical consultation should be obtained, generally after repeat imaging reveals the fracture has extended or a nonunion has developed. (See",
"    <a class=\"local\" href=\"#H42\">",
"     'High-risk sites'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H57\">",
"    <span class=\"h1\">",
"     RETURN TO ACTIVITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Athletes and laborers with a stress fracture often need to know their prognosis in terms of time required until they can compete or resume work. This may be difficult to determine and is based upon several factors, including the bone affected, radiological grade of the fracture, duration of symptoms, compliance with the treatment plan, and underlying bone health.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H58\">",
"    <span class=\"h2\">",
"     Affected bone",
"    </span>",
"    &nbsp;&mdash;&nbsp;German soldiers with metatarsal stress fractures required an average of 26.5 days to return to duty [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/68\">",
"     68",
"    </a>",
"    ]. A heterogeneous athletic population with tibial stress fractures needed an average of 13 weeks to return to their sport at reduced intensity and 19 weeks to return at full intensity. Patients with metatarsal stress fractures (all types) required 4 to 8 weeks to perform some activity, but up to 12 weeks before regaining preinjury intensity. Patients with fibular stress fractures needed 10 weeks and 13 weeks to return to some activity and preinjury activity, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H59\">",
"    <span class=\"h2\">",
"     Radiological grade of fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;A higher fracture grade often portends a longer recovery time. However, study results are conflicting. One retrospective study found a linear relationship between the stress fracture grade based on MRI and the time required before return to activity (3.3 weeks for grade 1; 5.5 weeks for grade 2; 11.4 weeks for grade 3; 14.3 weeks for grade 4) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/70\">",
"     70",
"    </a>",
"    ], while a small, retrospective study found no correlation [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H60\">",
"    <span class=\"h2\">",
"     Duration of symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;One retrospective study found that athletes under 20 years of age who sought treatment within three weeks of symptom onset had a markedly quicker return to activity (10.4 weeks) compared with those who delayed treatment (18.4 weeks) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H61\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evidence for prevention of stress fractures is quite limited. Studies suggest the following interventions provide benefit in some patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Shock absorbing boot inserts reduce the incidence of stress fractures in military recruits, according to a systematic review of three heterogeneous studies [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Modification of female military recruit training regimens reduces the risk of pelvic stress fractures, according to an uncontrolled trial [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/71\">",
"       71",
"      </a>",
"      ]. The incidence of pelvic stress fractures was reduced from 11.2 percent to 0.6 percent by lowering march speed from 7.5 to 5",
"      <span class=\"nowrap\">",
"       km/hour,",
"      </span>",
"      running on softer surfaces, encouraging individual step length and running speed rather than marching or running in step, and using interval training (eg, alternating sprints and jogging) instead of traditional middle-distance runs.",
"     </li>",
"     <li>",
"      Daily vitamin D supplementation may decrease stress fracture rates. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Bone health'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/21/3417?source=see_link&amp;anchor=H4#H4\">",
"       \"Treatment of vitamin D deficiency in adults\", section on 'Optimal intake'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/38/28266?source=see_link&amp;anchor=H23365817#H23365817\">",
"       \"Vitamin D insufficiency and deficiency in children and adolescents\", section on 'Recommendations for vitamin D intake'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Calcium supplementation may decrease stress fracture rates. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Bone health'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/21/33113?source=see_link&amp;anchor=H14#H14\">",
"       \"Prevention of osteoporosis\", section on 'Calcium and vitamin D'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/6/40040?source=see_link&amp;anchor=H9#H9\">",
"       \"Calcium requirements in adolescents\", section on 'Recommended intake'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Consumption of low-fat dairy products may reduce the risk of stress fractures and improve bone mineral density in susceptible individuals. (See",
"      <a class=\"local\" href=\"#H51\">",
"       'Decreased bone density'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Oral contraceptive (OC) use in female distance runners led to a nonsignificant decrease in stress fracture incidence compared with those who did not take OC, according to one randomized trial [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/25\">",
"       25",
"      </a>",
"      ]. The study was under-powered due to medication noncompliance, but women with oligomenorrhea or amenorrhea who took OCs had a significant increase in their bone mineral density.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Studies have found",
"    <strong>",
"     no",
"    </strong>",
"    benefit from the following interventions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rest from running for one week during the middle of an eight-week basic military training regimen [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/72\">",
"       72",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/41/17047?source=see_link\">",
"       risedronate",
"      </a>",
"      for 12 weeks in military recruits deemed to be at high risk for stress fracture [",
"      <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/73\">",
"       73",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Primary prevention of stress fractures should be guided by common sense. Patients must be educated in proper training techniques. They should increase the frequency and intensity of training in small, incremental steps. A rough guide is no more than 10 percent increase in volume or intensity per week.",
"   </p>",
"   <p>",
"    It may be prudent to screen military recruits for risk factors associated with stress fractures and to modify the training regimen for at-risk individuals (eg, increasing physical activity more gradually or using cross-training regimens) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Improved aerobic capacity and muscle strength and endurance may all play a part in reducing stress fracture risk. Several prospective studies demonstrate that military recruits who participate in ball sports for at least two years prior to enlistment have a significantly lower risk of developing stress fractures during initial military service [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/21,74,75\">",
"     21,74,75",
"    </a>",
"    ]. This implies that participation in ball sports confers some measure of increased physical fitness that may be protective of bone health.",
"   </p>",
"   <p>",
"    Weightbearing exercise improves bone density, while poor aerobic fitness is associated with an increased risk of stress fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/8,16,19,76\">",
"     8,16,19,76",
"    </a>",
"    ]. It remains unclear whether improved aerobic fitness independently reduces stress fracture risk, or the benefit stems from the effects of weightbearing activity.",
"   </p>",
"   <p>",
"    Stretching following exercise may help to reduce muscle fatigue and stress to the surrounding area while improving flexibility, but has not been shown conclusively to reduce the risk of fracture.",
"   </p>",
"   <p>",
"    Training on treadmills rather than \"over ground\" terrain may decrease the risk of primary tibial stress fractures for runners [",
"    <a class=\"abstract\" href=\"UTD.htm?23/19/23866/abstract/38\">",
"     38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/4/34890?source=see_link\">",
"     \"Overview of running injuries of the lower extremity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prevention of osteoporosis is important. A well-balanced diet, adequate calcium and vitamin D, muscle strength and flexibility training, and regular weightbearing exercise should be encouraged in all patients. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Bone health'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Young female athletes should be screened for menstrual irregularities and signs and symptoms of eating disorders, and provided appropriate treatment to prevent the female athlete triad. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Gender differences'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9472105\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATION",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A stress fracture occurs when a bone breaks after being subjected to repeated tensile or compressive stresses, none of which would be large enough individually to cause the bone to fail, in a person who is not known to have an underlying disease that would be expected to cause abnormal bone fragility. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definitions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      High-risk stress fractures are those at greater risk for displacement, nonunion, or fracture propagation. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical classification'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      High-risk sites include the pars interarticularis of the lumbar spine, femoral head, superior side of the femoral neck (ie, tension side), patella, anterior cortex of the tibia (ie, tension side), medial malleolus, talus, tarsal navicular, proximal fifth metatarsal, great toe sesamoids, and the base of the second metatarsal.",
"     </li>",
"     <li>",
"      Low-risk sites include the second through fourth metatarsal shafts, posteromedial tibial shaft, proximal humerus or humeral shaft, ribs, sacrum, and pubic rami.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Important risk factors for stress fractures include a history of prior stress fracture, low level of physical fitness, a sudden increase in the volume and intensity of physical activity, female gender and menstrual irregularity, a diet poor in calcium and vitamin D, poor bone health, and poor biomechanics (",
"      <a class=\"graphic graphic_table graphicRef79279 \" href=\"UTD.htm?35/11/36027\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Early diagnosis of stress fractures is essential to avoid complications. In most cases, the history and physical examination provide sufficient information to diagnose and manage low-risk stress fractures without imaging studies. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Many patients with stress fractures describe the insidious onset of localized pain within days to weeks of beginning a strenuous physical activity. Examination generally reveals focal tenderness at the fracture site. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'History'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21\">",
"       'Pain description'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H22\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Radiographic imaging is needed when high-risk stress fractures are suspected or a definitive diagnosis is necessary. Plain x-rays should be obtained initially and are helpful when positive due to their high specificity, but they are very insensitive. MRI is recommended if plain x-rays are negative, but clinical suspicion remains high and a need for definitive diagnosis exists. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Imaging studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis for stress fracture includes tendinopathy, muscle strain, joint sprain, nerve entrapment, exertional compartment syndrome, neoplasm, and infection. (See",
"      <a class=\"local\" href=\"#H30\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Stress fractures at low-risk sites are managed conservatively with the following interventions (See",
"      <a class=\"local\" href=\"#H41\">",
"       'Low-risk sites'",
"      </a>",
"      above.):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Acute pain control as needed using ice, and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      low-potency opioids",
"     </li>",
"     <li>",
"      Protection of the fracture site with reduced weightbearing or splinting in selected stress fracture locations",
"     </li>",
"     <li>",
"      Reduction or modification of activities such that pain is not present",
"     </li>",
"     <li>",
"      Gradual resumption of activities if pain-free",
"     </li>",
"     <li>",
"      Rehabilitative exercise to promote optimal biomechanics",
"     </li>",
"     <li>",
"      Risk factor reduction as indicated (see",
"      <a class=\"local\" href=\"#H39\">",
"       'Treatment concepts'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Orthopedic consultation is necessary for patients with fractures at high-risk sites or for whom a lengthy rehabilitation process is untenable, such as a laborer whose livelihood depends upon a timely return to work, or some high-level athletes (See",
"      <a class=\"local\" href=\"#H42\">",
"       'High-risk sites'",
"      </a>",
"      above.).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/1\">",
"      Bennell KL, Brukner PD. Epidemiology and site specificity of stress fractures. Clin Sports Med 1997; 16:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/2\">",
"      Milgrom C, Giladi M, Stein M, et al. Stress fractures in military recruits. A prospective study showing an unusually high incidence. J Bone Joint Surg Br 1985; 67:732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/3\">",
"      Kelsey JL, Bachrach LK, Procter-Gray E, et al. Risk factors for stress fracture among young female cross-country runners. Med Sci Sports Exerc 2007; 39:1457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/4\">",
"      Bennell KL, Malcolm SA, Thomas SA, et al. The incidence and distribution of stress fractures in competitive track and field athletes. A twelve-month prospective study. Am J Sports Med 1996; 24:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/5\">",
"      Jones BH, Thacker SB, Gilchrist J, et al. Prevention of lower extremity stress fractures in athletes and soldiers: a systematic review. Epidemiol Rev 2002; 24:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/6\">",
"      Bennell KL, Malcolm SA, Thomas SA, et al. Risk factors for stress fractures in track and field athletes. A twelve-month prospective study. Am J Sports Med 1996; 24:810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/7\">",
"      Rauh MJ, Macera CA, Trone DW, et al. Epidemiology of stress fracture and lower-extremity overuse injury in female recruits. Med Sci Sports Exerc 2006; 38:1571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/8\">",
"      Mattila VM, Niva M, Kiuru M, Pihlajam&auml;ki H. Risk factors for bone stress injuries: a follow-up study of 102,515 person-years. Med Sci Sports Exerc 2007; 39:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/9\">",
"      Vinther A, Kanstrup IL, Christiansen E, et al. Exercise-induced rib stress fractures: potential risk factors related to thoracic muscle co-contraction and movement pattern. Scand J Med Sci Sports 2006; 16:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/10\">",
"      Hughes LY. Biomechanical analysis of the foot and ankle for predisposition to developing stress fractures. J Orthop Sports Phys Ther 1985; 7:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/11\">",
"      Kaufman KR, Brodine SK, Shaffer RA, et al. The effect of foot structure and range of motion on musculoskeletal overuse injuries. Am J Sports Med 1999; 27:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/12\">",
"      Matheson GO, Clement DB, McKenzie DC, et al. Stress fractures in athletes. A study of 320 cases. Am J Sports Med 1987; 15:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/13\">",
"      M&auml;enp&auml;&auml; HM, Soini I, Lehto MU, Belt EA. Insufficiency fractures in patients with chronic inflammatory joint diseases. Clin Exp Rheumatol 2002; 20:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/14\">",
"      Bennell K, Matheson G, Meeuwisse W, Brukner P. Risk factors for stress fractures. Sports Med 1999; 28:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/15\">",
"      Callahan LR. Stress fractures in women. Clin Sports Med 2000; 19:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/16\">",
"      Shaffer RA, Rauh MJ, Brodine SK, et al. Predictors of stress fracture susceptibility in young female recruits. Am J Sports Med 2006; 34:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/17\">",
"      Myburgh KH, Hutchins J, Fataar AB, et al. Low bone density is an etiologic factor for stress fractures in athletes. Ann Intern Med 1990; 113:754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/18\">",
"      Winfield AC, Moore J, Bracker M, Johnson CW. Risk factors associated with stress reactions in female Marines. Mil Med 1997; 162:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/19\">",
"      Jones BH, Bovee MW, Harris JM 3rd, Cowan DN. Intrinsic risk factors for exercise-related injuries among male and female army trainees. Am J Sports Med 1993; 21:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/20\">",
"      Brudvig TJ, Gudger TD, Obermeyer L. Stress fractures in 295 trainees: a one-year study of incidence as related to age, sex, and race. Mil Med 1983; 148:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/21\">",
"      Lappe JM, Stegman MR, Recker RR. The impact of lifestyle factors on stress fractures in female Army recruits. Osteoporos Int 2001; 12:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/22\">",
"      Loud KJ, Micheli LJ, Bristol S, et al. Family history predicts stress fracture in active female adolescents. Pediatrics 2007; 120:e364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/23\">",
"      Beck TJ, Ruff CB, Mourtada FA, et al. Dual-energy X-ray absorptiometry derived structural geometry for stress fracture prediction in male U.S. Marine Corps recruits. J Bone Miner Res 1996; 11:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/24\">",
"      Muldoon MP, Padgett DE, Sweet DE, et al. Femoral neck stress fractures and metabolic bone disease. J Orthop Trauma 2001; 15:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/25\">",
"      Cobb KL, Bachrach LK, Sowers M, et al. The effect of oral contraceptives on bone mass and stress fractures in female runners. Med Sci Sports Exerc 2007; 39:1464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/26\">",
"      Lappe J, Cullen D, Haynatzki G, et al. Calcium and vitamin d supplementation decreases incidence of stress fractures in female navy recruits. J Bone Miner Res 2008; 23:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/27\">",
"      Burgi AA, Gorham ED, Garland CF, et al. High serum 25-hydroxyvitamin D is associated with a low incidence of stress fractures. J Bone Miner Res 2011; 26:2371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/28\">",
"      Frusztajer NT, Dhuper S, Warren MP, et al. Nutrition and the incidence of stress fractures in ballet dancers. Am J Clin Nutr 1990; 51:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/29\">",
"      Barnes A, Wheat J, Milner C. Association between foot type and tibial stress injuries: a systematic review. Br J Sports Med 2008; 42:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/30\">",
"      Milner CE, Davis IS, Hamill J. Free moment as a predictor of tibial stress fracture in distance runners. J Biomech 2006; 39:2819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/31\">",
"      Milner CE, Ferber R, Pollard CD, et al. Biomechanical factors associated with tibial stress fracture in female runners. Med Sci Sports Exerc 2006; 38:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/32\">",
"      Dixon SJ, Creaby MW, Allsopp AJ. Comparison of static and dynamic biomechanical measures in military recruits with and without a history of third metatarsal stress fracture. Clin Biomech (Bristol, Avon) 2006; 21:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/33\">",
"      Hetsroni I, Finestone A, Milgrom C, et al. The role of foot pronation in the development of femoral and tibial stress fractures: a prospective biomechanical study. Clin J Sport Med 2008; 18:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/34\">",
"      Gardner LI Jr, Dziados JE, Jones BH, et al. Prevention of lower extremity stress fractures: a controlled trial of a shock absorbent insole. Am J Public Health 1988; 78:1563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/35\">",
"      Rome K, Handoll HH, Ashford R. Interventions for preventing and treating stress fractures and stress reactions of bone of the lower limbs in young adults. Cochrane Database Syst Rev 2005; :CD000450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/36\">",
"      Marti B, Vader JP, Minder CE, Abelin T. On the epidemiology of running injuries. The 1984 Bern Grand-Prix study. Am J Sports Med 1988; 16:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/37\">",
"      Walter SD, Hart LE, McIntosh JM, Sutton JR. The Ontario cohort study of running-related injuries. Arch Intern Med 1989; 149:2561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/38\">",
"      Milgrom C, Finestone A, Segev S, et al. Are overground or treadmill runners more likely to sustain tibial stress fracture? Br J Sports Med 2003; 37:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/39\">",
"      Johnson AW, Weiss CB Jr, Wheeler DL. Stress fractures of the femoral shaft in athletes--more common than expected. A new clinical test. Am J Sports Med 1994; 22:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/40\">",
"      Boam WD, Miser WF, Yuill SC, et al. Comparison of ultrasound examination with bone scintiscan in the diagnosis of stress fractures. J Am Board Fam Pract 1996; 9:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/41\">",
"      Kijowski R, Choi J, Mukharjee R, de Smet A. Significance of radiographic abnormalities in patients with tibial stress injuries: correlation with magnetic resonance imaging. Skeletal Radiol 2007; 36:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/42\">",
"      Spitz DJ, Newberg AH. Imaging of stress fractures in the athlete. Radiol Clin North Am 2002; 40:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/43\">",
"      Gaeta M, Minutoli F, Scribano E, et al. CT and MR imaging findings in athletes with early tibial stress injuries: comparison with bone scintigraphy findings and emphasis on cortical abnormalities. Radiology 2005; 235:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/44\">",
"      Deutsch AL, Coel MN, Mink JH. Imaging of stress injuries to bone. Radiography, scintigraphy, and MR imaging. Clin Sports Med 1997; 16:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/45\">",
"      Zwas ST, Elkanovitch R, Frank G. Interpretation and classification of bone scintigraphic findings in stress fractures. J Nucl Med 1987; 28:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/46\">",
"      Fredericson M, Bergman AG, Hoffman KL, Dillingham MS. Tibial stress reaction in runners. Correlation of clinical symptoms and scintigraphy with a new magnetic resonance imaging grading system. Am J Sports Med 1995; 23:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/47\">",
"      Fayad LM, Kawamoto S, Kamel IR, et al. Distinction of long bone stress fractures from pathologic fractures on cross-sectional imaging: how successful are we? AJR Am J Roentgenol 2005; 185:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/48\">",
"      Bergman AG, Fredericson M, Ho C, Matheson GO. Asymptomatic tibial stress reactions: MRI detection and clinical follow-up in distance runners. AJR Am J Roentgenol 2004; 183:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/49\">",
"      Kiuru MJ, Pihlajamaki HK, Hietanen HJ, Ahovuo JA. MR imaging, bone scintigraphy, and radiography in bone stress injuries of the pelvis and the lower extremity. Acta Radiol 2002; 43:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/50\">",
"      Yao L, Johnson C, Gentili A, et al. Stress injuries of bone: analysis of MR imaging staging criteria. Acad Radiol 1998; 5:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/51\">",
"      Banal F, Etchepare F, Rouhier B, et al. Ultrasound ability in early diagnosis of stress fracture of metatarsal bone. Ann Rheum Dis 2006; 65:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/52\">",
"      Bodner G, St&ouml;ckl B, Fierlinger A, et al. Sonographic findings in stress fractures of the lower limb: preliminary findings. Eur Radiol 2005; 15:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/53\">",
"      Banal F, Gandjbakhch F, Foltz V, et al. Sensitivity and specificity of ultrasonography in early diagnosis of metatarsal bone stress fractures: a pilot study of 37 patients. J Rheumatol 2009; 36:1715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/54\">",
"      Ohta-Fukushima M, Mutoh Y, Takasugi S, et al. Characteristics of stress fractures in young athletes under 20 years. J Sports Med Phys Fitness 2002; 42:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/55\">",
"      Boden BP, Osbahr DC, Jimenez C. Low-risk stress fractures. Am J Sports Med 2001; 29:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/56\">",
"      Debnath UK, Freeman BJ, Grevitt MP, et al. Clinical outcome of symptomatic unilateral stress injuries of the lumbar pars interarticularis. Spine (Phila Pa 1976) 2007; 32:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/57\">",
"      Kim JW, Yoo JJ, Min BW, et al. Subchondral fracture of the femoral head in healthy adults. Clin Orthop Relat Res 2007; 464:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/58\">",
"      Pihlajam&auml;ki HK, Ruohola JP, Weckstr&ouml;m M, et al. Long-term outcome of undisplaced fatigue fractures of the femoral neck in young male adults. J Bone Joint Surg Br 2006; 88:1574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/59\">",
"      Boden BP, Osbahr DC. High-risk stress fractures: evaluation and treatment. J Am Acad Orthop Surg 2000; 8:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/60\">",
"      Stovitz SD, Arendt EA. NSAIDs should not be used in treatment of stress fractures. Am Fam Physician 2004; 70:1452, 1454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/61\">",
"      Rue JP, Armstrong DW 3rd, Frassica FJ, et al. The effect of pulsed ultrasound in the treatment of tibial stress fractures. Orthopedics 2004; 27:1192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/62\">",
"      Yadav, Y. Role of ultrasound therapy in the treatment of stress fracture. Med J Armed Forces India 2000; 56:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/63\">",
"      Yadav, Y, Salgotra, K, Banerjee, A. Does ultrasound expedite the healing process in stress fractures, enabling early return to training? Med J Armed Forces India 2008; 64:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/64\">",
"      Taki M, Iwata O, Shiono M, et al. Extracorporeal shock wave therapy for resistant stress fracture in athletes: a report of 5 cases. Am J Sports Med 2007; 35:1188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/65\">",
"      Beck BR, Matheson GO, Bergman G, et al. Do capacitively coupled electric fields accelerate tibial stress fracture healing? A randomized controlled trial. Am J Sports Med 2008; 36:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/66\">",
"      Nattiv A, Loucks AB, Manore MM, et al. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc 2007; 39:1867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/67\">",
"      Nieves JW, Melsop K, Curtis M, et al. Nutritional factors that influence change in bone density and stress fracture risk among young female cross-country runners. PM R 2010; 2:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/68\">",
"      Henningsen A, Hinz P, L&uuml;dde R, et al. [Retrospective analysis of march fractures in the german armed forces in the years 1998 to 2000]. Z Orthop Ihre Grenzgeb 2006; 144:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/69\">",
"      Heaslet MW, Kanda-Mehtani SL. Return-to-activity levels in 96 athletes with stress fractures of the foot, ankle, and leg: a retrospective analysis. J Am Podiatr Med Assoc 2007; 97:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/70\">",
"      Arendt EA, Griffiths HJ. The use of MR imaging in the assessment and clinical management of stress reactions of bone in high-performance athletes. Clin Sports Med 1997; 16:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/71\">",
"      Pope RP. Prevention of pelvic stress fractures in female army recruits. Mil Med 1999; 164:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/72\">",
"      Popovich RM, Gardner JW, Potter R, et al. Effect of rest from running on overuse injuries in army basic training. Am J Prev Med 2000; 18:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/73\">",
"      Milgrom C, Finestone A, Novack V, et al. The effect of prophylactic treatment with risedronate on stress fracture incidence among infantry recruits. Bone 2004; 35:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/74\">",
"      Milgrom C, Simkin A, Eldad A, et al. Using bone's adaptation ability to lower the incidence of stress fractures. Am J Sports Med 2000; 28:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/75\">",
"      Fredericson M, Ngo J, Cobb K. Effects of ball sports on future risk of stress fracture in runners. Clin J Sport Med 2005; 15:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/19/23866/abstract/76\">",
"      Shaffer RA, Brodine SK, Ito SI, Le AT. Epidemiology of illness and injury among U.S. Navy and Marine Corps female training populations. Mil Med 1999; 164:17.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 255 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-EE4A41C0CF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_19_23866=[""].join("\n");
var outline_f23_19_23866=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOPHYSIOLOGY OF STRESS FRACTURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Prior stress fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Physical fitness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Activity type and intensity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Gender differences",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Bone health",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Disordered eating",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Anatomical factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Biomechanical factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Footwear and running surface",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Other risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Overall approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Pain description",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Imaging studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Approach to stress fracture imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Plain radiographs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Bone scan",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - CT scan",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4290459\">",
"      Tendinopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Muscle strain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Sprain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Nerve entrapment syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Exertional compartment syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Medial tibial stress syndrome (shin splints)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Neoplasms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      TREATMENT CONCEPTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      General approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      Low-risk sites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H42\">",
"      High-risk sites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H43\">",
"      Conservative treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H44\">",
"      Pain control",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H45\">",
"      Protection of the fracture site",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H46\">",
"      Activity modification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H47\">",
"      Rehabilitative exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9471818\">",
"      Therapies of uncertain benefit",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H48\">",
"      - Therapeutic ultrasound",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4290467\">",
"      - Extracorporeal shock wave therapy (ECSWT)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4290481\">",
"      - Medications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9471850\">",
"      - Electrical stimulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H49\">",
"      RISK FACTOR REDUCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H50\">",
"      Disordered eating",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H51\">",
"      Decreased bone density",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H52\">",
"      Poor physical fitness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H53\">",
"      Anatomical and biomechanical factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H54\">",
"      PERIODIC REEVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H55\">",
"      Follow-up imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H56\">",
"      ORTHOPEDIC CONSULTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H57\">",
"      RETURN TO ACTIVITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H58\">",
"      Affected bone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H59\">",
"      Radiological grade of fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H60\">",
"      Duration of symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H61\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9472105\">",
"      SUMMARY AND RECOMMENDATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/255\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/255|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?34/7/34942\" title=\"diagnostic image 1\">",
"      Distal tibia stress fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?8/42/8878\" title=\"diagnostic image 2\">",
"      Periosteal thickening of tibial stress fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?22/36/23118\" title=\"diagnostic image 3\">",
"      Stress fracture of the anterior tibial cortex",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/255|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/11/36027\" title=\"table 1\">",
"      Stress fx risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/11/37051\" title=\"table 2\">",
"      Stress fx XR classificatn",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/3/36919?source=related_link\">",
"      Amenorrhea and infertility associated with exercise",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/53/35673?source=related_link\">",
"      Bone tumors: Diagnosis and biopsy techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/6/40040?source=related_link\">",
"      Calcium requirements in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/35/28215?source=related_link\">",
"      Chronic exertional compartment syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20087?source=related_link\">",
"      Clinical features of hematogenous osteomyelitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/7/14458?source=related_link\">",
"      Clinical manifestations and treatment of osteoporotic thoracolumbar vertebral compression fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/55/11128?source=related_link\">",
"      Diagnosis and evaluation of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/21/9562?source=related_link\">",
"      Drugs that affect bone metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=related_link\">",
"      Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44023?source=related_link\">",
"      Eating disorders: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/54/27494?source=related_link\">",
"      Epidemiology and etiology of osteomalacia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/35/42553?source=related_link\">",
"      Evaluation and treatment of premenopausal osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/49/17177?source=related_link\">",
"      Nonselective NSAIDs: Overview of adverse effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/41/21146?source=related_link\">",
"      Overview of cancer pain syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42233?source=related_link\">",
"      Overview of lower extremity peripheral nerve syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/34/4649?source=related_link\">",
"      Overview of osteomyelitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/10/2215?source=related_link\">",
"      Overview of overuse (chronic) tendinopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/4/34890?source=related_link\">",
"      Overview of running injuries of the lower extremity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/46/28394?source=related_link\">",
"      Overview of the benefits and risks of exercise",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/44/8906?source=related_link\">",
"      Overview of upper extremity peripheral nerve syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/21/33113?source=related_link\">",
"      Prevention of osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/54/873?source=related_link\">",
"      Proximal fifth metatarsal fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43812?source=related_link\">",
"      Stress fractures of the humeral shaft",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/61/33747?source=related_link\">",
"      Stress fractures of the metatarsal shaft",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/4/19527?source=related_link\">",
"      Stress fractures of the tibia and fibula",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/21/3417?source=related_link\">",
"      Treatment of vitamin D deficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/38/28266?source=related_link\">",
"      Vitamin D insufficiency and deficiency in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_19_23867="Diagnostic criteria juvenile myelomonocytic leukemia";
var content_f23_19_23867=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F85788&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F85788&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic criteria for juvenile myelomonocytic leukemia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Peripheral blood monocytosis &gt;1x10",
"        <sup>",
"         9",
"        </sup>",
"        /L",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Blasts (including promonocytes)* are &gt;20 percent of the leukocytes in the blood and of the nucleated bone marrow cells",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No Ph chromosome or",
"        <em>",
"         BCR-ABL1",
"        </em>",
"        fusion gene",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Plus two or more of the following:",
"        <br/>",
"        <ul>",
"         <li>",
"          Hemoglobin F increased for age",
"         </li>",
"         <li>",
"          Immature granulocytes in the peripheral blood",
"         </li>",
"         <li>",
"          WBC count &gt;10x10",
"          <sup>",
"           9",
"          </sup>",
"          /L",
"         </li>",
"         <li>",
"          Clonal chromosomal abnormality (may be monosomy 7)",
"         </li>",
"         <li>",
"          GM-CSF hypersensitivity of myeloid progenitors",
"          <em>",
"           in vitro",
"          </em>",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * In this classification, promonocytes are equivalent to blasts.",
"    </div>",
"    <div class=\"reference\">",
"     From Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC, Lyon, 2008. Reproduced with permission. Copyright &copy; 2008 IARC.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_19_23867=[""].join("\n");
var outline_f23_19_23867=null;
var title_f23_19_23868="Phases of management for enterocutaneous fistulae";
var content_f23_19_23868=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F57027&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F57027&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Phases of management for enterocutaneous fistulae",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Phase",
"       </td>",
"       <td class=\"subtitle1\">",
"        Description",
"       </td>",
"       <td class=\"subtitle1\">",
"        Timing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stabilization",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Rehydration",
"         </li>",
"         <li>",
"          Correction of anemia",
"         </li>",
"         <li>",
"          Electrolyte repletion",
"         </li>",
"         <li>",
"          Drainage of sepsis",
"         </li>",
"         <li>",
"          Control of fistula drainage",
"         </li>",
"         <li>",
"          Local skin care measures",
"         </li>",
"         <li>",
"          Commencement of nutritional support",
"         </li>",
"        </ul>",
"       </td>",
"       <td>",
"        24-48 h",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Investigation",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Fistulogram to define anatomy",
"         </li>",
"         <li>",
"          CT/US/MRI to localize collections and guide drainage",
"         </li>",
"        </ul>",
"       </td>",
"       <td>",
"        7-10 d",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Decision",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Assess likelihood of nonoperative closure",
"         </li>",
"         <li>",
"          Plan therapeutic course",
"         </li>",
"         <li>",
"          Decide optimal surgical timing",
"         </li>",
"        </ul>",
"       </td>",
"       <td>",
"        7-10 d to 4-6 wk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Definitive therapy",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Plan operative approach",
"         </li>",
"         <li>",
"          Bowel resection with end-to-end anastomosis",
"         </li>",
"         <li>",
"          Secure abdominal closure (+/- flap)",
"         </li>",
"         <li>",
"          Gastrostomy",
"         </li>",
"         <li>",
"          Jejunostomy",
"         </li>",
"        </ul>",
"       </td>",
"       <td>",
"        4-6 wk or if spontaneous closure unlikely",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Healing",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Continue nutrition support",
"         </li>",
"         <li>",
"          Transition to total oral/enteral feedings",
"         </li>",
"         <li>",
"          Physical and emotional rehabilitation",
"         </li>",
"        </ul>",
"       </td>",
"       <td>",
"        5-10 d after closure",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CT: computed tomography; US: ultrasound; MRI: magnetic resonance imaging.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fischer JE, Evenson AR. Gastrointestinal-cutaneous fistulae. In: Mastery of Surgery, Fischer JE (Ed), Lippincott Williams &amp; Wilkins 2007. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_19_23868=[""].join("\n");
var outline_f23_19_23868=null;
var title_f23_19_23869="Gold improves synovitis in RA";
var content_f23_19_23869=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F69559&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F69559&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 523px\">",
"   <div class=\"ttl\">",
"    Gold therapy improves synovitis in rheumatoid arthritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 503px; height: 260px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Results of a double-blind, randomized trial in which 27 patients who had RA for less then five years were followed for 30 months during a standard course and then maintenance therapy with gold sodium thiomalate (GSTM); they were compared to group of patients treated with placebo. The joint score (maximum value 44) was stable in the placebo group and fell in the patients receiving GSTM. The benefit with GSTM requires three months and sometimes as long as nine months to become apparent.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Sigler, JW, Bluhm, GB, Duncan, H, et al, Ann Intern Med 1974; 80:21.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_19_23869=[""].join("\n");
var outline_f23_19_23869=null;
var title_f23_19_23870="Physiologic Rx Malnutrition A";
var content_f23_19_23870=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F77579%7EPEDS%2F54640%7EPEDS%2F62304&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F77579%7EPEDS%2F54640%7EPEDS%2F62304&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Physiologic basis for treatment of severe malnutrition",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Affected organ or system",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effects",
"       </td>",
"       <td class=\"subtitle1\">",
"        Treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiovascular system",
"       </td>",
"       <td>",
"        <p>",
"         Cardiac output and stroke volume are reduced",
"        </p>",
"        <p>",
"         Infusion of saline may cause an increase in venous pressure",
"        </p>",
"        <p>",
"         Any increase in blood volume can easily produce acute heart failure; any decrease will further compromise tissue perfusion",
"        </p>",
"        <p>",
"         Blood pressure is low",
"        </p>",
"        <p>",
"         Renal perfusion and circulation time are reduced",
"        </p>",
"        <p>",
"         Plasma volume is usually normal and red cell volume is reduced",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         If the child appears dehydrated, give ReSoMal or F-75 diet; do not give fluids intravenously unless the child is in shock",
"        </p>",
"        <p>",
"         If there is evidence of congestive heart failure, restrict blood transfusion to 10 mL/kg and give a diuretic*",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Liver",
"       </td>",
"       <td>",
"        <p>",
"         Synthesis of all proteins is reduced",
"        </p>",
"        <p>",
"         Abnormal metabolites of amino acids are produced",
"        </p>",
"        <p>",
"         Capacity of liver to take up, metabolize and excrete toxins is severely reduced",
"        </p>",
"        <p>",
"         Energy production from substrates such as galactose and fructose is much slower than normal",
"        </p>",
"        <p>",
"         Gluconeogenesis is reduced, which increases the risk of hypoglycaemia during infection",
"        </p>",
"        <p>",
"         Bile secretion is reduced",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Do not give the child large meals",
"        </p>",
"        <p>",
"         Ensure that the amount of protein given does not exceed the metabolic capacity of the liver, but is sufficient to support synthesis of proteins (1-2 g/kg per day)",
"        </p>",
"        <p>",
"         Reduce the dosage of drugs that depend on hepatic disposal or are hepatotoxic",
"        </p>",
"        <p>",
"         Ensure that sufficient carbohydrate is given to avoid the need for gluconeogenesis",
"        </p>",
"        <p>",
"         Do not give iron supplements, which may be dangerous because transferrin levels are reduced",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Genitourinary system",
"       </td>",
"       <td>",
"        <p>",
"         Glomerular filtration is reduced",
"        </p>",
"        <p>",
"         Capacity of kidney to excrete excess acid or a water load is greatly reduced",
"        </p>",
"        <p>",
"         Urinary phosphate output is low",
"        </p>",
"        <p>",
"         Sodium excretion is reduced",
"        </p>",
"        <p>",
"         Urinary tract infection is common",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Prevent further tissue breakdown by treating any infections and providing adequate energy (80-100 kcal/kg or 336-420 kJ/kg per day)",
"        </p>",
"        <p>",
"         Do not give the child more protein than is required to maintain tissues",
"        </p>",
"        <p>",
"         Ensure that high-quality proteins are given, with balanced amino acids",
"        </p>",
"        <p>",
"         Avoid nutrients that give an acid load, such as magnesium chloride",
"        </p>",
"        <p>",
"         Restrict dietary sodium",
"        </p>",
"        <p>",
"         Ensure that water intake is sufficient but not excessive",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Gastrointestinal system",
"       </td>",
"       <td>",
"        <p>",
"         Production of gastric acid is reduced",
"        </p>",
"        <p>",
"         Intestinal motility is reduced",
"        </p>",
"        <p>",
"         Pancreas is atrophied and production of digestive enzymes is reduced",
"        </p>",
"        <p>",
"         Small intestinal mucosa is atrophied; activities of digestive enzymes are reduced",
"        </p>",
"        <p>",
"         Absorption of nutrients is reduced when large amounts of food are eaten",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Give the child small, frequent feeds",
"        </p>",
"        <p>",
"         If absorption is poor, increase the frequency and reduce the size of each feed",
"        </p>",
"        <p>",
"         If there is malabsorption of fat, treatment with pancreatic enzymes may be useful",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Diuretics should not be given to reduce edema in malnourished children.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Management of Severe Malnutrition: A Manual for Physicians and other Senior Health Workers. World Health Organization, Geneva, 1999. Copyright &copy; 1999 World Health Organization.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Physiologic basis for treatment of severe malnutrition",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Affected organ or system",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effects",
"       </td>",
"       <td class=\"subtitle1\">",
"        Treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Immune system",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        <p>",
"         All aspects of immunity are diminished",
"        </p>",
"        <p>",
"         Lymph glands, tonsils and the thymus are atrophied",
"        </p>",
"        <p>",
"         Cell-mediated (T-cell) immunity is severely depressed",
"        </p>",
"        <p>",
"         IgA levels in secretions are reduced",
"        </p>",
"        <p>",
"         Complement components are low",
"        </p>",
"        <p>",
"         Phagocytes do not kill ingested bacteria efficiently",
"        </p>",
"        <p>",
"         Tissue damage does not result in inflammation or migration of white cells to the affected area",
"        </p>",
"        <p>",
"         Acute phase immune response is diminished",
"        </p>",
"        <p>",
"         Typical signs of infection, such as an increased white cell count and fever, are frequently absent",
"        </p>",
"        <p>",
"         Hypoglycaemia and hypothermia are both signs of severe infection and are usually associated with septic shock",
"        </p>",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        <p>",
"         Treat all children with broad-spectrum antimicrobials",
"        </p>",
"        <p>",
"         Because of the risk of transmission of infection, ensure that newly",
"admitted children are kept apart from children who are recovering from",
"infection",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Endocrine system",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        <p>",
"         Insulin levels are reduced and the child has impaired glucose tolerance",
"        </p>",
"        <p>",
"         Insulin growth factor 1 (IGF-1) levels are reduced, although growth hormone levels are increased",
"        </p>",
"        <p>",
"         Cortisol levels are usually increased",
"        </p>",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        <p>",
"         Give the child small, frequent feeds",
"        </p>",
"        <p>",
"         Do not give steroids",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Circulatory system",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        <p>",
"         Basic metabolic rate is reduced by about 30 percent",
"        </p>",
"        <p>",
"         Energy expenditure due to activity is very low",
"        </p>",
"       </td>",
"       <td>",
"        Keep the child warm to prevent",
"hypothermia; dry the child quickly and properly after washing and cover",
"with clothes and blankets, ensure that windows are kept closed at night",
"and keep the temperature of the living environment at 25-30 &ordm;C",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Both",
"heat generation and heat loss are impaired; the child becomes",
"hypothermic in a cold environment and hyperthermic in a hot environment",
"       </td>",
"       <td>",
"        If a child has fever, cool the child by sponging with tepid (not cold) water (never alcohol rubs)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Management of Severe Malnutrition: A Manual for Physicians and other Senior Health Workers. World Health Organization, Geneva, 1999. Copyright &copy; 1999 World Health Organization.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Physiologic basis for treatment of severe malnutrition",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Affected organ or system",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effects",
"       </td>",
"       <td class=\"subtitle1\">",
"        Treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cellular function",
"       </td>",
"       <td>",
"        Sodium pump activity is reduced and cell membranes are more",
"permeable than normal, which leads to an increase in intracellular",
"sodium and a decrease in intracellular potassium and magnesium",
"        <br/>",
"        Protein synthesis is reduced",
"       </td>",
"       <td>",
"        Give large doses of potassium and magnesium to all children",
"        <br/>",
"        Restrict sodium intake",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skin, muscles and glands",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        The skin and subcutaneous fat are atrophied, which leads to loose folds of skin",
"        <br/>",
"        Many signs of dehydration are unreliable; eyes may be sunken because of loss of subcutaneous fat in the orbit",
"        <br/>",
"        Many glands, including the sweat, tear and salivary glands,",
"are atrophied; the child has dryness of the mouth and eyes and sweat",
"production is reduced",
"        <br/>",
"        Respiratory muscles are easily fatigued; the child is lacking in energy",
"       </td>",
"       <td>",
"        Rehydrate the child with ReSoMal or F-75 diet",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Management of Severe Malnutrition: A Manual for Physicians and other Senior Health Workers. World Health Organization, Geneva, 1999. Copyright &copy; 1999 World Health Organization.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_19_23870=[""].join("\n");
var outline_f23_19_23870=null;
var title_f23_19_23871="Steroid refractory UC";
var content_f23_19_23871=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F75726&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F75726&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 558px\">",
"   <div class=\"ttl\">",
"    Steroid-refractory ulcerative colitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 538px; height: 502px; background-image: url(data:image/gif;base64,R0lGODlhGgL2AcQAAP///wAAAIiIiLu7u0RERCIiIhEREZmZmTMzM2ZmZt3d3e7u7szMzFVVVXd3d6qqqt/f35+fnz8/P8/Pz+/v7w8PD19fX39/f7+/vx8fH6+vr4+Pj09PT29vby8vLwAAACH5BAAAAAAALAAAAAAaAvYBAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjSkBkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanlI6BAaqtiqyufbCxtIKztXi3uLt6urxzvr/CcsHDbsXGyWrIymnMzdBiz9Fk0z0D1gAKBQECWNvdJgEDKQIEOATe1CLjPdnrX+8qBQcu2C4O50rtLPko/CfMAUh3guAKg1MQ4hA4UN0LhjDukQCoQx48LhZR0LOXrYHDKx7/kUMBsYbCKCdt/5SMsZIGxRwZL2aJaWKjCAWRECwA0ACSgXsMCnwcYCCAgQMHIikYkRRSghIBuAVIAAmBiJ4BdDadCkBAAW46AYzDhsAog66RCGxNKiLBU4oDpAoQSDArpHoEBURiQPVuQxLm9CrAqpNB2QANxB6uR9Qo3sNPDUNKTHiniLWNj5bAagBt1rPpCEhKkHdv5noO9kZKoABy13QBFIgOQGDBvdaRBkhGjIOmTCu+SdgkgfOB16UAsAUdOcKAtwMGFqS8HMAyO28JCijAOUBAWAQOky44vkDz2HYEEjAI8OD1X7YA3IplDsD5CLrewnltuJ5+W6sKeUWOdzuB591E3gjQmf990El3DjYKHCgCgQCAR4JBDEZ3n3YirHcWaQMhsBRD6fTX3HPRsXefPg08pYABDAjYVQELLADePQ3oM46EMP3mTA7DMTBbAAfIJwI2BjhQAk7IxXbSAYfFNtGAOg7Ql1NQKsXQRue1lcABBUx4DkHwyQcQkyv+1Q6YDbF5X1FR/ZVmfKMNllU97UAopViyecOknQgUOdqFfu65Z3xPXRZmcmEaRKIAbmpjaITcJDCePlLdxZCRAiRwj03jAFrPDcH5KEWpIgyXgFULEHnckePYR4J9Ckr3EQAFKPnAofO5Nx+Fqeoa25Z4DiCRWx7yNKY3ELb2Fn2yulcXOWyWyE//cQA40OhHDAELWJjtaFtfgtERhOaEQoVlAgFKjtuVhugil2yOckpoLXO0wlvfARK2CJg+XtUoFI6JmYhub6aegSqukjTGDV4+AWVAokcWpdlJekXFazsMtYOVq5BwEyGmxR77VF8FLCuCaAYg8CwJjXWDX6/VJrjXbF/JKeYIH/MbCZ4hk3PaX0xmTCRPP5PQ1AFDX+iTZwiApg4DRZFmMyQMnFZeVQtQPRVukIw8wmy1AQXWjkmTmrAZC+fhbxkvmdr22kvMTcdsIrLtn9x0V9P331DYDXgRgg9ueAuFHw5E4jNMpwM2cccQeR/lIcfO3is4oG4TLa3A4wuMK+5O/xCOF3QrDxb2hvnkKrUD9qhjn26CbJAIXVQBZ9VwgD4jsH7Ci5b/4PvOLEBU+j+iY0S67Cgcf8NPMGH+Q1PkNJDYrtbpnEIBm9unuQ1qQSU9Cgm0+0TnJkD0wKKgJ7+FRUJJSmlRm2NmMexXRXJ11NI9HZdfqcEaYKrCl5BNZDENIYB2XAO285QFRvPZTWIyFjXF+AVsFBPBAwywK3Jw8HJM+RkFc6dBfa1nJxLpnVT6YhWkQcJPGmrgAHDCtfiVpz0jKAAOwaakwBwKg4yKRHxINp8EJGYgDrhSPQSSMdxZkEg05EqrSIg492kBfoWilMA+giEUWedV1voQAbBhHf/NbFAsOCRBskD0Ev10hgB589eLGECv+WCDHOn5VQsBsMZz6CdMcoQgrGbYDn4cLXZ8DIAYAQOnn0gEQgiKj3a4o6ClEMQB7arjmdjDpkixAznW4+NPZESCQFKNWawAEa5KFpv1WG5Vr6HaWRyQmD/6KlXjO0HorIgwGMSvaPrIIyLPdSgjpcNNccmWUQQQxbB5ZSrWQSa4/JMnJ6kjU0QClbFgYaYZ9iRQ0qRZmLAJuyvV7oO9QmQ456StEyZHFxyrkjG9IUhtCuln5RlAoKCCHJuopSXklNI9VMklPAogie8yoDm2Eqc1hakkBcilOHiJBYvkUTACeRH+2CWCfH3/kUYLEMq8eOdKzZjApIk8C73aSA5xGeRtVylYlxCVzhmNVJw8yeDsPHa96lxISTcdgSyzZRXv7RGEHesOSIXygD2Gsj+wbNUSEdCZEugwponsDu94lkFasWI/RCkWAKDzE2yJyxxD7R21HrrHKcJglxStgUUgV5YIReKIISRS00RgI6PEb4SQ48r/orK1rGRvhDVlR9Dk1EAFBMUu2/TSr5KGWIdqI0rBu4nrEKg0TRGwBIh1GBV7ldS+RkUAIenQ2Yx1u6O16nTlu8lherhV2SqlKdzQBljMM5KUrSxkDz2H0V7GJq89ZX2SiytwboC+90kUESHVS/ZYQJTpasMA/5mdQQqP4LyJKpcKpWruFZ9biLTMAAHmK4HmrBuD7Rbhcy6A63eTO9/6ts++gcOvflUg3/3yNwfuBYJ4iwcJHzhuwHJAsAoyBoQAE6G//kWeDGbqXt8VNm+iJUltYdAq8sogQADbMBPISagW7GoEGQ6IiF3QYdC9EF44IeEjITyRCDPBNzOuAXrd9T0V12A9QAAx8abgyhIfpMAd9UaP07fiFgD5rR4c1edynAQa27jGKTijUKszDqlE1C4QdKBZThDSA7jTvUY7hxIb1BWdzKaqqXLK0ELDPqhJTYFK1FkUE+AVsOykMnckUk5sYxfcsflzPHyNYNaVQfs5xgQSOf+zLtJMp7tw5539M4pw5Hy/BNa5V/7A1Ue8TJYxN/Es2cxOyFC9mEuT8RFX3ocKpgimCNUysu/E47PuOBCd0ulBsIBkh+JJAlhuhB6vLoFEMiSdvG15kXAMHiyFPCMFlIdf3xEANj5SHOXwJDHHxt9TRxnRE2wws10cq75gxe53Ws5EJYGlfNySbJjBgtnRFgc5Tlhdew+y10OlpVjwGiyxkIumRpJwrI/wDPAEyoj5wbXJ7MhNX19FPT7drpuYCKfgIleZ0Xqn/D75pEUl01Ed1163SGZOT8HinneRyH7M8fEcjuqfK45fCcw1KWW/POO32LhwU04UNKUm5LeZ1HT/+AGehLfbZAydJgAWcKWXQajovPLuwo3wDAU9xQBh3iYKK05xyTLliAhIjFHVqEhlmTVM5UndsC23bHLZqgQ35Xl7XMqtFhLLW8dilV5h4bKpt+xWT92RiGu1rnZ51OcnIirbVUqAt68s7Wyn+73tvvSReAV69h67l9IKQvFU6GXiChHBdbl1hq/ARKkfR1+/LNmZOn03GL7daFk4JuCKwAEaCmwGH9nplCDWIDjblhqrRiwXDr5iGmNaTpAD/OkmuiXlkd3S9vpbv6R4BLwfiO8B0MF3OsXfySn+6ZQy9TiVYPYTH26vwFaAtyyW/MOz8sL1v7w2BLi7XaBgM+Ef/wjGf1dmgD6APf6nCwp4Bi+SRmNAEQ/IAggYYRXYerRwgfulgRjYChyIXx/YgY0QgvVFgiL4CicoBCaYgoewgsqFCjAYgzI4gzRYgzZ4gziICiy4g3LFgz74g70DhEK4gy44hEa4C0V4hEroCkm4hE7ICE34hFLYglNYhRQ1ARYAAWIBABBgARNghWB4OBkQABJAhgGQAWGYhoCzAZOwAWr4hmtDARUQCRVAAXB4hz5iAZFgAXjYhxcxAZHwhX44iNFQhhJAiIjYDBEQABGQiI5oDIf4iJLIC1o4iZZ4iZhogTm4iZwoCplohVGIBqH4iRcximxDilNoinCDilKoiv9+w4pO6IoRCIuxuA6ySIvDYA0O5gIAuAW7+F+4eITFsCuJ8oss0IvH+EIAoXOmIwMlEWAoM1rsEIzC2DwEEHy+gYzH6A1vU2/rwjwRgQyhpHXUCITBEGMbcQ8+ZCeGFUVh8TGQoiGINlsz4mc75w0btBNGRAKZdhQitGpiASae0mkCMVisAB0vBH4Wd4vliAvBcCAF+VXlRiFyVxxg5A3hVkoFQ27WhlIrow4clE+hh0gBV0tHxGwCYR/3wFFCBUfsxZANmYEngE0KoI760HIwRyTz9Bo1lyo3xy9EZGS05Em/t0zvIQlSR0wjgyb3oE+0cRZEiWUx6YO+kGzsYpP/E7I5UeUqS+UNcYd4MqVVPnmPwyZ3eOckQCVIIOQutZKSNlNKFgcVU/mDvrCPl/ETX8U7PeMwRNJXBqBz1bck9Nh8Y+MXFZJ1wjdWnnV+/DA0AtEUZSF+UQGVnyaVc8mCVqaNoniZPEhjDWgHMMmZI2iLoomZpFmaJxiaXqCaqIkIrKk8rdmBnTibtKkJsXmbr3mbnJmbujmXvNmbMfmbwFmOwjmcwVicxkmLyJmcrLiczAkItRmd0jmd1EkKzwlew+mcqKid+sWdn+id9gWeVShA8BFf2ZkCOzYj7HWd4pAz5VlFwIkMHjKB7EmBCgIprJBosBafC5Z2iTFYqLEX//UZkHqhF98mSv4BAYIICxNQiZypoNMIAA06kxpiRp2hIgPKDgcQUgXmT/gDABRAhosYAWVoh6IZohIwoiXqY800LJWyntlZD01xoAZDAnooCXyImje6hxrWUR/qowN6SLmlnyUAiJIgiKVppIHYo0FEWHCyORkKA2UICZHYmlNKhlGqBIsICY0Ym1vKiFmqBHNYAb05pmGqBBcQABfQm2m6pmeKBBAQAA4am3E6p29aBBgwnHl6p3zap37ap9UZqIJqg8QwqIbaiWsjnnvgnYq6XAnTqHnAqHQDqVNAqXcgqYmaqSmIqY+qqalJDJPqqSLIqXzTqXJgjIkFAwJ4Av+o2oNxwJvhEw+iKg5hA2l5OWRGlgKzASUOYZftFWzPMDzlIGKt2qouAao7YDSrVzxNtgIvAqM3YKz0VaqPkEsD1l15sSg3pF3AugLCyqTcujjIqgP7sQ3g2AOdEgTS+lazqm/1aFh64hQCsWb/OJlk2WLQsXNSoUBGsRSVQWpgxgCHZhVi5kSpBqCeQRshcn73gJDdkGi3MZhfYVguBKX7CQd2sx85tY6VYZfsUpCdRlBmdhhHVG5g0wBl8hYCSWdA1GeG5WU8YKlREKwDoh3XhpW3FB8A4g0lSZY8oSQnQQDnkBTkIBQUqW3AqmurtLTnoVImCaQbBG9jAmw1yQr/LEmjjsQK46ZUHYltBXKuQfiqPLAfVMMvE5ltEOJKbqluVEcyn9NUV8E7KTtwl+evLgIj5HEU63pf1CoSvoJst+oeCmJAZIKUPntuWUcQEpEOLUdl8kFzizJT++E6kyB0RBMbTVkWBBAUP/kpP0ksLQefGDu2q+EroZsOCGUOSimyosIT1wQ7c8sPBkFOxLK35mmq1fq30tdmYmJ5HEV6PlsfCLBhigsL6QB4QCdZX3k5ElF4/IBSeZdF29UiiRdZ1ft3FuutZgABJqpwOaCxxOMt6gY9a9uWYRJWG9IqllFH7uYs6fRSGVS7PhWz7ToRzkQyEjMVdOF7SyN/hXlI/6nxo8X7kc63oWVBezSVLfByHlWxFI0Js+HHc1UrmbgDsfk5mETUM6I7BoDohd67EHUGERqMKyGWfo8GDlTlM5qCVycrfi3zMoyFWcQye/SLu3hwErZ7RWcwpSlKjmKAABAoqzZsB5/Zbj9iBl8aABVwAQ4qszNbv1tnEYeKCXvqxPk1xBgoxVWQxEvcxKGKxSJQeGCQrojkrFc1BTksl+xKBTzcpZbJA5WDA+DAPGk8ED86M+IKxlBib+pAQYfVrOCXkJIZly9QbmW8Av1GBN1lrLuoxVPQwUiqxjBzGOuyJ6JRtQ18GfrQKuyDTYtCjCYQavqWxs/KZNozA1Jhsf9W7ATBcMaiFA7Jkp64Sj5OhC4LQJ/a9Wm9uE9SwMjF4MhSwL3AOAI4EZeioSQ0VLWWdESx6h2gJ1QmJbTr5roqkMZkDFoqgwPRJck+4gs4YRka9Vd+xzt7RqTtRx8N0C4Kwa+0wQ3YlbA3qQ7wyDCTObC/t3qVJZClxDXOx0yWdUxV5R3uSGiXdX4uqxMwy80bDJsjIMrrco0LkA+YKyXlCi9C4XTmqlmc21lh42WoFlm/NNHYoMK1XG5b8RQzc2oBWX8GKWqGl0bDEaF9eySLktF/BTAhzCIbyRxIkpDIl0FCq5hFKwDr0R4Cob7Vpj25srQ2sTuTN0R0CxjZdpH/l1Yz17YvxMweOHK3MWKzevvL09oFunCNDYxbvaYW/qjMNvIUmAQrtgEva30fVrESJ7HUXRLSVcuzECRwcNtZl8Ife/209aEkDRsmbgIlvrbKTVCVi8JQMjPO/zKWdrxlGhQb6UzAiLS4kLIoTHRE80R1pQu5TLFV4fQSLTdPVa18op2Tu0u7+AvWa7yam6EOYjw2X4IYVzdo9ZE75nRzW0WTJQbajAnS0gsLUUfNYyXDy3LclLsU95BPvOx0YTvTkjJd8RPL6dUvYTkr9YA9AYPLf6HZNwXEthxdpld4y3vPT71SBLg5AbPNR6NAlxs/W7m7MKW73jjdtyvbUl0g/+nVa/WxTco8An29rby7KtZhlelVuAWya1aL0hPdIWqJ1LgiLGJTImqZTl6VlXB2sd08k0Gsc368fF9DjzDjzjd3fiWm2ZWWMlQzAn4pFPSXKIEZxh9aWXvTM6b1V1WhfPERfK21u401wwfswxQIBr6AFbWxcxST25aTWvmq0ZTgq1FOwDNednQV4ROyGqh1HyEzLCojf/yAW7DwWgrJenp8VFnQIm0NAwiRyDqgmaMT22LdAxSOBeSdrCY3zWhO3WFMyFCAN9nFAg24DUGMDmA7BMBc57WQMaAny8P84Zsa1gzt5/Cg2GJL55Uu6Za+f5T+Pl/c6bG26Jv+G5heN/+mqenvM8WsTqiP2uqwHuuW8OnRcOp4aOsfTA24Doe7buS1/qeEkwi9roLA/mDCburFrujHLhPDnobNrt+nmew8AAFdCgsRYKfQiezSzgNymAFtmgF1WF51IOuIep0dMAkdYAiKiunPPjhxKgnYnu10wO71yQGRwAFUOO9/0O6DowGRoAH5jgU9liwzQO/1OYZoGPBXsM2QTuu5MKBs6IYKfwVEoS237BoOe64Gz54UkAHdK+5bQBXVw9VXawIQUImwcPJ3AKFbKKHx3pt7OvEUDwvk5JSbawIo6u8asKJ2gKIqGgAfv+3AwAUScd9cdQI7Cgk5egdJHwBLL5vkHvX/pxDzc64FEtFYOCONEjoJkVwHSgoJXd96/G4EHkD1NRwHHhAJHrAHV1qlozo4oQOeX+rGeDD3qf43cU8HZsoHez/pgJP3c9CmfSD4d983gC8HddoHiV/4++BhNLCqL1DHfe4Dikr3e2D2bw8V+qPouBatgfuMzxBYKyb5vl4RQu8HvnA0RUz5jv8QJTwD4I1ic3P4gSP1qcCfULFEVVUZEvREjFF8DBQlkXXQf7b5I2CW6Ryv+juxOqGOzM9eRYZimaKY52dDHBRAbRfUCn32V4zkT+Dq4UmrWTEgU31UbuQuDRLUEKJJw+/V/PLOCiFweQQjOJu3u2v/NREOs4JK/34NAkcBiEDwAClAEKoauLE8029943kN673/z3jA4U1I3B2TyiWz2TSmAgeGAZUIYAMJRSOAOJgGgEFAUY4qCAKAWVEAh8kAQQvwTiRSatfDcBAg9I3B0KUU2h3IHb7NLDCmtA2SIGQpLBgMfM0VaC0gOclAgRKJjpranP6UMq2mur7CKolKAfQxAHrGCIwEiDmMGKwJGCzstTU0ADD0Kta97S44rrkYGCgMJysiGDonEna7JKwpBFMLwxQ41J4BGsT4AfyGvrbGBtmf1uPrH/Hj/wOENQvOLi5Z/hw0gaWAmAEGAsAzVoYBJ0oDmqV4s4BSgALTVDRosYCWHCpaFv95mwNOhQgsyVwcwEJpzsIzI9dckulJUwx//QLi8Ak06NCeqYQWTapUB1IavWA5grNUh8NcMS5ZRXV0qgukZAIcchJWxYA885Y27ZGWK1ula3uKOYqlTtsbCNSpogcQAoUiMQhgkeoCgbAWe0LF7TFWAYIELASbuEEBQqy3ROtizqxVM+etriwPmRDAwgSnMg7LwKRy1NiMT43OmGAhQGmBNQCPe820M++poHsD76oXoAQsEiKcdbGHDCUDDK50LKSGDIrGcTpC7BJAXUwseXY9RLCAcQIEBCCLilA8gAR7rQhwUmAmcY7fwe/n9X0Rim5W9Ova98k/EWQRQAUXUBb/xWlrkCEGAXk8Jd0afYQUxX5iFNBCTDAFsAA00qRQ1j0pQHBBBQUiV9ltjhEw3wpzZQUbfjMOh9Z+cOnQ3UJO/ZeDjpCNEqBppBRYpJFHFomBgn8xyAMeYax22BW5MMPDcjAcwFEZhzx4GQZIghmmmEeuSIYAvXxImIA0shkkV1Xi+EMDZiF2xDA15vPTEARmcWCCkTEpCQBPRmjYhBnWAecKTdqhzgNbtkAOkDKWeGIWKdpGQ5falWWWAHQm16aorLziwEuGbHNmRwxc1xNHB7hIRoyDKOACY1kMYIZOjunhwAEPgcXSCJ/hmR8Q6x0X6otSyDEohGJISAYDjjzb/+yVNGF3TRanrpmCesa5tyIbWAzwoUfdjpruEELOIAivDQhABaumttqVMO48+aQMd8VQIZSQnNBGGwTglcICCRTAKrELrxvaaLUpe98qstGmoqZmXeEgjOiq2/Furoz0AMG/MqBjR/W+0FAZDkUSw68xPtILA4AFtqgDeWQSAAGstsxwnqQMwZdfbNYzmcWmsOuxxLA04AcV7sjb1Y1SxzMsAQhwa/C5/SazTFnbjATGAAU458Kc/yQtIxBpA0oj22t7prTcl7kyzE6eZlEtfwvF9WiP0MhAkRfMPMQJHObpsRDPZxTrJtBIt/m2sY7PXfmI+LXGxCU9AuQTbuNyrv/25E5InqlbcVue+pL3kYPCKA5sc7oO8JXhIt1wQ060b6irbnnpvf+cw4MsuEgzAbO+xfbvPhf19vLAJ/U89E/08KCZaBYQjZqi+6D8mN+DH/73uwc/vdzSmy9L9Xlwqu+nEavldu/i05/+3Ojb/7jweehabvYgci9+M8IfbwiYP7YY8IAC3F8KMras48HvY/hJoGYoqMDo0S+DGtwgBzvowQI1boFLu2AASWjC3lhwhA0b4Ak308IXciaFwUme/F4oQxjikGM5pCELbZjDHwIIiCWsTw1beEMhAvGIBdTTBGGoRCTi8IkxZKIKTyhFKBoRi23DHdI+6MX6NVGLYgz/FxZ5mLseVnGMajwjEs1IuTCmcY1yJFUZqQiKK0pwhnPcI/XqqL83xnGJfBykHZNYyD6iUY+EXGQUvujIR0IyTIekYyI5A4Ha8GACf2Lk9FqXAmRMkpMivKPuekMB9hDoW30Rpfmg0Yda/ZGVoyNdKXszmwJZQJbpe9C5VJWwYmDBHTrU5dDYGMjMiKZAECNm78zQgqiZSlZEZGb3eKdI4KyHPdSc3h5MNgIHQOQjl9vm7UhZxN7wKQCYImfq9hC1GCwDluNk55CMeU3gnKgC9OzdYVSlha9oQQYQyMAGTkmBCGRgmftcHSDv2ZsLBOACC/1hcfIZAA9MdIjqO2dv/yAQgE1m9IQaKNI6M+q8WgZHSSHFYQb6tFIX0pKjL53pEDaQhQ7Q9KQypSlPdXBKLIDUpNYEjpAiaVTw9bQzs+EAT3VaySTgMZRJXYpoVDpTp8JxCVGN5VTbksumDhWFMe3YVrvaU6wec4VkNStbERhWQVJSXWWd3lHratcMQg+tDoXqEjI3lLnmlZCAjas5n1rIlnghdCrwqywUW8+XDrYzkd2oPYk61hQ8Cg7iwAFjAzLZ1H02M6HlKiKzStlPFiwjOKnC2LAggEI4BCJgACcWbkE2L3jCeAtokBSq1BxW+VJhMBXqIEer1oZatrQrgEwJSlAObgCgHC87wWL/5/+RNAnATBZq0AoSAM2sGfd8gg1s+dLKxU+CCgCb+0LP6NCyLXEiAR6qw4Pcl4Bm1QsP3tQoPZ/YWaQ5No+gfatkL7uOaWy2HSl47mrKYTcV+KEQkjJXdoWgKDy8M4ILtQ9tO0EDCc2Asah5QoCnOT8CT1G5cwAWAcRwkxAB67UtiK0fcoJbf75Et/i98Hfyxl92/uaVykCAPDUlzsXSJVB3LHE5fYfiChqYBlVJwn8JG9Igq0YF20MtHX7UWrDsoiJW8fJD4OECVSGAVVIoAMIU9y++Ak+vybXyDPhF5SSX98pMAEQ445GMLjkHxNH9SEEuIZjDSJcYKlgGq3gVgKz/pePNUvWYnMWqYlGFV2nsosID+vCHQLgDxO1diR5yA0vGkWBYY4PSwXzcH9Le78mijTKmwaqET3mCCmKoxjUMkAzp4IXBKFFOsO9lFUYDoEJPicndJA1r8eZ5zlrVtK2TkDPXflIktChEdxIR42GzJDA0hgya1SyGW3XkWdOOs6wxU1Rq53S87I62pekcuWrvMdPVpDdctXrXf2cB33PU9yhpXe+9ttXeYyS4gA3eb2kn/NJDwG/6GG5i5B4c4hFf9xIoTpa3AQbGq4rTDa5tCJ0ME96VzTjLNw7njuMPOgteA+xITgMz0AnZdp6nk/ldYNO6/OUhGlzCTCCC+3KC/yRJJ0QBxCyHX2FbtyZ41RiSDhnYnUkZHRJUAyshdRU4IMmAgO5jB+zzFJs36Pv+OKtA+egFg0EQ5VBEASzhBzkQrLraW0OwdhHduAvTEHXfULPIUOQI/W/LKwAWkQ/h97L3fOUPb7nazysovz9FV5U4A0YQIYec7cy+UBKB5rEgz6XXdusef4roQTKNxox9NZCvXKUnb/vKj65Z1nmNmWdOE9m/geJzovDogTGpcPu+5l1BAfEXKx4A3EXnqf2xXNsdRKDjPvdZIPK/vjyC7swEJXh3s9SXPQLvz2BDYyiccLtehq+DZGNontVwY312KGM/+6P0OBQt3mSJ3x7a6f+f5fFfG5GX5P1c2g3g7KmR/xUTxgUg/i3gLK2RA6ac0Cng9U3g2uXbAUJgAiLcBl6gH53Y/c1a/okgz1WgBxYWCkpgCgYFwMngDGIBCzocCGocDKIUZFlfW4SWBW4gEO7gDQpgENDgEXqQDh4XD5qgu/2fEymh5a1U7eGghmVRFHIgEyJgEVqhFWFhFk5hD7rVA/6QEIqRGRqWwlUh9V0QGpLgVYnhmzyhD10ZEtqhmJAQFXIhG6bPBCQLDKiHQm2TG1Kg+ejhC6rgCXmAgTAiRm0YHSrQIZ7gCB5QOmFBSZETIYJhxcUh+VDiAVmKgRCXF7ZhJ6LFHJoQRGGBRE3/lCYWHCc2oQYy4Al5FFCNogm54idKYQ4KhxBxQAAwFT1d0pJoUv4MI6AUo/1IohOSIQ59iVWR0ykdhzoVxyqljzSmUjXmzzLKYiK+UHss1C1lwVfljzhiATnC4hYiYhd+IW8kUxYI4vS8IxbE47w1AQRowJJEQFDVBT4uiQb8CQYkCA8IZDvSSDaBowIhZCSCAgVUAEFFVAboE284JERugERao0dJwEhFgAdMJAbdYUhqUOqkEyamT0kyJCiYYwDgVG90QJG0pAr8YoHEZPM0oOrk0wnlZEo6QS1mAT9ihk/aogt8SYEAJdrcZOpAFCuS0FKW4ihkUzBiUxYkpAu0/xQWSGX0JKXleNRRmk9XPiUopBM08sZIYUE+yoBNYQFZ/tVWWg5bKhBcGuIptFQGzEhd0oBDBoBdeqIW5aJBbuISQJRJdoZNbUANzAZhepbcvI8pAmbkNWQFWGNwGFQNQIBkyuFp1AxiFF4pVJn7HRkZmIVoLkuwZERcgBMcmAwtQB+qNWP3iGRsflB9yGamvY1c8gZupgBa9qVyHFkMFOCZ4dkMIEz7fdzWXUEedIm0VJ3BGAALyEB5eIJDKJ4usuMbzmLn1NoCrsKV/FYYJB1DYEneaN4WcASojETokIEaXIJ1dMnfDco0/ErPbAIsJUADlIAeDCdD7eIKoiJS3v8bdxrZIDiI3gwdh8wXerFB2QxdjNmBuK3Zp3RJl8SEJWzdCqgDapCMcz7A5uhndv6nX16cVgYoUxyVQJyoTc7AtThLvTydllyDMxSIVCwDZrmm4XHCzChnQgjAS5SequmGyaSXN47owBVpW5bokarhkk5aCC2KoBDKfkwnOjjKlsTO2cwAPDxKVhiedCgnqAQCqnAoFRwaXkiTPBBpiGJnmu7DdjYcAMIpBmqnZjKLkzzLRnSEItSEApiEeVaCC7RW7w2dPE1ozgXe1gwKvBTJmQjXufDEdYJo3ZhmEzxK1hyNdVrIB0YgHxYiETYp87SJA0wfEWBFpI7gA3AEfhL/AW3FxZn8pg5UarJRV6wSARlYaohCAc28XRAwWWDyIps+W5x+qmNuo5xehQEMS2MCQdLhzavKyazuKhCkan/2ogp0iSfVSQumIbAuoToGq+mI6KQtgwH4irC4xMlhGx94QTV4gqtiy0NwB7Akw6MgQL0ug6LKBL1Sgnjoq86oym/ea/wZJzvmah4gW3CFgeaJB3OsCjBBRNVtZv39KqTyKv/9jmUEZ9F45Wmtqa+qAHS41jJswxUghDrEh9mARRecQ7yczJk4gMjShAM8ikwEbBegwKMYBljg7IvAysnAU7R2wcD+WK4G0xp815uZwQMwJzJIE9zVQuDxpwuKDr1A/99LVCfKSOylAZTOcOYqTMxs1COTakZw1gDZKumbph84BUORmEqRuM64FEiqgNnbuazLrkMg7GrNQmsygJMAxKrNjgTUpkDAdqoLPchGcEeB8MIAzMxBNIvfqa0AlJ5r1uYGZaEgXII7jMTAKkq1DpXh4UDGykBHgguowsKIKUaSme3HHeiwpukDNADPICvMLlZAycCZvAQnlAtYMEfMwqzL0qrext3b9e3fnkDgBg7QBoDQem7ZXavTMKiFlId61WkKWMfgloGgNq/ZqcDmwm6aCQLCdm7W0hnousbIjW+1VgqKOKkroG6t+kNnGusr2sovzEWtIFbfFUijUlc8nP9EsNAWJcSrd6zDSwSsSeAt3+rs2wHuww7G/soq85LvFnXX0O0uARMOdniDTCgAQOFMeHKqm7qeAwgACZvK0aYvBVfW1iZGpKXwkhQlDfIB1C7DblndoCTE1RBw99KMHzjuDasBfKCbOsDW0pGAg8pAeDJs2XwZGAwOa04wpr4CYBzfHoZw2bqR6ohCj4JvAwTCfqXwxc6A+bYaBk9NcpTIVV4inmwu6fUofArCx24DdJrvIFgFogHeCnAfKOlaIcwdDOQdFltwBWupO/TdsESxqcKClowq5W3vEayuFA/h06jXQyxAhmFt1CKX+TIb9Bkoz32LNjEPYXzBfUpukfT/2o5IRJFF7pNObhpMwyOch3txHgyAntDKr7O8svldcSIboJpeqhZnqdXGjj998iNr66BCAkewWSbXn2xUQNhynCEYQB5UA6v0XtJWjSu7JvamQbAd2jTwMZq0gIMZwdn4y9BNaQNZs2DwMjKjrVsqMrgKcyx+q1QZDe94zTZD7MnQTNNxszx5MAmIGwgfxhCvBvgBsptlmcFQgniycz8vbqr1sibbg93SgM2mAu1yLLfSM/dq6jQnM4B6jMiY7itCRzp4yHYcQd+eGUtndP+aAkfngCUTbGbaY0h3tLCetCEVkkunwS3AdBNg9Axo9CnQNA7Y9NDidAl66/yK9Jye/6GcdgHB5FqBLABizasX1Kv/Ypu7dge8RmcwUZc/0dwTq8MCaEcBdChEAEbZCE54KIPxKEC/iod2DLVFd0Vt0hWxnu1Ot+nCyangcLDdwizJzqwX2C1gPICrLsMIAG8WkDADn4DdxodLW4TNmkH2PCzuPigDwCzZZLUW7OznLDU8a6FOQzVgk5Fo9Wpgw9oChN3cEjHb0qpGg9Nk+y3d5rX/roHN4jUWPIBL2yywZAHyViryiuwyxG2suvRp+/I+ceM9U7dff8ZrU4VlaLcMwEvXIYTBeoG6vsRiVzbvhndRn1yGljeo9K0jLG8XSAVyvx279i7ZyJNzB8tDFJleQ/9Win6GfwPFVr3aKRZSjxatenFEVi/dbp8KbZnzWQ/OqL41JTDf/qptzah1FhDDw8bqzO7rXG8Lfp9Db/8lZGZgU7sA1YopwoanmlEdysqWoo2ddhiyxujMJU/rE4tNmYEBHZzJhoQZbsmqkHs0xbaFS/em/hnXZK2Cu7QAvBytCriwMCByfUo5GDxD3aUMdsVeFNzLoB2xhzCEJBRahD3f1fI3MNcFkhN4xOnmkh9TyIyMc3hTGQfUO0c0kj3ACOiL9HrKFnSBJjyF4TEOpBwoSoCs7Rp5RUNhxIHlPPtgWjXNFFSDMkRvJ++eGOSn4MlTe1K5PGFPNCAq5vkCMBj/2yF03jM832vSrzyblVNC+hj+6oNdrzGjWzPjeeI4sAMo2rLU+AOtdM1kwZiPm+ylOhjg9fFt9xAQbnC4q2qv1E4Wuaw7sj28rypg92qruQs0uxJoNK2yBlggr90iL7XyFEpOO4qvIT5saWPBdrfqQLcnwVFLqjihN7wn1UKme5JbsU/f83Mv7wHrqoKfq76mWYG81vbd66OcH2+na+1igTp02MpGl3NgdaUzgJZIcJq/1DxWzKKre7+Xobb7dnQF/NuRjcIcthQkduxonTtodMBaRMZYNqp5dnq/SGPnd6jBdKVTQhUz+jatJDpGN7VvahSRPMCD9qNxtD9FPK0a/8RxxzxvJ4ABbENwyzS94/Z2uGulY3Sl68iqS3I0ohI1BsBkcvwkVvsOJT1LP8TSJ0PKY6/LF/An5XeHwLfWvYSDnsmQ0sSpkLfOr4HX226laxkUx7owYlIKJCNqi3w39h/Ju4HOvL3AH3f+MvjghoclIzDhghMiO337+ZPEH3jXa26CV7px+33QAxmrHz0CVW7sIwnJd2xX1QOcP2Z1/3LE3f4Q5n48C/bG9f5O/f62+3vCDf+2Fn/i08hznsnb/qyB0x/zP+LYy87yt7pRx21MQ78TsHm/yHRGNMCjKMzMToMZlLDgGv8tgjy/Yz+k0zv3A0X8Y2g82b3PRldjV//5X58VCADiSAbkiabqyran6cbyTNf2jed6STfBQ0IEfAGBIIBEPAKIJqEIeDJGS4QhQBA5kNCjYBEwPA2MY5K1MBiEwBxsB4/L57t3yk7P8/T8vv/Ph9dChOQAIDQwEAbgA7SUVKWARbLUAJBQdGT49OAFZgBwZNnYIiqqIwiouqqaOuLKegMbS1tr69bzExTA8MmoWzlSMKRLNRQa4EC65eC5GEzKMsxlsIB7i51dMzurvdLtHS6+Ck4SLSLUu+hzABAsYlZwEvxklBz14wwKHdC+oijvl4Br4wp642YwRrmEDBtuy8UFwSFevhhcUXJMRBoolMIgSaAFiYGB+tz/HbPIZIUPQyYDynIIkxyLhQVpxryJ0yacNKDmZcQpQidQFVyKGj2KNKnSpUyRzBz6CqrUqUJ1aELxbmjVqUG5EqXqNSzMrWLnkAVbNqrUs2nbmnV7iy1UudogQOgKYMLdnHD7xvVLiy5QwdgoBJAQIUAECRUoDAYMWWbkVpNREMZmwagFrZU757ns+UVovGIxGN3Ld7RqHKBXt3b4upYHLhLmrr69ranu3bx7+/7dVHVsWomRaLCNO7ny5X6G06oQIMNa5tSrW7fhPFaHABemX/8OPjyA7KwgBHCMXLz69bfJs8KAlr38+ZHdr7dPP7/+P/jF998PYIB1sAZcgQYe/4ggFy38J2CDDirEGn3dMPhghRaqhZ2EC17IYYeUvTTfhB6OSOJbIMonYokqrvjQieylyGKMMt4RIWQCZBEHjDPuKONWNiEwEBhB8mLWADYQMNAIN8qhI49OlugjDcq4Y4AlD/TEpJE7LJnjhk9+SWKUM1wJQDOgTBnPFNMUMAUTSPgjAgNCDIEJEgqkqYgiB5iBwBRIIoNEFlsg0WaSMzQJZqIPijkDGX0+KoBFU0wpjCFduBSKRK8YKWmZDSgyEANEJpAFkqIauWQxQRkqA6KKvgogozI0IMCZRyxwQFEFLFBnACAFYOQBmCrgAwLtAAtArlwUoIgIwoowgDxIPv8bShYCDJOANS7SCGu3AcoaQ61WrgFAp84GYA0CvwaLqZLy6GIuAM2WS2QDpUZaL44iGNCOui1+423A+oHrgqhDsmSGrwrMWcC6yWKacDt13slFAvMC2mcUA9WJAAEbMbEAGAr8+5XAJr9Y42gP6Huolye/DB7B/rkMc83UyRyeqzbvLFzKKD/Fc9Dt+czcACBxC7DQSoeGc6tavvA01HUYeXGyR50CQAEDGbUwqQTAiWHJS49dH9FZNhc1Cn+GokY7Wo8HdtbIWkYz2Xa7RTAB0+gdxshrtpmIm2T0qsDf4wUuBBkkKOtrKAUMgwCvXOSawtrX1rrA2/2M0HXHcY//V/fdooeVdxa5Gvl2pYfnGYXDJBRgaeBGEnD0CbkucK0CaRxLtQl1Hm35rgYkoDkXSRotdvKjLx8fySL8OS+Skn+0OgwJODx948DOe/3icwZwJ44F8C5vKsEDuvXnSa/PfPucbatx+c8LcPsh63L/KxD1+7u99bVnbYglhE8E4xsPEKo2gvPJLX0tA5r7HniTvA0kegJYGBIaVj0RdG9iDLuf/0gQD/BxqYB1opzaknStczGwVaGDoAtrYraZOfCFNBxH076jsxrqsBY3vE4OdwjED2UoRC0MohH5E8OcFfGITPxMEmO2xCZKEQ49tM4Pp4hF+LGQiDPMohcJkpsE/4lxjGQ0ShS/iMYzpud9aWxjA9tCIVS4cY4Qwlvz6IhH0djRO3nsY9jKEkcw+jGPgXQiHwdJyLJQYC8wgAB6IohIPxYSDubhgGk0wIHzPCaSiSxLZoqymU1yko6ThINpijIBNo7SjaWEQwZos8ZVprGVOyiOYmIpyy/SUgcUgI50cJnLLO5SB9vpDjCDOcVh5sA8qBElMr2ozBxE4I7PTOarollNHmFzNNvMZo9sWMYC8dCbwrThQcZJTmuKY5L/6WY6VURLdqLznUyM5zkDQ88m2lMb7cxnPc1JAy4xaZ7+BOI+obWstMGDZVQkaEF1eNDyjcwBmjqBQLuEz4caFP+gCB1ZAyxhwcYtqVftIMCcQHKAK0CBCJHbQyzcqVELRVQRgfIoSBRAhosmQCIEsISoGEAAlmQqXazqZ0whylGJptRvRdmTtVQqrST1YwBCIAADetW4PwrxqC+cKfjKFLkG/O9GkgCCA6JqkpGJQKwCaCndMsrVriZVEWolAAFCKsJSXVBaxsNHANj0ize5lBUwjauAIqqDtTlvq4Z1H2JzoFgaGLWxD3ysQxlL2eVZFq6EzWxlk/oXznp2dJt96WVHa7fSdla0qE0tOMP5m9O2dmmF3eIxZyu02tbxtrjlmW5d8FvS9HZswe1iaoZLXLgUt7jIvZlyqdncnTFXecf/jW7Qpos0VVpXus895HZtht238va7ASMLbM+L3t4Yl7wnM6+G2Mfel7mXi9SNr8Dmi6L12tdb+P1Zfffbrf7eR78AvqYg1YOQAptMJxBIJejy0szqNBgvehHBIvHiSAUHuAaGQYxiJKDJ73Q4MYsJsWEsGQAMZPKRGk6UUD7JhVCCB8ZIkDEAaBwAG7cYTEKZgFEcDB4fo5IEp+QCfHasqKqAGAm1Uc+SD4OC2SDBA0g2sA1sOU31YBkFW66yi3EAnQrIJ8wqILOXv3yDC3BHPmo2Jgq204Ezo9kGzJRPnVNwZzk/iSxHlk+fU5BlPe9Z0ISWbKFxm95EK9o35Fg0/6MP7d1vSQa0kIbkoia9zkqPl75IhKGmnXlYTIcjvHq+zEXNgA+GpsU9wyS1nPEwjb7OIFUDAIORrqStHFxUBmtTrCSMAhBrkMqvSIgaq1MwKF/lGrOfbkgqECgDgYpqoXDYdQwiiwIuAQQkw6bdfw1JCQOMTE5qFXWznZ0CCurtbWloAzy4kAVg7W1yeAJWP9I0njkd4NdZBQC/I6eIxDGAcQfAdrUQerpu/2+wzcGKAaI27KwdS1gWi7W/T6oxvUU8qOI9N2zSDQOTjuxZ1IoTsmg9ryV1ShmgKpfipnSpg6egrKzzdq8ryIWRaRt8GtdroPQIiFS0NQwbE9+xLP8BAAMYolli9TcZRO5v8Emi3Fr1uEGeHfIkpYGqYKMWymGwJMb9dV5ifxe7ZD4CoE4Of/FrOwhxRFdRTcLb2W34CizygIgXEFlTl1+s+6FYJDlg4cK1ekKwPj8lWeEEP2VEvANH7XjNK16He1imTrBTAIDhAGznuNuVBPevYqJUhC98HwQhgGy5fAApHAC/Kp90kpig6Qk0VLQU13HDXx3kidcIR0jAscenHEcJs9gbil/5Z6Gkdq7/61Q/qKyCs4raEo066b9NB0FQta+FY8Lr56asYVw855HtGPZ1nw2buH7ZzmU2DlLYgq2fH/2hlQEChGpFc9vADA93AUXhS39To1Yhx+ZpAUhpsaJ/6WeABdggBHiAC1h/DZiA2OBqZ1aBCuh+FAiB6+RoHeiBRdFoHxgcG0iCJWiCJ4iCKaiCK8iCLeiCLwiDMSiDM0iDNWgLIQAAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     6-MP: 6-mercaptopurine; AZA: azathioprine; anti-TNF: anti-tumor necrosis factor agents.",
"     <br/>",
"     * Infliximab or other approved anti-TNF therapy.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_19_23871=[""].join("\n");
var outline_f23_19_23871=null;
